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GLOBAL ANALYSIS REVEALS DIFFERENTIAL REGULATION OF MRNA DECAY IN 
HUMAN INDUCED PLURIPOTENT STEM CELLS 
 
 Induced Pluripotent Stem (iPS) cells are able to proliferate indefinitely while maintaining the 
capacity for unlimited differentiation and these properties are reflected by global changes in gene 
expression required for reprogramming of differentiated cells.  Although the rate of transcription is an 
important regulator of steady-state mRNA levels, mRNA decay also plays a significant role in modulating 
the expression of cell-specific genes.  The contribution of regulated mRNA decay towards establishing 
and maintaining pluripotency is largely unknown.  To address this, we sought to determine global mRNA 
decay rates in iPS cells and the genetically-matched fibroblasts (HFFs) they were derived from.  Using a 
microarray based approach, we determined half-lives for 5,481 mRNAs in both cell lines and identified 
three classes of mRNAs whose decay is differentially regulated in iPS cells compared to HFFs.          
 We found that replication-dependent histone mRNAs are more abundant and more stable in iPS 
cells, resulting in increased histone protein abundances.  This up-regulation of histone expression may 
facilitate the unique chromatin dynamics of pluripotent cells.  A large set of C2H2 ZNF mRNAs are also 
stabilized in iPS cells compared to HFFs, possibly through reduced expression of miRNAs that target their 
coding regions.  As many of these mRNAs encode transcriptional repressors, stabilization of these 
transcripts may support the overall increased expression of C2H2 ZNF transcription factors in early 
embryogenesis.  Finally, we found that mRNAs containing C-rich elements in their 3’UTR are destabilized 
in iPS cells compared to HFFs and many of these mRNAs encode factors important for development.  
Interestingly, we also identified the Poly(C)-Binding Protein (PCBP) family as differentially regulated in 
iPS cells and investigated their possible involvement in regulation of the mRNAs in our dataset identified 
as destabilized in iPS cells and having C-rich 3’UTR elements.     
iii 
 
 Thus, we identified several interesting classes of mRNAs whose decay is differentially regulated 
in iPS cells compared to HFFs and our results highlight the importance of post-transcriptional control in 
stem cell gene expression.  Coordinated control of mRNA decay is evident in pluripotency and 
characterization of the mechanisms involved would further contribute to our limited understanding of 
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Chapter	  1:	  Introduction	  	  
	  
	  
	   	  
	   Pluripotent	  stem	  cells	  are	  a	  unique	  cell	  type	  that	  can	  proliferate	  indefinitely	  and	  undergo	  
unrestricted	  differentiation	  (Thomson	  et	  al.,	  1998;	  Till	  and	  McCulloch,	  1961).	  	  As	  stem	  cells	  progress	  
towards	  differentiation,	  global	  changes	  in	  gene	  expression	  occur	  wherein	  distinct	  gene	  sets	  are	  up-­‐	  or	  
down-­‐regulated	  to	  support	  a	  lineage-­‐specific	  phenotype.	  	  DNA	  expression	  arrays	  have	  allowed	  genome-­‐
wide	  profiling	  of	  changes	  in	  gene	  expression	  upon	  differentiation	  into	  a	  number	  of	  cell	  types	  including	  
adipocytes	  (Gerhold	  et	  al.,	  2002;	  Jessen	  and	  Stevens,	  2002),	  myoblasts	  (Moran	  et	  al.,	  2002),	  and	  neurons	  
(Loring	  et	  al.,	  2001).	  	  These	  analyses	  have	  identified	  several	  transcription	  factors	  whose	  expression	  can	  
be	  manipulated	  to	  perform	  directed	  differentiation	  (Irion	  et	  al.,	  2008).	  	  In	  2007,	  human	  adult	  somatic	  
fibroblasts	  were	  reprogrammed	  back	  to	  an	  undifferentiated	  state	  using	  retrovirus-­‐mediated	  transfection	  
of	  pluripotency	  transcription	  factors	  OCT3/4,	  KLF4,	  SOX2,	  and	  MYC,	  generating	  Induced	  Pluripotent	  
Stem	  (iPS)	  cells	  (Takahashi	  et	  al.,	  2007).	  	  Expression	  of	  these	  four	  transcription	  factors	  is	  sufficient	  to	  
coordinately	  regulate	  the	  global	  changes	  necessary	  to	  achieve	  a	  pluripotent	  state.	  	  However,	  more	  
recent	  studies	  indicate	  that	  post-­‐transcriptional	  mechanisms,	  including	  mRNA	  decay,	  are	  also	  important	  
for	  establishing	  stem	  cell	  gene	  expression	  (Porciuncula	  et	  al.,	  2013;	  Qin	  et	  al.,	  2012;	  Richards	  et	  al.,	  
2004;	  Shibayama	  et	  al.,	  2009;	  Wang	  et	  al.,	  2013).	  	  As	  a	  prelude	  to	  discussion	  of	  the	  contribution	  of	  
mRNA	  stability	  to	  gene	  expression,	  general	  features	  of	  the	  typical	  mRNA	  life	  cycle	  are	  presented	  below,	  
giving	  particular	  emphasis	  to	  mRNA	  decay	  and	  the	  factors	  and	  enzymes	  important	  for	  regulated	  
transcript	  degradation.	  	  	  
	  
1.1	  The	  typical	  mRNA	  life	  cycle	  
	   The	  life	  of	  an	  mRNA	  begins	  with	  transcription	  in	  the	  nucleus	  and	  continues	  through	  several	  
processing	  steps	  before	  reaching	  its	  mature,	  translatable	  form	  in	  the	  cytoplasm.	  	  While	  the	  lifecycle	  
2	  
	  
dynamics	  of	  individual	  mRNAs	  can	  have	  distinguishing	  characteristics,	  the	  general	  processes	  from	  
synthesis	  to	  degradation	  are	  largely	  universal	  for	  eukaryotic	  mRNAs.	  
	  
1.1.1	  Transcription	  	  
	   In	  eukaryotic	  cells,	  genetic	  information	  encoded	  in	  DNA	  is	  transcribed	  into	  mRNA	  when	  RNA	  
Polymerase	  II	  (Pol	  II)	  binds	  the	  promoter	  region	  of	  a	  gene	  to	  form	  a	  preinitiation	  complex	  including	  
several	  general	  and	  specific	  transcription	  factors	  (Murakami	  et	  al.,	  2013;	  Safer	  et	  al.,	  1985).	  	  Binding	  of	  
the	  preinitiation	  complex	  activates	  a	  conformational	  change	  in	  DNA	  structure	  necessary	  for	  transcription	  
to	  proceed	  (Wilson	  and	  Spillman,	  1982).	  	  Chromatin	  remodeling	  factors	  and	  helicases	  unwind	  the	  DNA	  
duplex	  allowing	  Pol	  II	  access	  to	  the	  first	  two	  nucleotides	  of	  the	  template	  strand	  followed	  by	  formation	  of	  
a	  highly	  efficient	  elongation	  complex	  (Kettenberger	  et	  al.,	  2004).	  	  Elongation	  of	  nascent	  RNAs	  continues	  
in	  short	  bursts	  (Rajala	  et	  al.,	  2010)	  through	  the	  3’	  Untranslated	  Region	  (UTR)	  until	  termination	  is	  signaled	  
by	  a	  mechanism	  coupled	  with	  cleavage	  and	  polyadenylation	  (McCracken	  et	  al.,	  1997;	  Whitelaw	  and	  
Proudfoot,	  1986).	  	  
	  
1.1.2	  Capping	  
	   The	  5’	  end	  of	  nascent	  RNAs	  undergoes	  co-­‐transcriptional	  enzymatic	  events	  to	  add	  an	  inverted	  7-­‐
methylguanosine	  (m7G)	  residue	  that	  protects	  the	  transcript	  from	  5’3’	  exonuclease	  XRN1	  (Hsu	  and	  
Stevens,	  1993)	  and	  interacts	  with	  additional	  proteins	  to	  influence	  translation	  and	  decay	  processes	  
(Topisirovic	  et	  al.,	  2011).	  	  The	  cap	  also	  interacts	  with	  nuclear	  Cap-­‐Binding	  Proteins	  80/20	  (CBP80/20)	  to	  
influence	  pre-­‐mRNA	  splicing	  (Izaurralde	  et	  al.,	  1994),	  export	  to	  the	  cytoplasm	  (Izaurralde	  et	  al.,	  1995),	  





1.1.3	  Splicing	  	  
	   Pre-­‐mRNAs	  contain	  regions	  of	  sequence	  that	  will	  constitute	  the	  mature	  message	  that	  are	  
frequently,	  with	  rare	  exceptions,	  interspersed	  with	  non-­‐coding	  introns	  that	  must	  be	  spliced	  out.	  	  Splicing	  
takes	  place	  co-­‐transcriptionally	  in	  the	  nucleus	  and	  is	  performed	  by	  a	  large	  complex	  known	  as	  the	  
splicesome	  (Nilsen,	  2003).	  	  The	  splicesome	  recognizes	  conserved	  splice	  sites	  flanking	  regions	  to	  be	  
removed	  from	  the	  message	  and	  two	  nucleophilic	  attacks	  are	  then	  carried	  out	  to	  remove	  the	  intron	  and	  
join	  the	  two	  exons	  (Inoue	  et	  al.,	  1986;	  Query	  et	  al.,	  1994).	  	  At	  that	  point,	  a	  large	  multi-­‐protein	  complex	  
known	  as	  the	  Exon-­‐Junction	  Complex	  (EJC)	  is	  deposited	  upstream	  of	  the	  splice	  site	  and	  acts	  as	  a	  mark	  of	  
successful	  processing	  recognized	  by	  mRNA	  surveillance	  machinery	  in	  the	  nucleus	  and	  cytoplasm	  (Le	  Hir	  
et	  al.,	  2001;	  Palacios	  et	  al.,	  2004).	  	  Exons	  may	  be	  alternatively	  spliced,	  increasing	  the	  number	  of	  proteins	  
that	  can	  be	  encoded	  by	  a	  single	  gene.	  	  These	  splicing	  patterns	  can	  include	  or	  exclude	  entire	  exons	  or	  
portions	  of	  individual	  exons.	  	  The	  differences	  in	  function	  performed	  by	  protein	  isoforms	  compared	  to	  
their	  standard	  counterparts	  can	  range	  from	  subtle	  to	  dramatic	  and	  their	  expression	  is	  determined	  by	  an	  
array	  of	  factors	  that	  influence	  splice	  site	  choice	  (Imamura	  et	  al.,	  2010;	  Martemyanov	  et	  al.,	  2008;	  Mott	  
and	  Pak,	  2012).	  	  Splicing	  patterns	  of	  several	  genes	  are	  altered	  in	  embryonic	  stem	  (ES)	  cells	  compared	  to	  
cardiac	  precursor	  cells	  (Salomonis	  et	  al.,	  2009),	  although	  mechanisms	  leading	  to	  splice	  site	  selection	  are	  
unknown.	  	  	  
	  
1.1.4	  Cleavage	  and	  polyadenylation	  	  
	   Processing	  of	  the	  3’	  end	  of	  nascent	  mRNAs	  coincides	  with	  transcription	  termination	  and	  is	  the	  
final	  step	  of	  maturation	  prior	  to	  export	  from	  the	  nucleus.	  	  Following	  transcription	  of	  the	  coding	  region,	  
RNA	  Pol	  II	  continues	  to	  transcribe	  the	  3’UTR	  encoding	  cleavage	  and	  polyadenylation	  signals	  (Montell	  et	  
al.,	  1983;	  Zarkower	  et	  al.,	  1986).	  	  A	  conserved	  AAUAAA	  sequence	  and	  Downstream	  Element	  (DSE)	  bind	  
Cleavage	  and	  Polyadenylation	  Specificity	  Factor	  (CPSF;	  Murthy	  and	  Manley,	  1992),	  Cleavage	  Stimulation	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Factor	  (CstF),	  and	  Cleavage	  Factors	  I	  and	  II	  (CFI	  and	  CFII;	  Takagaki	  et	  al.,	  1989).	  	  Poly(A)	  Polymerase	  (PAP)	  
is	  recruited	  to	  the	  site	  of	  cleavage	  and	  adds	  150-­‐200	  adenosine	  nucleotides	  (Bardwell	  et	  al.,	  1990;	  
Sheets	  and	  Wickens,	  1989).	  	  Several	  mRNAs	  in	  stem	  cells	  exhibit	  differential	  poly(A)	  tail	  status	  compared	  
to	  differentiated	  cells,	  being	  either	  polyadenylated	  or	  non-­‐adenylated,	  although	  the	  mechanisms	  
governing	  mRNA	  poly(A)	  tail	  status	  are	  unknown	  (Yang	  et	  al.,	  2011).	  	  
	   	  
1.1.5	  Export	  and	  translation	  
	   mRNAs	  must	  be	  exported	  from	  the	  nucleus	  once	  they	  have	  reached	  maturation.	  	  Exit	  occurs	  
through	  a	  bidirectional	  channel	  known	  as	  the	  Nuclear	  Pore	  Complex	  (NPC)	  that	  allows	  the	  passage	  of	  
various	  macromolecules	  (Mattaj	  and	  Englmeier,	  1998).	  	  The	  mRNA	  is	  heavily	  decorated	  with	  proteins	  by	  
the	  time	  it	  has	  completed	  processing	  and	  many	  of	  these	  proteins	  act	  as	  marks	  of	  quality	  assurance	  that	  
classify	  transcripts	  appropriate	  for	  export	  and	  translation	  (Schmid	  and	  Jensen,	  2010).	  	  Spliced	  transcripts	  
are	  exported	  from	  the	  nucleus	  more	  efficiently	  than	  unspliced	  mRNAs,	  suggesting	  that	  mRNA	  export	  and	  
splicing	  are	  somehow	  linked	  (Valencia	  et	  al.,	  2008).	  	  In	  the	  cytoplasm,	  the	  cap	  of	  mRNAs	  is	  bound	  by	  
Eukaryotic	  Translation	  Initiation	  Factor	  4E	  (eIF4E).	  	  An	  interaction	  between	  eIF4E	  and	  Cytoplasmic	  
Poly(A)-­‐Binding	  Protein	  (PABPC)	  on	  the	  poly(A)	  tail	  bridged	  by	  eIF4G	  leads	  to	  transcript	  circularization	  
and	  stabilization	  that	  stimulates	  translation	  (Figure	  1.11;	  Wells	  et	  al.,	  1998).	  	  Ribosomes	  assemble	  on	  the	  
mRNA	  and	  synthesize	  nascent	  peptides	  until	  a	  stop	  codon	  signifying	  translation	  termination	  is	  reached	  
(Bienz	  et	  al.,	  1981).	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Figures	  presented	  in	  Chapter	  1	  were	  adapted	  from	  those	  that	  appeared	  in:	  Neff	  et	  al.	  mRNA	  stability.	  




Figure	  1.1	  Closed-­‐loop	  conformation	  of	  mRNA.	  	  Circularization	  of	  mRNAs	  are	  formed	  by	  an	  
interaction	  between	  PABPC	  on	  the	  3’	  poly(A)	  tail	  and	  eIF4E	  on	  the	  5’	  cap	  bridged	  by	  eIF4G	  











1.1.6	  mRNA	  decay	   	  
	   Most	  eukaryotic	  mRNA	  decay	  occurs	  through	  the	  deadenylation-­‐dependent	  pathway	  resulting	  in	  
either	  5’3’	  or	  3’5’	  degradation	  (Figure	  1.2).	  	  This	  process	  is	  initiated	  by	  removal	  of	  the	  poly(A)	  tail	  
which	  serves	  to	  disrupt	  the	  closed-­‐loop	  formation	  and	  render	  mRNA	  vulnerable	  to	  exonucleolytic	  
activities	  of	  XRN1	  in	  the	  5’3’	  direction	  or	  in	  the	  3’5’	  direction	  by	  the	  exosome	  or	  by	  DIS3L2	  (Malecki	  
et	  al.,	  2013).	  	  Several	  decay	  factors	  and	  enzymes	  are	  involved	  in	  the	  degradation	  of	  cellular	  transcripts	  














Figure	  1.2	  Deadenylation-­‐dependent	  pathway	  of	  mRNA	  decay	  in	  eukaryotic	  cells.	  	  Decay	  is	  initiated	  upon	  
removal	  of	  the	  poly(A)	  tail	  by	  a	  deadenylase.	  	  In	  5’3’	  decay,	  LSM1-­‐7/PAT1	  recruits	  the	  decapping	  complex	  
DCP1/2,	  leaving	  the	  mRNA	  susceptible	  to	  decay	  by	  XRN1.	  	  In	  exosome-­‐mediated	  decay,	  the	  exosome	  degrades	  














1.1.6.1	  Deadenylation	  	  
	   Rapid	  shortening	  of	  the	  poly(A)	  tail	  is	  performed	  in	  a	  controlled	  manner	  by	  deadenylases	  that	  
hydrolyze	  adenosine	  nucleotides	  in	  a	  Mg2+-­‐dependent	  fashion	  releasing	  5’-­‐AMP	  as	  the	  product	  (Beese	  
and	  Steitz,	  1991).	  	  The	  mammalian	  deadenylases	  identified	  to	  date	  include	  Poly(A)-­‐specific	  Ribonuclease	  
(PARN;	  Copeland	  and	  Wormington,	  2001),	  PAN2	  (Boeck	  et	  al.,	  1996),	  and	  CCR4-­‐NOT	  subunits	  CNOT7	  
and	  CNOT8	  (Bianchin	  et	  al.,	  2005;	  Daugeron	  et	  al.,	  2001)	  which	  are	  members	  of	  the	  RNase	  D	  
deadenylase	  superfamily.	  	  RNase	  D-­‐type	  proteins	  are	  in	  the	  DEDD	  superfamily	  that	  share	  three	  sequence	  
motifs	  containing	  four	  invariant	  Asp	  and	  Glu	  amino	  acids	  surrounded	  by	  a	  region	  of	  conserved	  residues.	  	  
The	  activity	  of	  these	  nucleases	  is	  catalyzed	  by	  a	  mechanism	  involving	  two	  metal	  ions	  (Steitz	  and	  Steitz,	  
1993).	  	  CCR4-­‐NOT	  subunits	  CNOT6,	  CNOT6L	  (Mittal	  et	  al.,	  2011),	  2’	  phosphodiesterase	  (2’PDE;	  Rorbach	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et	  al.,	  2011),	  Angel	  (Dupressoir	  et	  al.,	  2001),	  and	  Nocturnin	  (Baggs	  and	  Green,	  2003)	  deadenylases	  make	  
up	  the	  Exonuclease-­‐Endonuclease-­‐Phosphatase	  (EEP)	  superfamily	  (Zuo	  and	  Deutscher,	  2001).	  	  EEP-­‐type	  
deadenylases	  are	  related	  through	  conserved	  catalytic	  Asp	  and	  His	  residues	  within	  their	  exonuclease	  
domains.	  	  These	  proteins	  are	  thought	  to	  have	  at	  least	  some	  functional	  redundancy	  as	  individual	  
knockdown	  studies	  show	  little	  effect	  on	  cell	  viability	  (Mittal	  et	  al.,	  2011;	  Wahle	  and	  Winkler,	  2013).	  	  	  
	   When	  mRNA	  is	  in	  a	  circular	  configuration,	  deadenylase	  PARN	  is	  blocked	  from	  gaining	  access	  to	  
the	  poly(A)	  tail	  and	  5’	  cap	  due	  to	  inhibition	  by	  eIF4E	  in	  the	  translation	  initiation	  complex	  (Ramirez	  et	  al.,	  
2002).	  	  Upon	  removal	  of	  this	  complex,	  an	  interaction	  with	  the	  5’	  cap	  stimulates	  PARN	  activity	  leading	  to	  
removal	  of	  the	  poly(A)	  tail.	  	  PARN	  is	  the	  only	  deadenylase	  able	  to	  interact	  with	  both	  mRNA	  termini	  to	  
influence	  tail	  shortening	  (Wu	  et	  al.,	  2005).	  	  PARN	  has	  an	  important	  role	  in	  maintaining	  particular	  poly(A)	  
tail	  lengths	  during	  early	  development	  where	  mRNAs	  are	  kept	  translationally	  silent	  until	  polyadenylation	  
and	  translation	  are	  induced	  (Copeland	  and	  Wormington,	  2001).	  	  This	  status	  is	  maintained	  through	  an	  
interaction	  between	  PARN	  and	  Cytoplasmic	  Polyadenylation	  Element	  Binding	  protein	  CPEB	  that	  
becomes	  disrupted	  upon	  maturation	  (Kim	  and	  Richter,	  2006).	  	  Although	  PARN	  appears	  to	  have	  a	  major	  
role	  in	  higher	  eukaryotes,	  homologs	  do	  not	  exist	  in	  either	  Saccharomyces	  cerevisiae	  (Collart,	  2003;	  
Daugeron	  et	  al.,	  2001;	  Tucker	  et	  al.,	  2001)	  or	  Drosophila	  melanogaster	  (Grönke	  et	  al.,	  2009;	  Temme	  et	  
al.,	  2010).	  	  	  	  	  	  
	   PAN2	  functions	  as	  a	  dimer	  with	  PAN3	  to	  trim	  the	  lengths	  of	  nascent	  mRNAs	  from	  lengths	  of	  
approximately	  200	  nucleotides	  to	  about	  30	  nucleotides	  (Uchida	  et	  al.,	  2004).	  	  Like	  CCR4-­‐NOT	  function,	  
PAN2	  activity	  is	  stimulated	  by	  the	  presence	  of	  PABPC	  (Khanna	  and	  Kiledjian,	  2004).	  	  This	  shortened	  tail	  
then	  acts	  as	  a	  substrate	  for	  the	  CCR4-­‐NOT	  complex	  (Wahle	  and	  Winkler,	  2013).	  	  	  
	   The	  CCR4-­‐NOT	  complex	  is	  a	  very	  large	  multi-­‐subunit	  protein	  whose	  comprising	  factors	  allow	  it	  to	  
function	  in	  several	  diverse	  cell	  processes	  (Collart	  and	  Panasenko,	  2012).	  	  Scaffold	  proteins	  CNOT1-­‐5,	  
CCR4-­‐Associated	  Factors	  CAF130,	  and	  CAF40	  function	  with	  two	  deadenylase	  components	  CNOT6	  or	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CNOT6L,	  and	  CNOT7,	  or	  CNOT8.	  	  CCR4-­‐NOT	  can	  be	  recruited	  by	  a	  variety	  of	  factors	  to	  destabilize	  
mRNAs.	  	  The	  RNA	  stability	  factor	  Tristetraprolin	  (TTP)	  also	  recruits	  the	  CCR4-­‐NOT	  complex	  to	  target	  
transcripts	  (Fabian	  et	  al.,	  2013;	  Sandler	  et	  al.,	  2011)	  while	  miRNA-­‐associated	  protein	  GW182	  directly	  
interacts	  with	  the	  complex	  to	  mediate	  deadenylation	  (Fabian	  et	  al.,	  2011).	  	  	  
	   Significant	  reduction	  in	  length	  of	  the	  poly(A)	  tail	  during	  deadenylation	  leaves	  the	  transcript	  with	  
a	  short	  oligo(A)	  tail	  that	  facilitates	  further	  degradation	  of	  the	  mRNA.	  	  Once	  the	  closed-­‐loop	  formation	  
has	  been	  fully	  disrupted,	  the	  transcript	  is	  susceptible	  to	  decay	  from	  both	  the	  3’5’	  and	  5’3’	  
directions.	  	  Deadenylation-­‐independent	  decapping	  is	  discussed	  in	  Section	  1.1.6.4.	  
	  
1.1.6.2	  Exosome-­‐mediated	  decay	  	  
	   Transcript	  degradation	  in	  the	  3’5’	  direction	  is	  mediated	  by	  a	  large,	  multi-­‐subunit	  decay	  
complex	  known	  as	  the	  exosome.	  	  In	  humans,	  the	  ~2	  MDa	  cytoplasmic	  exosome	  is	  comprised	  of	  three	  S1-­‐
family	  proteins	  (EXOSC1-­‐3)	  and	  six	  RNase	  PH-­‐domain	  proteins	  (EXOSC4-­‐9)	  that	  form	  a	  catalytically	  
inactive	  core	  and	  two	  RNase	  D-­‐like	  enzymes,	  DIS3	  and	  EXOSC10	  (Brouwer	  et	  al.,	  2001;	  Chlebowski	  et	  al.,	  
2011;	  Mitchell	  et	  al.,	  1997).	  	  DIS3	  gives	  the	  complex	  its	  catalytic	  properties.	  	  Exonucleolytic	  activity	  is	  
conferred	  through	  an	  RNase	  II	  region	  (Dziembowski	  et	  al.,	  2007)	  while	  the	  PIN	  domain	  performs	  
endonucleolytic	  reactions	  (Lebreton	  et	  al.,	  2008).	  	  The	  nuclear	  exosome	  includes	  an	  additional	  subunit,	  
M-­‐Phase	  Phosphoprotein	  6	  (MPP6;	  Milligan	  et	  al.,	  2008;	  Schilders	  et	  al.,	  2005).	  	  In	  the	  cytoplasm,	  the	  
exosome	  is	  recruited	  to	  the	  3’	  end	  of	  mRNAs	  destined	  for	  degradation	  through	  an	  interaction	  with	  SKI7,	  
a	  component	  of	  the	  SKI	  complex	  which	  also	  contains	  the	  RNA	  helicase	  SKI2	  (Araki	  et	  al.,	  2001;	  Houseley	  
et	  al.,	  2006).	  
	   Exonuclease	  activity	  of	  the	  exosome	  requires	  a	  3’	  OH	  and	  region	  of	  unstructured	  RNA	  which	  is	  
often	  provided	  by	  the	  remnants	  of	  the	  poly(A)	  tail	  following	  deadenylation	  (Schmid	  and	  Jensen,	  2008).	  	  
The	  inactive	  core	  forms	  a	  ring-­‐shaped	  structure	  through	  which	  mRNA	  is	  threaded	  while	  being	  degraded	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(Tsanova	  and	  van	  Hoof,	  2010).	  	  The	  crystal	  structure	  of	  the	  yeast	  nuclear	  exosome	  reveals	  that	  the	  pore	  
unwinds	  RNA	  into	  a	  single	  stranded	  conformation	  and	  the	  DIS3	  homologue	  catalyzes	  decay	  of	  
nucleotides	  as	  the	  strand	  leaves	  the	  pore	  complex	  (Makino	  et	  al.,	  2013).	  	  When	  only	  a	  few	  nucleotides	  
remain	  on	  the	  mRNA	  substrate,	  Scavenger	  Decapping	  enzyme	  DCPS	  cleaves	  and	  recycles	  the	  5’	  cap	  (Liu	  
et	  al.,	  2002).	  	  The	  yeast	  DCPS	  homologue	  Dcs1p	  is	  also	  able	  to	  influence	  decay	  from	  the	  5’	  direction	  by	  
acting	  as	  a	  co-­‐factor	  for	  5’3’	  exonuclease	  XRN1	  (van	  Dijk	  et	  al.,	  2003).	  	  
	   Interestingly,	  a	  paralogue	  of	  the	  enzymatic	  subunit	  DIS3	  known	  as	  DIS3L2	  does	  not	  associate	  
with	  the	  exosome	  complex	  and	  functions	  in	  the	  cytoplasm	  (Malecki	  et	  al.,	  2013).	  	  Studies	  of	  DIS3L2	  in	  
mouse	  embryonic	  stem	  cells	  reveals	  that	  this	  3’5’	  exonuclease	  has	  a	  preference	  for	  3’	  uridylated	  
substrates.	  	  	  
	  
1.1.6.3	  Decapping	  and	  5’3’	  exoribonucleolytic	  decay	  	  
	   Following	  deadenylation,	  mRNAs	  may	  be	  decapped	  and	  degraded	  in	  the	  5’3’	  direction	  by	  the	  
highly	  processive	  enzyme	  XRN1	  (Coller	  and	  Parker,	  2004;	  Muhlrad	  et	  al.,	  1994).	  	  The	  3’	  end	  of	  
deadenylated	  transcripts	  is	  recognized	  and	  bound	  by	  the	  ring-­‐shaped	  LSM1-­‐7/PAT1	  complex	  (Tharun,	  
2009;	  Tharun	  et	  al.,	  2000).	  	  In	  conjunction	  with	  DEAD	  box	  helicase	  DHH1,	  the	  complex	  then	  recruits	  the	  
Decapping	  Protein	  DCP1-­‐DCP2	  complex	  for	  removal	  of	  the	  5’	  m7G	  cap	  structure	  (Coller	  et	  al.,	  2001;	  
Fischer	  and	  Weis,	  2002).	  	  DCP2	  is	  a	  member	  of	  the	  Nudix	  superfamily	  of	  hydrolases	  and	  is	  the	  catalytic	  
member	  of	  the	  complex	  with	  co-­‐activator	  DCP1	  (Dunckley	  and	  Parker,	  1999).	  	  DCP2	  is	  the	  best	  studied	  
decapping	  enzyme	  but	  other	  Nudix	  hydrolases,	  including	  NUDT16,	  also	  appear	  to	  have	  a	  role	  in	  
regulating	  decapping	  of	  a	  distinct	  subset	  of	  mRNAs	  (Song	  et	  al.,	  2013).	  	  Once	  a	  transcript	  has	  been	  
decapped,	  the	  5’	  monophosphorylated	  mRNA	  becomes	  a	  substrate	  of	  5’3’	  exonucleolytic	  decay	  by	  
XRN1	  (Muhlrad	  et	  al.,	  1994).	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   As	  mentioned	  previously,	  the	  closed	  loop	  formation	  of	  mRNA	  protects	  the	  5’	  cap	  from	  
decapping	  therefore	  it	  is	  not	  surprising	  that	  cap-­‐binding	  protein	  eIF4E	  and	  poly(A)	  tailing-­‐binding	  protein	  
PABPC	  negatively	  regulate	  decapping	  activity	  (Ramirez	  et	  al.,	  2002;	  Vilela	  et	  al.,	  2000).	  	  Conversely,	  there	  
are	  also	  factors	  that	  stimulate	  decapping	  known	  as	  Enhancers	  of	  Decapping	  proteins	  EDC3	  and	  
EDC4/HEDLS/Ge-­‐1	  (Simon	  et	  al.,	  2006).	  	  These	  proteins,	  as	  well	  as	  LSM14-­‐homologue	  SCD6,	  interact	  
with	  the	  DCP1-­‐DCP2	  complex	  to	  encourage	  an	  active	  conformation	  (Harigaya	  et	  al.,	  2010;	  Ling	  et	  al.,	  
2011).	  	  Interestingly,	  the	  decapping	  complex	  is	  also	  required	  for	  miRNA-­‐mediated	  gene	  silencing	  by	  
RNA-­‐Induced	  Silencing	  Complex	  (RISC)	  component	  GW182,	  demonstrating	  interplay	  between	  these	  two	  
post-­‐transcriptional	  processes	  (Rehwinkel	  et	  al.,	  2005).	  	  	  	  	  	  	  	  
	  
1.1.6.4	  Deadenylation-­‐independent	  decapping	  	  
	   Although	  the	  predominant	  mechanism	  of	  mRNA	  decay	  is	  deadenylation-­‐dependent,	  there	  are	  
also	  other	  minor	  pathways	  that	  are	  deadenylation-­‐independent.	  	  An	  important	  class	  of	  mRNAs	  
regulated	  in	  this	  manner	  are	  those	  encoding	  replication-­‐dependent	  histones.	  	  Instead	  of	  a	  poly(A)	  tail,	  
these	  mRNAs	  end	  in	  a	  conserved	  3’	  stem	  loop.	  	  Regulation	  of	  histone	  mRNAs	  is	  discussed	  in	  detail	  in	  
Chapter	  4.	  	  Briefly,	  addition	  of	  an	  oligo(U)	  tract	  to	  the	  3’	  end	  of	  histone	  messages	  recruits	  the	  LSM1-­‐
7/PAT1	  complex,	  which	  in	  turn	  recruits	  DCP1-­‐DCP2	  followed	  by	  decapping	  and	  bi-­‐directional	  decay	  in	  
the	  5’3’	  and	  3’5’	  directions	  (Herrero	  and	  Moreno,	  2011;	  Mullen	  and	  Marzluff,	  2008).	  	  	  
	   Deadenylation-­‐independent	  decapping	  also	  serves	  to	  rid	  the	  cell	  of	  aberrant	  mRNAs	  through	  
nuclear	  surveillance	  pathways	  including	  Nonsense-­‐Mediated	  Decay	  (NMD,	  Huang	  and	  Wilkinson,	  2012),	  
Non-­‐Stop	  Decay	  (NSD;	  Klauer	  and	  van	  Hoof,	  2012),	  and	  No-­‐Go	  Decay	  (NGD;	  Harigaya	  and	  Parker,	  2010).	  	  
These	  mechanisms	  have	  been	  reviewed	  at	  length	  and	  will	  not	  be	  included	  in	  discussion	  here.	  	  However,	  
much	  of	  the	  quality	  control	  degradation	  performed	  on	  these	  abnormal	  transcripts	  occurs	  through	  
endonucleolytic	  cleavage.	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1.1.6.5	  Endonucleolytic	  cleavage	  	  
	   Endonucleolytic	  cleavage	  differs	  from	  deadenylation-­‐dependent	  decay	  in	  that	  it	  instantly	  
renders	  a	  transcript	  unusable	  rather	  than	  slowly	  inactivating	  it	  over	  time.	  	  Once	  the	  mRNA	  has	  been	  
cleaved	  creating	  two	  fragments,	  the	  unprotected	  ends	  are	  subject	  to	  5’3’	  decay	  by	  XRN1	  or	  3’5’	  
decay	  by	  the	  exosome	  (Figure	  1.3).	  	  Many	  endonucleases	  also	  exhibit	  sequence	  specificity	  rather	  than	  
targeting	  universal	  mRNA	  features	  and	  appear	  to	  only	  regulate	  a	  subset	  of	  transcripts.	  	  	  
	   The	  SMG6	  protein	  functions	  in	  the	  NMD	  pathway	  and	  cleaves	  mRNAs	  near	  the	  site	  of	  premature	  
termination	  codons	  (Eberle	  et	  al.,	  2009)	  while	  RNase	  L	  and	  ZC3H12A	  function	  in	  pathways	  important	  for	  
immune	  response.	  	  RNase	  L	  combats	  viral	  infection	  by	  rapidly	  cleaving	  both	  cellular	  and	  viral	  RNAs,	  
often	  leading	  to	  apoptosis	  (Li	  et	  al.,	  1998).	  	  Like	  RNase	  L,	  ZC3H12A	  is	  induced	  during	  an	  infection	  and	  
targets	  mRNAs	  encoding	  cytokines	  such	  as	  IL-­‐6	  (Schoenberg,	  2011).	  	  Polysome-­‐associated	  endonuclease	  
PMR1	  regulates	  a	  subset	  of	  mRNAs	  required	  for	  cell	  mobility	  (Bremer	  et	  al.,	  2003).	  	  Perhaps	  the	  best	  
studied	  endonuclease	  of	  late	  is	  the	  Argonaute	  2	  (AGO2)	  protein.	  	  As	  discussed	  in	  Section	  1.2.2	  below,	  
AGO2	  is	  a	  component	  of	  RISC	  required	  for	  cleavage	  of	  targets	  following	  their	  base-­‐pairing	  with	  the	  






5’	   3’	  decay3’ 5’	  decay
AAAAAA	  
XRN1
Figure	  1.3	  Endonucleolytic	  cleavage	  pathway.	  	  Degradation	  by	  endonucleolytic	  cleavage	  
results	  in	  two	  RNA	  fragments	  subject	  to	  exosome-­‐mediated	  decay	  3’ 5’	  decay	  and	  5’	  






1.2	  Regulated	  mRNA	  stability	  contributes	  to	  changes	  in	  gene	  expression	  
	   While	  degradation	  of	  mRNAs	  is	  likely	  very	  similar	  between	  cell	  types,	  differential	  regulation	  of	  
mRNA	  stability	  factors	  such	  as	  RNA-­‐binding	  proteins	  (RBPs)	  and	  miRNAs	  help	  define	  stem	  cell-­‐	  or	  
differentiation-­‐specific	  expression	  patterns.	  	  The	  general	  mRNA	  features,	  a	  5’	  m7G	  cap	  and	  3’	  poly(A)	  
tail,	  are	  able	  to	  influence	  mRNA	  stability	  (as	  described	  in	  Section	  1.1)	  but	  further	  control	  is	  
demonstrated	  through	  cis-­‐acting	  elements	  encoded	  within	  the	  transcript.	  	  Cis-­‐acting	  elements	  can	  
reside	  in	  the	  5’UTR	  and	  coding	  region	  of	  an	  mRNA	  but	  they	  are	  more	  frequently	  found	  in	  the	  3’UTR	  (Lee	  
and	  Gorospe,	  2011).	  	  Alternative	  polyadenylation	  can	  influence	  the	  presence	  of	  sequence	  elements	  in	  
the	  3’UTR	  (Lu	  and	  Bushel,	  2013;	  Touriol	  et	  al.,	  1999),	  as	  demonstrated	  in	  mouse	  embryos	  where	  mRNA	  
3’UTRs	  are	  lengthened	  as	  development	  progresses	  (Ji	  et	  al.,	  2009).	  	  Usage	  of	  downstream	  poly(A)	  sites	  
allows	  the	  3’UTR	  to	  include	  additional	  elements	  that	  regulate	  mRNA	  stability	  in	  a	  developmentally-­‐
dependent	  fashion	  (Ji	  et	  al.,	  2009).	  	  RBPs	  and	  miRNAs	  interact	  with	  3’UTR	  elements	  to	  either	  stimulate	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or	  inhibit	  mRNA	  decay	  through	  a	  variety	  of	  mechanisms	  (Schoenberg	  and	  Maquat,	  2012).	  	  Figure	  1.4	  
below	  illustrates	  examples	  by	  which	  trans-­‐acting	  factors	  recruit	  or	  inhibit	  mRNA	  decay	  machinery.	  	  The	  
role	  of	  cis-­‐acting	  elements	  and	  their	  associated	  trans-­‐acting	  factors	  are	  discussed	  here,	  highlighting	  
those	  important	  for	  stem	  cell	  gene	  expression.	  	  	  
	  
	  
Figure	  1.4	  Trans-­‐acting factors	  can	  either	  recruit	  or	  inhibit	  mRNA	  decay	  machinery.	  	  
Binding	  of	  proteins	  to	  AU-­‐rich	  elements	  (AREs)	  can	  result	  in	  stimulation	  or	  repression	  
of	  deadenylation	  and	  also	  elicit	  decapping	  and	  exonucleolytic decay.	  	  miRNAs	  









1.2.1	  Cis-­‐acting	  elements	  and	  their	  associated	  RNA-­‐binding	  proteins	  	  
	   Although	  mRNA	  stability	  elements	  and	  factors	  are	  widely	  studied,	  their	  influences	  specific	  to	  
stem	  cell	  gene	  expression	  are	  largely	  uncharacterized.	  	  Regardless,	  several	  sequence	  motifs	  important	  
for	  regulated	  mRNA	  decay	  have	  been	  identified	  throughout	  the	  transcriptome	  and	  their	  elucidation	  has	  
strengthened	  our	  overall	  understanding	  of	  post-­‐transcriptional	  control	  in	  gene	  expression.	  	  The	  best-­‐
characterized	  cis-­‐acting	  element	  is	  the	  AU-­‐rich	  element	  (ARE).	  	  AREs	  are	  15-­‐150	  base	  sequences	  that	  
contain	  one	  or	  more	  AUUUA	  motifs	  surrounded	  by	  U-­‐rich	  context	  (Chen	  et	  al.,	  2001;	  Stoecklin	  et	  al.,	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2003).	  	  These	  are	  generally	  found	  in	  the	  3’UTR	  of	  mRNAs	  that	  require	  transient	  expression	  such	  as	  
cytokines,	  transcription	  factors,	  and	  cell	  cycle	  modulators,	  representing	  up	  to	  9%	  of	  all	  transcripts	  
(Anderson,	  2008;	  Gingerich	  et	  al.,	  2004).	  	  Most	  proteins	  that	  bind	  AREs	  (ARE-­‐BPs)	  recruit	  deadenylases	  
such	  as	  CCR4-­‐NOT	  and	  PARN	  to	  the	  message	  to	  elicit	  destabilization.	  	  Well-­‐characterized	  destabilizing	  
ARE-­‐BPs	  include	  the	  TTP	  family	  of	  CCCH-­‐type	  ZNF	  proteins	  ZNF36,	  ZPF36L1,	  and	  ZFP36L2	  (Lai	  et	  al.,	  
2006),	  KHSRP	  (Gherzi	  et	  al.,	  2004),	  and	  AUF1	  (hnRNP	  D;	  Li	  et	  al.,	  2009).	  	  Conversely,	  transcript	  
stabilization	  is	  conferred	  wherein	  binding	  of	  ARE-­‐BPs	  such	  as	  HuR	  (ELAVL1;	  Dean	  et	  al.,	  2001;	  Peng	  et	  al.,	  
1998),	  TIA1,	  and	  TIAR	  (Gueydan	  et	  al.,	  1999)	  protect	  the	  mRNA	  from	  deadenylase	  activity.	  	  	  
	   GU-­‐rich	  elements	  (GREs)	  are	  motifs	  that	  consist	  of	  UG-­‐repeats	  or	  U-­‐rich	  regions	  interspersed	  
with	  guanine	  residues	  (e.g.	  UGUUUGU;	  Rattenbacher	  et	  al.,	  2010).	  	  Global	  functional	  analysis	  estimates	  
that	  at	  least	  5%	  of	  human	  genes	  contain	  GREs	  (Halees	  et	  al.,	  2011),	  with	  many	  being	  important	  for	  
regulating	  transcription,	  nucleic	  acid	  metabolism,	  and	  developmental	  processes	  (Vlasova	  and	  Bohjanen,	  
2008).	  	  Many	  of	  these	  mRNAs	  bearing	  GU-­‐rich	  elements	  are	  regulated	  through	  binding	  of	  CELF1,	  also	  
known	  as	  CUGBP1	  (Vlasova	  et	  al.,	  2008;	  Vlasova-­‐St	  Louis	  et	  al.,	  2013).	  	  Destabilization	  of	  transcripts	  
occurs	  in	  one	  mechanism	  through	  a	  direct	  interaction	  between	  CELF1	  and	  PARN	  deadenylase	  (Moraes	  et	  
al.,	  2006).	  	  Expression	  patterns	  of	  CELF1	  in	  various	  tissues	  illustrate	  that	  this	  protein	  is	  developmentally	  
regulated	  (Blech-­‐Hermoni	  et	  al.,	  2013;	  Matsui	  et	  al.,	  2012).	  	  Interestingly,	  stabilizing	  RBP	  HuR	  has	  similar	  
binding	  preferences	  as	  CELF1	  and	  may	  compete	  for	  binding	  in	  some	  cases	  (López	  de	  Silanes	  et	  al.,	  2004),	  
demonstrating	  the	  complexity	  of	  regulated	  mRNA	  decay.	  	  	  	  
	   Pyrimidine-­‐rich	  or	  C-­‐rich	  elements	  are	  among	  the	  least	  understood	  of	  cis-­‐acting	  elements	  
identified	  to	  date	  but	  their	  role	  in	  mRNA	  stability	  upon	  binding	  of	  Poly(C)-­‐Binding	  Proteins	  (PCBPs)	  has	  
been	  extensively	  described	  for	  human	  α-­‐globin	  mRNA	  (Kong	  et	  al.,	  2006)	  and	  collagen	  I	  (COL1A1)	  mRNA	  
(Czyzyk-­‐Krzeska	  and	  Bendixen,	  1999).	  	  Interestingly,	  PCBP1	  is	  essential	  for	  maintaining	  a	  
transcriptionally-­‐silent	  state	  in	  mouse	  oocytes	  (Xia	  et	  al.,	  2012)	  and	  PCBP4	  is	  a	  tumor	  suppressor	  (Zhu	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and	  Chen,	  2000)	  whose	  down-­‐regulation	  likely	  supports	  pluripotency.	  	  The	  involvement	  of	  C-­‐rich	  
elements	  and	  PCBPs	  in	  regulated	  mRNA	  decay	  is	  discussed	  in	  more	  detail	  in	  Chapter	  6.	  	  
	   Although	  stem	  cell-­‐specific	  cis-­‐acting	  elements	  and	  trans-­‐acting	  factors	  have	  yet	  to	  be	  fully	  
characterized,	  a	  recent	  study	  found	  that	  more	  than	  200	  RBPs	  are	  over-­‐expressed	  in	  mouse	  ES	  cells	  
compared	  to	  differentiated	  cells,	  although	  whether	  these	  proteins	  modulate	  mRNA	  stability	  has	  yet	  to	  
be	  fully	  determined	  (Kwon	  et	  al.,	  2013).	  	  Regardless,	  many	  of	  the	  validated	  proteins	  were	  not	  previously	  
annotated	  as	  RBPs,	  suggesting	  that	  there	  are	  more	  RNA-­‐protein	  interactions	  that	  regulate	  stem	  cell	  
gene	  expression	  than	  previously	  appreciated.	  	  LIN28	  is	  a	  well-­‐known,	  developmentally-­‐regulated	  RBP	  
(Richards	  et	  al.,	  2004)	  that	  binds	  pluripotency	  transcription	  factor	  OCT4	  mRNA	  in	  human	  ES	  cells	  to	  
maintain	  stem	  cell	  gene	  expression	  (Qiu	  et	  al.,	  2010).	  	  LIN28	  is	  also	  a	  negative	  regulator	  of	  miRNA	  let-­‐7	  
biogenesis	  to	  repress	  differentiation	  (Viswanathan	  et	  al.,	  2008)	  and	  is	  likely	  one	  of	  several	  RBPs	  with	  
essential	  roles	  in	  stem	  cell	  maintenance.	  	  	  
	  
1.2.2	  MicroRNAs	  	  
	   MicroRNAs	  are	  small	  non-­‐coding	  RNAs	  ~22	  nucleotides	  in	  length	  that	  interact	  with	  mRNAs	  to	  
regulate	  the	  expression	  for	  as	  many	  as	  30%	  of	  human	  genes	  (Neilson	  et	  al.,	  2007).	  	  Overall	  expression	  of	  
miRNAs	  is	  lower	  in	  early	  development	  but	  levels	  of	  unique	  subsets	  are	  also	  regulated	  in	  cell-­‐specific	  
patterns	  (Lakshmipathy	  et	  al.,	  2007;	  Smith-­‐Vikos	  and	  Slack,	  2012;	  Zhao	  and	  Srivastava,	  2007).	  	  Like	  RBPs,	  
this	  differential	  expression	  allows	  miRNAs	  to	  facilitate	  maintaining	  transcriptome	  profiles	  that	  support	  
specific	  cell	  functions,	  such	  as	  pluripotency.	  	  	  
	   MicroRNAs	  are	  derived	  from	  sequences	  encoded	  in	  introns	  or	  portions	  of	  primary	  mRNAs	  and	  
biogenesis	  requires	  several	  proteins	  that	  process	  miRNAs	  into	  their	  mature	  form.	  	  Primary	  miRNA	  (pri-­‐
miRNA)	  transcripts	  are	  bound	  by	  DGCR8,	  the	  RNA-­‐binding	  competent	  of	  the	  Microprocessor	  (Gregory	  et	  
al.,	  2004;	  Han	  et	  al.,	  2004).	  	  Interestingly,	  DGCR8	  expression	  is	  required	  for	  silencing	  of	  self-­‐renewal	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during	  differentiation	  of	  ES	  cells	  (Wang	  et	  al.,	  2007).	  	  The	  catalytic	  component,	  Drosha,	  then	  cleaves	  the	  
pri-­‐miRNA	  to	  a	  reduced	  length.	  	  The	  fragment	  is	  exported	  to	  the	  cytoplasm	  where	  it	  is	  further	  processed	  
by	  DICER	  to	  yield	  the	  final	  ~22	  nucleotide	  length	  (Lee	  et	  al.,	  2003).	  	  Mature	  miRNAs	  are	  incorporated	  
into	  RISC	  which	  contains	  core	  proteins	  AGO2	  (Hammond	  et	  al.,	  2001)	  and	  GW182	  (Liu	  et	  al.,	  2005).	  	  The	  
sequence	  of	  the	  miRNA	  guides	  RISC	  to	  the	  complementary	  binding	  site	  on	  target	  mRNAs.	  	  Perfect	  
complementarity	  of	  sequences	  activates	  the	  AGO2	  component	  of	  RISC	  leading	  to	  endonucleolytic	  
cleavage	  ad	  subsequent	  bi-­‐directional	  degradation	  by	  XRN1	  and	  the	  exosome	  (Figure	  1.5;	  Meister	  et	  al.,	  
2004).	  	  However,	  this	  mechanism	  is	  more	  prevalent	  in	  plant	  genomes	  and	  infrequent	  in	  humans	  
(Bracken	  et	  al.,	  2011;	  Karginov	  et	  al.,	  2010;	  Shin	  et	  al.,	  2010).	  	  Imperfect	  base-­‐pairing	  results	  in	  activation	  
of	  the	  GW182	  component	  of	  RISC	  which	  interacts	  with	  deadenylases	  to	  stimulate	  shortening	  of	  the	  
poly(A)	  tail	  and	  induce	  mRNA	  silencing	  (Braun	  et	  al.,	  2011).	  	  GW182	  serves	  as	  a	  docking	  platform	  to	  
guide	  deadenylase	  complexes	  PAN2-­‐PAN3	  and	  CCR4-­‐NOT	  to	  their	  miRNA	  targets	  (Braun	  et	  al.,	  2011;	  
Fabian	  et	  al.,	  2011).	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Figure	  1.5	  MicroRNA-­‐mediated	  regulation	  of	  mRNA	  stability.	  	  A	  complex	  (RISC)	  containing	  AGO2	  and	  
GW182	  is	  guided	  to	  target	  mRNAs	  by	  miRNAs.	  	  The	  complementarity	  of	  binding	  determines	  whether	  
the	  transcript	  undergoes	  endonucleolytic	  cleavage	  and	  degradation	  or	  translational	  repression.	  	  In	  























	   	  
	   Expression	  of	  GW182	  is	  important	  during	  early	  embryo	  development	  in	  Drosophila	  (Schneider	  et	  
al.,	  2006)	  while	  proper	  AGO2	  expression	  is	  also	  required	  for	  various	  stages	  of	  development	  (Alisch	  et	  al.,	  
2007;	  Deshpande	  et	  al.,	  2005;	  Lykke-­‐Andersen	  et	  al.,	  2008),	  illustrating	  the	  importance	  of	  the	  miRNA	  
pathway	  for	  regulating	  gene	  expression.	  	  Further,	  several	  miRNAs	  have	  been	  implicated	  in	  the	  regulation	  
of	  pluripotent	  gene	  expression	  including	  the	  miR-­‐290-­‐295	  and	  miR-­‐302/367	  families	  that	  are	  over-­‐
expressed	  in	  stem	  cells	  (Kaspi	  et	  al.,	  2013;	  Lüningschrör	  et	  al.,	  2012)	  and	  the	  let-­‐7	  and	  miR-­‐200	  families	  
that	  are	  down-­‐regulated	  (Peter,	  2009;	  Porciuncula	  et	  al.,	  2013).	  	  Many	  miRNAs	  have	  also	  been	  used	  to	  
increase	  reprogramming	  efficiency	  upon	  induction	  of	  pluripotency	  (Bao	  et	  al.,	  2013;	  Leonardo	  et	  al.,	  
2012;	  Wang	  et	  al.,	  2013).	  	  These	  examples	  demonstrate	  the	  ability	  of	  miRNAs	  to	  control	  global	  changes	  
in	  gene	  expression	  and	  identifying	  additional	  pluripotency-­‐associated	  miRNA	  families	  and	  their	  mRNA	  
targets	  would	  be	  insightful	  to	  stem	  cell	  biology.	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1.3	  Rationale	  and	  hypothesis	  
	   As	  discussed	  in	  this	  chapter,	  the	  contribution	  of	  mRNA	  decay	  to	  pluripotency	  is	  largely	  unknown,	  
despite	  the	  notable	  importance	  of	  post-­‐transcriptional	  control	  in	  regulated	  gene	  expression.	  	  By	  
investigating	  mRNA	  decay	  in	  human	  iPS	  cells	  compared	  to	  the	  fully	  differentiated	  cells	  they	  were	  derived	  
from,	  we	  can	  add	  to	  our	  limited	  understanding	  of	  RNA	  stability	  mechanisms	  that	  regulate	  stem	  cell	  gene	  
expression.	  	  Specifically,	  we	  hypothesized	  that	  determination	  of	  global	  mRNA	  half-­‐lives	  in	  iPS	  cells	  and	  
HFFs	  (Human	  Foreskin	  Fibroblasts)	  would	  reveal	  differentially	  regulated	  mRNAs	  that	  may	  be	  
coordinately	  controlled	  and	  we	  hoped	  to	  identify	  novel	  regulatory	  mechanisms	  that	  are	  specific	  to	  
either	  stem	  cells	  or	  differentiated	  cells.	  	  We	  expected	  that	  these	  results	  would	  further	  our	  
























2.1	  Cell	  culture	  
2.1.1	  Cell	  line	  maintenance	  
2.1.1.1	  Human	  foreskin	  fibroblasts	  
	   Human	  Foreskin	  Fibroblasts	  (HFFs)	  were	  purchased	  in	  a	  matched	  set	  with	  induced	  Pluripotent	  
Stem	  (iPS)	  cells	  from	  System	  Biosciences	  and	  cultured	  according	  to	  company	  recommendations.	  	  
Fibroblast	  culture	  medium	  included	  Dulbecco’s	  Modified	  Eagle	  Medium	  (DMEM,	  Cellgro)	  supplemented	  
with	  10%	  Fetal	  Bovine	  Serum	  (FBS,	  Atlas),	  2	  mM	  L-­‐glutamine	  (Hyclone),	  0.1	  mM	  non-­‐essential	  amino	  
acids	  (Cellgro),	  50	  U/mL	  penicillin,	  and	  50	  µg/mL	  streptomycin	  (Hyclone).	  	  Cells	  were	  incubated	  at	  37°C	  
with	  5%	  CO2	  and	  passaged	  when	  90%	  confluent	  at	  a	  split	  ratio	  of	  1:3	  using	  0.25%	  trypsin-­‐EDTA	  (Hyclone)	  
in	  Phosphate	  Buffered	  Saline	  (PBS,	  Hyclone).	  	  Cryovial	  cell	  stocks	  were	  made	  in	  50%	  fibroblast	  culture	  
medium,	  40%	  FBS,	  and	  10%	  DMSO	  (Sigma).	  	  Figure	  2.1	  below	  is	  an	  image	  of	  HFF	  cells	  at	  ~80%	  
confluence	  under	  100x	  magnification	  on	  a	  Diaphot	  200	  microscope	  (Nikon)	  with	  CoolSNAP	  camera	  and	  
RS	  Image	  software	  (Roper	  Scientific).	  	  	  
	  
Figure	  2.1	  Cultured	  human	  foreskin	  fibroblasts.	  	  Human	  Foreskin	  Fibroblasts	  (HFFs)	  at	  ~80%	  confluence	  





2.1.1.2	  Mouse	  embryonic	  fibroblasts	  	  
	   Mouse	  Embryonic	  Fibroblasts	  (MEFs)	  were	  purchased	  from	  American	  Type	  Culture	  Collection	  
(ATCC)	  and	  maintained	  using	  the	  fibroblast	  protocol	  described	  in	  Section	  2.1.1.1.	  	  To	  prepare	  cells	  for	  
use	  as	  a	  non-­‐dividing	  feeder	  layer,	  MEFs	  were	  grown	  to	  confluence	  in	  a	  T75	  flask	  and	  treated	  with	  50	  µL	  
of	  1	  mg/mL	  mitomycin	  C	  (Sigma)	  in	  6	  mL	  of	  fibroblast	  medium	  for	  3	  hours	  at	  37°C	  to	  effectively	  halt	  cell	  
cycle	  progression.	  	  Following	  treatment,	  cells	  were	  seeded	  at	  a	  density	  of	  1.5x105	  cells	  per	  well	  onto	  6-­‐
well	  plates	  coated	  with	  0.1%	  gelatin	  (Andwin	  Scientific).	  	  Alternatively,	  arrested	  cells	  were	  frozen	  in	  50%	  
fibroblast	  medium,	  40%	  FBS,	  and	  10%	  DMSO	  in	  aliquots	  of	  9x105	  cells,	  enough	  for	  all	  the	  wells	  of	  a	  single	  
6-­‐well	  plate.	  	  Feeder-­‐layer	  MEF	  cells	  were	  allowed	  to	  adhere	  overnight	  and	  were	  ready	  for	  iPS	  cell	  
plating	  the	  following	  day.	  	  Figure	  2.2	  shows	  a	  MEF	  feeder	  layer	  on	  0.1%	  gelatin	  at	  100x	  magnification.	  	  	  
	  
Figure	  2.2	  Cultured	  mouse	  embryonic	  fibroblasts.	  	  Mouse	  Embryonic	  Fibroblast	  (MEF)	  feeder	  layer	  on	  0.1%	  





2.1.1.3	  Human	  induced	  pluripotent	  stem	  cells	  cultured	  on	  MEF	  feeder	  layer	  
	   Stocks	  of	  iPS	  cells	  reprogrammed	  from	  HFFs	  were	  purchased	  from	  System	  Biosciences	  (SC101A-­‐
1,	  Lot	  #090725-­‐08).	  	  The	  reprogramming	  was	  achieved	  using	  lentiviral	  expression	  of	  pluripotency	  genes	  
OCT4,	  SOX2,	  c-­‐MYC,	  and	  KLF4,	  the	  same	  cocktail	  used	  in	  Takahashi	  et	  al.,	  2007.	  	  The	  iPS	  cell	  line	  was	  
certified	  as	  pluripotent	  by	  the	  company	  prior	  to	  purchase	  through	  staining	  of	  stem	  cell	  markers	  NANOG,	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OCT4,	  SSEA3,	  and	  TRA-­‐1-­‐60.	  	  To	  establish	  the	  stock	  cryovial	  of	  2x105	  iPS	  cells,	  cells	  were	  seeded	  at	  a	  
density	  of	  approximately	  5x104	  cells	  per	  well	  of	  a	  MEF	  feeder	  layer	  6-­‐well	  plate	  in	  medium	  containing	  
DMEM/F12	  (Cellgro)	  supplemented	  with	  20%	  Knockout	  Serum	  Replacement	  (Gibco),	  2	  mM	  L-­‐glutamine,	  
0.1	  mM	  non-­‐essential	  amino	  acids,	  0.1	  mM	  2-­‐mercaptoethaol,	  10	  ng/mL	  recombinant	  human	  Basic	  
Fibroblast	  Growth	  Factor	  (bFGF,	  Gibco),	  50	  U/mL	  penicillin,	  and	  50	  µg/mL	  streptomycin	  (complete	  
DMEM/F12	  medium).	  	  Knockout	  Serum	  Replacement	  is	  a	  defined,	  serum-­‐free	  formulation	  that	  replaces	  
FBS	  in	  stem	  cell	  culture	  medium	  to	  maintain	  pluripotency.	  	  Cells	  were	  incubated	  at	  37°C	  with	  5%	  CO2	  and	  
medium	  was	  changed	  daily.	  	  Cells	  were	  split	  when	  the	  edges	  of	  colonies	  became	  close	  in	  proximity.	  	  
Passaging	  of	  iPS	  cells	  was	  performed	  at	  a	  split	  ratio	  of	  1:10	  –	  1:20	  using	  StemPro	  Accutase	  (Invitrogen)	  
and	  DMEM/F12	  supplemented	  with	  15	  mM	  HEPES	  (pH	  7.0),	  2	  mM	  L-­‐glutamine,	  50	  U/mL	  penicillin,	  and	  
50	  µg/mL	  streptomycin	  (DMEM/F12).	  	  Cryovial	  cell	  stocks	  were	  made	  in	  50%	  complete	  DMEM/F12	  
medium,	  40%	  FBS,	  and	  10%	  DMSO.	  	  Figure	  2.3	  below	  shows	  iPS	  cell	  colonies	  cultured	  on	  a	  MEF	  feeder	  
layer	  at	  100x	  magnification.	  	  	  
	  
	  
Figure	  2.3	  Cultured	  induced	  pluripotent	  stem	  cells	  on	  feeder	  layer.	  	  Induced	  Pluripotent	  Stem	  (iPS)	  cells	  











2.1.1.4	  Human	  induced	  pluripotent	  stem	  cells	  cultured	  on	  Matrigel	  (feeder-­‐free)	  
	   To	  eliminate	  contamination	  with	  the	  feeder	  layer	  MEFs,	  iPS	  cells	  were	  adapted	  to	  feeder-­‐free	  
conditions	  following	  establishment	  and	  expansion.	  	  For	  the	  initial	  adaptation,	  cells	  were	  seeded	  at	  a	  high	  
density	  onto	  plates	  coated	  with	  0.3	  mg/mL	  Matrigel	  Basement	  Membrane	  Matrix	  Growth	  Factor	  
Reduced	  (Matrigel,	  BD	  Biosciences)	  diluted	  in	  DMEM/F12.	  	  Cell	  loss	  following	  plating	  typically	  ranged	  
from	  50	  –	  75%	  and	  a	  recovery	  time	  of	  approximately	  5	  –	  7	  days	  was	  expected	  before	  noticeable	  
formation	  of	  distinct	  colonies.	  	  Cells	  were	  cultured	  in	  mTeSR1	  medium	  (Stemcell	  Technologies)	  
supplemented	  with	  50	  U/mL	  penicillin	  and	  50	  µg/mL	  streptomycin.	  	  Passaging	  was	  performed	  using	  
Dispase	  Solution	  (Stemcell	  Technologies)	  at	  a	  concentration	  of	  1	  mg/ml	  in	  1x	  Hank’s	  Balanced	  Salt	  
Solution	  (Gibco).	  	  Cryovial	  cell	  stocks	  were	  made	  in	  50%	  mTeSR1	  medium,	  40%	  FBS,	  and	  10%	  DMSO.	  	  As	  
depicted	  in	  Figure	  2.4,	  iPS	  cell	  colony	  morphology	  is	  slightly	  different	  when	  cultured	  on	  Matrigel	  as	  
compared	  to	  those	  cultured	  on	  a	  feeder	  layer.	  	  Cells	  are	  more	  columnar	  and	  colonies	  tend	  to	  be	  flatter.	  	  
This	  difference	  in	  colony	  appearance	  is	  expected	  according	  to	  the	  mTeSR1	  technical	  manual.	  	  	  
	  
Figure	  2.4	  Cultured	  induced	  pluripotent	  stem	  cells	  on	  Matrigel.	  	  Induced	  Pluripotent	  Stem	  (iPS)	  cells	  on	  
Matrigel	  viewed	  at	  100x	  magnification.
	  
	  
	   To	  maintain	  cells	  in	  a	  pluripotent	  state,	  medium	  was	  changed	  daily	  and	  cells	  were	  passaged	  
before	  colony	  borders	  began	  to	  merge.	  	  As	  differentiation	  often	  begins	  in	  cells	  skirting	  the	  colonies,	  it	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was	  important	  to	  sufficiently	  treat	  cells	  with	  Dispase	  which	  slowly	  detaches	  colonies	  from	  Matrigel	  by	  
first	  loosening	  the	  edges.	  	  When	  cells	  on	  the	  edges	  were	  lifted	  with	  the	  majority	  of	  the	  colony	  intact,	  
thorough	  rinsing	  of	  wells	  with	  DMEM/F12	  ensured	  removal	  of	  these	  border	  cells	  with	  the	  most	  
likelihood	  of	  encountering	  differentiation	  signals.	  	  After	  washing,	  adherent	  colonies	  were	  pipetted	  more	  
aggressively	  several	  times	  in	  DMEM/F12	  to	  detach	  and	  reduce	  colony	  size,	  lessening	  potential	  for	  
embryoid	  body	  formation.	  	  	  
	   After	  iPS	  cells	  were	  adapted	  to	  feeder-­‐free	  conditions	  on	  Matrigel,	  total	  RNA	  was	  collected	  from	  
culture	  dishes	  to	  determine	  whether	  MEF	  cells	  had	  been	  removed.	  	  To	  do	  this,	  cDNA	  was	  made	  and	  
analyzed	  by	  PCR	  (as	  described	  in	  Section	  2.2)	  for	  the	  presence	  of	  a	  mouse-­‐specific	  product	  (mRhoC).	  	  
While	  humans	  also	  express	  RhoC	  mRNA,	  these	  primers	  (generously	  provided	  by	  Dr.	  Jerome	  Lee)	  were	  
designed	  to	  specifically	  detect	  the	  mouse	  homologue	  and	  do	  not	  amplify	  non-­‐specific	  products.	  	  Using	  
C2C12	  mouse	  myoblasts	  as	  a	  positive	  control,	  we	  saw	  that	  although	  mRhoC	  was	  readily	  detectable	  in	  iPS	  
cell	  samples	  collected	  from	  colonies	  cultured	  on	  a	  feeder	  layer	  (Figure	  2.5A),	  PCR	  products	  were	  not	  
amplified	  using	  any	  of	  four	  cultures	  adapted	  to	  Matrigel	  (Figure	  2.5B).	  	  In	  contrast,	  human	  GAPDH	  was	  
detected	  in	  cDNA	  from	  iPS	  cells	  under	  both	  culture	  conditions.	  	  GAPDH	  was	  chosen	  as	  the	  reference	  
gene	  for	  all	  PCR	  experiments	  as	  it	  is	  a	  housekeeping	  gene	  with	  a	  relatively	  long	  half-­‐life	  whose	  
expression	  is	  fairly	  equal	  between	  each	  of	  the	  cell	  types.	  	  All	  experiments	  described	  throughout	  this	  
thesis	  were	  performed	  using	  iPS	  cells	  cultured	  on	  Matrigel.	  	  	  
	  
Figure	  2.5	  Feeder	  layer	  contamination	  is	  removed	  following	  adaption	  to	  feeder-­‐free	  conditions.	  	  RT-­‐PCR	  
analysis	  of	  cDNA	  prepared	  from	  iPS	  cells	  cultured	  on	  A)	  a	  MEF	  feeder	  layer	  or	  B)	  Matrigel	  for	  detection	  of	  








2.1.1.5	  HeLa	  cells	  	  
	   HeLa	  cells	  were	  used	  in	  some	  experiments	  for	  comparison	  to	  the	  human	  primary	  fibroblast	  and	  
stem	  cell	  lines.	  	  These	  cells	  were	  incubated	  at	  37°C	  with	  5%	  CO2	  and	  cultured	  in	  DMEM	  supplemented	  
with	  10%	  FBS,	  2mM	  L-­‐glutamine,	  100	  U/mL	  penicillin,	  and	  100	  µg/mL	  streptomycin.	  	  Cells	  were	  passaged	  
at	  70	  –	  95%	  confluence	  at	  a	  split	  ratio	  of	  1:5	  –	  1:20	  using	  0.25%	  trypsin-­‐EDTA	  and	  PBS.	  	  Cryovial	  cell	  
stocks	  were	  made	  using	  50%	  culture	  medium,	  40%	  FBS,	  and	  10%	  DMSO.	  	  	  
	  
2.1.2	  Cell	  cycle	  analysis	  	  
	   To	  measure	  the	  percentage	  of	  cells	  in	  S	  phase	  in	  an	  asynchronous	  population,	  HFFs	  were	  
cultured	  on	  chamber	  slides	  and	  iPS	  cells	  were	  cultured	  on	  chamber	  slides	  coated	  with	  0.3	  mg/mL	  
Matrigel.	  	  Cells	  were	  treated	  with	  10	  µM	  Bromodeoxyuridine	  (BrdU,	  BD	  Biosciences)	  in	  culture	  medium	  
for	  30	  minutes	  at	  37°C	  then	  fixed	  with	  70%	  ethanol	  in	  50	  mM	  glycine	  (pH	  2.0)	  for	  30	  minutes	  at	  -­‐20°C.	  	  
To	  expose	  DNA	  for	  staining,	  cells	  were	  treated	  with	  1.5	  M	  HCl	  for	  30	  minutes	  at	  room	  temperature.	  	  
After	  rinsing,	  slides	  were	  blocked	  in	  3%	  Bovine	  Serum	  Albumin	  (BSA)/0.5%	  Tween-­‐20	  in	  PBS	  for	  1	  hour	  at	  
room	  temperature.	  	  Anti-­‐BrdU	  (BU-­‐1,	  Thermo	  Scientific)	  diluted	  1:500	  in	  1%	  BSA/PBS	  was	  applied	  to	  the	  
cells	  and	  left	  overnight	  at	  4°C.	  	  Following	  rinsing	  with	  PBS,	  secondary	  antibody	  Alexa	  Fluor	  594	  goat	  anti-­‐
mouse	  IgG	  (Invitrogen)	  was	  applied	  at	  a	  concentration	  of	  1:2,500	  in	  1%	  BSA/PBS	  for	  2	  hours	  at	  room	  
temperature.	  	  Slides	  were	  then	  mounted	  using	  ProLong	  Gold	  antifade	  reagent	  with	  DAPI	  (Life	  
Technologies	  Corporation)	  and	  visualized	  using	  an	  Olympus	  IX71	  microscope.	  	  Positive	  staining	  with	  anti-­‐
BrdU	  identified	  cells	  in	  S	  phase	  and	  the	  percentage	  was	  determined	  based	  on	  the	  total	  number	  of	  cells	  
counted.	  	  Three	  replicates	  of	  slides	  were	  analyzed	  for	  each	  cell	  line	  and	  calculations	  were	  based	  on	  





2.1.3	  Growth	  rate	  measurement	  	  
	   The	  growth	  rates	  of	  HFF	  and	  iPS	  cells	  were	  determined	  by	  measuring	  the	  number	  of	  cells	  in	  each	  
population	  over	  a	  period	  of	  five	  days.	  	  To	  do	  this,	  cells	  were	  seeded	  into	  five	  dishes	  at	  an	  equal	  seed	  
density.	  	  Each	  day,	  cells	  were	  detached	  and	  suspended	  into	  a	  single-­‐cell	  suspension	  using	  0.25%	  trypsin-­‐
EDTA	  and	  PBS.	  	  For	  iPS	  cells,	  0.05%	  trypsin	  and	  pipetting	  was	  necessary	  to	  diffuse	  the	  colonies.	  	  The	  total	  
number	  of	  live	  cells	  collected	  for	  each	  of	  three	  replicates	  per	  day	  was	  determined	  following	  0.4%	  Trypan	  
Blue	  Solution	  (Cellgro)	  staining	  using	  a	  hemocytometer.	  	  	  
	  
2.2	  RNA	  preparation	  and	  assays	  
2.2.1	  RNA	  isolation	  and	  quantification	  
	   Total	  RNA	  was	  collected	  from	  cells	  using	  TRIzol	  (Invitrogen)	  according	  to	  the	  manufacturer’s	  
protocol.	  	  Briefly,	  RNA	  was	  extracted	  from	  TRIzol	  following	  addition	  of	  chloroform	  and	  transfer	  of	  the	  
upper	  aqueous	  phase.	  	  Nucleic	  acids	  were	  precipitated	  in	  isopropanol	  using	  glycogen	  (Fermentas)	  as	  a	  
carrier	  and	  then	  treated	  with	  DNase1	  (Fermentas)	  for	  20	  minutes	  at	  37°C.	  	  Following	  phenol:chloroform	  
extraction,	  RNAs	  were	  precipitated	  by	  the	  addition	  of	  0.33	  volumes	  10	  M	  ammonium	  acetate	  and	  2.5	  
volumes	  100%	  ethanol	  using	  glycogen	  as	  a	  carrier.	  	  After	  drying,	  RNA	  pellets	  were	  resuspended	  in	  
RNase-­‐free	  distilled	  water	  (dH20)	  and	  concentration	  was	  measured	  on	  a	  NanoDrop	  2000c	  
spectrophotometer	  (Thermo	  Fisher	  Scientific).	  	  For	  routine	  RNA	  preparations,	  samples	  were	  then	  diluted	  
to	  1	  µg/µl	  in	  RNase-­‐free	  dH20.	  	  
	  
2.2.2	  Measuring	  RNA	  per	  cell	  
	   To	  estimate	  the	  amount	  of	  total	  RNA	  per	  cell,	  HFF	  and	  iPS	  cells	  were	  collected	  and	  counted	  
using	  a	  hemocytometer.	  	  Total	  RNA	  was	  isolated	  from	  a	  known	  number	  of	  cells	  using	  TRIzol	  and	  
quantification	  on	  a	  NanoDrop	  2000c	  spectrophotometer	  allowed	  calculation	  of	  µg	  RNA/cell.	  	  
26	  
	  
2.2.3	  Reverse	  transcription	  	  
	   Complementary	  DNA	  (cDNA)	  was	  made	  using	  random	  hexamers	  (Integrated	  DNA	  Technologies	  
Inc)	  and	  ImProm-­‐II	  Reverse	  Transcriptase	  (Promega)	  following	  the	  manufacturer’s	  protocol.	  	  Briefly,	  1	  µg	  
of	  total	  RNA	  was	  annealed	  to	  500	  ng	  random	  hexamer	  in	  a	  5	  µL	  reaction	  at	  70°C	  for	  5	  minutes	  followed	  
by	  rapid	  cooling	  to	  4°C.	  	  Reverse	  transcription	  was	  then	  carried	  out	  by	  adding	  15	  µL	  of	  a	  prepared	  
mixture	  containing	  4	  µL	  5x	  Reaction	  Buffer	  (250	  mM	  Tris-­‐HCl	  (pH	  8.3),	  375	  mM	  KCl,	  and	  50	  mM	  DTT),	  1	  
µL	  10	  mM	  dNTPs,	  2.4	  µL	  25	  mM	  MgCl2,	  5.6	  uL	  RNase-­‐free	  dH20,	  1	  µL	  RiboLock	  RNase	  Inhibitor	  
(Fermentas),	  and	  1	  µL	  ImProm-­‐II	  Reverse	  Transcriptase	  and	  incubated	  in	  a	  thermal	  cycler	  at	  25°C	  for	  10	  
minutes,	  50°C	  for	  60	  minutes	  and	  70°C	  for	  15	  minutes.	  	  	  
	  
2.2.4	  Semi-­‐quantitative	  PCR	  	  
	   Semi-­‐quantitative	  PCR	  was	  carried	  out	  using	  the	  GoTaq	  Flexi	  Polymerase	  kit	  by	  Promega.	  	  In	  a	  25	  
µL	  reaction,	  2	  µL	  of	  cDNA	  was	  mixed	  with	  5	  µL	  5x	  Green	  GoTaq	  Reaction	  Buffer,	  0.5	  µL	  forward	  primer,	  
0.5	  µL	  reverse	  primer,	  0.5	  µL	  10	  mM	  dNTPs,	  2	  µL	  25	  mM	  MgCl2,	  14	  µL	  dH20	  and	  0.5	  µL	  Taq	  polymerase.	  	  
Amplification	  was	  performed	  in	  a	  Gene	  Amp	  PCR	  System	  2700	  thermal	  cycler	  (Applied	  Biosystems)	  and	  
PCR	  products	  were	  visualized	  on	  1-­‐2%	  agarose	  gels	  containing	  EtBr	  with	  GeneRuler	  1kb	  DNA	  Ladder	  or	  
GeneRuler	  DNA	  Ladder	  Mix	  (Thermo	  Fisher	  Scientific).	  	  Quantification	  of	  band	  intensities	  was	  performed	  
using	  ImageQuant	  software	  (GE	  Healthcare).	  	  The	  primers	  used	  for	  semi-­‐quantitative	  PCR	  are	  listed	  in	  
Table	  2.1	  below.	  	  
	  
Table	  2.1	  List	  of	  primers	  used	  for	  RT-­‐PCR	  experiments.
Primer	  name Gene	  ID Gene Forward	  sequence Reverse	  sequence Annealing Elongation	   Cycles
mRhoC	  F/R 11853 Rhoc AAAGCTTCCTCAACCCTCCCA CTACCCAAAGCAGAAACCCCCA 50°C 1	  min 32
GAPDH	  F/R 2597 GAPDH AAGGTGAAGGTCGGAGTCAA AATGAAGGGGTCATTGATGG 60°C 1	  min 32
PCBP4	  Exon	  9	  F/R 57060 PCBP4 CTCCTGCAAATGGTGGAAAT TCGGATGGTAGGGGATAGTG 60°C 30	  sec 30




2.2.5	  Quantitative	  PCR	  
	   To	  perform	  quantitative	  PCR	  (qPCR),	  a	  3x	  master	  mix	  was	  prepared	  for	  each	  reaction	  using	  15	  µL	  
of	  iQ	  SYBR	  Green	  Supermix	  (Bio-­‐Rad),	  1.2	  µL	  of	  each	  primer	  (2.5mM),	  1.2	  µL	  of	  dH2O	  and	  2.4	  µL	  of	  cDNA.	  	  
Reactions	  were	  divided	  into	  three	  10	  µL	  aliquots	  for	  three	  replicates.	  	  Thermal	  cycling	  was	  performed	  
using	  the	  CFX96	  Real-­‐Time	  PCR	  Detection	  System	  and	  analyzed	  using	  CFX	  Manager	  software	  (Bio-­‐Rad).	  	  
All	  primer	  pairs	  were	  standardized	  using	  5-­‐	  or	  10-­‐fold	  cDNA	  serial	  dilutions	  to	  allow	  determination	  of	  
PCR	  efficiency.	  	  All	  primers	  were	  required	  to	  meet	  the	  following	  standards:	  PCR	  efficiency	  was	  between	  
80-­‐120%,	  the	  correlation	  coefficient	  of	  the	  standard	  curve	  was	  >0.98,	  and	  produced	  a	  single	  product	  of	  
the	  correct	  size	  as	  visualized	  by	  agarose	  gel	  electrophoresis.	  	  For	  relative	  abundance	  data,	  target	  gene	  
expression	  was	  normalized	  to	  reference	  gene	  GAPDH	  mRNA.	  	  To	  calculate	  this	  output,	  the	  CFX	  Manager	  
software	  applied	  the	  Pfaffl	  Method	  (Pfaffl,	  2001)	  to	  determine	  expression	  relative	  to	  the	  reference	  gene,	  
taking	  into	  account	  individual	  primer	  amplification	  efficiencies.	  	  	  	  	  
	   Primers	  were	  designed	  and	  chosen	  using	  various	  web-­‐based	  programs	  such	  as	  Primer3	  Input	  
(Version	  0.4.0;	  http://frodo.wi.mit.edu/),	  Primer_BLAST	  (http://www.ncbi.nlm.nih.gov/tools/primer-­‐
blast/),	  and	  qPrimerDepot	  (http://primerdepot.nci.nih.gov/).	  	  Primer	  sets	  were	  designed	  using	  
parameters	  for	  GC	  content	  of	  40-­‐60%,	  annealing	  temperature	  between	  58°C	  and	  60°C,	  and	  length	  of	  ~20	  
nucleotides.	  	  Sequences	  used	  as	  input	  for	  primer	  design	  corresponded	  to	  the	  open	  reading	  frame	  of	  
each	  transcript.	  	  As	  DNAse	  treatment	  was	  routinely	  performed	  on	  isolated	  total	  RNA	  samples,	  primers	  
were	  not	  specifically	  designed	  to	  span	  introns.	  	  The	  primers	  used	  for	  qPCR	  are	  listed	  in	  Table	  2.2	  below.	  	  
For	  histone	  mRNA	  detections,	  primer	  sets	  that	  recognize	  core	  histones	  H2A,	  H2B,	  H3,	  and	  H4	  and	  linker	  
histone	  H1	  were	  generously	  provided	  by	  Dr.	  Paul	  Laybourn	  and	  detect	  multiple	  transcripts	  within	  each	  
histone	  family	  (Bogenberger	  and	  Laybourn,	  2008),	  therefore	  a	  specific	  gene	  ID	  was	  not	  provided	  for	  




Table	  2.2	  List	  of	  primers	  used	  for	  qRT-­‐PCR	  experiments.
Primer	  name Gene	  ID Gene	  name Forward	  sequence Reverse	  sequence Efficiency	  (%)
DGCR8_3	  F/R 	  54487 DGCR8 CAAGCAGGAGACATCGGACAAG CACAATGGACATCTTGGGCTTC 108.1
DUSP7_2	  F/R 1849 DUSP7 CTGAGGCCATCAGCTTCATT TAGGCGTCGTTGAGTGACAG 115.4
FOS_1	  F/R 	  2353 FOS GTGGGAATGAAGTTGGCACT CTACCACTCACCCGCAGACT 95.8
GAPDH	  F/R 2597 GAPDH AAGGTGAAGGTCGGAGTCAA AATGAAGGGGTCATTGATGG 112.1
H1	  F/R N/A H1 CCGGTGTCCGAGCTCATTACTAAA GCTTTCTTGAGAGCGGCCAAAGAT 99.5
H2A	  F/R N/A H2A AGCTCAACAAGCTTCTGGGCAA TTGTGGTGGCTCTCGGTCTTCTT 110.7
H2B	  F/R N/A H2B TGCGCCCAAGAAGGGTTCTAAA ACGAAGGAGTTCATGCCCA 117.5
H3	  F/R N/A H3 TGCTCATCCGCAAACTGCCATT AGTGACACGCTTGGCGTGAATA 105.5
H4F/R N/A H4 ACCGTAAAGTACTGCGCGACAA TTCTCCAGGAACACCTTCAGCA 98.4
LATS2_3	  F/R 	  26524 LATS2 AAGAGCTACTCGCCATACGCCTTT AGCTTTGGCCATTTCTTGCTCCAG 94.2
PCBP1_1	  F/R 5093 PCBP1 GTAACGAGCCCAACTCCCCCGA CCTCCGAGATGTTGATCCGCGC 93.8
PCBP2_1	  F/R 	  5094 PCBP2 GCTGCACCAGTTGGCAATGCAA AGCCTTTCACCTCTGGAGAGCTGG 107.9
PCBP3_3	  F/R 54039 PCBP3 TATAGCCTGCTTATGGGGGA AGGCCACCTTCTGAGACCTT 95.9
PCBP4_1	  F/R 57060 PCBP4 GGCGAGACTGTAAAGCGAAT TGGAGACTGCATGGAAGACA 111.7
TOB2_1	  F/R 10766 TOB2 CACCCTGGAGGGAGAAGC AGAGAATCAGCACAGGGCAC 108.5
TUT1_1	  F/R 64852 TUT1 TACTTCCAGACATTTGGCCC CTGTGCTTGGGCTGTGATAA 98.6
WEE1_4	  F/R 7465 WEE1 ATTTCTCTGCGTGGGCAGAAG CAAAAGGAGATCCTTCAACTCTGC 108.7
ZNF134_1	  F/R 7693 ZNF134 GAGTCATGCCCTCTCAGGC CTACGAACTGTGATGGCGG 108.2
ZNF43_1	  F/R 7594 ZNF43 TGGCCAAAAGTCTTGGGTAA TGATCACCTGTCTGGAGCAA 114.2
ZNF627_2	  F/R 199692 ZNF627 TTGAGGATGTGGCTGTGAAC CAGAAGCCAGGTTCCTGAAG 97.8 	  
	  
	  
2.2.6	  Measuring	  mRNA	  half-­‐life	  
	   To	  determine	  mRNA	  half-­‐lives,	  cells	  were	  treated	  with	  5	  µg/mL	  actinomycin	  D	  (Invitrogen)	  
starting	  20	  minutes	  before	  the	  collection	  of	  the	  0	  minute	  time	  point.	  	  Cells	  were	  collected	  in	  TRIzol	  at	  0,	  
15,	  30,	  60,	  120	  and	  240	  minutes	  after	  the	  20	  minute	  pre-­‐incubation.	  	  Total	  RNA	  was	  isolated	  in	  TRIzol	  
and	  cDNA	  was	  made	  as	  described	  in	  Sections	  2.2.1	  and	  2.2.3.	  	  Quantitative	  PCR	  was	  used	  to	  measure	  the	  
abundance	  of	  specific	  mRNAs	  at	  each	  time	  point.	  	  The	  mRNA	  abundances	  were	  then	  fit	  to	  an	  
exponential	  curve	  to	  provide	  a	  decay	  rate	  constant	  (k)	  and	  a	  half-­‐life	  was	  derived	  based	  on	  the	  equation	  





2.2.7	  Preparation	  and	  hybridization	  of	  RNAs	  for	  microarrays	  
	   For	  the	  microarrays,	  transcription	  shut-­‐off	  was	  performed	  in	  four	  replicates	  for	  each	  cell	  line.	  	  To	  
confirm	  that	  transcription	  had	  been	  effectively	  inhibited,	  decay	  rates	  of	  FOS	  and	  TUT1	  mRNAs	  were	  
measured	  using	  GAPDH	  mRNA	  as	  a	  reference	  gene.	  	  After	  appropriate	  half-­‐lives	  were	  calculated,	  the	  
replicates	  were	  compared	  to	  one	  another	  to	  choose	  the	  three	  that	  gave	  the	  lowest	  standard	  deviation.	  	  
These	  were	  then	  sent	  to	  Erin	  Petrilli	  at	  the	  CSU	  Genomics	  and	  Proteomics	  Core	  who	  used	  a	  Bioanalyzer	  
(Agilent)	  to	  verify	  RNA	  quality	  and	  then	  processed	  the	  samples	  for	  hybridization	  to	  18	  Affymetrix	  Human	  
Gene	  1.0	  ST	  microarrays	  (one	  per	  time	  point	  per	  replicate).	  	  Datasets	  were	  sent	  to	  collaborators	  at	  
Rutgers	  University	  –	  New	  Jersey	  Medical	  School	  where	  Dr.	  Ju	  Youn	  Lee	  performed	  bioinformatic	  analysis	  
under	  the	  mentorship	  of	  Dr.	  Bin	  Tian.	  	  	  
	  
2.2.8	  Inhibition	  of	  DNA	  synthesis	  using	  hydroxyurea	  	  
	   To	  measure	  half-­‐lives	  of	  histone	  mRNAs	  following	  the	  end	  of	  S	  phase,	  cells	  were	  treated	  with	  5	  
µg/mL	  of	  hydroxyurea	  (HU,	  Sigma)	  in	  complete	  medium	  and	  incubated	  at	  37°C	  with	  5%	  CO2.	  	  Thirty	  
minutes	  following	  the	  addition	  of	  HU,	  the	  0	  minute	  time	  point	  was	  collected	  in	  TRIzol.	  	  Additional	  
samples	  were	  collected	  at	  15,	  30,	  60,	  120	  and	  240	  minutes.	  	  RNA	  isolation	  and	  qRT-­‐PCR	  analysis	  of	  half-­‐
life	  was	  performed	  as	  previously	  described	  in	  Sections	  2.2.1,	  2.2.3,	  2.2.5,	  and	  2.2.6.	  	  	  
	  
2.2.9	  Measuring	  microRNA	  abundance	  	  
	   Measurement	  of	  microRNA	  (miRNA)	  abundance	  by	  qRT-­‐PCR	  was	  performed	  as	  previously	  
described	  (Git	  et	  al.,	  2010).	  	  Approximately	  1	  µg	  of	  total	  RNA	  was	  polyadenylated	  in	  a	  25	  µL	  reaction	  
using	  the	  Poly(A)	  Tailing	  Kit	  (Ambion)	  according	  to	  the	  manufacturer’s	  protocol.	  	  After	  
phenol:chloroform	  extraction,	  cDNA	  was	  made	  using	  500	  ng	  of	  Poly(T)	  adapter	  (Integrated	  DNA	  
Technologies	  Inc)	  and	  ImProm-­‐II	  Reverse	  Transcriptase.	  	  The	  resulting	  cDNA	  as	  treated	  with	  RNase	  H	  
30	  
	  
(Fermentas)	  at	  37°C	  for	  1	  hour	  and	  12.5	  ng	  was	  added	  to	  each	  reaction	  for	  qPCR	  analysis.	  	  MicroRNA	  
abundances	  were	  measured	  using	  a	  universal	  reverse	  primer	  and	  miRNA-­‐specific	  forward	  primers	  and	  
normalized	  to	  human	  5S	  rRNA.	  	  MicroRNA	  targets	  were	  chosen	  based	  on	  those	  identified	  in	  Schnall-­‐
Levin	  et	  al.	  (2011)	  and	  primer	  sequences	  were	  provided	  in	  the	  Supplemental	  Materials	  of	  Git	  et	  al.	  





2.3	  Protein	  preparation	  and	  assays	  
2.3.1	  Preparation	  of	  whole	  cell	  lysates	  
	   Whole	  cell	  lysates	  were	  prepared	  by	  washing	  cells	  twice	  in	  PBS	  and	  lysing	  in	  Radio	  
Immunoprecipitation	  (RIPA)	  buffer	  (50	  mM	  Tris-­‐Cl	  (pH	  7.4),	  150	  mM	  NaCl,	  1	  mM	  EDTA,	  1%	  Triton	  X-­‐100,	  
1%	  Na-­‐deoxycholate,	  0.1%	  SDS,	  1	  mM	  PMSF	  and	  1x	  Protease	  Inhibitor	  Cocktail	  Tablets	  (Roche)).	  	  
Extracts	  were	  sonicated	  three	  times	  for	  3	  seconds	  each	  with	  resting	  on	  ice	  for	  30	  seconds	  and	  insoluble	  
material	  was	  removed	  by	  centrifugation	  at	  maximum	  speed,	  or	  16,100	  x	  g,	  for	  5	  minutes	  at	  4°C.	  	  
	   Protein	  concentrations	  were	  measured	  using	  the	  Bio-­‐Rad	  Protein	  Assay	  (Bio-­‐Rad)	  according	  to	  
the	  manufacturer’s	  protocol.	  	  Briefly,	  1	  mL	  of	  reagent	  diluted	  1:5	  in	  dH2O	  was	  added	  to	  20	  µL	  of	  lysate	  
Table	  2.3	  List	  of	  oligonucleotides	  used	  for	  quantification	  of	  miRNAs	  by	  qRT-­‐PCR.
Oligonucleotide Sequence Efficiency	  (%)
Poly(T)	  adapter GCGAGCACAGAATTAATACGACTCACTATAGGTTTTTTTTTTTT(A/G/C)(A/G/C/T)
Universal	  Reverse GCGAGCACAGAATTAATACGACTC









diluted	  1:10	  in	  dH2O.	  	  After	  10	  minutes	  of	  incubation	  at	  room	  temperature,	  the	  absorbance	  was	  
measured	  at	  595	  nm	  wavelength	  on	  an	  Ultrospec	  2000	  spectrophotometer	  (Pharmacia	  Biotech).	  	  A	  
standard	  curve	  was	  generated	  using	  known	  concentrations	  of	  BSA	  and	  then	  was	  applied	  to	  the	  sample	  
absorbance	  values	  to	  determine	  sample	  concentration.	  
	  
2.3.2	  Measuring	  protein	  per	  cell	  
	   To	  estimate	  the	  amount	  of	  protein	  per	  cell,	  cells	  were	  counted	  prior	  to	  protein	  extraction	  and	  
protein	  abundance	  was	  determined	  by	  two	  methods.	  	  First,	  a	  known	  number	  of	  cells	  were	  lysed	  in	  RIPA	  
buffer	  and	  protein	  concentration	  was	  measured	  using	  the	  Bio-­‐Rad	  Protein	  Assay	  (described	  in	  Section	  
2.3.1).	  	  Second,	  equal	  numbers	  of	  cells	  were	  pelleted	  and	  resuspended	  in	  1x	  SDS	  protein	  dye	  (diluted	  
from	  6x	  SDS	  protein	  dye	  (0.375	  M	  Tris-­‐Cl	  (pH	  6.8),	  12%	  SDS,	  60%	  glycerol,	  0.6	  M	  DTT,	  and	  0.06%	  
bromophenol	  blue))	  and	  separated	  on	  a	  15%	  SDS-­‐PAGE	  gel.	  	  The	  gel	  was	  Coomassie	  stained	  as	  described	  
in	  Section	  2.3.4	  and	  compared	  to	  a	  Coomassie	  stained	  gel	  resolving	  equal	  µg	  amounts	  of	  whole	  cell	  
lysates.	  	  
	  
2.3.3	  Western	  blot	  analysis	  
	   To	  determine	  protein	  abundance,	  western	  blot	  analysis	  was	  performed	  using	  whole	  cell	  lysates	  
from	  HFF	  and	  iPS	  cells.	  	  Protein	  samples	  of	  25	  µg	  each	  were	  prepared	  for	  SDS-­‐PAGE	  by	  adding	  6x	  SDS	  
protein	  dye	  and	  boiling	  at	  95°C	  for	  2	  minutes.	  	  Samples	  for	  detection	  of	  core	  histones	  H2A,	  H2B,	  H3,	  and	  
H4	  were	  separated	  on	  15%	  SDS-­‐PAGE	  gels	  and	  transferred	  to	  0.2	  µm	  PVDF	  Immobilon-­‐PSQ	  Membrane	  
(Millipore)	  in	  1x	  Transfer	  Buffer	  (25	  mM	  Tris	  and	  192	  mM	  glycine,	  pH	  8.3)	  containing	  35%	  methanol.	  	  All	  
other	  proteins	  were	  resolved	  on	  8%	  or	  10%	  SDS-­‐PAGE	  gels	  in	  1x	  SDS-­‐PAGE	  Buffer	  (25	  mM	  Tris,	  192	  mM	  
glycine	  and	  0.1%	  SDS)	  and	  transferred	  to	  0.45	  µm	  PVDF	  Immobilon	  Transfer	  Membranes	  (Millipore)	  in	  1x	  
Transfer	  Buffer	  containing	  20%	  methanol.	  	  Membranes	  for	  the	  detection	  of	  CELF1	  (also	  known	  as	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CUGBP1)	  were	  blocked	  and	  incubated	  in	  5%	  non-­‐fat	  dry	  milk	  in	  1x	  PBS	  and	  0.05%	  Tween-­‐20	  (PBST),	  
while	  all	  others	  were	  blocked	  and	  incubated	  in	  5%	  non-­‐fat	  dry	  milk	  in	  1x	  Tris	  Buffered	  Saline	  (TBS)	  and	  
0.1%	  Tween-­‐20	  (TBST).	  	  Antibody	  incubations	  took	  place	  for	  1.5	  hours	  at	  room	  temperature	  followed	  by	  
three	  10	  minute	  washes	  with	  1xTBST.	  	  SuperSignal	  West	  Pico	  Chemiluminescent	  Substrate	  (Thermo	  
Fisher	  Scientific)	  was	  used	  for	  detection	  in	  concert	  with	  a	  ChemiDoc	  XRS+	  System	  (Bio-­‐Rad).	  	  
Quantification	  was	  performed	  using	  ImageLab3.0	  software	  (Bio-­‐Rad).	  	  Antibodies	  used	  for	  western	  blot	  
analysis	  are	  listed	  in	  Table	  2.4	  below.	  	  
	  
Table	  2.4	  List	  of	  antibodies	  used	  for	  western	  blot	  analysis.
Protein	  target Product	  name Company Type Dilution
Alpha-­‐tubulin Anti-­‐a-­‐Tubulin Sigma mouse	  monoclonal 1:15,000	  -­‐	  1:20,000
AUF1 Anti-­‐AUF1	   Mill ipore rabbit	  polyclonal 1:5,000
CUGBP1/CELF1 CUG-­‐BP1	  (3B1) Santa	  Cruz	  Biotechnology	  Inc.	   mouse	  monoclonal 1:5,000
GAPDH Anti-­‐GAPDH Millipore mouse	  monoclonal 1:20,000
H1	   Histone	  H1	  (AE-­‐4) Santa	  Cruz	  Biotechnology	  Inc.	   mouse	  monoclonal 1:150
H2A Anti-­‐Histone	  H2A	  (acidic	  patch) Mill ipore rabbit	  polyclonal 1:250
H2A Histone	  H2A	  (C-­‐19) Santa	  Cruz	  Biotechnology	  Inc.	   goat	  polyclonal 1:1,000
H2B Anti-­‐Histone	  H2B	  Antibody Mill ipore rabbit	  polyclonal 1:1,000
H3 Anti-­‐Histone	  H3	  Antibody Mill ipore rabbit	  polyclonal 1:1,000
H4 Histone	  H4	  Antibody Bethyl	  Laboratories,	  Inc. rabbit	  polyclonal 1:10,000
HuR HuR	  (3A2) Hybridoma mouse	  monoclonal 1:50
KHSRP KHSRP	  Antibody Novus	  Biologicals rabbit	  polyclonal 1:5,000
PARN Anti-­‐PARN	  serum BIOO	  Scientific/in	  house rabbit	  polyclonal 1:5,000
PCBP1 Anti-­‐PCBP1	  	   MBL	  International rabbit	  polyclonal 1:1,000
PCBP1 Anti-­‐PCBP1	  	   Abnova mouse	  polyclonal 1:1,000
PCBP2 hnRNP	  E2	  (23-­‐G) Santa	  Cruz	  Biotechnology	  Inc.	   mouse	  monoclonal 1:2:50
PCBP2 Anti-­‐PCBP2 Abnova rabbit	  polyclonal 1:5,000
PCBP3 Anti-­‐PCBP3 Sigma rabbit	  polyclonal 1:1,000
PCBP3 Anti-­‐PCBP3 MBL	  International rabbit	  polyclonal 1:15,000
PCBP4	  (Isoform	  C) PCBP4	  (B-­‐25) Santa	  Cruz	  Biotechnology	  Inc.	   rabbit	  polyclonal 1:150
PCBP4	  (Isoform	  A) Anti-­‐PCBP4	  (196-­‐210) Sigma rabbit	  polyclonal 1:1,000
PTBP1 PTBP1 Abcam goat	  polyclonal 1:500
PUM2 Pumilio	  2	  Antibody Bethyl	  Laboratories,	  Inc. rabbit	  polyclonal 1:5,000
SLBP SLBP	  Antibody	  (2C4-­‐1C8) Novus	  Biologicals mouse	  monoclonal 1:500
XRN1 XRN1	  (C-­‐1) Santa	  Cruz	  Biotechnology	  Inc.	   mouse	  monoclonal 1:5,000
ZFP36L2 Anti-­‐ZFP36L2 Genway rabbit	  polyclonal 1:500
Donkey	  anti-­‐goat	  IgG-­‐HRP Santa	  Cruz	  Biotechnology	  Inc.	   Secondary 1:5,000	  -­‐	  1:10,000
Goat	  anti-­‐mouse	  IgG-­‐HRP Santa	  Cruz	  Biotechnology	  Inc.	   Secondary 1:10,000	  -­‐	  1:20,000
Goat	  anti-­‐rabbit	  IgG	  (H+L)-­‐HRP Bio-­‐Rad Secondary 1:2,000	  -­‐	  1:20,000 	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2.3.4	  Coomassie	  staining	  of	  SDS-­‐PAGE	  gels	  
	   To	  visualize	  histone	  proteins	  in	  a	  total	  lysate	  sample,	  25	  µg	  of	  protein	  was	  resolved	  on	  a	  15%	  
SDS-­‐PAGE	  gel	  which	  was	  then	  fixed	  in	  50%	  methanol/10%	  acetic	  acid	  for	  10	  minutes.	  	  The	  gel	  was	  
stained	  with	  0.5%	  Coomassie	  Blue	  R-­‐250	  for	  2	  hours	  then	  destained	  in	  40%	  methanol/10%	  acetic	  acid	  
and	  washed	  in	  MilliQ	  water.	  	  The	  gel	  was	  imaged	  with	  a	  ChemiDoc	  XRS+	  System	  and	  then	  allowed	  to	  dry	  
between	  two	  sheets	  of	  cellophane	  after	  which	  a	  scanned	  image	  was	  taken	  using	  PhotoSuite	  (MGI).	  	  Core	  
histones	  (H2A,	  H2B,	  H3,	  and	  H4)	  were	  the	  predominant	  bands	  with	  molecular	  weights	  between	  10	  –	  15	  
kDA.	  	  Quantification	  was	  performed	  using	  ImageQuant	  software.	  	  
	  
2.3.5	  Two	  dimensional	  protein	  electrophoresis	  	  
2.3.5.1	  Lysate	  preparation	  
	   Cells	  were	  lysed	  in	  RIPA	  buffer	  containing	  Protease	  Inhibitor	  Cocktail	  and	  100x	  Halt	  Phosphatase	  
Inhibitor	  Cocktail	  (Pierce)	  at	  a	  final	  concentration	  of	  1x.	  	  Lysate	  samples	  were	  sonicated	  and	  protein	  
concentration	  was	  measured	  as	  previously	  described	  in	  Section	  2.3.1.	  	  Aliquots	  were	  then	  made	  of	  300	  
µg	  lysate	  each	  and	  stored	  at	  -­‐80°C	  until	  use.	  	  Pellets	  were	  resuspended	  in	  125	  µL	  Rehydration	  Buffer	  (8	  
M	  urea,	  2	  M	  thiourea,	  2%	  CHAPS,	  0.3%	  DTT,	  0.2%	  Triton-­‐X	  100,	  and	  ~0.002%	  bromophenol	  blue)	  
containing	  2.5%	  carrier	  ampholytes,	  pH	  3-­‐10	  (Fluka).	  	  	  
	  
2.3.5.2	  Isoelectric	  focusing	  	  
	   Prior	  to	  loading	  for	  two	  dimensional	  (2D)	  protein	  electrophoresis,	  protein	  samples	  were	  
centrifuged	  at	  maximum	  speed	  for	  5	  minutes.	  	  Samples	  were	  loaded	  on	  ReadyStrip	  Immobilized	  pH	  
Gradient	  (IPG)	  Strips,	  pH	  3-­‐10	  (Bio-­‐Rad)	  using	  the	  Bio-­‐Rad	  Protean	  IEF	  Cell.	  	  The	  first	  dimension	  was	  run	  
following	  12	  hours	  of	  active	  rehydration	  at	  50	  V	  and	  focusing	  was	  performed	  initially	  at	  250	  V	  for	  15	  
minutes	  then	  for	  a	  total	  of	  30	  kV-­‐hours.	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2.3.5.3	  Second	  dimension	  analysis	  
	  	   After	  focusing,	  strips	  were	  washed	  in	  Equilibration	  Buffer	  (6	  M	  urea,	  30%	  glycerol,	  2%	  SDS,	  and	  
24	  mM	  Tris-­‐Cl	  (pH	  6.8))	  containing	  2%	  DTT	  followed	  by	  Equilibration	  Buffer	  containing	  2.5%	  
iodoacetamide.	  	  Strips	  were	  then	  loaded	  onto	  precast	  Mini-­‐Protean	  TGX	  Gels	  (Bio-­‐Rad)	  with	  Precision	  
Plus	  Protein	  Standard	  Plugs,	  unstained	  (Bio-­‐Rad).	  	  To	  seal	  the	  strip	  and	  plug	  into	  the	  gel,	  an	  agarose	  
overlay	  (0.5%	  agarose	  and	  ~0.003%	  bromophenol	  blue	  in	  1x	  SDS-­‐PAGE	  Running	  Buffer)	  was	  applied	  to	  
the	  top	  of	  each	  well.	  	  After	  the	  overlay	  had	  solidified,	  the	  gel	  was	  run	  in	  1x	  SDS-­‐PAGE	  Buffer	  at	  150	  V	  for	  
approximately	  1.5	  hours.	  	  Proteins	  were	  transferred	  to	  0.45	  µm	  PVDF	  Immobilon	  Transfer	  Membranes	  
using	  a	  semi-­‐dry	  transfer	  apparatus	  and	  1x	  Transfer	  Buffer	  containing	  20%	  methanol	  at	  18	  V	  for	  20-­‐25	  
minutes.	  	  	  
	   To	  mark	  the	  ladder,	  membranes	  were	  stained	  in	  0.1%	  Ponceau	  S	  in	  1%	  acetic	  acid	  for	  5	  minutes	  
followed	  by	  two	  5	  minutes	  washes	  in	  5%	  acetic	  acid	  and	  two	  5	  minute	  washes	  in	  dH2O.	  	  A	  pencil	  was	  
used	  to	  mark	  the	  ladder	  and	  then	  membranes	  were	  blocked	  in	  5%	  milk	  in	  TBST.	  	  Antibody	  detection	  was	  
performed	  as	  previously	  described	  in	  Section	  2.3.3.	  	  The	  antibodies	  used	  for	  2D	  protein	  electrophoresis	  
are	  listed	  below	  in	  Table	  2.5.	  	  
	  
Table	  2.5	  List	  of	  antibodies	  used	  for	  two	  dimensional	  protein	  electrophoresis.
Protein	  target Product	  name Company Type Dilution
PCBP1 Anti-­‐PCBP1	  	   MBL	  International rabbit	  polyclonal 1:1,000
PCBP2 hnRNP	  E2	  (23-­‐G) Santa	  Cruz	  Biotechnology	  Inc.	   mouse	  monoclonal 1:250
PCBP3 Anti-­‐PCBP3 Sigma rabbit	  polyclonal 1:1,000
PCBP4	  (Isoform	  C) PCBP4	  (B-­‐25) Santa	  Cruz	  Biotechnology	  Inc.	   rabbit	  polyclonal 1:150
PCBP4	  (Isoform	  A) Anti-­‐PCBP4	  (196-­‐210) Sigma rabbit	  polyclonal 1:1,000
alpha-­‐tubulin Anti-­‐α-­‐Tubulin Sigma mouse	  monoclonal 1:15,000
GAPDH Anti-­‐GAPDH Millipore mouse	  monoclonal 1:20,000
Goat	  anti-­‐mouse	  IgG-­‐HRP Santa	  Cruz	  Biotechnology	  Inc.	   Secondary 1:15,000





2.4	  Bioinformatic	  analysis	  of	  microarray	  data	  	  
	   As	  bioinformatic	  analyses	  described	  here	  were	  performed	  in	  large	  part	  by	  Dr.	  Ju	  Youn	  Lee	  and	  
Dr.	  Carol	  Wilusz,	  explanation	  of	  methodology	  has	  been	  adapted	  from	  descriptions	  that	  appeared	  in:	  	  
Neff	  et	  al.	  Global	  analysis	  reveals	  multiple	  pathways	  for	  unique	  regulation	  of	  mRNA	  decay	  in	  induced	  
pluripotent	  stem	  cells.	  Genome	  Research.	  Vol.	  22,	  No.	  8,	  pg.	  1457-­‐1467,	  August	  2012.	  	  
2.4.1	  Half-­‐life	  analysis	  by	  microarray	  
	   Microarray	  data	  were	  first	  processed	  by	  the	  Affymetrix	  Power	  Tools	  (APT)	  program,	  using	  the	  
GC-­‐bin	  method	  for	  background	  correction.	  	  All	  probe	  set	  values	  were	  then	  normalized	  to	  the	  fifth-­‐
percentile	  value	  of	  the	  same	  array.	  	  Transcripts	  whose	  probe	  sets	  with	  Detection	  Above	  Background	  
(DABG)	  P-­‐value	  <0.05	  for	  at	  least	  two	  out	  of	  three	  replicates	  at	  the	  0	  min	  time	  point	  were	  considered	  
“expressed”	  and	  used	  for	  subsequent	  analysis.	  	  	  
	   Global	  mRNA	  half-­‐lives	  were	  determined	  from	  microarray	  data	  by	  Dr.	  Ju	  Youn	  Lee	  who	  applied	  a	  
nonlinear	  least	  squares	  model	  (NLS;	  Wang	  et	  al.,	  2002).	  	  Similar	  to	  that	  described	  in	  Section	  2.2.6,	  the	  
abundance	  values	  of	  each	  transcript	  at	  time	  points	  following	  actinomycin	  D	  treatment	  were	  fitted	  to	  a	  
first-­‐order	  exponential	  decay	  curve	  over	  time	  to	  determine	  the	  decay	  rate	  constant	  (k).	  	  Half-­‐life	  (T1/2)	  
was	  defined	  as	  ln(2)/k.	  	  All	  three	  replicates	  were	  used	  to	  generate	  a	  single	  decay	  curve	  for	  each	  
transcript	  and	  half-­‐lives	  were	  deemed	  reliable	  for	  those	  that	  fit	  the	  exponential	  decay	  curve	  with	  P-­‐value	  
<0.05.	  	  	  
	  
2.4.2	  Gene	  Ontology	  analysis	  
	   Gene	  Ontology	  (GO)	  analysis	  was	  performed	  by	  Dr.	  Ju	  Youn	  Lee	  and	  Dr.	  Carol	  Wilusz.	  	  Gene	  lists	  
were	  uploaded	  to	  DAVID	  (Huang	  et	  al.,	  2009)	  along	  with	  a	  background	  list	  consisting	  of	  all	  the	  genes	  for	  
which	  half-­‐lives	  were	  generated	  in	  both	  cell	  types.	  	  Terms	  that	  were	  significantly	  over-­‐represented	  in	  the	  
list	  of	  interest	  were	  selected	  based	  on	  P-­‐value.	  	  For	  analysis	  of	  domains	  enriched	  in	  ZNF	  mRNAs,	  DAVID	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was	  used	  to	  retrieve	  lists	  of	  genes	  associated	  with	  terms	  defined	  by	  Simple	  Modular	  Architecture	  
Research	  Tool	  (SMART;	  Letunic	  et	  al.,	  2009).	  	  The	  accession	  numbers	  for	  these	  terms	  are	  C2H2-­‐ZNF	  
#SM00355	  or	  KRAB	  #SM00349.	  	  Half-­‐lives	  for	  genes	  in	  each	  list	  were	  then	  used	  to	  generate	  a	  box-­‐and-­‐
whiskers	  plot	  and	  P-­‐values	  were	  determined	  using	  the	  Kolmogorov-­‐Smirnov	  Test.	  	  	  
	  
2.4.3	  Cis-­‐element	  analysis	  	  
	   Analysis	  of	  cis-­‐elements	  over-­‐represented	  in	  mRNAs	  was	  performed	  by	  Dr.	  Ju	  Youn	  Lee	  who	  
examined	  5’	  untranslated	  regions	  (UTRs),	  ORFs,	  and	  3’	  UTRs	  for	  hexamers	  that	  were	  significantly	  
enriched	  in	  the	  most	  stable	  (top	  10%	  in	  half-­‐life)	  and	  the	  least	  stable	  (bottom	  10%	  in	  half-­‐life)	  
transcripts.	  	  Sequences	  and	  their	  annotations	  were	  retrieved	  from	  the	  RefSeq	  database	  and	  the	  
significance	  of	  a	  hexamer	  was	  calculated	  by	  the	  Fisher’s	  exact	  test	  comparing	  its	  frequencies	  in	  the	  most	  
stable	  and	  least	  stable	  mRNA	  sets.	  	  A	  significance	  score	  was	  assigned	  to	  each	  hexamer	  equaling	  –log10(P-­‐
value)*s	  where	  s	  equals	  -­‐1	  if	  the	  hexamer	  is	  more	  common	  in	  the	  least	  stable	  transcripts	  and	  s	  equals	  1	  















Chapter	  3:	  Global	  analysis	  reveals	  multiple	  pathways	  for	  unique	  regulation	  of	  




3.1	  Introduction	  	  
	   Large-­‐scale	  approaches	  to	  studying	  mRNA	  decay	  have	  been	  used	  for	  more	  than	  a	  decade	  
(Bernstein	  et	  al.,	  2002;	  Holstege	  et	  al.,	  1998;	  Wang	  et	  al.,	  2002)	  and	  have	  allowed	  researchers	  to	  both	  
further	  characterize	  molecular	  mechanisms	  important	  for	  gene	  expression	  as	  well	  as	  identify	  cross-­‐talk	  
events	  that	  were	  previously	  unsuspected	  (Ghosh,	  2000;	  Liang	  et	  al.,	  2004).	  	  This	  chapter	  will	  highlight	  
the	  use	  of	  global	  mRNA	  decay	  analyses	  for	  understanding	  regulated	  gene	  expression	  as	  well	  as	  discuss	  
our	  own	  results	  following	  genome-­‐wide	  determination	  of	  mRNA	  half-­‐lives	  in	  induced	  pluripotent	  stem	  
cells	  and	  the	  differentiated	  cells	  they	  were	  generated	  from.	  	  	  
	  
3.1.1	  Global	  approaches	  for	  characterization	  of	  sequences	  and	  factors	  involved	  in	  mRNA	  decay	  
	   The	  use	  of	  global	  approaches	  to	  study	  cell	  networks	  has	  been	  encouraged	  by	  the	  advancement	  
and	  accessibility	  of	  high-­‐throughput	  technologies.	  	  At	  the	  start	  of	  this	  project,	  there	  had	  only	  been	  a	  
limited	  number	  of	  studies	  investigating	  mRNA	  decay	  on	  a	  global	  scale	  in	  mammalian	  cells	  (Dolken	  et	  al.,	  
2008;	  Friedel	  et	  al.,	  2009;	  Lam	  et	  al.,	  2001;	  Raghavan	  et	  al.,	  2002;	  Sharova	  et	  al.,	  2009;	  Yang	  et	  al.,	  2003)	  
and	  little	  effort	  had	  been	  made	  to	  compare	  rates	  of	  decay	  between	  different	  cell	  types.	  	  One	  study	  
focused	  on	  mouse	  Embryonic	  Stem	  (ES)	  cells	  prior	  to	  and	  following	  differentiation	  (Sharova	  et	  al.,	  2009)	  
and	  provided	  interesting	  insights	  into	  stem	  cell-­‐specific	  mRNA	  decay	  rates.	  	  However,	  there	  are	  several	  
significant	  differences	  between	  mouse	  and	  human	  stem	  cells	  (Dowell,	  2011;	  Zheng-­‐Bradley	  et	  al.,	  2010),	  
supporting	  that	  a	  similar	  study	  in	  human	  cells	  would	  give	  additional	  information.	  	  The	  dramatic	  changes	  
in	  gene	  expression	  that	  occur	  during	  reprogramming	  must	  involve	  widespread	  coordinated	  changes	  in	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mRNA	  decay	  rates	  and	  a	  global	  approach	  would	  allow	  us	  to	  identify	  sets	  of	  transcripts	  that	  showed	  
differential	  decay	  in	  pluripotent	  and	  fully	  differentiated	  cell	  types.	  	  	  
	   	  Global	  analysis	  of	  mRNA	  degradation	  has	  provided	  insight	  into	  gene	  expression	  regulation	  by	  
allowing	  the	  grouping	  of	  mRNAs	  based	  on	  their	  decay	  rates.	  	  Genes	  that	  share	  similar	  regulation	  of	  their	  
mRNA	  half-­‐lives	  during	  a	  cellular	  response	  often	  encode	  proteins	  involved	  in	  particular	  pathways	  or	  
functions	  (Raghavan	  et	  al.,	  2002;	  Yang	  et	  al.,	  2003).	  	  Gene	  Ontology	  (GO)	  analysis	  may	  be	  used	  to	  
identify	  cellular	  processes	  regulated	  at	  the	  level	  of	  mRNA	  decay.	  	  Studies	  investigating	  mRNA	  decay	  
dynamics	  during	  development	  and	  differentiation	  indicate	  that	  mRNA	  decay	  is	  spatiotemporally	  
regulated	  within	  an	  organism	  (Sharova	  et	  al.,	  2009;	  Thomsen	  et	  al.,	  2010).	  	  Additionally,	  changes	  in	  
mRNA	  half-­‐life	  in	  response	  to	  various	  growth	  or	  stress	  conditions	  highlight	  the	  importance	  of	  mRNA	  
decay	  to	  regulating	  gene	  expression	  (Miller	  and	  Olivas,	  2011;	  Munchel	  et	  al.,	  2011;	  Rabani	  et	  al.,	  2011).	  	  
One	  of	  our	  goals	  in	  determining	  global	  mRNA	  decay	  rates	  in	  pluripotent	  and	  differentiated	  cells	  was	  to	  
identify	  cellular	  processes	  that	  are	  differentially	  regulated	  at	  the	  level	  of	  mRNA	  decay	  through	  the	  use	  of	  
GO	  analysis.	  	  It	  seemed	  likely	  that	  some	  of	  these	  processes	  may	  facilitate	  the	  maintenance	  or	  
achievement	  of	  pluripotency.	  	  
	   Transcripts	  with	  similar	  decay	  rates	  may	  also	  be	  enriched	  for	  sequence	  motifs	  serving	  as	  cis-­‐
acting	  stability	  elements	  that	  interact	  with	  RNA-­‐binding	  proteins	  (RBPs)	  and/or	  miRNAs.	  	  Identification	  
of	  common	  cis-­‐elements	  could	  give	  clues	  to	  mechanism(s)	  of	  targeted	  transcript	  stabilization	  or	  
destabilization.	  	  Previous	  global	  analyses	  identified	  high	  association	  of	  AU-­‐rich	  elements	  with	  mRNA	  
instability	  (Schwanhäusser	  et	  al.,	  2011,	  2013;	  Sharova	  et	  al.,	  2009;	  Thomsen	  et	  al.,	  2010)	  although	  
presence	  of	  these	  elements	  alone	  is	  not	  predictive	  of	  stability,	  suggesting	  combinatorial	  effects	  of	  other	  
RBPs	  and	  miRNAs	  (Yang	  et	  al.,	  2003).	  	  GU-­‐rich	  motifs	  are	  also	  important	  cis-­‐acting	  elements	  associated	  
with	  mRNA	  destabilization	  (Lee	  et	  al.,	  2010;	  Vlasova	  et	  al.,	  2008).	  	  Characterization	  of	  this	  element	  
identified	  CELF1	  (also	  known	  as	  CUGBP1)	  as	  a	  trans-­‐acting	  factor	  responsible	  for	  binding	  mRNAs	  at	  these	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sequences	  to	  elicit	  rapid	  decay	  (Vlasova	  et	  al.,	  2008).	  	  By	  studying	  the	  sequences	  of	  mRNAs	  exhibiting	  
differential	  decay	  in	  iPS	  and	  differentiated	  cells,	  we	  hoped	  to	  identify	  novel	  cis-­‐acting	  elements	  through	  
which	  transcript	  stability	  is	  regulated	  to	  support	  stem	  cell	  gene	  expression.	  	  
	   Bioinformatic	  analysis	  of	  genome-­‐wide	  decay	  datasets	  has	  recently	  led	  to	  observations	  of	  
coordinated	  regulation	  between	  transcription	  and	  decay	  networks.	  	  In	  yeast,	  impairment	  of	  RNA	  
polymerase	  II	  activity	  affects	  the	  degradation	  of	  a	  select	  set	  of	  transcripts	  (Shalem	  et	  al.,	  2011)	  and	  
genes	  with	  similar	  promoters	  have	  similar	  decay	  patterns	  (Dori-­‐Bachash	  et	  al.,	  2012).	  	  Coupling	  of	  
transcription	  and	  decay	  is	  also	  evident	  in	  mammalian	  genomes	  (Dori-­‐Bachash	  et	  al.,	  2012).	  	  
Interestingly,	  increased	  mRNA	  degradation	  is	  often	  correlated	  with	  increased	  mRNA	  abundance,	  
suggesting	  feedback	  to	  transcription	  processes.	  	  This	  cross-­‐talk	  between	  pathways	  allows	  for	  a	  quick	  but	  
transient	  response	  to	  the	  environment	  (Dori-­‐Bachash	  et	  al.,	  2012).	  	  As	  stem	  cells	  must	  be	  able	  to	  
respond	  efficiently	  to	  differentiation	  cues,	  it	  seems	  likely	  that	  they	  would	  also	  demonstrate	  network	  
cross-­‐talk.	  	  
	   	  Our	  objective	  was	  to	  determine	  global	  mRNA	  half-­‐lives	  in	  HFFs	  and	  iPS	  cells	  to	  (i)	  fully	  
characterize	  mRNA	  decay	  rates	  in	  these	  two	  genetically	  identical	  cell	  types	  for	  the	  first	  time,	  (ii)	  identify	  
differentially	  regulated	  mRNAs,	  and	  (iii)	  characterize	  pathways	  of	  gene	  expression	  regulated	  at	  the	  level	  
of	  mRNA	  decay.	  	  Together,	  these	  results	  would	  characterize	  the	  contribution	  of	  regulated	  mRNA	  decay	  
to	  stem	  cell	  gene	  expression.	  	  	  
	  
3.1.2	  Methods	  for	  performing	  global	  analysis	  of	  mRNA	  decay	  rates	  
	   Initial	  experiments	  to	  measure	  mRNA	  decay	  were	  first	  performed	  by	  impairing	  RNA	  polymerase	  
activity	  and	  this	  method	  continues	  to	  be	  used	  today	  (Ross,	  1995).	  	  Drugs	  such	  as	  actinomycin	  D	  
(Bleyman	  and	  Woese,	  1969)	  and	  5,6-­‐Dichlorobenzimidazole	  1-­‐b-­‐D-­‐ribofuranoside	  (DRB;	  Tamm	  et	  al.,	  
1976)	  are	  used	  to	  inhibit	  transcription,	  eliminating	  the	  addition	  of	  nascent	  transcripts	  to	  the	  total	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population	  such	  that	  any	  decrease	  in	  mRNA	  abundance	  can	  be	  attributed	  to	  mRNA	  degradation.	  	  The	  
first	  global	  analysis	  of	  mRNA	  decay	  rates	  in	  human	  cells	  was	  performed	  almost	  serendipitously	  when	  
lymphoma	  cells	  were	  used	  to	  investigate	  the	  effects	  of	  potential	  anti-­‐cancer	  drug	  flavopiridol.	  	  
Microarray	  analysis	  performed	  on	  cells	  following	  treatment	  revealed	  that	  the	  drug	  inhibited	  
transcription	  and	  thus	  allowed	  for	  the	  generation	  of	  mRNA	  half-­‐lives	  for	  2,794	  genes	  (Lam	  et	  al.,	  2001).	  	  
In	  recent	  years,	  methods	  utilizing	  metabolic	  labeling	  of	  nascent	  mRNAs	  have	  been	  developed	  since	  
prolonged	  transcription	  inhibition	  can	  have	  cytotoxic	  effects	  which	  may	  influence	  gene	  expression	  in	  
unpredictable	  ways	  (Sawicki	  and	  Godman,	  1971).	  	  Furthermore,	  recent	  studies	  indicate	  that	  
transcription	  and	  degradation	  events	  are	  coupled	  (Dori-­‐Bachash	  et	  al.,	  2012;	  Shalem	  et	  al.,	  2011),	  
therefore	  inhibiting	  transcription	  almost	  certainly	  has	  indirect	  effects	  on	  mRNA	  decay	  rates.	  	  In	  
metabolic	  labelling,	  chemically	  modified	  bases	  such	  as	  4-­‐thiouridine	  (4sU)	  or	  5-­‐bromouridine	  (5BrU)	  are	  
incorporated	  into	  newly	  transcribed	  mRNAs	  allowing	  for	  the	  selective	  separation	  of	  labeled	  transcripts	  
from	  previously	  existing	  unlabeled	  pools	  (Dolken	  et	  al.,	  2008;	  Tani	  et	  al.,	  2012).	  	  Although	  half-­‐lives	  
generated	  from	  metabolic	  labeling	  are	  less	  likely	  to	  be	  influenced	  by	  generalized	  transcriptome	  
impairment,	  the	  isolation	  of	  RNA	  prior	  to	  analysis	  is	  more	  challenging	  and	  the	  algorithms	  used	  for	  
analysis	  are	  distinct	  from	  those	  used	  in	  microarray-­‐based	  half-­‐life	  assays	  (Friedel	  and	  Dölken,	  2009).	  	  
	   Global	  decay	  rates	  are	  calculated	  by	  determining	  the	  change	  in	  abundance	  for	  individual	  
transcripts	  over	  time.	  	  High-­‐density	  oligonucleotide	  microarrays	  have	  traditionally	  been	  used	  to	  
generate	  mRNA	  half-­‐lives	  by	  plotting	  changes	  in	  probe	  intensities	  over	  time	  (Raghavan	  and	  Bohjanen,	  
2004).	  	  More	  recently,	  high-­‐throughput	  sequencing	  of	  RNA	  samples	  has	  been	  used	  wherein	  the	  number	  
of	  sequencing	  reads	  are	  used	  to	  determine	  transcript	  abundance	  (Imamachi	  et	  al.,	  2013).	  	  Although	  this	  
method	  provides	  more	  data	  than	  microarrays,	  both	  are	  adequate	  for	  determining	  global	  mRNA	  decay	  




3.1.3	  Rationale	  for	  experimental	  design	  
	   To	  determine	  global	  mRNA	  decay	  rates	  in	  HFF	  and	  iPS	  cells,	  we	  decided	  to	  use	  actinomycin	  D	  for	  
several	  reasons:	  1)	  the	  method	  was	  already	  established	  and	  in	  practice	  in	  the	  lab;	  2)	  we	  felt	  that	  we	  
could	  minimize	  effects	  of	  inhibition	  of	  transcription	  by	  treating	  cells	  for	  only	  a	  relatively	  short	  period	  of	  
time.	  	  Functional	  annotation	  of	  unstable	  transcripts	  with	  half-­‐lives	  less	  than	  2	  hours	  in	  mouse	  ES	  cells	  
identified	  by	  Sharova	  et	  al.	  revealed	  that	  short	  mRNA	  half-­‐lives	  correspond	  to	  genes	  involved	  in	  cell	  
cycle	  regulation	  as	  well	  as	  pluripotency	  and	  early	  development	  (Sharova	  et	  al.,	  2009).	  	  Therefore,	  we	  felt	  
that	  a	  short	  time	  period	  would	  be	  long	  enough	  to	  reliably	  determine	  a	  large	  proportion	  of	  shorter	  mRNA	  
half-­‐lives	  but	  also	  allow	  for	  extrapolation	  to	  estimate	  decay	  rates	  for	  longer	  lived	  transcripts.	  	  In	  
addition,	  3)	  our	  results	  would	  be	  more	  directly	  comparable	  to	  those	  generated	  previously	  in	  our	  lab	  (Lee	  
et	  al.,	  2010)	  and	  to	  those	  from	  other	  labs,	  including	  the	  mouse	  ES	  cell	  decay	  study	  (Sharova	  et	  al.,	  2009).	  	  
Finally,	  4)	  the	  bioinformaticist	  working	  on	  the	  project	  with	  us	  had	  already	  developed	  algorithms	  for	  this	  
type	  of	  analysis	  (Lee	  et	  al.,	  2010,	  2012),	  thus	  making	  data	  analysis	  much	  simpler.	  	  We	  decided	  to	  use	  
microarrays	  to	  assess	  mRNA	  abundances	  because	  other	  methods	  that	  use	  deep-­‐sequencing	  of	  RNA	  
samples	  at	  various	  time	  points	  generate	  a	  vast	  amount	  more	  information	  than	  is	  required	  to	  determine	  
half-­‐lives	  and	  at	  the	  time	  when	  this	  experiment	  was	  performed,	  deep-­‐sequencing	  was	  significantly	  more	  
expensive	  than	  microarrays.	  	  	  
	   We	  chose	  to	  use	  induced	  pluripotent	  stem	  cells	  because	  there	  are	  no	  ethical	  implications	  that	  
restrict	  their	  use	  in	  research	  and	  characterized	  cell	  lines	  along	  with	  genetically	  matched	  precursor	  
fibroblast	  cell	  lines	  were	  commercially	  available	  (System	  Biosciences).	  	  As	  all	  the	  genetic	  information	  in	  
these	  two	  cell	  types	  is	  identical,	  any	  differences	  in	  mRNA	  decay	  rates	  could	  be	  attributed	  to	  either	  the	  
differentiated	  or	  pluripotent	  phenotype.	  	  Although	  these	  iPS	  cells	  are	  not	  exactly	  the	  same	  as	  ES	  cells	  
(Bilic	  and	  Belmonte,	  2012),	  they	  provide	  a	  very	  convenient	  system	  for	  studying	  stem	  cells	  and	  were	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therefore	  used	  in	  this	  study	  investigating	  global	  mRNA	  decay	  in	  pluripotency.	  	  The	  combined	  results	  and	  
discussion	  of	  global	  mRNA	  decay	  analysis	  in	  HFFs	  and	  iPS	  cells	  are	  presented	  below2.	  	  
	  
3.2	  Generation	  and	  quality	  control	  of	  RNA	  samples	  for	  microarray	  hybridization	  	  
	   Cells	  were	  treated	  with	  actinomycin	  D	  to	  inhibit	  transcription	  and	  total	  RNA	  was	  collected	  at	  0,	  
15,	  30,	  60,	  120	  and	  240	  minute	  time	  points	  starting	  20	  minutes	  following	  treatment.	  	  This	  20	  minute	  
delay	  was	  chosen	  to	  allow	  the	  inhibitor	  enough	  time	  to	  effectively	  halt	  transcription	  and	  is	  routinely	  
used	  in	  determination	  of	  half-­‐lives	  in	  mammalian	  cells.	  	  By	  plotting	  the	  change	  in	  mRNA	  abundance	  over	  
time	  and	  fitting	  to	  an	  exponential	  decay	  curve,	  a	  decay	  rate	  constant	  (k)	  was	  provided	  to	  calculate	  
mRNA	  half-­‐life	  (T1/2)	  where	  T1/2	  =	  ln(2)/k.	  	  	  	  	  
	   To	  minimize	  variation,	  triplicate	  sample	  sets	  were	  selected	  from	  experiments	  performed	  
simultaneously	  in	  quadruplicate	  (replicates	  A,	  B,	  C,	  and	  D).	  	  For	  each	  cell	  line,	  24	  culture	  dishes	  (four	  
replicates	  for	  six	  time	  points)	  were	  treated	  with	  actinomycin	  D	  and	  processed	  for	  RNA	  isolation	  from	  
TRIzol	  at	  the	  same	  time.	  	  To	  choose	  the	  three	  replicates	  with	  the	  lowest	  standard	  deviation,	  half-­‐lives	  of	  
two	  test	  mRNAs	  were	  determined	  by	  qRT-­‐PCR.	  	  FOS	  mRNA	  was	  selected	  to	  represent	  short-­‐lived	  mRNAs	  
as	  previous	  studies	  indicate	  this	  transcript	  has	  a	  half-­‐life	  ranging	  from	  20	  –	  60	  minutes	  in	  human	  
monocytes	  (Sariban	  et	  al.,	  1988).	  	  FOS	  mRNA	  abundance	  was	  assessed	  at	  0,	  15,	  30	  and	  60	  minutes.	  	  To	  
assess	  the	  quality	  of	  samples	  taken	  at	  later	  time	  points	  (0,	  60,	  120	  and	  240	  minutes),	  the	  moderately	  
unstable	  TUT1	  mRNA	  was	  chosen.	  	  In	  mouse	  C2C12	  myoblasts,	  TUT1	  mRNA	  half-­‐life	  is	  ~93	  ±	  10	  minutes	  
(Lee	  et	  al.,	  2010).	  	  After	  measuring	  transcript	  abundances	  at	  each	  time	  point	  and	  calculating	  half-­‐lives,	  
triplicate	  combinations	  of	  replicates	  (ABC,	  ABD,	  ACD,	  and	  BCD)	  were	  compared	  in	  each	  cell	  line	  to	  select	  
the	  replicates	  with	  the	  lowest	  standard	  deviation	  (Appendix	  A1).	  	  Based	  on	  these	  data,	  we	  found	  that	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2	  The	  majority	  of	  the	  results	  presented	  in	  Chapter	  3	  appeared	  in:	  Neff	  et	  al.	  Global	  analysis	  reveals	  
multiple	  pathways	  for	  unique	  regulation	  of	  mRNA	  decay	  in	  induced	  pluripotent	  stem	  cells.	  Genome	  




HFF	  replicates	  A,	  B,	  and	  C	  and	  iPS	  replicates	  A,	  C,	  and	  D	  had	  the	  lowest	  standard	  deviation	  among	  time	  
points	  and	  were	  therefore	  chosen	  to	  represent	  each	  cell	  line.	  	  It	  is	  important	  to	  note	  that	  although	  
experiments	  described	  here	  were	  performed	  using	  HFFs	  cultured	  on	  plastic,	  analysis	  of	  HFFs	  cultured	  on	  
Matrigel	  showed	  no	  measurable	  effect	  on	  mRNA	  abundances	  (Appendix	  A2).	  	  
	   Figure	  3.1	  below	  shows	  the	  half-­‐lives	  of	  FOS	  and	  TUT1	  mRNAs	  in	  HFF	  (Figure	  3.1A)	  and	  iPS	  cells	  
(Figure	  3.1B)	  as	  determined	  using	  the	  selected	  replicates.	  	  These	  data	  indicate	  that	  the	  half-­‐lives	  
measured	  for	  test	  mRNAs	  in	  each	  cell	  line	  were	  within	  the	  expected	  range.	  	  Consistent	  with	  published	  
data	  (Sariban	  et	  al.,	  1988),	  the	  half-­‐life	  of	  FOS	  mRNA	  in	  HFFs	  was	  ~34	  ±	  2	  minutes	  and	  ~42	  ±	  13	  minutes	  
in	  iPS	  cells.	  	  In	  both	  cell	  lines,	  TUT1	  mRNAs	  were	  slightly	  more	  stable	  than	  in	  C2C12	  myoblast	  cells	  (Lee	  
et	  al.,	  2010)	  with	  a	  half-­‐life	  of	  ~116	  ±	  13	  minutes	  in	  HFFs	  and	  ~161	  ±	  15	  minutes	  in	  iPS	  cells.	  	  These	  
differences	  are	  not	  surprising	  given	  that	  this	  comparison	  is	  between	  different	  cell	  types	  and	  species.	  	  
Nevertheless,	  the	  results	  support	  that	  TUT1	  mRNA	  is	  more	  stable	  than	  FOS	  mRNA,	  as	  predicted,	  in	  both	  
HFF	  and	  iPS	  cells.	  	  Both	  sets	  of	  samples	  were	  used	  to	  proceed	  with	  global	  analysis.	  	  	  	  	  
	  
Figure	  3.1	  Determination	  of	  half-­‐lives	  for	  test	  mRNAs	  FOS and	  TUT1	  allows	  selection	  of	  microarray	  sample	  
replicates.	  	  Half-­‐lives	  were	  calculated	  for	  FOS and	  TUT1mRNAs	  in	  (A)	  HFF	  and	  (B)	  iPS	  cells	  following	  
actinomycin	  D	  treatment.	  	  mRNA	  levels	  were	  measured	  by	  qRT-­‐PCR	  at	  each	  time	  point	  and	  normalized	  to	  
GAPDH	  mRNA.	  	  The	  standard	  deviations	  were	  derived	  from	  three	  independent	  replicates.	  	  Half-­‐lives	  for	  each	  
mRNA	  and	  the	  R2 values	  are	  denoted	  to	  the	  right	  of	  the	  cell-­‐line	  keys.	  
A.	   B.	  
~34	  +/-­‐ 2	  min
~116	  +/-­‐ 13	  min
~42	  +/-­‐ 13	  min




	   Total	  RNA	  samples	  were	  used	  to	  generate	  cDNA	  probes	  which	  were	  hybridized	  to	  Affymetrix	  
Human	  Gene	  Chip	  1.0	  ST	  microarrays	  (Erin	  Petrilli,	  Colorado	  State	  University	  Genomics	  and	  Proteomics	  
Core	  Facility).	  	  Probe	  intensities	  were	  measured	  to	  indicate	  transcript	  abundance	  and	  data	  files	  were	  
sent	  to	  collaborators	  Dr.	  Bin	  Tian	  and	  Dr.	  Ju	  Youn	  Lee	  at	  the	  Rutgers	  University	  –	  New	  Jersey	  Medical	  
School	  for	  analysis.	  	  	  
	  
3.3	  Estimation	  of	  mRNA	  half-­‐lives	  in	  HFF	  and	  iPS	  cells	  from	  gene	  expression	  data	  
	   Microarray	  data	  were	  first	  processed	  by	  Dr.	  Ju	  Youn	  Lee	  with	  the	  Affymetrix	  Power	  Tools	  (APT)	  
program	  using	  the	  GC-­‐bin	  method	  for	  background	  correction.	  	  All	  probe	  set	  values	  were	  normalized	  to	  
the	  fifth-­‐percentile	  value	  of	  the	  same	  array	  and	  transcripts	  whose	  probe	  sets	  had	  a	  Detection	  Above	  
Background	  (DABG)	  P-­‐value	  <0.05	  for	  at	  least	  two	  out	  of	  three	  replicates	  at	  the	  0	  minute	  time	  point	  
were	  considered	  “expressed”	  and	  used	  for	  subsequent	  analysis.	  	  As	  shown	  in	  Figure	  3.2,	  20,434	  mRNAs	  
in	  iPS	  cells	  and	  19,791	  mRNAs	  in	  HFFs	  were	  expressed	  at	  the	  0	  minute	  time	  point	  with	  19,190	  mRNAs	  
expressed	  in	  both	  cell	  lines.	  	  	  
	  
Figure	  3.2	  Venn	  diagram	  showing	  the	  number	  of	  mRNAs	  expressed	  in	  HFF	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   Following	  normalization	  and	  processing	  of	  the	  data	  (described	  in	  Chapter	  2),	  the	  0	  minute	  time	  
point	  from	  each	  replicate	  was	  then	  compared	  to	  determine	  correlation	  of	  expression	  between	  sample	  
sets.	  	  As	  seen	  in	  Figure	  3.3,	  there	  was	  high	  correlation	  within	  replicates	  of	  each	  cell	  line	  (0.99)	  and	  less	  
correlation	  between	  the	  two	  cell	  lines	  (0.88).	  	  These	  results	  were	  expected	  and	  provided	  sample	  quality	  
assurance.	  	  
Figure	  3.3	  Correlation	  of	  microarray	  array	  data	  between	  and	  within	  replicates	  at	  the	  0	  minute	  time	  point.	  	  
Heat	  map	  showing	  the	  correlation	  between	  microarrays	  for	  the	  0	  minute	  time	  point	  of	  each	  HFF	  and	  iPS	  cell	  
replicate	  using	  Robust	  Multi-­‐array	  Average	  (RMA)	  normalization.	  	  Raw	  intensity	  values	  were	  background	  
corrected,	  log2 transformed,	  and	  quantile	  normalized.	   	  
	   	  
	   Global	  mRNA	  half-­‐lives	  were	  determined	  by	  applying	  the	  Nonlinear	  Least	  Squares	  (NLS)	  model	  
(Wang	  et	  al.,	  2002).	  	  Similar	  to	  calculations	  performed	  using	  qRT-­‐PCR	  data,	  microarray	  expression	  values	  
for	  each	  transcript	  at	  time	  points	  following	  actinomycin	  D	  treatment	  were	  fit	  to	  a	  first-­‐order	  exponential	  
decay	  curve	  to	  determine	  the	  mRNA	  decay	  rate	  constant	  (k)	  (T1/2	  =	  ln(2)/k).	  	  All	  three	  replicates	  were	  
used	  to	  generate	  a	  single	  decay	  curve	  for	  each	  transcript	  and	  half-­‐lives	  were	  deemed	  reliable	  for	  those	  
that	  fit	  the	  exponential	  decay	  curve	  with	  a	  P-­‐value	  <0.05.	  	  Figure	  3.4	  below	  shows	  decay	  curves	  
generated	  for	  HIST1H14B	  mRNA	  to	  calculate	  a	  half-­‐life	  of	  ~81	  minutes	  (P-­‐value	  =	  2.59x10-­‐7)	  in	  HFFs	  and	  
~277	  minutes	  (P-­‐value	  =	  6.42x10-­‐5)	  in	  iPS	  cells	  within	  a	  95%	  Confidence	  Interval	  (CI).	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Figure	  3.4	  Exponential	  decay	  curves	  for	  HIST1H4BmRNA	  in	  HFF	  and	  iPS	  cells	  as	  determined	  by	  microarray	  
analysis.	  	  Each	  symbol	  denotes	  HIST1H4BmRNA	  abundance	  in	  a	  single	  replicate	  with	  closed	  symbols	  
representing	  abundance	  in	  HFFs	  and	  open	  symbols	  representing	  mRNA	  abundance	  in	  iPS	  cells.	  	  Three	  replicates	  
were	  performed	  in	  each	  cell	  type	  at	  each	  time	  point.	  	  All	  three	  replicates	  were	  used	  to	  generate	  a	  single	  half-­‐life	  
in	  both	  cell	  types.	  	  The	  P-­‐value	  for	  each	  cell	  type	  indicates	  how	  well	  the	  data	  fit	  to	  the	  exponential	  decay	  curve	  
(solid	  line).	  	  
	  
	   	  
	   When	  this	  method	  was	  applied	  to	  all	  detectable	  transcripts,	  reliable	  half-­‐lives	  were	  determined	  
for	  8,283	  HFF	  mRNAs	  and	  10,445	  iPS	  mRNAs	  (Figure	  3.5).	  	  The	  microarray	  data	  were	  deposited	  in	  the	  
NCBI	  Gene	  Expression	  Omnibus	  (GEO)	  database	  (http://www.ncbi.nlm.nih.gov/geo/)	  under	  accession	  
number	  GSE33417.	  
	  
Figure	  3.5	  Venn	  diagram	  showing	  the	  number	  of	  mRNA	  half-­‐lives	  in	  HFF	  
and	  iPS	  cells	  determined	  by	  microarray.	  	  Half-­‐lives	  for	  5,481	  mRNAs	  were	  




	   Half-­‐lives	  of	  5,481	  mRNAs	  were	  determined	  in	  both	  cell	  types	  and	  this	  subset	  was	  used	  for	  all	  
subsequent	  analyses.	  	  When	  the	  half-­‐life	  distribution	  of	  these	  common	  transcripts	  was	  graphed	  (Figure	  
3.6),	  we	  found	  that	  generally	  speaking,	  mRNAs	  decay	  slightly	  faster	  in	  iPS	  cells	  than	  in	  HFFs	  as	  indicated	  
by	  median	  half-­‐lives	  of	  8.6	  hours	  and	  9.2	  hours,	  respectively.	  	  Although	  this	  difference	  is	  not	  large,	  it	  is	  
highly	  significant	  with	  P-­‐value	  =	  1.59x10-­‐10.	  	  The	  median	  half-­‐life	  in	  mouse	  embryonic	  fibroblasts	  
measured	  by	  Sharova	  et	  al.	  was	  approximately	  7	  hours	  and	  differentiation	  caused	  this	  half-­‐life	  median	  to	  
change.	  	  Spontaneous	  differentiation	  induced	  by	  depletion	  of	  leukemia	  inhibitory	  factor	  from	  culture	  
medium	  (Williams	  et	  al.,	  1988)	  resulted	  in	  a	  median	  half-­‐life	  of	  5.5	  hours	  while	  inducing	  neuron	  
formation	  through	  addition	  of	  retinoic	  acid	  (Bain	  et	  al.,	  1995;	  Slager	  et	  al.,	  1993)	  lengthened	  the	  median	  
to	  8.6	  hours	  (Sharova	  et	  al.,	  2009).	  	  Our	  data	  are	  consistent	  with	  the	  median	  decay	  rates	  of	  10	  hours	  
described	  for	  human	  hepatocellular	  carcinoma	  cells	  (HepG2)	  and	  primary	  fibroblasts	  (Bud8;	  Yang	  et	  al.,	  
2003)	  and	  9	  hours	  in	  mouse	  fibroblasts	  (Schwanhäusser	  et	  al.,	  2011,	  2013).	  	  When	  comparing	  the	  
median	  half-­‐life	  to	  that	  established	  in	  yeast	  and	  bacteria,	  investigators	  reasoned	  that	  the	  median	  mRNA	  
half-­‐life	  was	  proportional	  to	  length	  of	  cell	  cycle	  for	  each	  cell	  type	  (Yang	  et	  al.,	  2003).	  	  Hence,	  it	  seems	  
reasonable	  that	  the	  faster	  cell	  cycle	  of	  stem	  cells	  contributes	  to	  their	  slightly	  shorter	  median	  mRNA	  half-­‐
life.	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Figure	  3.6	  The	  median	  mRNA	  half-­‐life	  in	  iPS	  cells	  is	  slightly	  shorter	  than	  the	  median	  mRNA	  
half-­‐life	  in	  HFFs.	  	  Graph	  showing	  the	  distribution	  of	  5,481	  mRNA	  half-­‐lives	  in	  HFFs	  (gray)	  and	  
iPS	  cells	  (black).	  	  The	  median	  half-­‐life	  in	  each	  cell	  line	  is	  denoted	  by	  a	  dotted	  line.	  	  
	  
	   	  
	   One	  possible	  explanation	  for	  this	  difference	  in	  overall	  decay	  rates	  could	  be	  due	  to	  differential	  
expression	  of	  mRNA	  decay	  enzymes.	  	  Although	  it	  was	  not	  feasible	  to	  investigate	  expression	  of	  all	  mRNA	  
decay	  enzymes,	  we	  measured	  the	  abundances	  of	  mRNA	  decay	  factors	  for	  which	  antibodies	  were	  readily	  
available,	  namely	  XRN1	  and	  PARN,	  to	  determine	  whether	  they	  are	  differentially	  regulated	  in	  the	  two	  cell	  
types.	  	  XRN1	  is	  a	  cytoplasmic	  exoribonuclease	  that	  functions	  to	  decay	  a	  large	  proportion	  of	  cellular	  
transcripts	  in	  the	  5’3’	  direction	  (Bashkirov	  et	  al.,	  1997;	  Muhlrad	  et	  al.,	  1994).	  	  XRN1	  has	  been	  shown	  
very	  recently	  to	  be	  essential	  for	  coupling	  mRNA	  decay	  rates	  to	  transcription	  in	  yeast,	  highlighting	  its	  
wide-­‐ranging	  impact	  on	  gene	  expression	  (Haimovich	  et	  al.,	  2013).	  	  PARN	  is	  a	  deadenylase	  that	  often	  acts	  
at	  the	  first	  step	  of	  mRNA	  decay	  (Körner	  and	  Wahle,	  1997)	  and	  has	  vital	  roles	  for	  oogenesis	  and	  
embryogenesis	  (Copeland	  and	  Wormington,	  2001;	  Kang	  and	  Han,	  2011;	  Radford	  et	  al.,	  2008).	  	  Western	  
blot	  analysis	  of	  these	  decay	  factors	  in	  HFF	  and	  iPS	  cells	  is	  shown	  in	  Figure	  3.7.	  	  The	  abundance	  of	  each	  
protein	  was	  normalized	  to	  GAPDH	  levels	  and	  iPS	  abundance	  was	  quantified	  relative	  to	  HFF	  expression.	  	  
Although	  this	  experiment	  was	  performed	  twice,	  one	  replicate	  was	  developed	  on	  film	  and	  therefore	  not	  
quantified.	  	  Results	  from	  both	  replicates	  indicated	  that	  expression	  of	  XRN1	  is	  relatively	  similar	  between	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cell	  lines	  and	  PARN	  is	  ~2-­‐fold	  more	  abundant	  in	  iPS	  cells.	  	  The	  increased	  abundance	  of	  PARN	  in	  iPS	  cells	  
could	  contribute	  to	  the	  slightly	  faster	  turnover	  of	  mRNAs	  in	  these	  cells	  but	  other	  factors,	  such	  as	  the	  
abbreviated	  pluripotent	  cell	  cycle,	  could	  also	  influence	  overall	  mRNA	  decay	  rates.	  	  These	  results	  are	  
supported	  by	  mouse	  ES	  decay	  data	  wherein	  more	  than	  70	  mRNAs	  encoding	  decay	  factors	  showed	  
decreased	  abundance	  upon	  differentiation,	  although	  XRN1	  and	  PARN	  were	  not	  represented	  (Sharova	  et	  
al.,	  2009).	  	  In	  our	  abundance	  data	  at	  the	  0	  minute	  time	  point,	  expression	  of	  XRN1	  and	  PARN	  mRNA	  was	  
slightly	  increased	  in	  HFFs	  by	  1.09-­‐	  and	  1.17-­‐fold	  change,	  respectively,	  compared	  to	  iPS	  cells	  although	  









Figure	  3.7	  Differential	  expression	  of	  decay	  factors	  may	  contribute	  to	  differences	  in	  median	  mRNA	  half-­‐life.	  	  
Western	  blot	  analysis	  of	  decay	  factors	  XRN1	  and	  PARN	  in	  HFF	  and	  iPS	  cells	  using	  25µg	  of	  whole	  cell	  lysate	  on	  a	  
10%	  SDS-­‐PAGE	  gel	  transferred	  to	  polyvinylidene difluoride (PVDF)	  membranes.	  	  Quantification	  using	  
ImageQuant	  software	  is	  based	  on	  a	  single	  replicate	  where	  levels	  of	  XRN1	  or	  PARN	  are	  normalized	  to	  levels	  of	  
GAPDH	  and	  relative	  to	  expression	  in	  HFF	  cells.	  	  
	  
	   	  
	   We	  next	  sought	  to	  identify	  stable	  and	  unstable	  transcripts	  in	  each	  cell	  line	  by	  evaluating	  HFF	  and	  
iPS	  mRNA	  half-­‐life	  distributions	  for	  5,481	  transcripts	  (Figure	  3.8).	  	  Transcripts	  in	  the	  10th	  percentile	  were	  
considered	  unstable	  while	  those	  in	  the	  90th	  percentile	  for	  each	  cell	  line	  were	  designated	  as	  stable.	  	  As	  
these	  stable	  and	  unstable	  mRNA	  sets	  exhibited	  differential	  regulation	  compared	  to	  the	  other	  4,385	  
transcripts	  (80%)	  in	  the	  dataset,	  Gene	  Ontology	  analysis	  was	  performed	  to	  determine	  functional	  terms	  




A.	   B.	  
Figure	  3.8	  Graphing	  the	  mRNA	  half-­‐life	  distribution	  in	  HFF	  and	  iPS	  cells	  identified	  10th,	  median,	  and	  90th
percentiles	  for	  5,481	  mRNAs.	  	  Half-­‐life	  distribution	  of	  5,481	  mRNAs	  in	  A)	  HFFs	  and	  B)	  iPS	  cells	  determines	  
unstable	  (bottom	  10%)	  and	  stable	  (top	  10%)	  mRNAs	  in	  each	  dataset.	  	  	  
	  
	   	  
3.4	  Gene	  Ontology	  terms	  associated	  with	  instability	  or	  stability	  
	   We	  next	  assigned	  functional	  classifications	  to	  the	  stable	  and	  unstable	  mRNAs	  in	  each	  cell	  line.	  	  
Common	  pathways	  associated	  with	  stable	  and	  unstable	  transcripts	  could	  indicate	  a	  mechanism	  of	  
coordinate	  regulation.	  	  To	  perform	  Gene	  Ontology	  analysis,	  gene	  lists	  were	  uploaded	  to	  DAVID	  (Huang	  
et	  al.,	  2009a)	  along	  with	  a	  background	  list	  consisting	  of	  all	  the	  genes	  for	  which	  half-­‐lives	  were	  generated	  
in	  both	  cell	  types.	  	  Table	  3.1	  shows	  the	  top	  20	  terms	  significantly	  over-­‐represented	  in	  unstable	  mRNAs	  
and	  terms	  enriched	  in	  stable	  mRNAs	  using	  a	  similar	  P-­‐value	  cutoff	  for	  each	  cell	  line.	  	  The	  results	  are	  



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.4.1	  Gene	  Ontology	  terms	  associated	  with	  instability	  or	  stability	  in	  HFFs	  
	   Table	  3.1	  shows	  that	  unstable	  HFF	  mRNAs	  were	  enriched	  for	  functions	  associated	  with	  
“transcription”	  and	  “chromatin	  assembly”	  amongst	  other	  more	  general	  terms.	  	  Numerous	  studies	  have	  
shown	  that	  mRNAs	  encoding	  transcriptional	  regulators	  have	  a	  high	  propensity	  to	  be	  unstable	  
(Schwanhäusser	  et	  al.,	  2011,	  2013;	  Yang	  et	  al.,	  2003).	  	  Regulation	  of	  transcription	  also	  involves	  
chromatin	  modulation	  so	  it	  is	  not	  surprising	  to	  have	  found	  terms	  related	  to	  both	  functions	  represented	  
here.	  	  	  
	   In	  stable	  HFF	  mRNAs,	  we	  found	  an	  enrichment	  of	  terms	  associated	  with	  neurophysiological	  
processing	  such	  as	  “sensory	  perception”	  and	  “cognition”.	  	  “Ion	  transport”	  was	  also	  over-­‐represented.	  	  
Previous	  studies	  have	  indicated	  that	  transcripts	  encoding	  housekeeping	  genes	  tend	  to	  be	  stable	  as	  their	  
expression	  does	  not	  need	  to	  change	  in	  response	  to	  signals	  (Schwanhäusser	  et	  al.,	  2011,	  2013).	  	  While	  
ion	  transport	  could	  be	  considered	  a	  housekeeping	  function,	  the	  reason	  for	  enrichment	  of	  
neurophysiological	  processing	  terms	  is	  not	  clear.	  	  	  	  	  	  	  
	  
3.4.2	  Gene	  Ontology	  terms	  associated	  with	  instability	  or	  stability	  in	  iPS	  cells	  
	   As	  in	  HFFs,	  we	  found	  that	  relatively	  short-­‐lived	  iPS	  cell	  mRNAs	  encoded	  proteins	  enriched	  with	  
functions	  related	  to	  “transcription”.	  	  To	  a	  lesser	  extent,	  we	  also	  saw	  that	  functions	  in	  “cell	  cycle”	  and	  
“chromosome	  organization”	  are	  represented.	  	  Pluripotent	  stem	  cells	  are	  characterized	  by	  their	  
abbreviated	  cell	  cycle	  and	  unique	  chromatin	  structure	  so	  it	  was	  interesting	  to	  find	  these	  functions	  in	  our	  
unstable	  mRNA	  dataset.	  	  Unstable	  mRNAs	  in	  mouse	  ES	  cells	  were	  enriched	  for	  genes	  with	  functions	  in	  
“transcription	  factors”,	  “cell	  cycle”,	  “apoptosis”	  and,	  “development”	  (Sharova	  et	  al.,	  2009),	  consistent	  
with	  our	  analysis.	  	  As	  shown	  in	  stable	  HFF	  mRNAs,	  we	  also	  found	  that	  stable	  iPS	  cell	  mRNAs	  are	  enriched	  
for	  GO	  terms	  related	  to	  “sensory	  perception”	  but	  the	  significance	  of	  this	  is	  unclear.	  	  	  	  
53	  
	  
	   The	  smaller	  number	  of	  enriched	  terms	  in	  the	  stable	  mRNA	  set	  could	  possibly	  be	  explained	  by	  the	  
wide	  range	  of	  functions	  performed	  by	  proteins	  encoded	  by	  stable	  mRNAs	  as	  compared	  to	  the	  relatively	  
smaller	  set	  of	  functions	  performed	  by	  proteins	  encoded	  by	  unstable	  mRNAs	  (Halees	  et	  al.,	  2011;	  Khabar,	  
2005).	  	  Additionally,	  half-­‐life	  P-­‐values	  were	  much	  lower	  for	  unstable	  mRNAs	  in	  general	  than	  for	  stable	  
mRNAs	  that	  had	  half-­‐lives	  of	  >19	  hours	  extrapolated	  from	  a	  4-­‐hour	  time	  course.	  	  	  
	  
3.5	  Sequence	  elements	  associated	  with	  instability	  or	  stability	  
	   Having	  identified	  stable	  and	  unstable	  mRNAs	  in	  each	  cell	  type,	  we	  next	  wanted	  to	  determine	  
whether	  specific	  sequence	  elements	  that	  might	  modulate	  mRNA	  decay	  rates	  were	  over-­‐represented	  in	  
either	  set.	  	  This	  information	  could	  give	  clues	  as	  to	  the	  identity	  of	  trans-­‐acting	  factors	  that	  might	  be	  
specifically	  regulating	  mRNA	  decay	  in	  a	  specific	  cell	  type.	  	  Analysis	  of	  hexamer-­‐sized	  cis-­‐elements	  over-­‐
represented	  in	  5’	  UTR,	  ORF,	  and	  3’	  UTR	  of	  mRNAs	  was	  performed	  on	  the	  dataset	  containing	  stable	  or	  
unstable	  HFF	  and	  iPS	  cell	  transcripts.	  	  Sequences	  and	  their	  annotations	  were	  retrieved	  from	  the	  RefSeq	  
database	  and	  the	  significance	  of	  a	  hexamer	  was	  calculated	  by	  the	  Fisher’s	  exact	  test	  comparing	  its	  
frequency	  in	  the	  most	  stable	  and	  least	  stable	  mRNA	  sets.	  	  A	  significance	  score	  was	  assigned	  to	  each	  
hexamer	  equaling	  –log10(P-­‐value)*s,	  where	  s	  equals	  -­‐1	  if	  the	  hexamer	  is	  more	  common	  in	  the	  least	  
stable	  transcripts,	  and	  s	  equals	  1	  if	  otherwise.	  	  A	  heat	  map	  representation	  of	  hexamer	  sequences	  found	  







































































































































































































3.5.1	  5’UTR	  elements	  are	  over-­‐represented	  in	  unstable	  and	  stable	  mRNAs	  
	   Cis-­‐acting	  elements	  in	  the	  5’UTR	  of	  mRNAs	  such	  as	  Internal	  Ribosome	  Entry	  Sites	  (IRES),	  
Upstream	  Open	  Reading	  Frames	  (uORFs),	  Terminal	  Oligopyrimidine	  (TOP)	  sequences,	  and	  secondary	  
structures	  can	  influence	  mRNA	  activities	  through	  a	  variety	  of	  mechanisms.	  	  The	  role	  of	  5’UTR	  cis-­‐
elements	  is	  predominantly	  in	  regulation	  of	  translation,	  but	  they	  can	  also	  influence	  other	  mRNA	  
metabolism	  events	  including	  decay	  (de	  la	  Cruz	  et	  al.,	  2002;	  Dibbens	  et	  al.,	  1999;	  Vilela	  et	  al.,	  1999).	  	  We	  
were	  encouraged	  to	  find	  the	  enrichment	  of	  hexamer	  sequences	  in	  the	  5’UTR	  of	  unstable	  and	  stable	  HFF	  
and	  iPS	  cell	  mRNAs	  that	  could	  potentially	  be	  important	  for	  maintaining	  differentiation	  or	  pluripotency.	  	  
These	  5’UTR	  elements	  are	  discussed	  further	  here.	  	  	  
	  
3.5.1.1	  GC-­‐rich	  5’UTR	  elements	  are	  over-­‐represented	  in	  unstable	  mRNAs	  in	  both	  cell	  types	  
	   Analysis	  of	  5’UTR	  hexamer	  sequences	  indicated	  that	  GC-­‐rich	  elements	  in	  this	  region	  were	  
associated	  with	  instability	  in	  both	  cell	  lines,	  although	  more	  so	  in	  iPS	  cells.	  	  These	  data	  are	  consistent	  with	  
previous	  findings	  that	  CpG	  dinucleotides	  are	  over-­‐represented	  in	  unstable	  mRNAs	  in	  mouse	  ES	  cells	  
(Sharova	  et	  al.,	  2009).	  	  In	  general,	  the	  5’UTR	  of	  mRNAs	  is	  more	  GC-­‐rich	  than	  the	  3’UTR	  (Pesole	  et	  al.,	  
1997),	  but	  it	  was	  interesting	  to	  find	  that	  these	  elements	  were	  correlated	  with	  transcript	  instability.	  	  
Higher	  GC-­‐content	  in	  this	  region	  can	  lead	  to	  more	  complex	  RNA	  structure	  that	  inhibits	  ribosomal	  
scanning	  resulting	  in	  transcript	  degradation	  (Linz	  et	  al.,	  1997).	  	  Therefore,	  it	  is	  possible	  that	  these	  GC-­‐
rich	  hexamer	  sequences	  in	  the	  5’UTR	  of	  unstable	  mRNAs	  are	  able	  to	  elicit	  instability	  through	  this	  
mechanism.	  	  	  	  	  
	   	  
3.5.1.2	  Di-­‐	  and	  mononucleotide	  repeat	  5’UTR	  elements	  are	  over-­‐represented	  in	  stable	  iPS	  cell	  mRNAs	  
	   Sequences	  in	  the	  5’UTR	  that	  correlated	  with	  increased	  stability	  in	  both	  cell	  types	  included	  the	  
hexamer	  AAAAAA,	  although	  the	  correlation	  was	  stronger	  in	  HFFs.	  	  Pre-­‐AUG	  poly(A)	  tracts	  less	  than	  12	  
56	  
	  
nucleotides	  in	  length	  bind	  translation	  initiation	  factors	  whereas	  elements	  longer	  than	  12	  nucleotides	  
likely	  bind	  poly(A)-­‐binding	  protein	  to	  repress	  translation	  (Gilbert	  et	  al.,	  2007;	  Xia	  et	  al.,	  2011).	  	  Lsm1-­‐7	  
binds	  poly(A)	  tracts	  10	  to	  21	  nucleotides	  in	  length	  in	  the	  5’UTR	  of	  orthopoxvirus	  mRNAs,	  preventing	  
3’5’	  decay	  and	  decapping	  (Bergman	  et	  al.,	  2007).	  	  These	  examples	  demonstrate	  that	  even	  simple	  
homopolymer	  repeats	  can	  have	  various	  functions.	  	  A	  UUUUUU	  element	  was	  also	  identified	  in	  stable	  iPS	  
cell	  mRNAs,	  but	  little	  correlation	  with	  stability	  was	  seen	  in	  HFFs.	  	  Additionally,	  we	  found	  that	  increased	  
mRNA	  stability	  is	  associated	  with	  5’UTR	  CA-­‐,	  CU-­‐,	  and	  AU-­‐	  repeat	  elements	  in	  iPS	  cells,	  although	  this	  
association	  is	  barely	  detected	  in	  HFFs.	  	  Interestingly,	  these	  appear	  to	  be	  actual	  repeat	  elements	  rather	  
than	  general	  nucleotide	  enrichments	  since	  related	  elements	  such	  as	  CACCAC	  are	  not	  over-­‐represented.	  	  
It	  is	  possible	  that	  these	  repeat	  elements	  recruit	  iPS	  cell-­‐specific	  RNA-­‐binding	  proteins,	  such	  as	  HNRNP	  L	  
which	  binds	  CA-­‐repeat	  elements	  to	  regulate	  decay	  and	  translation	  processes	  (Lee	  et	  al.,	  2009,	  2004).	  
	  	  
	  3.5.2	  GC-­‐rich	  ORF	  elements	  are	  strongly	  associated	  with	  instability	  in	  both	  cell	  types	  
	   Unstable	  mRNAs	  in	  both	  cell	  lines	  showed	  over-­‐representation	  of	  GC-­‐rich	  elements	  within	  the	  
coding	  regions.	  	  The	  presence	  of	  this	  class	  of	  elements	  could	  lead	  to	  the	  formation	  of	  secondary	  
structures	  that	  impede	  ribosome	  progression.	  	  Surveillance	  mechanisms	  recognize	  stalled	  ribosomes	  
and	  initiate	  decay	  of	  the	  transcript	  to	  release	  the	  translation	  machinery	  so	  that	  it	  may	  continue	  
synthesizing	  proteins	  (Doma	  and	  Parker,	  2006).	  	  However,	  it	  is	  important	  to	  note	  that	  studies	  in	  
differentiated	  cells	  (HeLa	  and	  293T)	  investigating	  the	  stability	  of	  GC-­‐rich	  and	  GC-­‐poor	  genes	  under	  the	  
same	  promoter	  and	  UTR	  sequences	  found	  that	  mRNA	  decay	  rates	  are	  not	  correlated	  with	  GC	  content	  






3.5.3	  3’UTR	  elements	  are	  over-­‐represented	  in	  stable	  and	  unstable	  mRNAs	  
	   We	  expected	  to	  find	  sequence	  elements	  that	  correlate	  with	  stability	  in	  the	  3’UTR	  since	  this	  is	  
typically	  where	  most	  cis-­‐acting	  stability	  elements	  have	  been	  located	  to	  date	  (Schoenberg	  and	  Maquat,	  
2012).	  	  The	  stability	  of	  an	  mRNA	  is	  in	  large	  part	  specified	  by	  the	  recruitment	  of	  trans-­‐acting	  factors	  such	  
as	  miRNAs	  and	  RNA-­‐binding	  proteins.	  	  Identification	  of	  over-­‐represented	  hexamer	  sequences	  could	  give	  
clues	  as	  to	  which	  miRNAs	  and	  RBPs	  might	  be	  involved	  in	  modulating	  mRNA	  decay	  in	  HFF	  and	  iPS	  cells.	  	  
Indeed,	  we	  found	  enrichment	  of	  sequences	  in	  both	  stable	  and	  unstable	  mRNAs	  in	  both	  cell	  lines	  and	  
those	  are	  discussed	  in	  more	  detail	  below.	  
	  
3.5.3.1	  U-­‐rich	  and	  GU-­‐rich	  3’UTR	  elements	  are	  over-­‐represented	  in	  unstable	  mRNAs	  in	  both	  cell	  lines	  
	   As	  shown	  in	  Figure	  3.9	  above,	  U-­‐rich	  and	  GU-­‐rich	  elements	  are	  over-­‐represented	  in	  unstable	  HFF	  
mRNAs.	  	  In	  iPS	  cells,	  U-­‐rich	  elements	  were	  correlated	  with	  instability	  to	  a	  higher	  degree	  compared	  to	  
HFFs.	  	  Association	  of	  U-­‐rich	  elements	  with	  instability	  is	  not	  surprising	  as	  destabilization	  induced	  by	  AU-­‐	  
and	  GU-­‐rich	  sequences	  is	  well	  studied	  (Schoenberg	  and	  Maquat,	  2012).	  	  Transcripts	  bearing	  these	  
elements	  usually	  encode	  transcription	  factors,	  growth	  factors,	  and	  cytokines	  (Halees	  et	  al.,	  2011;	  
Khabar,	  2005).	  	  Such	  elements	  are	  reported	  to	  bind	  to	  CELF	  proteins	  (Vlasova	  et	  al.,	  2008;	  Vlasova-­‐St	  
Louis	  et	  al.,	  2013)	  and	  ELAV-­‐like	  proteins	  including	  HuR	  (Brennan	  and	  Steitz,	  2001;	  Dean	  et	  al.,	  2001);	  
both	  well-­‐known	  regulators	  of	  mRNA	  decay.	  	  U-­‐rich	  cis-­‐elements	  are	  also	  able	  to	  confer	  regulation	  in	  a	  
developmentally-­‐dependent	  manner,	  allowing	  temporal	  control	  (Liu	  et	  al.,	  2009).	  	  However,	  we	  were	  
surprised	  to	  note	  that	  typical	  AU-­‐rich	  elements	  (e.g.	  UAUUUAU	  and	  variants	  thereof)	  were	  not	  over-­‐
represented	  in	  either	  iPS	  or	  HFF	  unstable	  mRNAs.	  	  At	  this	  time	  we	  do	  not	  understand	  why	  AU-­‐rich	  
elements	  were	  not	  detected	  but	  it	  is	  possibly	  due	  to	  the	  under-­‐representation	  of	  very	  unstable	  mRNAs	  
in	  our	  dataset.	  	  Half-­‐lives	  <2	  hours	  were	  only	  determined	  for	  69	  mRNAs	  in	  HFFs	  and	  26	  mRNAs	  in	  iPS	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cells.	  	  Low	  abundance	  due	  to	  instability	  may	  have	  prevented	  a	  higher	  proportion	  of	  these	  transcripts	  
from	  meeting	  our	  criteria	  for	  good	  half-­‐life	  determination.	  	  
	  
3.5.3.2	  C-­‐rich	  3’UTR	  elements	  are	  exclusively	  over-­‐represented	  in	  unstable	  iPS	  cell	  mRNAs	  	  
	   In	  addition	  to	  U-­‐rich	  elements,	  unstable	  iPS	  cell	  mRNAs	  also	  show	  enrichment	  of	  C-­‐rich	  
hexamers.	  	  As	  C-­‐rich	  elements	  are	  typically	  associated	  with	  transcript	  stabilization	  (Holcik	  and	  Liebhaber,	  
1997;	  Wang	  et	  al.,	  1995),	  their	  identification	  here	  in	  unstable	  mRNAs	  was	  surprising.	  	  Several	  proteins	  
are	  known	  to	  bind	  these	  RNA	  elements	  including	  HNRNP	  K	  (Siomi	  et	  al.,	  1993),	  PTBP1	  (Kosinski	  et	  al.,	  
2003),	  NOVA	  proteins	  (Buckanovich	  and	  Darnell,	  1997;	  Yang	  et	  al.,	  1998),	  and	  the	  family	  of	  Poly(C)-­‐
Binding	  Proteins	  (PCBPs;	  Kiledjian	  et	  al.,	  1995;	  Makeyev	  and	  Liebhaber,	  2000).	  	  Further	  investigation	  of	  
C-­‐rich	  elements	  and	  their	  potential	  role	  in	  regulating	  decay	  in	  stem	  cells	  is	  presented	  in	  Chapter	  6.	  	  	  	  
	  
3.5.3.3	  CAU-­‐containing	  3’UTR	  elements	  are	  over-­‐represented	  in	  stable	  iPS	  cell	  mRNAs	  
	   Additionally,	  we	  found	  that	  CAU-­‐containing	  hexamer	  sequences	  (CAUACA,	  AAACAU,	  CAUUCA,	  
CAUCCA,	  and	  CAUCGC)	  are	  enriched	  in	  the	  3’UTR	  of	  stable	  mRNAs	  in	  iPS	  cells.	  	  A	  similar	  element	  in	  the	  
3’	  region	  of	  GLUT1	  mRNA	  stabilizes	  the	  transcript	  during	  glucose	  deprivation	  and	  hypoxia	  (Boado	  and	  
Pardridge,	  2002).	  	  Such	  elements	  are	  also	  found	  in	  the	  3’UTR	  of	  VEGF	  mRNA	  (Claffey	  et	  al.,	  1998)	  and	  
may	  be	  bound	  by	  RNA-­‐binding	  proteins	  HNRNP	  L	  (Shih	  and	  Claffey,	  1999),	  HuR	  (Levy	  et	  al.,	  1998;	  Tang	  et	  
al.,	  2002),	  or	  PTB	  (Coles	  et	  al.,	  2004)	  to	  confer	  transcript	  stabilization.	  	  	  
	  
3.5.3.4	  CA-­‐rich	  3’UTR	  elements	  are	  over-­‐represented	  in	  stable	  HFF	  mRNAs	  
	   In	  stable	  HFF	  mRNA	  3’UTRs	  we	  found	  an	  enrichment	  of	  CA-­‐repeat	  elements	  (CACACA	  and	  
ACACAC)	  that	  are	  not	  over-­‐represented	  in	  stable	  iPS	  cell	  mRNAs.	  	  Although	  these	  elements	  may	  be	  
bound	  by	  proteins	  such	  as	  HNRNP	  L	  to	  destabilize	  mRNAs	  (Lee	  et	  al.,	  2009,	  2004)	  through	  miRNA-­‐
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independent	  endonucleolytic	  cleavage	  (Bracken	  et	  al.,	  2011),	  binding	  of	  HNRNP	  L	  to	  CA-­‐rich	  elements	  
can	  also	  stabilize	  transcripts	  by	  inhibiting	  miRNA	  activity	  (Jafarifar	  et	  al.,	  2011).	  	  As	  these	  cis-­‐elements	  
are	  not	  well	  characterized,	  it	  is	  difficult	  to	  speculate	  on	  their	  contribution	  to	  pluripotency	  or	  
differentiation	  in	  HFF	  and	  iPS	  cells.	  	  	  
	  
3.6	  Identification	  of	  mRNAs	  that	  show	  significant	  differences	  in	  decay	  rate	  between	  HFF	  and	  iPS	  cells	  
	   To	  identify	  differentially	  regulated	  transcripts,	  the	  5,481	  mRNAs	  whose	  half-­‐lives	  were	  
determined	  in	  both	  cell	  lines	  were	  compared	  to	  calculate	  half-­‐life	  fold-­‐change	  differences.	  	  The	  half-­‐life	  
difference	  was	  graphed	  to	  determine	  the	  most	  significantly	  stabilized	  (top	  10%,	  90th	  percentile)	  and	  
most	  significantly	  destabilized	  (bottom	  10%,	  10th	  percentile)	  mRNAs	  in	  iPS	  cells	  compared	  to	  HFFs	  
(Figure	  3.10).	  	  Both	  of	  these	  data	  sets	  (each	  containing	  548	  mRNAs)	  were	  then	  analyzed	  in	  more	  detail	  
using	  bioinformatic	  approaches	  to	  discern	  possible	  mechanisms	  of	  transcript	  stabilization	  and/or	  
destabilization.	  	  	  
	  
Figure	  3.10	  Plotting	  the	  distribution	  of	  fold-­‐change	  in	  half-­‐life	  difference	  between	  HFF	  and	  iPS	  cells	  
reveals	  differentially	  regulated	  mRNAs.	  	  For	  5,481	  mRNAs,	  the	  fold-­‐change	  in	  half-­‐life	  difference	  was	  






3.6.1	  Functional	  analysis	  reveals	  histone	  and	  C2H2	  ZNF	  mRNAs	  are	  stabilized	  in	  iPS	  cells	  
	   The	  functional	  annotation	  tool	  DAVID	  (Huang	  et	  al.,	  2009a,	  2009b)	  was	  used	  to	  identify	  
enrichment	  of	  functionally-­‐related	  genes	  within	  the	  set	  of	  mRNAs	  differentially	  regulated	  in	  iPS	  cells	  
compared	  to	  HFFs.	  	  Table	  3.2	  summarizes	  these	  results.	  	  Although	  the	  dataset	  of	  destabilized	  mRNAs	  did	  
not	  reveal	  significant	  term	  enrichment	  (data	  not	  shown),	  mRNAs	  that	  were	  destabilized	  in	  iPS	  cells	  were	  
more	  likely	  to	  encode	  proteins	  associated	  with	  the	  plasma	  membrane	  (P-­‐value	  =1.2x10-­‐4).	  	  Analysis	  of	  
the	  mRNAs	  that	  were	  stabilized	  in	  iPS	  cells	  relative	  to	  HFFs	  identified	  several	  enrichments	  for	  GO	  terms	  
including	  “nucleosome”,	  “regulation	  of	  transcription”,	  and	  “DNA	  binding”	  (P-­‐value	  <1x10-­‐7).	  	  Transcripts	  
that	  were	  associated	  with	  increased	  stability	  in	  mouse	  ES	  cells	  compared	  to	  differentiated	  cells	  were	  
also	  enriched	  for	  functions	  including	  “transcription	  regulation”	  and	  “chromatin	  binding”	  (Sharova	  et	  al.,	  
2009).	  	  Many	  of	  the	  transcripts	  contained	  in	  the	  group	  linked	  with	  the	  “nucleosome”	  GO	  term	  encode	  
histones	  while	  many	  zinc	  finger	  (ZNF)	  protein	  mRNAs	  were	  associated	  with	  terms	  “regulation	  of	  
transcription”	  and	  “DNA	  binding.”	  	  To	  identify	  functional	  domains	  over-­‐represented	  in	  these	  mRNAs,	  the	  
SMART	  protein	  domain	  annotation	  tool	  (Letunic	  et	  al.,	  2012;	  Schultz	  et	  al.,	  1998)	  was	  used.	  	  Consistent	  
with	  the	  identified	  GO	  terms,	  we	  found	  enrichment	  of	  histones	  (P-­‐value	  =3.1x10-­‐4)	  and	  significant	  over-­‐
representation	  of	  KRAB	  (Krüppel-­‐Associated	  Box)	  and	  C2H2	  (Krüppel-­‐like	  domain)	  zinc	  finger	  domains	  




Table	  3.2	  List	  of	  Gene	  Ontology	  and	  SMART	  terms	  associated	  with	  mRNAs	  stabilized	  in	  iPS	  cells.	  	  
Functional	  analysis	  revealed	  histone	  and	  KRAB	  C2H2	  ZNF	  mRNAs	  are	  stabilized	  in	  iPS	  cells.	  
	  
ID	   Term	   p-­‐value	  
GO:Cellular	  Component	  
GO:0000786	   nucleosome	   1.1x10-­‐8	  
GO:0032993	   protein	  DNA	  Complex	   7.9x10-­‐7	  
GO:0000785	   chromatin	   4.2x10-­‐4	  
GO:Biological	  Process	  
GO:0006355	  	   regulation	  of	  transcription,	  DNA-­‐dependent	   3.1x10-­‐8	  
GO:0051252	  	  	   regulation	  of	  RNA	  metabolic	  process	   3.9x10-­‐8	  
GO:0006350	   transcription	   5.2x10-­‐8	  
GO:0045449	   regulation	  of	  transcription	   1.6x10-­‐6	  
GO:0006334	   nucleosome	  assembly	   1.2x10-­‐5	  
GO:0031497	  	   chromatin	  assembly	   2.6x10-­‐5	  
GO:0065004	   protein-­‐DNA	  complex	  assembly	   3.7x10-­‐5	  
GO:0034728	   nucleosome	  organization	   3.7x10-­‐5	  
GO:0006323	   DNA	  packaging	   6.6x10-­‐4	  
GO:0006333	   chromatin	  assembly	  or	  disassembly	   7.3x10-­‐4	  
GO:Molecular	  Function	  
GO:0003677	   DNA	  binding	   1.5x10-­‐8	  
GO:0008270	   zinc	  ion	  binding	   5.6x10-­‐8	  
GO:0046914	   transition	  metal	  ion	  binding	   4.8x10-­‐7	  
GO:0046872	   metal	  ion	  binding	   7.7x10-­‐5	  
GO:0043169	   cation	  binding	   8.5x10-­‐5	  
SMART	  
SM00349	   Kruppel	  associated	  box	  (KRAB)	   1.2x10-­‐23	  
SM00355	   C2H2	  zinc	  finger	   7.4x10-­‐18	  
SM00414	   histone	  2A	   3.1x10-­‐4	   	  
	  
	   Given	  the	  dramatic	  stabilization	  of	  mRNAs	  encoding	  histones	  and	  C2H2	  ZNF	  proteins,	  regulation	  
of	  histone	  mRNA	  stability	  was	  further	  investigated	  and	  is	  presented	  in	  Chapter	  4	  while	  the	  mechanism	  
of	  C2H2	  ZNF	  mRNA	  stabilization	  is	  explored	  in	  Chapter	  5.	  	  	  
	  
3.6.2	  Sequence	  analysis	  reveals	  mRNAs	  with	  U-­‐rich	  or	  C-­‐rich	  3’UTR	  elements	  are	  destabilized	  in	  iPS	  cells	  
	   As	  determined	  through	  cis-­‐element	  analysis	  of	  unstable	  iPS	  mRNAs,	  we	  also	  found	  significant	  
enrichment	  of	  U-­‐rich	  and	  C-­‐rich	  elements	  in	  the	  3’UTR	  of	  transcripts	  significantly	  destabilized	  in	  iPS	  cells	  
compared	  to	  HFFs.	  	  Using	  the	  top	  50	  hexamer	  sequences	  identified	  in	  these	  mRNAs,	  we	  found	  that	  the	  
most	  abundantly	  represented	  sequences	  are	  UUUUUU	  (P-­‐value	  =	  4.74x10-­‐27),	  CCCCCC	  (P-­‐value	  =	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1.40x10-­‐18),	  and	  a	  CUG-­‐containing	  motif	  (Figure	  3.11).	  	  We	  investigated	  the	  regulation	  of	  U-­‐rich	  and	  C-­‐
rich	  element	  containing	  mRNAs	  in	  more	  detail	  (Section	  3.6.3	  and	  Chapter	  6,	  respectively).	  	  Although	  we	  
elected	  not	  to	  study	  the	  CUG-­‐rich	  motif	  any	  further,	  these	  elements	  in	  the	  3’UTR	  of	  mRNAs	  may	  be	  
bound	  by	  Muscleblind-­‐like	  splicing	  regulator	  1	  (MBNL1)	  which	  destabilizes	  transcripts	  (Masuda	  et	  al.,	  
2012;	  Warf	  and	  Berglund,	  2007).	  	  Interestingly,	  MBNL	  proteins	  are	  negative	  regulators	  of	  pluripotency	  
that	  repress	  stem	  cell-­‐specific	  alternative	  splicing	  of	  transcription	  factor	  FOXP1	  mRNA.	  	  Knockdown	  of	  
MBNL	  proteins	  promotes	  pluripotent	  splicing	  patterns	  and	  enhances	  reprogramming	  of	  fibroblasts	  (Han	  
et	  al.,	  2013).	  	  	  
	  
UUUUU 4.74E-­‐27 UGUUU 7.59E-­‐17
UUGUU 6.26E-­‐16 UUUUG 5.76E-­‐15
UUUGU 3.99E-­‐14 GUUUU 5.38E-­‐13
GUUUU 3.17E-­‐12 GGUUU 2.36E-­‐11
CUUUUU 1.30E-­‐09 CCUUUU 4.39E-­‐09
UUUUUA 6.05E-­‐09 UUUUAA 2.02E-­‐08
UGGUU 1.24E-­‐07
CCCCCC 1.40E-­‐18 CCCCUC 4.80E-­‐13
CCCUCC 1.17E-­‐11 CCCCCA 4.92E-­‐11
CCCCAC 5.00E-­‐11 GCCCUC 8.21E-­‐10
CCCCAG 9.68E-­‐10 UCCCCC 1.05E-­‐09
CUCCCC 5.04E-­‐09 CACCCC 1.18E-­‐08
CCCCCU 1.76E-­‐08 GCCCCC 7.10E-­‐08
CCACCC 4.15E-­‐07
GCCGCC 1.58E-­‐13 CUGCCG 2.52E-­‐11
UGCCGG 2.06E-­‐09 GGCCUG 3.59E-­‐09
CCUGCC 3.83E-­‐09 GGGCCU 4.56E-­‐09
UGGGCC 8.82E-­‐09 GGCCGC 1.20E-­‐08
GCCUGC 3.69E-­‐08 CUGCCC 4.93E-­‐08
GGUGCC 7.30E-­‐08 GCCGGC 8.22E-­‐08
CCGCCC 8.59E-­‐08 CCGCCG 2.05E-­‐07
GCUGCC 2.98E-­‐07 GCGCCU 3.36E-­‐07
GGCGCC 4.20E-­‐07 UGCUGC 4.33E-­‐07
	  	  	  	  	  	  	  	  Hexamers	  clustered	  for	  sequence	  logos:
Figure	  3.11	  U-­‐rich,	  C-­‐rich,	  and	  CUG-­‐containing	  motifs	  are	  over-­‐represented	  in	  the	  3’UTR	  of	  mRNAs	  
destabilized	  in	  iPS	  cells	  relative	  to	  HFFs.	  	  Sequence	  logos	  were	  generated	  from	  the	  top	  50	  hexamer	  
sequences	  over-­‐represented	  in	  the	  dataset	  of	  548	  destabilized	  iPS	  mRNAs.	  	  	  
Hexamers	  clustered	  for	  
sequence	  logos:
	  




3.6.3	  qRT-­‐PCR	  confirms	  destabilization	  of	  mRNAs	  containing	  U-­‐rich	  sequence	  elements	   	  
	   The	  half-­‐lives	  of	  two	  mRNAs	  containing	  U-­‐rich	  sequence	  elements	  in	  their	  3’UTR,	  WEE1	  and	  
LATS2,	  as	  measured	  by	  qRT-­‐PCR	  analysis	  in	  actinomycin	  d-­‐treated	  cells	  were	  consistent	  with	  the	  
hexamer	  data	  (Figure	  3.11)	  indicating	  that	  these	  elements	  are	  more	  highly	  associated	  with	  instability	  in	  
iPS	  cells	  than	  HFFs	  (Figure	  3.12).	  	  This	  increased	  stability	  was	  also	  seen	  in	  mouse	  ES	  data	  where	  WEE1	  
mRNA	  half-­‐life	  was	  increased	  from	  ~108	  minutes	  to	  ~126	  minutes	  and	  LATS2	  mRNA	  half-­‐life	  was	  
increased	  from	  ~180	  minutes	  to	  ~252	  minutes	  upon	  differentiation	  with	  retinoic	  acid	  (Sharova	  et	  al.,	  
2009).	  	  Our	  microarray	  data	  indicated	  that	  HFF	  and	  iPS	  cells	  exhibit	  half-­‐lives	  of	  246	  minutes	  and	  199	  
minutes	  for	  WEE1	  mRNA	  while	  LATS2	  mRNA	  had	  a	  half-­‐life	  of	  503	  minutes	  in	  iPS	  cells.	  	  Although	  LATS2	  
was	  identified	  as	  a	  stabilized	  mRNA	  in	  an	  earlier	  analysis	  of	  the	  microarray	  data,	  it	  did	  not	  meet	  the	  
criteria	  for	  good	  half-­‐life	  determination	  in	  the	  final	  analysis	  described	  here	  in	  HFFs.	  	  WEE1	  encodes	  a	  
checkpoint	  kinase	  that	  negatively	  regulates	  mitotic	  entry	  through	  phosphorylation	  of	  cyclin	  B/Cdk2	  
(McGowan	  and	  Russell,	  1995)	  and	  LATS2	  is	  a	  tumor	  suppressor	  required	  for	  embryonic	  development	  
(McPherson	  et	  al.,	  2004).	  	  Interestingly,	  knockdown	  of	  LATS2	  by	  RNAi	  was	  recently	  shown	  to	  increase	  




Figure	  3.12	  WEE1 and	  LATS2mRNAs	  containing	  U-­‐rich	  3’UTR	  elements	  are	  destabilized	  in	  iPS	  cells	  compared	  to	  
HFFs.	  	  Half-­‐lives	  were	  assessed	  in	  HFF	  and	  iPS	  cells	  for	  WEE1 and	  LATS2mRNAs	  containing	  U-­‐rich	  3’UTR	  elements	  
following	  actinomycin	  D	  treatment.	  	  mRNA	  levels	  were	  measured	  by	  qRT-­‐PCR	  at	  each	  time	  point	  and	  normalized	  
to	  GAPDH	  mRNA.	  	  The	  standard	  deviations	  were	  derived	  from	  three	  independent	  replicates.	  	  Half-­‐lives	  for	  each	  
mRNA	  are	  denoted	  to	  the	  right	  of	  the	  cell-­‐line	  keys.	  
	  
	  
3.7	  Several	  RNA-­‐binding	  proteins	  are	  more	  abundant	  in	  iPS	  cells	  
	   The	  expression	  of	  PTBP1	  and	  several	  RNA-­‐Binding	  Proteins	  (RBPs)	  known	  to	  interact	  with	  U-­‐
containing	  sequence	  elements	  was	  measured	  using	  whole	  cell	  lysates	  and	  western	  blot	  analysis.	  	  The	  
abundance	  values,	  normalized	  to	  α-­‐TUBULIN	  and	  relative	  to	  HFF	  expression,	  and	  standard	  deviation	  
derived	  from	  three	  replicates	  are	  summarized	  in	  Figure	  3.13	  which	  also	  includes	  the	  preferred	  binding	  
sequence	  of	  each	  protein.	  	  Specifically,	  we	  assayed	  expression	  of	  CELF1	  (CUGBP1;	  Vlasova	  et	  al.,	  2008),	  
ELAVL1	  (HuR;	  Meisner	  and	  Filipowicz,	  2010),	  PUM2	  (Miller	  and	  Olivas,	  2011),	  KHSRP	  (Gherzi	  et	  al.,	  2010),	  
PTBP1	  (Kosinski	  et	  al.,	  2003),	  HNRNP	  D	  (AUF1;	  Gratacós	  and	  Brewer,	  2010),	  and	  ZFP36L2	  (Hudson	  et	  al.,	  
2004).	  	  We	  found	  that	  all	  seven	  of	  these	  proteins,	  which	  (except	  for	  ELAVL1)	  are	  known	  to	  confer	  
instability,	  are	  elevated	  in	  iPS	  cells	  relative	  to	  HFFs	  to	  varied	  degrees.	  	  Increased	  abundance	  of	  KHSRP	  in	  
iPS	  cells	  was	  also	  verified	  in	  an	  independent	  set	  of	  matched	  cell	  lines	  (A.	  Jalkanen	  personal	  
communication).	  	  Interestingly,	  repression	  of	  PTBP1	  in	  fibroblasts	  is	  sufficient	  to	  reprogram	  the	  cells	  into	  
neurons	  (Xue	  et	  al.,	  2013)	  supporting	  that	  altered	  abundance	  of	  RBPs	  can	  have	  profound	  effects	  on	  gene	  
expression.	  	  The	  increased	  abundance	  of	  destabilizing	  RBPs	  that	  recognize	  U-­‐rich	  elements	  correlates	  
well	  with	  the	  fact	  that	  U-­‐rich	  elements	  are	  more	  associated	  with	  instability	  in	  iPS	  cells	  (Figure	  3.6).	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Figure	  3.13	  Several	  RNA-­‐binding	  proteins	  are	  more	  abundant	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  Western	  blot	  
analysis	  of	  PTBP1	  and	  various	  RNA-­‐binding	  proteins	  known	  to	  interact	  with	  U-­‐containing	  sequences	  was	  
performed	  in	  HFF	  and	  iPS	  cells	  using	  25µg	  of	  whole	  cell	  lysate	  on	  a	  10%	  SDS-­‐PAGE	  gel	  transferred	  to	  PVDF	  
membrane.	  Quantification	  using	  ImageQuant	  software	  was	  based	  on	  a	  three	  replicates	  where	  levels	  of	  each	  
protein	  are	  normalized	  to	  levels	  of	  α-­‐TUBULIN	  and	  relative	  to	  expression	  in	  HFF	  cells. The	  preferred	  target	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3.8	  Transcription	  rates	  and	  decay	  rates	  are	  inversely	  correlated	  	  
	   In	  addition	  to	  providing	  mRNA	  decay	  rates,	  our	  microarray	  analysis	  allowed	  mRNA	  abundances	  
to	  be	  assessed	  from	  the	  0	  minute	  time	  points.	  	  We	  wondered	  whether	  changes	  in	  mRNA	  stability	  might	  
have	  a	  predictable	  effect	  on	  mRNA	  abundances.	  	  In	  order	  to	  detect	  a	  correlation,	  we	  plotted	  the	  fold-­‐
change	  in	  half-­‐life	  against	  the	  fold-­‐change	  in	  abundance	  (Figure	  3.14).	  	  Somewhat	  surprisingly,	  we	  found	  
a	  negative	  correlation	  meaning	  that	  when	  mRNAs	  are	  destabilized,	  their	  abundance	  actually	  tends	  to	  
increase	  rather	  than	  decrease.	  	  The	  only	  explanation	  for	  this	  is	  that	  transcription	  can	  be	  increased	  to	  
compensate	  for	  the	  increased	  rates	  of	  decay.	  	  These	  results	  are	  consistent	  with	  recent	  studies	  
demonstrating	  that	  regulation	  of	  transcription	  and	  degradation	  processes	  are	  linked	  (Dori-­‐Bachash	  et	  
al.,	  2012;	  Haimovich	  et	  al.,	  2013;	  Shalem	  et	  al.,	  2011).	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Figure	  3.14	  mRNA	  decay	  rates	  negatively	  correlate	  with	  mRNA	  abundance.	  	  Scatter	  plot	  of	  differences	  in	  
mRNA	  abundance	  (y-­‐axis)	  and	  differences	  in	  mRNA	  half-­‐life	  (x-­‐axis)	  for	  5,481	  genes	  quantified	  as	  log2(ratio	  
of	  HFF/iPS)	  indicate	  that	  mRNA	  half-­‐life	  correlates	  negatively	  with	  mRNA	  abundance.	  	  






















3.9	  Concluding	  remarks	  	  	  
	   Establishment	  of	  this	  large	  dataset	  of	  mRNA	  half-­‐lives	  has	  emphasized	  the	  utility	  of	  global	  mRNA	  
decay	  analyses	  and	  opened	  up	  several	  new	  avenues	  for	  investigation.	  	  By	  determining	  genome-­‐wide	  
mRNA	  decay	  rates	  in	  HFF	  and	  iPS	  cells,	  we	  identified	  three	  groups	  of	  differentially	  regulated	  transcripts.	  	  	  
Using	  Gene	  Ontology	  and	  functional	  domain	  analyses,	  we	  revealed	  that	  replication-­‐dependent	  histone	  
mRNAs	  and	  C2H2	  ZNF	  mRNAs	  are	  significantly	  stabilized	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  Given	  the	  clear	  
ability	  of	  histones	  and	  transcription	  factors	  to	  influence	  gene	  expression,	  their	  stabilization	  was	  
investigated	  further	  and	  is	  discussed	  in	  more	  detail	  in	  Chapters	  4	  and	  5,	  respectively.	  	  Sequence	  analysis	  
of	  hexamer	  motifs	  enriched	  in	  unstable	  mRNAs	  also	  revealed	  possible	  mechanisms	  of	  coordinated	  
regulation.	  	  U-­‐rich,	  C-­‐rich,	  and	  CUG-­‐containing	  elements	  were	  over-­‐represented	  in	  the	  3’UTR	  of	  mRNAs	  
destabilized	  in	  iPS	  cells.	  	  We	  focused	  on	  C-­‐rich	  elements	  primarily	  because	  their	  association	  with	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instability	  has	  not	  been	  reported	  in	  any	  cell	  types	  other	  than	  iPS	  cells.	  	  Possible	  mechanisms	  regulating	  
destabilized	  mRNAs	  bearing	  this	  element	  are	  discussed	  further	  in	  Chapter	  6.	  	  	  
	   This	  dataset	  has	  provided	  a	  foundation	  for	  expanding	  this	  project	  into	  characterizing	  the	  
mechanisms	  by	  which	  coordinated	  regulation	  is	  achieved	  and	  has	  also	  already	  been	  used	  by	  others	  to	  
study	  mRNA	  decay	  rates	  (Dori-­‐Bachash	  et	  al.,	  2012).	  	  	  Although	  we	  have	  focused	  our	  efforts	  on	  just	  
three	  groups	  of	  differentially	  regulated	  mRNAs,	  there	  are	  certainly	  other	  groups	  that	  may	  be	  worthy	  of	  
further	  study.	  	  It	  was	  intriguing	  to	  find	  that	  CA-­‐repeat	  elements	  were	  enriched	  in	  the	  3’UTR	  of	  stable	  HFF	  
mRNAs	  but	  not	  stable	  iPS	  cell	  mRNAs,	  possibly	  demonstrating	  a	  mechanism	  of	  coordinated	  regulation	  of	  
stability.	  	  Moreover,	  there	  is	  also	  likely	  a	  great	  deal	  to	  be	  learned	  from	  examining	  regulated	  decay	  of	  
certain	  individual	  transcripts	  whose	  turnover	  differs	  between	  HFF	  and	  iPS	  cells.	  	  For	  example,	  HES1	  
encodes	  a	  transcription	  factor	  which	  represses	  stem	  cell	  differentiation	  and	  its	  mRNA	  is	  destabilized	  
significantly	  in	  iPS	  cells	  (169	  minutes	  versus	  261	  minutes	  in	  HFFs)	  but	  shows	  a	  ~3-­‐fold	  increase	  in	  
abundance.	  	  The	  HES1	  mRNA	  has	  a	  long	  A-­‐rich	  region	  in	  the	  5’UTR	  as	  well	  as	  C-­‐rich,	  AU-­‐rich,	  and	  GU-­‐rich	  



















4.1.	  Introduction	  	  	  	  
	   Several	  studies	  have	  revealed	  dramatic	  differences	  in	  chromatin	  status	  and	  histone	  expression	  
between	  stem	  cells	  and	  differentiated	  cells	  that	  are	  clearly	  important	  for	  the	  achievement	  and	  
maintenance	  of	  pluripotency	  (Boyer,	  2009;	  Delgado-­‐Olguin	  and	  Recillas-­‐Targa,	  2011;	  Meshorer	  and	  
Misteli,	  2006).	  	  Two	  very	  obvious	  differences	  are	  (i)	  that	  stem	  cells	  express	  a	  unique	  subset	  of	  histones	  
(Yang	  et	  al.,	  2011;	  Zhang	  et	  al.,	  2012)	  and	  (ii)	  that	  the	  epigenetic	  profile	  of	  stem	  cells	  is	  very	  different	  
from	  that	  of	  differentiated	  cells	  (Larson	  and	  Yuan,	  2012;	  Song	  et	  al.,	  2012).	  	  In	  the	  context	  of	  these	  
differences,	  we	  were	  intrigued	  to	  find	  that	  the	  stability	  of	  many	  histone	  mRNAs	  is	  enhanced	  in	  iPS	  cells	  
as	  compared	  to	  HFFs	  (discussed	  in	  Chapter	  3).	  	  As	  an	  introduction	  to	  the	  further	  analysis	  of	  these	  results,	  
the	  function	  and	  regulation	  of	  histone	  gene	  expression	  is	  discussed	  below,	  highlighting	  the	  unique	  
aspects	  of	  these	  processes	  in	  pluripotency.	  	  	  
	  
4.1.1	  Histones	  are	  essential	  for	  genome	  packaging	  and	  gene	  expression	  regulation	  
	   One	  role	  of	  histone	  proteins	  is	  to	  efficiently	  compartmentalize	  genomic	  DNA.	  	  It	  is	  estimated	  
that	  each	  human	  diploid	  cell	  contains	  two	  meters	  of	  DNA	  which	  must	  be	  packaged	  as	  chromatin	  into	  a	  
nucleus	  that	  is	  less	  than	  10	  microns	  across.	  	  Histones	  exert	  organizational	  control	  over	  this	  large	  amount	  
of	  genetic	  information	  through	  the	  formation	  of	  nucleosomes	  that	  allow	  the	  DNA	  in	  chromosomes	  to	  be	  
packed	  into	  deliberate,	  rather	  than	  random,	  positions.	  	  Histone	  proteins	  enable	  genome	  compaction	  
through	  their	  interaction	  with	  DNA	  and	  chromatin	  remodeling	  factors.	  	  Each	  nucleosome	  contains	  147	  
bases	  of	  DNA	  wrapped	  in	  two	  turns	  around	  an	  octamer	  containing	  two	  molecules	  each	  of	  core	  histones	  
H2A,	  H2B,	  H3,	  and	  H4.	  	  DNA	  is	  effectively	  locked	  into	  place	  by	  linker	  histone	  H1	  (Luger	  et	  al.,	  1997).	  	  	  
69	  
	  
	   In	  addition	  to	  reducing	  the	  physical	  space	  requirement	  of	  the	  genome,	  chromatin	  structure	  is	  
also	  established	  to	  support	  cell-­‐	  and	  stage-­‐specific	  gene	  expression	  patterns	  by	  spatiotemporally	  
controlling	  access	  of	  the	  transcription	  machinery	  to	  certain	  gene	  loci.	  	  The	  composition	  of	  the	  
nucleosomes	  at	  specific	  positions	  can	  have	  profound	  effects	  on	  transcription	  and	  RNA	  processing	  (van	  
Bakel	  et	  al.,	  2013;	  Koerber	  et	  al.,	  2009).	  	  In	  this	  respect,	  it	  is	  important	  to	  note	  that	  each	  of	  the	  core	  
histones	  as	  well	  as	  the	  linker	  histone	  are	  encoded	  by	  multiple	  genes	  resulting	  in	  a	  staggering	  number	  of	  
possible	  arrangements	  (Lichtler	  et	  al.,	  1982;	  Marzluff	  et	  al.,	  2002).	  	  Moreover,	  each	  histone	  protein	  can	  
experience	  multiple	  post-­‐translational	  modifications	  ranging	  from	  acetylation	  to	  ubiquitination	  to	  
further	  increase	  the	  number	  of	  permutations	  (Grewal	  and	  Moazed,	  2003;	  Lennartsson	  and	  Ekwall,	  2009;	  
Rossetto	  et	  al.,	  2012).	  	  
	  
4.1.2	  Histone	  expression	  	  
	   Expression	  of	  replication-­‐dependent	  histone	  mRNAs	  is	  tightly	  coupled	  to	  DNA	  synthesis	  and	  is	  
therefore	  cell	  cycle-­‐regulated	  (Marzluff	  and	  Duronio,	  2002).	  	  As	  stem	  cells	  have	  abbreviated	  cell	  cycles	  
(Becker	  et	  al.,	  2006),	  the	  temporal	  regulation	  of	  histone	  expression	  is	  also	  altered	  compared	  to	  
differentiated	  cell	  types.	  	  Although	  histone	  genes	  are	  highly	  conserved	  within	  histone	  families,	  stem	  cells	  
express	  a	  unique	  subset	  of	  histones	  that	  likely	  support	  pluripotency	  (Yang	  et	  al.,	  2011).	  	  Regulation	  of	  
histone	  mRNA	  biology,	  aspects	  of	  which	  have	  been	  characterized	  from	  transcription	  through	  decay,	  may	  
provide	  some	  clues	  to	  stem	  cell-­‐specific	  patterns	  of	  histone	  gene	  expression.	  	  	  
	  
4.1.2.1	  Histone	  gene	  transcription	  and	  maturation	  of	  pre-­‐mRNAs	  
	   The	  replication-­‐dependent	  histone	  proteins	  are	  encoded	  by	  a	  large	  family	  of	  highly	  conserved	  
genes	  that	  are	  present	  in	  chromosomal	  clusters	  (Tripputi	  et	  al.,	  1986).	  	  The	  genes	  encoding	  the	  four	  core	  
histones	  exhibit	  the	  most	  homology	  between	  one	  another	  with	  few	  differences	  at	  the	  amino	  acid	  level	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while	  the	  linker	  histone	  H1	  show	  more	  variation	  between	  the	  five	  subtypes	  (Marino-­‐Ramirez	  et	  al.,	  
2006;	  Thatcher	  and	  Gorovsky,	  1994).	  	  Although	  not	  all	  mechanisms	  of	  histone	  transcription	  induction	  
have	  been	  characterized,	  it	  is	  evident	  that	  the	  expression	  of	  replication-­‐dependent	  histones	  is	  tightly	  
linked	  to	  the	  cell	  cycle	  wherein	  histone	  mRNAs	  are	  transcribed	  only	  during	  S	  phase	  (Marzluff	  and	  
Duronio,	  2002).	  	  As	  such,	  histone	  genes	  exhibit	  cell	  cycle-­‐dependent	  promoter	  activity.	  	  Histones	  are	  the	  
most	  significantly	  up-­‐regulated	  set	  of	  genes	  in	  the	  G1/S	  transition	  (Medina	  et	  al.,	  2012)	  with	  
transcription	  rates	  increasing	  3	  –	  10-­‐fold	  during	  this	  period	  (Harris	  et	  al.,	  1991)	  and	  histone	  mRNA	  
stability	  increasing	  as	  much	  as	  5-­‐fold	  (Heintz	  et	  al.,	  1983).	  	  	  
	   Transcription	  of	  histone	  mRNAs	  at	  the	  G1/S	  boundary	  is	  triggered	  by	  phosphorylation	  of	  
p220NPAT	  by	  cyclin	  E/Cdk2	  (Ma	  et	  al.,	  2000).	  	  Nuclear	  protein	  p220NPAT	  is	  a	  co-­‐activator	  of	  histone	  
transcription	  factor	  HINFP	  which	  associates	  with	  HINFP	  upstream	  of	  transcription	  start	  sites	  to	  activate	  
transcription	  of	  histone	  genes	  (Medina	  et	  al.,	  2008).	  	  The	  activity	  of	  cyclin	  E/Cdk2	  effectively	  links	  
histone	  regulation	  to	  cell	  cycle	  progression	  (Miele	  et	  al.,	  2005).	  	  The	  p220NPAT/cyclin	  E/Cdk2	  interaction	  
constitutes	  a	  forward-­‐feed	  loop	  that	  sustains	  HINFP	  expression	  for	  synthesis	  of	  histone	  pre-­‐mRNAs	  
throughout	  S	  phase	  (Xie	  et	  al.,	  2009).	  	  FLASH	  is	  another	  component	  of	  histone	  transcription	  machinery	  
that	  associates	  with	  promoter	  sequences	  and	  is	  also	  required	  for	  cell	  cycle	  progression	  (Barcaroli	  et	  al.,	  
2006).	  	  The	  role	  of	  FLASH	  is	  essential	  for	  proper	  histone	  transcription	  during	  embryogenesis	  (De	  Cola	  et	  
al.,	  2012).	  	  
	   Histone	  genes	  do	  not	  contain	  introns	  so	  their	  post-­‐transcriptional	  processing	  is	  limited	  to	  3’	  end	  
formation	  (Dominski	  and	  Marzluff,	  1999;	  Martin	  et	  al.,	  1997).	  	  Unlike	  typical	  mRNAs,	  mammalian	  
replication-­‐dependent	  histone	  transcripts	  are	  not	  polyadenylated	  and	  instead	  end	  in	  a	  highly	  conserved	  
stem	  loop	  structure	  that	  controls	  their	  post-­‐transcriptional	  fate.	  	  Stem	  Loop	  Binding	  Protein	  (SLBP)	  
interacts	  with	  this	  3’	  stem	  loop	  element	  to	  regulate	  histone	  mRNA	  processing,	  translation,	  and	  decay	  
(Figure	  4.1).	  	  Binding	  of	  SLBP	  to	  histone	  pre-­‐mRNA	  initiates	  3’	  end	  processing	  by	  causing	  a	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conformational	  change	  to	  expose	  the	  Histone	  Downstream	  Element	  (HDE;	  Jaeger	  et	  al.,	  2006).	  	  The	  U7	  
snRNP	  containing	  U7	  snRNA,	  five	  Sm	  proteins,	  and	  two	  LSm	  proteins	  (LSM10	  and	  LSM11)	  is	  then	  able	  to	  
bind	  the	  HDE	  (Bond	  et	  al.,	  1991;	  Pillai	  et	  al.,	  2001;	  Schaufele	  et	  al.,	  1986)	  through	  base	  pairing	  of	  the	  U7	  
snRNA	  (Georgiev	  and	  Birnstiel,	  1985;	  Mowry	  and	  Steitz,	  1987).	  	  U7	  snRNP	  also	  recruits	  Zinc	  Finger	  
Protein	  ZFP100	  that	  stabilizes	  the	  U7	  snRNP/SLBP/stem	  loop	  complex	  through	  an	  interaction	  between	  
the	  complex	  and	  SLBP	  (Dominski	  et	  al.,	  2002).	  	  LSM11	  of	  the	  U7	  snRNP	  interacts	  with	  FLASH	  to	  recruits	  
CPSF73,	  a	  factor	  that	  also	  participates	  in	  the	  standard	  polyadenylation	  event	  on	  mRNAs,	  for	  
endonucleolytic	  cleavage	  five	  nucleotides	  after	  the	  conserved	  stem	  loop	  sequence	  (Dominski	  et	  al.,	  
2003,	  2005;	  Yang	  et	  al.,	  2013).	  	  3’	  exonuclease	  3’hExo/ERI1	  is	  also	  recruited	  to	  precisely	  trim	  the	  cleaved	  
end	  (Yang	  et	  al.,	  2006,	  2009).	  	  Association	  of	  3’hExo/ERI1	  causes	  further	  conformational	  changes	  to	  the	  
3’UTR	  which	  structurally	  limits	  the	  amount	  of	  trimming	  the	  exonuclease	  can	  perform	  (Tan	  et	  al.,	  2013).	  	  
The	  result	  is	  a	  mature	  histone	  mRNA	  ending	  with	  a	  highly	  conserved	  structure	  consisting	  of	  a	  24-­‐base	  







Figure	  4.1	  Histone	  mRNA	  3’	  end	  processing.	  	  SLBP	  binds	  the	  stem	  loop	  of	  replication-­‐dependent	  histone	  mRNAs	  to	  expose	  
the	  histone	  downstream	  element	  (HDE)	  which	  is	  then	  bound	  by	  U7	  snRNP and	  stabilized	  by	  ZFP100.	  	  CPSF73	  cleaves	  five	  
nucleotides	  after	  the	  stem	  loop	  and	  3’hExo/ERI1	  trims	  the	  cleaved	  end	  to	  yield	  a	  mature	  histone	  transcript.	  
Binding	  of	  SLBP	  exposes	  the	  
Histone	  Downstream	  Element	  
(HDE)	  on	  pre-­‐mRNA	  3’UTR
U7	  snRNA	  binds	  the	  HDE	  and	  
recruits	  ZFP100	  and	  FLASH
ZFP100	  binds	  the	  U7	  snRNP	  and	  
SLBP	  to	  stabilize	  U7	  
snRNP/SLBP/stem	  loop	  complex
U7	  snRNP	  also	  recruits	  
3’hExo/ERI1
FLASH	  binds	  LSM11	  to	  recruit	  
CPSF73	  
CPSF73	  cleaves	  5	  nucleotides	  
downstream	  from	  the	  stem	  loop
3’hExo/ERI1	  trims	  the	  cleaved	  
end	  to	  yield	  a	  mature	  message
	  
	   	  
	   Both	  transcription	  and	  processing	  of	  histone	  pre-­‐mRNAs	  are	  performed	  within	  sub-­‐nuclear	  foci	  
close	  to	  histone	  gene	  clusters	  known	  as	  Histone	  Locus	  Bodies	  (HLBs).	  	  These	  bodies	  arise	  at	  active	  sites	  
of	  histone	  transcription	  and	  are	  present	  through	  interphase	  but	  disappear	  at	  mitosis	  (Nizami	  et	  al.,	  
2010).	  	  Several	  histone	  processing	  factors	  localize	  to	  these	  foci	  including	  FLASH,	  p220NPAT,	  LSM10/	  
LSM11,	  and	  U7	  snRNP	  (Machyna	  et	  al.,	  2013).	  	  During	  Drosophila	  melanogaster	  development,	  factors	  
are	  recruited	  to	  HLBs	  in	  a	  hierarchical	  fashion	  (White	  et	  al.,	  2011).	  	  FLASH	  and	  LSM11	  interact	  directly	  
which	  guides	  FLASH	  to	  the	  processing	  bodies	  (Burch	  et	  al.,	  2011);	  localization	  of	  FLASH	  is	  important	  for	  
the	  establishment	  of	  these	  foci	  (Barcaroli	  et	  al.,	  2006).	  	  LSM10/LSM11	  are	  also	  important	  for	  localization	  
of	  the	  U7	  snRNP	  to	  histone	  locus	  bodies	  (Godfrey	  et	  al.,	  2009).	  	  Together,	  these	  components	  work	  to	  
convert	  newly	  transcribed	  histone	  mRNAs	  into	  their	  mature	  forms.	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4.1.2.2	  Histone	  mRNA	  translation	  
	   A	  mature	  histone	  mRNA	  is	  exported	  from	  the	  nucleus	  while	  SLBP	  is	  still	  bound	  (Sullivan	  et	  al.,	  
2009)	  so	  that	  it	  may	  facilitate	  translation	  (Whitfield	  et	  al.,	  2004).	  	  Synthesis	  of	  histone	  proteins	  is	  
initiated	  when	  SLBP	  is	  phosphorylated	  at	  up	  to	  23	  sites	  by	  multiple	  serine/threonine	  kinases,	  allowing	  
recruitment	  of	  SLBP-­‐Interacting	  Protein	  1	  (SLIP1;	  Bansal	  et	  al.,	  2013).	  	  Binding	  of	  SLIP1	  to	  SLBP	  facilitates	  
bridging	  of	  the	  5’	  end	  and	  3’	  stem	  loop	  of	  histone	  mRNA	  (Cakmakci	  et	  al.,	  2008)	  similar	  to	  circularization	  
of	  polyadenylated	  transcripts	  that	  occurs	  though	  cap	  and	  poly(A)	  tail	  binding	  factors	  (Wells	  et	  al.,	  1998).	  	  
A	  physical	  interaction	  between	  SLBP,	  eIF4G,	  and	  eIF3	  further	  stimulates	  translation	  of	  histone	  mRNAs	  
(Ling	  et	  al.,	  2002).	  	  Synthesis	  of	  histone	  H4	  proteins	  begins	  when	  eIF4E	  binds	  the	  first	  of	  two	  structural	  
elements	  in	  the	  open	  reading	  frame	  to	  allow	  positioning	  of	  the	  ribosome	  at	  the	  start	  codon	  (Martin	  et	  
al.,	  2011).	  	  Translation	  of	  replication-­‐dependent	  histones	  ceases	  at	  the	  end	  of	  S	  phase,	  largely	  due	  to	  
destabilization	  of	  transcripts	  resulting	  in	  their	  decay	  (Pandey	  and	  Marzluff,	  1987).	  	  	  
	  
4.1.2.3	  Histone	  mRNA	  decay	  
	   Replication-­‐dependent	  histone	  mRNAs	  are	  degraded	  upon	  completion	  of	  DNA	  synthesis.	  	  Just	  as	  
transcripts	  are	  stabilized	  at	  the	  start	  of	  S	  phase	  to	  accumulate	  histone	  mRNAs	  (Heintz	  et	  al.,	  1983),	  
stability	  is	  again	  altered	  at	  the	  end	  of	  S	  phase	  leading	  to	  rapid	  degradation	  (Pandey	  and	  Marzluff,	  1987).	  	  
Because	  replication-­‐dependent	  histone	  transcripts	  end	  in	  a	  3’	  stem	  loop	  instead	  of	  a	  poly(A)	  tail,	  these	  
mRNAs	  escape	  the	  widely	  used	  deadenylation-­‐dependent	  degradation	  pathway	  (discussed	  in	  Chapter	  1)	  
and	  are	  instead	  degraded	  by	  a	  deadenylation-­‐independent	  mechanism	  that	  requires	  active	  translation	  
of	  the	  message	  (Kaygun	  and	  Marzluff,	  2005a).	  	  As	  described	  in	  Section	  4.1.2.2,	  mRNAs	  in	  this	  state	  are	  
circularized	  through	  an	  interaction	  between	  SLBP	  with	  eIF4G	  and	  eIF3	  (Ling	  et	  al.,	  2002)	  bridged	  by	  SLIP1	  
(Cakmakci	  et	  al.,	  2008).	  	  Once	  DNA	  synthesis	  is	  complete,	  checkpoint	  kinase	  ATR	  phosphorylates	  UPF1,	  a	  
key	  regulator	  of	  Nonsense-­‐Mediated	  Decay	  (NMD),	  which	  promotes	  the	  interaction	  between	  UPF1	  and	  
74	  
	  
the	  histone	  stem	  loop/SLBP	  complex	  (Kaygun	  and	  Marzluff,	  2005b).	  	  Binding	  of	  UPF1	  results	  in	  the	  
recruitment	  of	  TUTase	  ZCCHC11	  and	  oligouridylation	  of	  the	  3’end	  (Schmidt	  et	  al.,	  2011),	  providing	  an	  
oligo(U)	  tract	  that	  permits	  binding	  of	  the	  LSM1-­‐7	  complex.	  	  Similar	  to	  the	  decay	  mechanism	  for	  
deadenylated	  mRNAs,	  binding	  of	  LSM1-­‐7	  recruits	  DCP1/DCP2	  to	  initiate	  decapping	  and	  decay	  by	  XRN1	  in	  
the	  5’3’	  directions	  (Coller	  et	  al.,	  2001;	  Mullen	  and	  Marzluff,	  2008).	  	  Although	  decapping	  mediated	  by	  
oligouridylation	  is	  the	  predominant	  mechanism	  of	  histone	  mRNA	  decay	  (Su	  et	  al.,	  2013),	  simultaneous	  
decay	  in	  the	  3’5’	  direction	  can	  also	  occur	  through	  recruitment	  of	  3’hExo/Eri-­‐1	  by	  the	  LSM1-­‐7	  complex	  
leading	  to	  exonucleolytic	  degradation	  of	  the	  stem	  loop	  structure	  (Hoefig	  et	  al.,	  2013)	  and	  subsequent	  






Figure	  4.2	  Histone	  mRNA	  decay.	  	  At	  the	  end	  of	  S	  phase,	  checkpoint	  kinase	  ATR	  phosphorylates	  UPF1	  to	  promote	  
its	  interaction	  with	  the	  stem	  loop/SLBP	  mRNP complex	  of	  actively	  translating	  histone	  mRNAs.	  	  UPF1	  recruits	  
ZCCHC11	  to	  oligouridylate	  the	  3’	  end	  providing	  a	  substrate	  for	  the	  LSM1-­‐7	  complex.	  	  In	  the	  predominant	  
mechanism	  of	  histone	  mRNA	  degradation,	  recruitment	  of	  DCP1/DCP2	  by	  LSM1-­‐7	  leads	  to	  5’3’	  decay	  by	  XRN1.	  	  
In	  addition,	  recruitment	  of	  3’hExo/ERI1	  by	  LSM1-­‐7	  degrades	  the	  stem	  loop	  structure	  and	  allows	  simultaneous	  
decay	  in	  the	  3’5’	  direction	  by	  the	  exosome.	  	  
Histone	  mRNAs	  are	  circularized	  by	  an	  
interaction	  between	  SLBP	  and	  eIF4G/eIF3	  
through	  SLIP1
At	  the	  end	  of	  S	  phase,	  UPF1	  is	  
phosphorylated	  by	  ATR	  and	  binds	  SLBP
UPF1	  recruits	  TUTase ZCCHC11	  to	  perform	  
oligouridylation
The	  oligo(U)	  tract	  is	  bound	  by	  LSM1-­‐7	  
which	  recruits	  DCP1/DCP2
XRN1	  degrades	  the	  mRNA	  in	  the	  5’3’	  
direction
LSM1-­‐7	  can	  also	  recruit	  3’hExo/ERI1	  to	  
degrade	  the	  stem	  loop	  and	  elicit	  3’5’	  






4.1.2.4	  SLBP	  expression	  correlates	  with	  histone	  mRNA	  expression	  
	   Given	  its	  importance	  at	  every	  step	  of	  histone	  gene	  expression,	  it	  comes	  as	  no	  surprise	  that	  SLBP	  
expression	  is	  also	  dependent	  on	  the	  cell	  cycle	  with	  levels	  increasing	  10-­‐	  to	  20-­‐fold	  shortly	  before	  S	  phase	  
and	  decreasing	  following	  DNA	  synthesis	  (Whitfield	  et	  al.,	  2000).	  	  Although	  histone	  and	  SLBP	  expression	  
parallel	  one	  another,	  studies	  have	  shown	  that	  expression	  of	  SLBP	  outside	  of	  S	  phase	  activates	  histone	  
pre-­‐mRNA	  processing,	  indicating	  that	  SLBP	  is	  a	  master	  regulator	  of	  histone	  expression	  (Wang	  et	  al.,	  
1996).	  	  SLBP	  remains	  associated	  with	  histone	  mRNAs	  to	  facilitate	  processing	  and	  translation.	  	  At	  the	  
S/G2	  transition	  when	  histones	  are	  targeted	  for	  decay,	  PIN1,	  a	  prolyl	  isomerase	  important	  for	  regulation	  
of	  cell	  cycle	  and	  differentiation	  (Lu	  et	  al.,	  2007),	  induces	  SLBP	  polyubiquitination	  to	  cause	  dissociation	  of	  
SLBP-­‐histone	  mRNA	  complexes	  (Krishnan	  et	  al.,	  2012).	  	  SLBP	  is	  then	  phosphorylated	  by	  cyclin	  A/Cdk1	  
(Koseoglu	  et	  al.,	  2008)	  on	  two	  threonine	  residues	  leading	  to	  degradation	  of	  the	  protein	  (Zheng	  et	  al.,	  
2003).	  	  Studies	  on	  the	  role	  of	  SLBP	  in	  oogenesis	  also	  show	  that	  expression	  of	  this	  protein	  is	  
developmentally	  regulated	  (Allard	  et	  al.,	  2005).	  
	  
4.1.2.5	  Histone	  profiles	  are	  established	  through	  regulated	  expression	  of	  histone	  subtypes	  
	   Although	  all	  replication-­‐dependent	  histone	  mRNAs	  share	  the	  highly	  conserved	  3’	  stem	  loop	  that	  
modulates	  their	  metabolism	  at	  every	  step	  (Marzluff	  et	  al.,	  2008),	  their	  expression	  is	  also	  controlled	  at	  
other	  levels.	  	  The	  complement	  of	  histone	  proteins	  is	  unique	  to	  different	  cell	  types	  (Lin	  et	  al.,	  2004;	  Yang	  
et	  al.,	  2011;	  Zhang	  et	  al.,	  2012)	  suggesting	  that	  in	  addition	  to	  the	  coordinated	  control	  that	  facilitates	  
their	  production	  during	  S	  phase,	  there	  are	  further	  layers	  of	  control	  specific	  to	  each	  histone	  subtype.	  	  
Most	  histone	  subtype	  studies	  have	  investigated	  expression	  of	  linker	  H1	  subtypes	  (Happel	  and	  Doenecke,	  
2009).	  	  Levels	  of	  HIST1H1T	  are	  specifically	  regulated	  in	  male	  germ	  cells	  to	  maintain	  a	  proper	  gene	  
expression	  profile	  (Lin	  et	  al.,	  2004)	  and	  liver	  cells	  demonstrate	  distinct	  changes	  in	  H1	  subtype	  expression	  
in	  response	  to	  stress	  (Jeong	  et	  al.,	  2003).	  	  The	  control	  of	  expression	  of	  individual	  core	  histone	  subtypes	  is	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virtually	  unstudied,	  primarily	  due	  to	  the	  challenges	  of	  distinguishing	  such	  closely	  related	  genes.	  	  
However,	  subtype-­‐specific	  regulation	  of	  transcription,	  processing,	  mRNA	  decay,	  translation,	  or	  protein	  
decay	  could	  all	  influence	  the	  final	  complement	  of	  histone	  proteins	  in	  the	  cell.	  	  	  
	  
4.1.2.6	  Histone	  variants	  	  
	   Although	  replication-­‐dependent	  histones	  are	  coordinately	  regulated	  through	  the	  various	  
pathways	  outlined	  above,	  there	  are	  additional,	  replication-­‐independent	  histones	  that	  have	  alternate	  
mechanisms	  for	  expression.	  	  Variant	  histones,	  or	  replication-­‐independent	  histones,	  are	  different	  from	  
typical	  histones	  in	  that	  their	  mRNAs	  end	  with	  a	  polyadenylated	  tail	  rather	  than	  the	  conserved	  3’	  stem	  
loop	  structure.	  	  Without	  this	  regulatory	  element,	  variant	  histone	  mRNAs	  are	  not	  subject	  to	  the	  same	  cell	  
cycle	  control.	  	  These	  histones	  are	  also	  transcribed	  from	  loci	  separate	  from	  those	  of	  the	  standard	  
histones,	  further	  contributing	  to	  their	  atypical	  regulation	  of	  transcription.	  	  Histone	  variants	  have	  specific	  
roles	  in	  chromatin	  metabolism	  such	  as	  DNA	  repair	  and	  active	  transcription	  and	  their	  expression	  often	  
fluctuates	  based	  on	  cell	  cycle,	  differentiation	  and	  development	  (Law	  and	  Cheung,	  2012).	  	  Just	  as	  stem	  
cells	  express	  a	  unique	  complement	  of	  core	  and	  linker	  histone	  genes	  compared	  to	  differentiated	  cells	  
(Yang	  et	  al.,	  2011),	  they	  also	  express	  distinct	  histone	  variants	  (Binda	  et	  al.,	  2013;	  Cao	  et	  al.,	  2013)	  that	  
establish	  inherent	  differences	  in	  stem	  cell	  chromatin	  compared	  to	  the	  genome	  of	  differentiated	  cells.	  	  	  
	   	  	  	  
4.1.3	  Pluripotent	  cells	  have	  a	  unique	  histone	  profile	  
	   Although	  histones	  are	  obviously	  important	  for	  chromatin	  compaction	  in	  every	  cell	  type,	  their	  
roles	  in	  modulating	  genes	  expression	  vary	  widely	  and,	  as	  alluded	  to	  above,	  the	  relative	  abundance	  of	  
different	  subtypes	  and	  of	  the	  replication-­‐independent	  variants	  also	  differs.	  	  As	  such,	  stem	  cells	  have	  
several	  unique	  features	  with	  regards	  to	  their	  histone	  profile	  and	  chromatin	  conformation.	  	  First,	  the	  
complement	  of	  histones	  in	  stem	  cells	  is	  distinctive.	  	  Of	  the	  five	  canonical	  H1	  histone	  subtypes,	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HIST1H1A,	  HIST1H1D,	  and	  HIST1H1B	  have	  elevated	  expression	  in	  stem	  cells	  (Saeki	  et	  al.,	  2005;	  Terme	  et	  
al.,	  2011;	  Yang	  et	  al.,	  2011).	  	  In	  addition,	  expression	  of	  the	  variant	  histone	  H1F0	  is	  low	  during	  
pluripotency	  (Terme	  et	  al.,	  2011)	  but	  increases	  when	  differentiation	  is	  induced	  (van	  Hemert	  et	  al.,	  1992).	  	  	  
The	  stem	  cell	  histone	  H2A	  profile	  is	  also	  different.	  	  Histone	  MacroH2A	  variants	  have	  a	  role	  in	  terminal	  
differentiation	  and	  act	  as	  a	  barrier	  to	  reprogramming	  of	  differentiated	  cells	  into	  induced	  pluripotent	  
stem	  cells	  (Gaspar-­‐Maia	  et	  al.,	  2013).	  	  Their	  role	  in	  the	  formation	  of	  chromatin	  signatures	  specific	  to	  
stages	  of	  development	  or	  disease	  has	  been	  the	  focus	  of	  several	  literature	  reviews	  to	  date	  (Law	  and	  
Cheung,	  2012;	  Millar,	  2013;	  Szenker	  et	  al.,	  2011;	  Vardabasso	  et	  al.,	  2013).	  	  Second,	  stem	  cells	  have	  a	  
relatively	  open	  chromatin	  configuration	  supported	  in	  part	  by	  their	  abbreviated	  cell	  cycle.	  	  The	  shortened	  
G1	  and	  predominant	  S	  phase	  allow	  stem	  cells	  to	  maintain	  chromatin	  plasticity	  (Becker	  et	  al.,	  2006)	  
where	  the	  truncated	  G1	  allows	  insufficient	  time	  for	  the	  complete	  compaction	  of	  heterochromatin	  
(Hindley	  and	  Philpott,	  2013).	  	  The	  chromatin	  structure	  of	  pluripotent	  stem	  cells	  is	  less	  tightly	  bound	  and	  
more	  euchromatic	  in	  formation	  while	  differentiated	  cell	  types	  exhibit	  more	  compact	  chromatin	  exposing	  
fewer	  regions	  of	  chromosome	  to	  transcription	  factors	  (Gaspar-­‐Maia	  et	  al.,	  2011).	  	  Third,	  stem	  cells	  
exhibit	  an	  exceptional	  epigenetic	  profile	  that	  supports	  their	  key	  features	  of	  infinite	  self-­‐renewal	  with	  the	  
ability	  for	  unlimited	  differentiation,	  by	  allowing	  the	  cell	  to	  be	  in	  “poised”	  for	  differentiation	  (Fisher	  and	  
Fisher,	  2011;	  Spivakov	  and	  Fisher,	  2007).	  	  Pluripotent	  cells	  exhibit	  transcriptional	  hyperactivity	  with	  
increased	  expression	  of	  chromatin	  remodeling	  factors	  and	  transcriptional	  machinery	  (Efroni	  et	  al.,	  2008)	  
but	  also	  employ	  chromatin	  regulators	  that	  suppress	  lineage-­‐specific	  gene	  sets	  (Lessard	  and	  Crabtree,	  
2010).	  	  	  This	  hyper-­‐dynamic	  quality	  of	  pluripotent	  chromatin	  is	  a	  hallmark	  of	  stem	  cells	  wherein	  genomic	  
plasticity	  must	  be	  maintained	  should	  differentiation	  be	  induced	  (Meshorer	  et	  al.,	  2006).	  	  In	  addition	  to	  
expressing	  unique	  core,	  linker,	  and	  variant	  histones,	  many	  stem	  cell-­‐specific	  histone	  modifications	  
define	  pluripotent	  chromatin	  architecture.	  	  For	  example,	  the	  importance	  of	  histone	  acetylation	  is	  
highlighted	  by	  the	  fact	  that	  Histone	  DeACetylase	  (HDAC)	  inhibitors	  can	  enhance	  reprogramming	  of	  cells	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into	  a	  pluripotent	  state	  (Plath	  and	  Lowry,	  2011)	  presumably	  by	  blocking	  the	  removal	  of	  acetyl	  groups	  
that	  are	  associated	  with	  condensed	  chromatin	  structure.	  	  DNA	  methylation	  on	  cytosine	  residues	  is	  a	  
critical	  epigenetic	  regulator	  of	  stem	  cell	  differentiation	  and	  embryogenesis	  (Lister	  et	  al.,	  2009).	  	  
Characterizations	  of	  highly	  dynamic	  and	  stage-­‐specific	  chromatin	  features	  have	  been	  used	  to	  identify	  
states	  of	  differentiation	  and	  development	  (Guibert	  and	  Weber,	  2013;	  Larson	  and	  Yuan,	  2012).	  	  In	  the	  
poised	  state,	  any	  combination	  of	  histone	  modifications	  has	  the	  potential	  to	  cause	  chromatin	  re-­‐
organization	  during	  stem	  cell	  differentiation	  (Binder	  et	  al.,	  2013).	  	  	  	  
	   Global	  analysis	  of	  mRNA	  decay	  rates	  in	  HFF	  and	  iPS	  cells	  (discussed	  in	  Chapter	  3)	  revealed	  that	  
many	  replication-­‐dependent	  histone	  mRNAs	  exhibited	  significant	  stabilization	  in	  a	  pluripotent	  state.	  	  As	  
the	  chromatin	  status	  of	  stem	  cells	  is	  unique	  from	  that	  of	  differentiated	  cells	  and	  plays	  a	  significant	  role	  
in	  defining	  and	  maintaining	  pluripotent	  gene	  expression,	  we	  hypothesized	  that	  differential	  regulation	  of	  
histone	  mRNA	  stability	  might	  be	  an	  important	  factor	  in	  defining	  the	  histone	  profiles	  in	  iPS	  cells.	  	  We	  
therefore	  further	  investigated	  histone	  mRNA	  stabilization	  and	  the	  effects	  on	  overall	  histone	  expression.	  	  
Our	  results	  are	  discussed	  below3.	  	  	  
	  
4.2	  Histone	  mRNA	  half-­‐lives	  are	  increased	  in	  iPS	  cells	  
	   We	  found	  that	  a	  significant	  proportion	  of	  replication-­‐dependent	  histone	  mRNAs	  are	  stabilized	  in	  
iPS	  cells.	  	  For	  the	  50	  transcripts	  encoding	  histone	  proteins	  which	  half-­‐lives	  were	  determined	  for	  (data	  for	  
three	  transcripts	  out	  of	  53	  total	  were	  duplicates	  of	  the	  same	  gene	  with	  the	  same	  assessed	  half-­‐life),	  an	  
arbitrary	  cut-­‐off	  of	  a	  2-­‐fold	  difference	  was	  used	  to	  find	  that	  23	  histone	  mRNAs	  were	  stabilized	  >2-­‐fold,	  
26	  exhibited	  a	  less	  than	  2-­‐fold	  change,	  and	  a	  single	  histone	  mRNA,	  HIST3H2BB,	  showed	  a	  2.7-­‐fold	  
destabilization	  in	  iPS	  cells.	  	  These	  data	  are	  summarized	  in	  Table	  4.1	  below	  where	  the	  most	  stabilized	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3	  Many	  of	  the	  results	  presented	  in	  Chapter	  4	  appeared	  in:	  Neff	  et	  al.	  Global	  analysis	  reveals	  multiple	  
pathways	  for	  unique	  regulation	  of	  mRNA	  decay	  in	  induced	  pluripotent	  stem	  cells.	  Genome	  Research.	  




transcripts	  are	  highlighted	  in	  light	  shading	  while	  the	  destabilized	  transcript	  HIST3H2BB	  is	  in	  dark	  
shading.	  	  All	  four	  core	  histones	  and	  the	  linker	  histone	  were	  represented	  in	  the	  stabilized	  set	  of	  mRNAs.	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Table	  4.1	  Summary	  of	  histone	  mRNA	  half-­‐lives	  as	  determined	  by	  microarray.	  	  Twenty-­‐three	  
	  mRNAs	  were	  stabilized	  >2-­‐fold	  (light	  shading)	  and	  1	  transcript	  was	  destabilized	  >2-­‐fold	  










HIST1H3I 273 1.05E-­‐02 27 1.05E-­‐05 10.06
HIST1H1E 536 3.32E-­‐03 64 3.77E-­‐06 8.38
HIST2H2AC 354 9.33E-­‐03 47 4.76E-­‐07 7.49
HIST2H2AB 363 6.63E-­‐03 59 2.05E-­‐06 6.11
HIST1H1A 1122 2.50E-­‐02 193 4.66E-­‐05 5.82
HIST1H4K 533 2.73E-­‐02 93 5.01E-­‐05 5.74
HIST2H3A 451 6.71E-­‐04 97 4.15E-­‐05 4.65
HIST1H3J 435 6.47E-­‐03 102 2.42E-­‐05 4.26
HIST1H2BE 997 1.05E-­‐03 242 2.43E-­‐05 4.13
HIST1H2AB 282 3.29E-­‐03 70 2.64E-­‐06 4.05
HIST2H3D 448 7.09E-­‐04 112 5.09E-­‐05 4.00
HIST1H3G 1808 1.41E-­‐02 478 3.12E-­‐05 3.79
HIST1H4J 502 1.82E-­‐02 135 2.00E-­‐05 3.72
HIST1H3D 366 6.09E-­‐03 102 4.18E-­‐05 3.60
HIST1H4B 277 6.42E-­‐05 81 2.59E-­‐07 3.42
HIST2H3D 488 5.12E-­‐03 147 1.82E-­‐04 3.32
HIST1H1D 274 4.70E-­‐03 85 1.84E-­‐05 3.24
HIST2H2AA3 373 1.30E-­‐03 117 9.70E-­‐05 3.20
HIST1H3F 443 4.11E-­‐03 150 1.07E-­‐05 2.95
HIST1H4E 343 1.18E-­‐02 132 4.67E-­‐06 2.60
HIST1H3B 193 6.14E-­‐03 87 1.10E-­‐04 2.23
HIST1H4C 323 3.89E-­‐02 157 4.23E-­‐05 2.06
HIST1H2AK 413 1.36E-­‐02 202 6.36E-­‐05 2.05
HIST1H4A 621 2.75E-­‐02 319 6.12E-­‐05 1.95
HIST1H1C 372 3.93E-­‐02 192 4.60E-­‐04 1.94
HIST1H2BK 345 1.67E-­‐02 186 1.10E-­‐03 1.85
HIST2H2BE 399 1.52E-­‐02 223 5.82E-­‐03 1.79
HIST1H2AI 342 1.12E-­‐03 191 1.06E-­‐04 1.79
HIST1H2AL 596 3.59E-­‐03 344 6.76E-­‐07 1.73
HIST1H3E 865 2.11E-­‐02 519 1.05E-­‐03 1.67
HIST1H3A 336 1.89E-­‐02 208 3.78E-­‐05 1.62
HIST1H2BG 735 4.61E-­‐02 496 1.73E-­‐03 1.48
HIST1H4D 273 3.09E-­‐02 192 4.30E-­‐06 1.42
HIST2H2BE 510 1.96E-­‐02 362 6.13E-­‐03 1.41
HIST4H4 714 4.65E-­‐04 555 1.05E-­‐03 1.29
HIST1H3H 300 7.10E-­‐04 253 5.40E-­‐04 1.18
HIST1H2BD 329 3.20E-­‐03 292 5.06E-­‐04 1.13
HIST1H4I 686 4.08E-­‐03 644 8.90E-­‐03 1.06
HIST2H2BF 248 1.16E-­‐04 236 2.48E-­‐05 1.05
HIST1H2AH 337 1.18E-­‐02 402 2.69E-­‐05 0.84
HIST1H2AC 245 9.74E-­‐03 292 2.43E-­‐03 0.84
HIST1H2BJ 288 3.90E-­‐04 348 5.04E-­‐04 0.83
HIST1H2AE 465 2.67E-­‐04 637 1.16E-­‐02 0.73
HIST1H4H 238 1.86E-­‐03 332 1.15E-­‐02 0.72
HIST2H2BF 244 5.19E-­‐05 351 7.87E-­‐04 0.69
HIST1H2AG 376 9.80E-­‐04 589 3.39E-­‐03 0.64
HIST2H4A 290 9.93E-­‐04 487 1.42E-­‐02 0.59
HIST1H2BN 527 3.69E-­‐03 909 2.75E-­‐02 0.58
HIST1H2BL 501 1.44E-­‐02 922 9.00E-­‐03 0.54
HIST3H2BB 289 5.28E-­‐04 784 1.16E-­‐03 0.37 	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   When	  compared	  to	  all	  mRNAs	  that	  half-­‐lives	  were	  determined	  for,	  we	  saw	  that	  the	  histone	  
mRNAs	  as	  a	  group	  exhibit	  more	  stabilization	  in	  iPS	  cells	  versus	  HFFs	  (P=2.2x10-­‐11;	  Figure	  4.3A).	  	  Figure	  
4.3B	  shows	  the	  half-­‐life	  for	  each	  histone	  family	  when	  the	  half-­‐lives	  of	  all	  50	  individual	  transcripts	  are	  
averaged.	  	  As	  depicted	  by	  the	  error	  bars	  indicating	  standard	  deviation	  between	  related	  transcripts,	  
histone	  mRNAs	  within	  the	  same	  family	  exhibited	  a	  wide	  range	  in	  half-­‐life.	  	  This	  was	  most	  evident	  for	  
histone	  H3	  in	  iPS	  cells	  where	  estimated	  half-­‐lives	  ranged	  from	  ~193	  minutes	  (HIST1H3B)	  to	  ~1800	  
minutes	  (HIST1H3G)	  and	  histone	  H2B	  in	  HFFs	  where	  HIST1H2BK	  mRNA	  had	  a	  half-­‐life	  of	  ~186	  minutes	  
while	  HIST1H2BL	  mRNA	  was	  more	  stable	  with	  a	  half-­‐life	  of	  ~922	  minutes.	  	  Despite	  the	  half-­‐life	  variation	  
seen	  within	  each	  histone	  set,	  the	  averages	  shown	  here	  indicated	  that	  histone	  mRNAs	  are	  generally	  more	  
stable	  in	  iPS	  cells	  than	  in	  HFFs.	  	  	  
	  
Figure	  4.3	  Histone	  half-­‐lives	  are	  increased	  in	  iPS	  cells	  compared	  to	  HFFs	  as	  determined	  by	  microarray.	  	  A)	  
Comparison	  of	  the	  change	  in	  half-­‐life	  for	  histone	  mRNAs	  in	  HFF	  and	  iPS	  cells	  to	  changes	  for	  all	  5,481	  half-­‐lives	  and	  B)	  
Bar	  graph	  presentation	  	  of	  averaged	  mRNA	  half-­‐lives	  for	  each	  histone	  family	  as	  determined	  by	  microarray.	  
A. B.
	  
	   	  
	   To	  validate	  this	  observation,	  histone	  mRNA	  half-­‐lives	  were	  measured	  by	  qRT-­‐PCR	  in	  HFF	  and	  iPS	  
cells	  using	  the	  same	  RNA	  samples	  that	  were	  used	  to	  generate	  the	  microarray	  data.	  	  Primer	  sets	  to	  
recognize	  core	  histones	  H2A,	  H2B,	  H3,	  and	  H4	  and	  linker	  histone	  H1	  were	  generously	  provided	  by	  Dr.	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Paul	  Laybourn	  and	  detect	  multiple	  transcripts	  within	  each	  histone	  family	  (Bogenberger	  and	  Laybourn,	  
2008).	  	  However,	  when	  the	  detection	  of	  each	  transcript	  was	  predicted	  based	  on	  homology	  to	  the	  primer	  
sequences,	  we	  noted	  that	  several	  transcripts	  escape	  detection	  (shown	  in	  Table	  4.2	  below).	  	  Specifically,	  
forward	  and	  reverse	  primer	  sequences	  ~24	  bases	  in	  length	  were	  aligned	  to	  mRNA	  sequences	  for	  all	  
individuals	  within	  a	  histone	  family	  and	  analyzed	  for	  the	  number	  of	  base	  mismatches.	  	  Transcripts	  
containing	  more	  than	  four	  mismatches	  in	  a	  row	  or	  several	  mismatches	  close	  in	  proximity	  in	  one	  or	  both	  
primer	  oligos	  were	  unlikely	  to	  be	  effectively	  detected	  by	  the	  primer	  set.	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Table	  4.2	  Histone	  transcripts	  detected	  by	  histone	  family	  primers.
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   Summarized	  from	  the	  microarray	  data,	  Table	  4.3	  below	  shows	  the	  mean	  log2	  (intensity)	  values	  at	  
the	  0	  minute	  time	  point	  averaged	  from	  three	  replicates	  for	  each	  cell	  line.	  	  Although	  our	  qRT-­‐PCR	  primers	  
only	  detected	  the	  HIST1H1E	  transcript,	  this	  mRNA	  was	  the	  most	  abundant	  of	  the	  H1	  family	  members	  in	  
both	  cell	  lines.	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Table	  4.3	  Mean	  log2(intensity)	  values	  at	  the	  0	  minute	  time	  point	  for	  all	  histone	  H1	  mRNAs.
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   In	  Figure	  4.4	  we	  saw	  that	  by	  qRT-­‐PCR,	  histone	  mRNA	  half-­‐lives	  were	  indeed	  increased	  in	  iPS	  cells	  
compared	  to	  HFFs.	  	  From	  the	  data	  we	  found	  that	  in	  HFFs,	  histones	  H1,	  H2A,	  H2B,	  and	  H4	  have	  transcript	  
half-­‐lives	  ranging	  from	  85	  –	  110	  minutes	  and	  H3	  mRNAs	  were	  the	  least	  stable	  with	  a	  half-­‐life	  of	  ~44	  
minutes.	  	  In	  iPS	  cells,	  all	  histone	  mRNAs	  were	  significantly	  stabilized	  (ANOVA)	  with	  half-­‐lives	  ranging	  
from	  approximately	  150	  –	  270	  minutes.	  	  We	  importantly	  note	  that	  stabilization	  of	  H2A	  transcripts	  was	  
verified	  in	  an	  independent	  set	  of	  matched	  HFF	  and	  iPS	  cells	  also	  purchased	  from	  System	  Biosciences	  
(SC101A-­‐1,	  Lot	  #110415-­‐01),	  supporting	  that	  these	  differences	  are	  not	  due	  to	  the	  insertion	  positions	  of	  
transgenes	  resulting	  from	  lentiviral	  reprogramming	  (A.	  Jalkanen	  personal	  communication).	  
	  
Figure	  4.4	  Histone	  mRNA	  half-­‐lives	  are	  increased	  in	  iPS	  cells	  compared	  to	  HFFs	  as	  determined	  by	  qRT-­‐PCR.	  	  
Half-­‐lives	  of	  individual	  histone	  mRNA	  families	  were	  assessed	  in	  HFF	  and	  iPS	  cells	  following	  actinomycin	  D	  
treatment.	  	  mRNA	  levels	  were	  measured	  by	  qRT-­‐PCR	  and	  normalized	  to	  GAPDHmRNA.	  	  Standard	  deviations	  




	   The	  half-­‐lives	  estimated	  here	  by	  qRT-­‐PCR	  were	  shorter	  than	  the	  averages	  shown	  in	  Figure	  4.3B	  
above.	  	  Discrepancies	  between	  half-­‐lives	  generated	  from	  microarray	  and	  qRT-­‐PCR	  data	  may	  be	  
explained	  by	  the	  specificity	  of	  the	  histone	  primers	  used	  which	  are	  not	  all-­‐inclusive.	  	  Also,	  the	  microarray	  
average	  weights	  each	  histone	  transcript	  the	  same	  regardless	  of	  abundance	  whereas	  qRT-­‐PCR	  will	  give	  
the	  most	  abundant	  mRNAs	  most	  weight,	  skewing	  the	  stability	  of	  less	  stable	  mRNAs.	  	  In	  addition,	  the	  
linear	  range	  of	  the	  qRT-­‐PCR	  assay	  is	  greater	  than	  that	  of	  the	  microarray	  (Etienne	  et	  al.,	  2004;	  Wang	  et	  
al.,	  2006).	  	  	  
	  
4.3	  Histone	  abundance	  is	  increased	  at	  the	  mRNA	  and	  protein	  levels	  
	   Given	  that	  histone	  mRNAs	  were	  quite	  dramatically	  stabilized	  in	  iPS	  cells,	  it	  was	  important	  to	  
determine	  whether	  this	  resulted	  in	  an	  increased	  abundance	  of	  histone	  mRNA	  and	  protein.	  	  The	  0	  minute	  
time	  point	  of	  the	  microarray	  data	  was	  used	  to	  determine	  the	  relative	  abundance	  of	  histone	  transcripts	  
in	  HFF	  and	  iPS	  cells.	  	  As	  seen	  in	  Figure	  4.5	  below,	  there	  was	  a	  significant	  (P=6.5x10-­‐9)	  increase	  in	  histone	  
mRNA	  abundance	  in	  iPS	  cells	  compared	  to	  HFFs	  that	  correlated	  with	  the	  half-­‐life	  increase	  shown	  in	  
Figure	  4.3	  (above).	  	  	  
Figure	  4.5	  Histone	  mRNAs	  are	  more	  abundant	  in	  iPS	  cells	  compared	  to	  HFFs	  as	  determined	  by	  microarray.	  	  
Comparison	  of	  the	  change	  in	  abundance	  for	  histone	  mRNAs	  in	  HFF	  and	  iPS	  cells	  to	  changes	  for	  all	  19,190	  




	   Relative	  steady-­‐state	  histone	  mRNA	  abundances	  were	  also	  measured	  in	  cells	  that	  had	  not	  been	  
treated	  with	  actinomycin	  D	  using	  qRT-­‐PCR.	  	  In	  Figure	  4.6,	  we	  found	  that	  iPS	  cells	  have	  up-­‐regulated	  
expression	  of	  histone	  mRNAs	  ranging	  from	  a	  3.7-­‐fold	  to	  a	  >200-­‐fold	  increase	  in	  abundance.	  	  	  
	  
Figure	  4.6	  Histone	  mRNAs	  are	  more	  abundant	  in	  iPS	  cells	  compared	  to	  HFFs	  as	  determined	  by	  qRT-­‐PCR.	  	  HFF	  
and	  iPS	  cells	  were	  not	  treated	  with	  actinomycin	  D	  and	  were	  assessed	  for	  abundance	  of	  individual	  histone	  
mRNA	  families.	  mRNA	  levels	  were	  measured	  by	  qRT-­‐PCR	  and	  normalized	  to	  GAPDH	  mRNA.	  	  Standard	  
deviations	  represents	  three	  replicates.	  	  
	  
	  	   	  
	   We	  next	  measured	  histone	  protein	  expression	  in	  both	  cell	  lines.	  	  Histone	  proteins	  are	  so	  
abundant	  that	  they	  may	  be	  visualized	  by	  Coomassie	  staining	  (Irie	  and	  Sezaki,	  1983).	  	  As	  shown	  in	  Figure	  
4.7,	  Coomassie	  staining	  of	  HFF	  and	  iPS	  cell	  extracts	  containing	  ~4.2x104	  cells	  resolved	  on	  a	  15%	  SDS-­‐
PAGE	  gel	  revealed	  ~10-­‐fold	  higher	  levels	  of	  core	  histones	  in	  iPS	  cells	  (normalized	  to	  a	  ~36	  kDa	  band,	  
asterisk)	  compared	  to	  HFFs.	  	  As	  histone	  H1	  is	  larger	  than	  core	  histones	  with	  a	  molecular	  weight	  of	  ~32	  
kDa,	  it	  was	  difficult	  to	  distinguish	  this	  protein	  from	  non-­‐specific	  proteins	  of	  a	  similar	  size.	  	  Nonetheless,	  
increased	  abundance	  of	  core	  histone	  proteins	  was	  again	  consistent	  with	  increased	  transcript	  stability	  
(Figures	  4.3	  and	  4.4)	  and	  abundance	  (Figures	  4.5	  and	  4.6)	  observed	  previously.	  	  These	  results	  were	  
reproduced	  in	  an	  independent	  set	  of	  matched	  HFF	  and	  iPS	  cells,	  confirming	  increased	  expression	  of	  




Figure	  4.7	  Core	  histone	  proteins	  are	  more	  abundant	  in	  iPS	  cells	  compared	  to	  HFFs	  as	  determined	  by	  
Coomassie	  staining.	  	  Equal	  numbers	  of	  cells	  and	  equal	  amounts	  of	  whole	  cell	  lysate	  were	  resolved	  on	  a	  
15%	  SDS-­‐PAGE	  gel	  and	  stained	  with	  Coomassie	  Blue	  to	  reveal	  protein	  bands	  corresponding	  to	  core	  
histones	  H2A,	  H2B,	  H3,	  and	  H4.	  	  The	  asterisk	  denotes	  the	  ~36	  kDa	  band	  used	  for	  quantification	  
normalization.	  	  
	   	  
	  
	   Western	  blot	  analysis	  was	  also	  used	  to	  investigate	  histone	  protein	  abundance.	  	  We	  found	  that	  
protein	  levels	  of	  all	  four	  core	  histones	  H2A,	  H2B,	  H3,	  and	  H4	  are	  elevated	  in	  iPS	  cells	  (Figure	  4.8)	  
consistent	  with	  Coomassie	  staining,	  and	  that	  linker	  histone	  H1	  was	  also	  more	  abundant.	  	  However,	  the	  
fold-­‐change	  differences	  for	  core	  histones	  seen	  here	  does	  not	  reflect	  the	  ~10-­‐fold	  increase	  determined	  
by	  Coomassie	  quantification.	  	  As	  antibodies	  have	  several	  idiosyncrasies	  that	  influence	  their	  range	  of	  
detection,	  we	  believe	  that	  histone	  abundances	  determined	  by	  staining	  likely	  reflect	  true	  abundances	  
since	  the	  Coomassie	  stain	  exhibits	  more	  general	  binding	  properties	  that	  would	  stain	  these	  proteins	  
equally.	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Figure	  4.8	  Histone	  proteins	  are	  more	  abundant	  in	  iPS	  cells	  compared	  to	  HFFs	  as	  determined	  by	  western	  blot.	  	  
A)	  Western	  blot	  analysis	  showing	  histone	  protein	  abundances	  in	  HFF	  and	  iPS	  cells.	  	  Equal	  numbers	  of	  cells	  
and	  amounts	  of	  whole	  cell	  lysate	  were	  resolved	  on	  a	  15%	  SDS-­‐PAGE	  gel	  and	  transferred	  to	  0.2	  µm	  
polyvinylidene difluoride (PVDF)	  membranes.	  	  B)	  Quantification	  of	  iPS	  histone	  abundance	  normalized	  to	  





























	   	  
	   Although	  we	  found	  increased	  levels	  of	  histone	  protein	  in	  iPS	  cells,	  the	  fold-­‐change	  does	  not	  
correlate	  directly	  with	  the	  change	  in	  mRNA	  abundance	  suggesting	  there	  are	  differences	  in	  translation	  
efficiency	  as	  well	  as	  mRNA	  stability	  in	  iPS	  cells.	  	  Regardless,	  it	  is	  evident	  that	  histone	  mRNAs	  are	  
stabilized	  in	  iPS	  cells	  and	  this	  finding	  correlated	  with	  increased	  levels	  of	  mRNA	  and	  protein.	  	  	  	  
	  
4.4	  Expression	  of	  SLBP	  is	  increased	  in	  iPS	  cells	  	  
	   As	  SLBP	  is	  a	  critical	  regulator	  of	  histone	  mRNA	  metabolism	  (discussed	  in	  Section	  4.1.2),	  it	  was	  
thought	  that	  SLBP	  might	  be	  expressed	  at	  a	  higher	  level	  in	  iPS	  cells	  to	  facilitate	  the	  production	  of	  
increased	  levels	  of	  histone	  message.	  	  Indeed,	  by	  western	  blot	  we	  found	  that	  SLBP	  is	  undetectable	  in	  
HFFs	  and	  much	  more	  abundant	  in	  iPS	  cells	  (Figure	  4.9).	  	  In	  support	  of	  this,	  SLBP	  mRNA	  levels	  were	  
increased	  1.89-­‐fold	  in	  iPS	  cells	  based	  on	  the	  abundance	  determined	  from	  the	  0	  minute	  time	  point	  of	  the	  
microarray	  data.	  	  While	  this	  analysis	  does	  not	  account	  for	  the	  contribution	  of	  other	  factors	  involved	  in	  
histone	  mRNA	  metabolism	  such	  as	  LSM1	  (mRNA	  abundance	  increased	  1.54-­‐fold	  in	  HFFs	  at	  the	  0	  minute	  
time	  point),	  UPF1	  (mRNA	  abundance	  increased	  1.46-­‐fold	  in	  iPS	  cells	  at	  the	  0	  minute	  time	  point),	  and	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TUTase	  ZCCHC11	  (mRNA	  abundance	  increased	  2.40-­‐fold	  in	  iPS	  cells	  at	  the	  0	  minute	  time	  point),	  the	  
elevated	  levels	  of	  SLBP	  in	  iPS	  cells	  seen	  here	  likely	  contribute	  to	  the	  processing	  and	  turnover	  of	  the	  
numerous	  histone	  mRNAs	  that	  must	  be	  transcribed,	  translated,	  and	  degraded	  over	  each	  cell	  cycle.	  	  	  
	  
Figure	  4.9	  SLBP	  protein	  expression	  is	  increased	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  Equal	  numbers	  of	  cells	  
and	  equal	  amounts	  of	  whole	  cell	  lysate	  were	  resolved	  on	  a	  10%	  SDS-­‐PAGE	  gel	  and	  transferred	  to	  PVDF	  
membrane.	  	  Expression	  of	  SLBP	  was	  assessed	  relative	  to	  levels	  of	  α-­‐TUBULIN	  as	  determined	  by	  






4.5	  Inhibition	  of	  DNA	  synthesis	  leads	  to	  faster	  degradation	  of	  histone	  mRNAs	  in	  iPS	  cells	  
	   One	  of	  the	  caveats	  of	  the	  experiments	  described	  thus	  far	  was	  that	  the	  cells	  analyzed	  were	  an	  
asynchronous	  population	  at	  different	  phases	  of	  the	  cell	  cycle.	  	  To	  mimic	  the	  coordinated	  decay	  of	  
histone	  mRNAs	  at	  the	  end	  of	  S	  phase,	  cells	  were	  treated	  with	  hydroxyurea	  (HU)	  to	  inhibit	  DNA	  synthesis.	  	  
Previous	  studies	  suggest	  that	  fibroblasts	  may	  not	  be	  as	  responsive	  to	  HU	  treatment	  (CJ	  Wilusz	  
communication	  from	  WF	  Marzluff);	  therefore,	  HeLa	  cells	  were	  included	  in	  this	  analysis	  for	  comparison.	  	  	  
	   Starting	  30	  minutes	  following	  HU	  treatment,	  total	  RNA	  was	  collected	  at	  time	  points	  0,	  15,	  30,	  60,	  
120	  and	  240	  minutes.	  	  This	  30	  minute	  delay	  was	  chosen	  to	  allow	  the	  inhibitor	  enough	  time	  to	  effectively	  
halt	  DNA	  synthesis.	  We	  found	  that	  in	  contrast	  to	  significant	  stabilization	  overall,	  histone	  mRNAs	  were	  
degraded	  much	  more	  quickly	  in	  iPS	  cells	  than	  HFFs	  (Figure	  4.10)	  following	  inhibition	  of	  DNA	  synthesis.	  	  
The	  ineffectiveness	  of	  inhibiting	  DNA	  synthesis	  in	  HFFs	  may	  explain	  the	  relatively	  unchanged	  half-­‐lives	  of	  
H1	  and	  H2B	  mRNAs	  at	  68	  and	  70	  minutes,	  respectively,	  compared	  to	  those	  determined	  following	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actinomycin	  D	  treatment.	  	  In	  HeLa	  cells,	  the	  half-­‐lives	  of	  histone	  transcripts	  H1,	  H2A,	  H2B	  and	  H4	  were	  
fairly	  consistent	  and	  ranged	  from	  32	  –	  39	  minutes.	  	  The	  half-­‐life	  for	  H3	  was	  the	  shortest	  in	  all	  cells	  types	  
and	  was	  about	  23	  minutes	  in	  HeLa	  cells.	  	  Histone	  half-­‐lives	  determined	  in	  iPS	  cells	  demonstrated	  more	  
destabilization	  of	  transcripts	  after	  HU	  treatment	  compared	  to	  the	  differentiated	  cell	  types.	  	  Half-­‐lives	  of	  
H1,	  H2B,	  and	  H4	  mRNAs	  ranged	  from	  20	  –	  23	  minutes	  while	  those	  for	  H2A	  and	  H3	  mRNAs	  were	  14	  and	  6	  
minutes,	  respectively.	  	  From	  this,	  we	  found	  that	  histone	  mRNAs	  were	  generally	  more	  stable	  in	  iPS	  cells	  
than	  differentiated	  cells	  but	  were	  degraded	  more	  quickly	  upon	  inhibition	  of	  DNA	  synthesis.	  	  Compared	  
to	  HeLa	  cells,	  the	  difference	  was	  not	  as	  dramatic	  but	  histone	  transcripts	  were	  still	  degraded	  more	  
quickly	  in	  iPS	  cells	  than	  in	  HeLa.	  	  	  	  	  
	  
Figure	  4.10	  Histone	  mRNAs	  are	  degraded	  faster	  in	  iPS	  cells	  upon	  inhibition	  of	  DNA	  synthesis	  compared	  to	  HFF	  and	  
HeLa	  cells.	  	  Half-­‐lives	  of	  histone	  mRNA	  families	  were	  assessed	  in	  HeLa,	  HFF,	  and	  iPS	  cells	  following	  hydroxyurea	  
(HU)	  treatment.	  mRNA	  levels	  were	  measured	  by	  qRT-­‐PCR	  and	  normalized	  to	  GAPDHmRNA.	  	  Standard	  deviations	  
represents	  three	  replicates.	  	  
	  
	  
4.6	  Differences	  in	  cell	  cycle	  contribute	  to	  differences	  in	  histone	  abundance	  	  	   	  
	   Given	  that	  stem	  cells	  are	  reported	  to	  have	  an	  abbreviated	  cell	  cycle,	  and	  expression	  of	  
replication-­‐dependent	  histones	  is	  cell	  cycle	  regulated,	  we	  questioned	  how	  much	  this	  might	  contribute	  to	  
differences	  in	  histone	  gene	  expression.	  	  Specifically,	  we	  wondered	  whether	  an	  increased	  proportion	  of	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cells	  in	  S	  phase	  might	  explain	  the	  elevated	  abundance	  of	  histone	  mRNAs	  and	  proteins	  (which	  only	  
accumulate	  in	  S	  phase	  in	  most	  cell	  types)	  in	  iPS	  cells.	  	  To	  answer	  this	  question,	  we	  considered	  several	  
measures	  of	  cell	  cycle.	  	  In	  the	  first,	  we	  confirmed	  that	  our	  iPS	  cells	  have	  a	  faster	  growth	  rate	  than	  HFFs.	  	  
By	  measuring	  cell	  populations	  over	  a	  period	  of	  5	  days,	  we	  found	  that	  HFF	  cells	  have	  a	  doubling	  rate	  of	  
~36	  hours	  while	  iPS	  cells	  duplicate	  every	  ~22	  hours.	  	  	  	  	  
	   We	  also	  sought	  to	  determine	  the	  percentage	  of	  each	  cell	  population	  in	  S	  phase	  at	  any	  given	  
time.	  	  To	  do	  this,	  a	  BrdU	  incorporation	  assay	  was	  performed	  to	  stain	  the	  nuclei	  of	  cells	  that	  were	  actively	  
synthesizing	  DNA	  within	  an	  asynchronous	  population.	  	  BrdU	  incorporation	  was	  assessed	  by	  
immunofluorescence	  using	  anti-­‐BrdU	  antibodies.	  	  By	  determining	  the	  percentage	  of	  cells	  with	  nuclear	  
BrdU	  staining	  (three	  replicates	  each),	  it	  was	  found	  that	  iPS	  cells	  have	  ~33.2	  ±	  4.8%	  cells	  in	  S	  phase	  while	  
HFFs	  have	  ~14.2	  ±	  1.0%	  (Figure	  4.11).	  	  This	  2-­‐fold	  difference	  certainly	  contributes	  to	  the	  increased	  levels	  
of	  histones	  observed	  in	  iPS	  cells	  but	  cannot	  account	  for	  the	  50-­‐	  to	  100-­‐fold	  higher	  level	  of	  histone	  mRNA	  







	   	  
	   Both	  of	  these	  analyses	  confirmed	  that	  iPS	  cells	  have	  an	  abbreviated	  cell	  cycle	  (as	  noted	  by	  a	  
faster	  doubling	  rate)	  and	  more	  cells	  in	  S	  phase,	  consistent	  with	  previously	  published	  reports	  (Becker	  et	  
al.,	  2006;	  Fluckiger	  et	  al.,	  2006;	  Savatier	  et	  al.,	  1994).	  	  However,	  it	  is	  clear	  that	  other	  features	  of	  
pluripotent	  gene	  expression	  also	  influence	  histone	  regulation.	  	  	  
	  
4.7	  The	  absolute	  amount	  of	  histone	  expression	  in	  iPS	  cells	  is	  increased	  
	  
	   Although	  each	  HFF	  and	  iPS	  cell	  contain	  the	  same	  amount	  of	  DNA,	  there	  may	  be	  significant	  
differences	  in	  the	  overall	  amount	  of	  RNA	  or	  protein	  per	  cell	  that	  could	  contribute	  to	  the	  perceived	  
increases	  in	  abundance	  of	  histone	  mRNA	  and	  proteins.	  	  Quantification	  of	  nucleolar	  DNA,	  RNA,	  proteins,	  
and	  lipids	  in	  iPS	  cells	  compared	  to	  differentiated	  fibroblasts	  indicates	  that	  the	  nucleolar	  molecular	  
signature	  of	  iPS	  cells	  is	  characterized	  by	  increases	  in	  all	  of	  these	  molecules	  except	  lipids	  (Pliss	  et	  al.,	  
2013).	  	  We	  therefore	  sought	  to	  compare	  the	  absolute	  amount	  of	  histone	  mRNA	  and	  protein	  per	  cell	  
rather	  than	  normalizing	  to	  equal	  amounts	  of	  total	  RNA	  or	  protein.	  	  As	  shown	  in	  Figure	  4.12,	  iPS	  cells	  
have	  twice	  as	  much	  RNA	  per	  cell	  as	  HFFs.	  	  Following	  TRIzol	  extraction,	  we	  found	  that	  iPS	  cells	  have	  ~30.6	  
HFF iPS	  
Figure	  4.11	  A	  larger	  proportion	  of	  iPS	  cells	  in	  an	  asynchronous	  population	  are	  in	  S	  phase	  compared	  to	  HFFs.	  	  The	  BrdU	  
incorporation	  assay	  was	  used	  to	  stain	  cells	  in	  S	  phase.	  	  A)	  Percentage	  of	  cells	  in	  S	  phase	  within	  an	  asynchronous	  
population.	  	  Standard	  deviations	  represents	  three	  replicates	  consisting	  of	  100	  cells	  each.	  	  B)	  Representative	  images	  of	  
BrdU	  staining	  in	  HFF	  and	  iPS	  cells	  as	  determined	  by	  immunofluorescence.	  	  S	  phase	  positive	  cells	  are	  stained	  with	  anti-­‐
BrdU	  (red)	  and	  nuclei	  are	  stained	  with	  DAPI	  (blue).	  
A.	   B.	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±	  2.1	  pg	  RNA	  per	  cell	  while	  HFFs	  have	  ~14.0	  ±	  1.8	  pg,	  fairly	  consistent	  with	  the	  estimation	  that	  
mammalian	  cells	  contain	  ~20	  –	  30	  pg	  RNA	  each	  (Alberts	  et	  al.,	  1994).	  	  Based	  on	  these	  results,	  the	  
relative	  histone	  mRNA	  abundances	  determined	  by	  qRT-­‐PCR	  may	  actually	  underestimate	  the	  fold-­‐change	  
increase	  in	  iPS	  cells	  as	  each	  HFF	  reaction	  contained	  the	  equivalent	  of	  twice	  as	  many	  cells	  but	  still	  had	  
dramatically	  less	  histone	  mRNA.	  	  	  	  	   	  
	   	  
Figure	  4.12	  	  iPS	  cells	  have	  twice	  as	  much	  total	  RNA	  per	  cell	  compared	  to	  HFFs.	  	  HFF	  and	  iPS	  cells	  were	  
assessed	  for	  the	  amount	  of	  RNA	  per	  cell	  by	  measuring	  RNA	  isolated	  by	  TRIzol	  from	  a	  known	  number	  of	  cells	  
(~3x106 HFFs	  and	  ~4.5x105 iPS	  cells).	  	  Standard	  deviations	  represents	  three	  replicates.	  	  	  	  
	  
	   	  
	   To	  determine	  the	  amount	  of	  protein	  per	  cell,	  two	  approaches	  were	  used.	  	  In	  the	  first,	  we	  
measured	  the	  amount	  of	  protein	  by	  preparing	  whole	  cell	  lysate	  from	  a	  known	  number	  of	  cells	  and	  
measuring	  concentration	  using	  the	  Bio-­‐Rad	  Protein	  Assay.	  	  Interestingly,	  despite	  obvious	  differences	  in	  
cell	  size	  and	  amounts	  of	  RNA,	  Figure	  4.13	  showed	  that	  HFF	  and	  iPS	  cells	  both	  have	  ~600	  pg	  of	  protein	  
per	  cell	  (599.2	  ±	  15.0	  pg	  in	  HFF	  and	  601.7	  ±	  45.2	  pg	  in	  iPS	  cells).	  	  The	  typical	  mammalian	  cell	  is	  estimated	  





Figure	  4.13	  HFF	  and	  iPS	  cells	  have	  equal	  amounts	  of	  protein	  per	  cell	  compared	  to	  HFFs.	  	  Cells	  were	  assessed	  
for	  amount	  of	  protein	  per	  cell	  using	  the	  Bio-­‐Rad	  Protein	  Assay	  to	  measure	  lysates	  made	  from	  a	  known	  number	  
of	  cells.	  Standard	  deviations	  represents	  three	  replicates.	  	  	  	  
	  
	  	  	  
	   In	  an	  alternative	  method,	  equal	  numbers	  of	  cells	  were	  resuspended	  in	  1x	  SDS	  protein	  dye	  and	  
resolved	  on	  a	  15%	  SDS-­‐PAGE	  gel.	  	  Following	  Coomassie	  staining,	  the	  gel	  was	  compared	  to	  a	  Coomassie-­‐	  
stained	  gel	  loaded	  with	  25	  µg	  of	  whole	  cell	  lysate	  (Figure	  4.7)	  showing	  no	  discernable	  differences,	  giving	  
further	  evidence	  that	  HFFs	  and	  iPS	  cells	  have	  equal	  amounts	  of	  protein	  per	  cell.	  	  
	   Given	  these	  analyses	  indicating	  that	  HFF	  and	  iPS	  cells	  contain	  the	  same	  amount	  of	  protein	  per	  
cell,	  all	  comparisons	  of	  histone	  protein	  abundance	  can	  be	  assumed	  to	  represent	  the	  same	  numbers	  of	  
cells.	  	  In	  conjunction	  with	  the	  Coomassie	  data,	  we	  determined	  that	  there	  is	  ~10-­‐fold	  more	  core	  histone	  
protein	  per	  iPS	  cell	  than	  HFF.	  	  Considering	  the	  importance	  of	  histones	  in	  chromatin	  dynamics	  and	  the	  
well-­‐accepted	  description	  of	  pluripotent	  heterochromatin	  structure,	  this	  finding	  is	  very	  intriguing.	  	  	  
	  
	  4.8	  Discussion	  	  
	   Based	  on	  both	  microarray	  and	  qRT-­‐PCR	  data,	  we	  showed	  that	  iPS	  cells	  express	  more	  histone	  
mRNA	  and	  protein	  than	  HFF	  cells,	  supported	  in	  part	  by	  significant	  stabilization	  of	  replication-­‐dependent	  
transcripts.	  	  Assuming	  that	  the	  stabilized	  mRNAs	  are	  translatable	  and	  intact,	  it	  seems	  likely	  that	  an	  early	  
step	  in	  the	  decay	  pathway	  is	  inhibited	  in	  iPS	  cells.	  	  As	  TUTase	  ZCCHC11	  (Schmidt	  et	  al.,	  2011)	  and	  UPF1	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(Kaygun	  and	  Marzluff,	  2005b)	  initiate	  degradation	  of	  histone	  mRNAs,	  it	  would	  be	  interesting	  to	  see	  how	  
they	  are	  regulated	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  Analogous	  to	  the	  “poised”	  nature	  of	  pluripotent	  
chromatin,	  these	  decay	  factors	  must	  be	  inactive	  towards	  histone	  transcripts	  during	  S	  phase	  but	  rapidly	  
induce	  destabilization	  once	  DNA	  synthesis	  is	  complete,	  as	  seen	  in	  Figure	  4.10.	  	  It	  is	  possible	  that	  these	  
decay	  proteins	  exhibit	  differential	  post-­‐translational	  regulation,	  contributing	  to	  differential	  histone	  
mRNA	  stability.	  	  In	  our	  microarray	  data,	  the	  transcripts	  encoding	  these	  proteins	  showed	  2.40-­‐fold	  and	  
1.46-­‐fold	  increases	  in	  iPS	  cells,	  respectively,	  but	  this	  does	  not	  give	  any	  information	  about	  the	  protein	  
abundance	  or	  activity.	  	  	  
	   The	  overall	  stabilization	  of	  histone	  mRNAs	  during	  S	  phase	  and	  dramatic	  decay	  immediately	  upon	  
inhibition	  of	  DNA	  synthesis	  in	  iPS	  cells	  suggests	  that	  these	  cells	  exert	  sharper	  control	  over	  histone	  
regulation	  than	  their	  differentiated	  counterparts.	  	  Consistent	  with	  this,	  in	  ES	  cells,	  histone	  locus	  body	  
formation	  is	  induced	  2	  hours	  prior	  to	  S	  phase	  whereas	  induction	  begins	  6	  hours	  before	  S	  phase	  in	  
differentiated	  cells	  (Ghule	  et	  al.,	  2008).	  	  Further,	  knockdown	  of	  reprogramming	  factors	  OCT4	  and	  SOX2	  
in	  ES	  cells	  leads	  to	  down-­‐regulated	  expression	  of	  20	  to	  30	  histone	  mRNAs	  (Greber	  et	  al.,	  2007).	  	  
Considering	  the	  importance	  of	  chromatin	  plasticity	  to	  maintaining	  pluripotent	  gene	  expression	  (see	  
Section	  4.1.3),	  it	  seems	  reasonable	  that	  iPS	  cells	  would	  dedicate	  more	  stringent	  control	  to	  histone	  
mRNAs	  than	  HFFs	  wherein	  chromatin	  remodeling	  is	  less	  utilized	  (Efroni	  et	  al.,	  2008).	  	  	  
	   We	  also	  found	  that	  histone	  mRNAs,	  even	  within	  families,	  exhibited	  a	  wide	  range	  in	  half-­‐lives	  
despite	  being	  predominantly	  regulated	  through	  the	  same	  conserved	  3’UTR	  element.	  	  For	  instance,	  H3	  
transcripts	  in	  iPS	  cells	  and	  H2B	  transcripts	  in	  HFFs	  had	  half-­‐lives	  ranging	  up	  to	  10-­‐fold	  more	  stabilized	  
than	  the	  least	  stable	  transcript.	  	  It	  is	  possible	  that	  other	  structural	  or	  sequence	  elements	  within	  histone	  
transcripts	  determine	  stability.	  	  Further	  analysis	  of	  the	  individual	  mRNAs	  identified	  by	  microarray	  may	  
reveal	  more	  insightful	  clues	  to	  differential	  histone	  stability	  within	  the	  same	  cell	  line.	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   From	  our	  data,	  we	  also	  find	  that	  the	  fold-­‐change	  in	  histone	  protein	  expression	  (~10-­‐fold	  higher	  
in	  iPS	  cells)	  is	  much	  lower	  than	  what	  would	  be	  predicted	  based	  on	  mRNA	  levels.	  	  This	  suggests	  that	  iPS	  
cells	  have	  more	  mRNA	  undergoing	  less	  translation	  than	  HFFs.	  	  Presumably,	  these	  cells	  have	  a	  way	  of	  
keeping	  histone	  transcripts	  translationally	  inactive.	  	  Fluorescence	  in	  situ	  hybridization	  studies	  could	  
indicate	  whether	  these	  mRNAs	  are	  sequestered	  to	  a	  particular	  part	  of	  cell,	  whether	  in	  the	  nucleus	  within	  
foci	  similar	  to	  histone	  locus	  bodies	  or	  processing	  bodies	  found	  in	  the	  cytoplasm.	  	  Either	  way,	  it	  seems	  
likely	  that	  the	  transcripts	  are	  also	  kept	  in	  a	  reversibly	  silenced,	  or	  readily	  activated,	  state.	  	  One	  of	  the	  
defining	  features	  of	  pluripotency	  is	  the	  capacity	  for	  unlimited	  differentiation.	  	  To	  carry	  out	  such	  lineage	  
progression,	  the	  genome	  must	  be	  re-­‐packaged	  to	  facilitate	  the	  new	  gene	  expression	  requirements	  of	  the	  
cell	  (Meshorer	  and	  Misteli,	  2006)	  and	  this	  likely	  requires	  an	  influx	  of	  histone	  proteins.	  	  Perhaps	  
additional	  histone	  mRNAs	  are	  kept	  “on	  deck”	  in	  iPS	  cells	  in	  the	  event	  that	  differentiation	  signals	  are	  
encountered.	  	  	  
	   Although	  we	  find	  that	  differences	  in	  histone	  protein	  abundance	  are	  not	  as	  dramatic	  as	  the	  
mRNA	  data	  would	  suggest,	  the	  ~10-­‐fold	  increase	  seen	  in	  iPS	  cells	  (Figure	  4.7)	  raises	  several	  questions	  
regarding	  the	  regulation	  of	  these	  proteins.	  	  It	  is	  important	  to	  note	  that	  Coomassie	  and	  western	  blot	  
analyses	  merely	  reflect	  the	  overall	  abundance	  of	  histones	  and	  do	  not	  give	  information	  as	  to	  whether	  the	  
histones	  detected	  were	  associated	  with	  DNA	  or	  in	  unbound	  populations.	  	  The	  nuclear	  environment	  of	  
stem	  cells	  is	  characterized	  as	  having	  a	  slightly	  larger	  proportion	  of	  unbound	  histones	  than	  differentiated	  
cells	  (Meshorer	  et	  al.,	  2006).	  	  We	  found	  that	  iPS	  cells	  express	  ~10-­‐fold	  more	  histone	  protein	  per	  cell	  than	  
HFFs	  (Figure	  4.7	  and	  Figure	  4.13)	  even	  though	  the	  number	  of	  cells	  in	  S	  phase	  was	  only	  increased	  2-­‐fold	  
(Figure	  4.11).	  	  Assuming	  the	  chromatin	  structure	  of	  the	  iPS	  cells	  used	  in	  this	  study	  is	  consistent	  with	  
previously	  published	  descriptions,	  it	  is	  likely	  that	  iPS	  cells	  have	  a	  much	  larger	  proportion	  of	  unbound	  
histones	  than	  previously	  appreciated.	  	  Unlike	  histone	  mRNAs,	  histone	  proteins	  persist	  throughout	  the	  
cell	  cycle.	  	  It	  would	  be	  interesting	  to	  determine	  whether	  the	  unbound	  histones	  are	  restricted	  to	  cells	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synthesizing	  DNA	  or	  if	  they	  are	  somehow	  stored	  in	  a	  discrete	  location	  outside	  of	  S	  phase.	  	  In	  yeast,	  
excess	  histone	  protein	  results	  in	  mitotic	  chromosome	  loss	  (Meeks-­‐Wagner	  and	  Hartwell,	  1986)	  and	  
cytotoxicity	  (Gunjan	  and	  Verreault,	  2003;	  Gunjan	  et	  al.,	  1999)	  so	  the	  high	  abundance	  of	  histones	  in	  iPS	  
cells	  is	  intriguing.	  	  	  
	   In	  iPS	  cells	  where	  there	  is	  an	  increased	  abundance	  of	  unbound	  histones,	  it	  may	  be	  necessary	  for	  
histone	  chaperones	  to	  maintain	  interactions	  longer	  rather	  than	  immediately	  delivering	  histones	  to	  
nucleosomes.	  	  NASP,	  a	  protein	  containing	  three	  histone-­‐binding	  domains,	  is	  able	  to	  interact	  with	  
histones	  (Batova	  and	  O’Rand,	  1996)	  in	  a	  cell	  cycle-­‐regulated	  manner	  (Richardson	  et	  al.,	  2000).	  	  More	  
specifically,	  NASP	  is	  a	  chaperone	  for	  linker	  histone	  H1	  to	  assist	  chromatin	  formation.	  	  NASP	  shares	  
sequences	  homology	  with	  the	  N1/N2	  family	  of	  histone	  chaperone	  proteins	  that	  preferentially	  associate	  
with	  H3	  and	  H4	  (Wang	  et	  al.,	  2008).	  	  	  Nucleoplasmin	  family	  members	  NPM2/NPM3	  preferentially	  bind	  
histones	  H2A	  and	  H2B	  (Laskey	  et	  al.,	  1993;	  Ramos	  et	  al.,	  2010).	  	  These	  proteins	  function	  to	  escort	  
histone	  proteins	  to	  nuclear	  locations	  where	  they	  perform	  their	  roles	  in	  supporting	  chromatin	  
architecture.	  	  Co-­‐immunoprecipitations	  of	  these	  factors	  with	  histones	  could	  indicate	  whether	  their	  
associations	  are	  more	  persistent	  in	  stem	  cells	  versus	  HFFs.	  	  Even	  if	  excess	  histones	  are	  not	  bound	  to	  
chaperones	  more	  frequently	  in	  pluripotent	  cells,	  co-­‐localization	  of	  histones	  with	  markers	  for	  various	  
cytoplasmic	  and	  nuclear	  foci	  could	  give	  clues	  as	  to	  a	  mechanism	  of	  bulk	  histone	  storage.	  	  	  
	   The	  amount	  of	  histone	  proteins	  in	  the	  nucleus	  is	  closely	  monitored	  to	  assure	  proper	  levels	  are	  
maintained.	  	  Imbalanced	  expression	  of	  histones	  can	  lead	  to	  compromised	  genomic	  integrity	  and	  
chromosomal	  instability	  (Williamson	  and	  Pinto,	  2012).	  	  It	  has	  been	  previously	  shown	  in	  dividing	  starfish	  
embryos	  that	  the	  histone/DNA	  ratio	  changes	  through	  development	  (Shabalkin,	  1996).	  	  Although	  these	  
embryos	  experience	  increased	  histone	  expression	  during	  the	  first	  four	  cleavages,	  this	  examples	  provides	  
evidence	  that	  histone	  mRNAs	  are	  developmentally	  regulated	  in	  addition	  to	  the	  regulation	  conferred	  by	  
the	  cell	  cycle.	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   Overall,	  our	  observations	  indicating	  that	  replication-­‐dependent	  histone	  mRNAs	  are	  significantly	  
stabilized	  in	  iPS	  cells	  further	  emphasizes	  the	  importance	  of	  histones	  to	  pluripotent	  gene	  expression.	  	  
Although	  it	  seems	  counter	  intuitive	  for	  a	  cell	  type	  with	  less	  compact	  chromatin	  to	  express	  more	  
histones,	  the	  plasticity	  demonstrated	  by	  stem	  cells	  provides	  a	  possible	  explanation	  for	  the	  dramatic	  
increase	  compared	  to	  differentiated	  cells.	  	  Further	  investigation	  to	  identify	  mechanisms	  responsible	  for	  
differential	  stability	  of	  histone	  mRNAs	  within	  and	  between	  cell	  lines	  might	  provide	  additional	  targets	  for	  

























	   The	  second	  class	  of	  mRNAs	  that	  showed	  altered	  stability	  in	  our	  global	  analysis	  were	  those	  
encoding	  C2H2	  Zinc	  Finger	  (ZNF)	  proteins.	  	  As	  C2H2	  ZNFs	  represent	  the	  largest	  class	  of	  transcription	  
factors	  in	  eukaryotes,	  their	  expression	  is	  highly	  likely	  to	  influence	  the	  establishment	  and	  maintenance	  of	  
the	  pluripotent	  state	  making	  their	  regulation	  a	  high	  priority	  for	  further	  study.	  	  Genes	  containing	  C2H2	  
ZNF	  domains	  are	  highly	  transcribed	  during	  early	  embryogenesis	  relative	  to	  the	  expression	  of	  all	  
transcription	  factors	  but	  decrease	  through	  later	  stages	  in	  organisms	  ranging	  from	  Drosophila	  to	  Xenopus	  
(Adryan	  and	  Teichmann,	  2010;	  Schep	  and	  Adryan,	  2013).	  	  Correlating	  well	  with	  this	  observation,	  our	  
global	  analysis	  data	  indicated	  that	  C2H2	  ZNF	  mRNAs	  were	  more	  stable	  in	  iPS	  cells	  as	  compared	  to	  HFFs	  
(discussed	  in	  Chapter	  3).	  	  While	  mechanisms	  regulating	  C2H2	  ZNF	  mRNA	  stability	  are	  not	  well	  
characterized,	  recent	  studies	  have	  identified	  two	  features	  of	  ZNF	  mRNAs	  that	  may	  contribute	  to	  this	  
regulation.	  	  These	  features	  as	  well	  as	  further	  analysis	  of	  the	  stabilization	  of	  C2H2	  ZNF	  mRNAs	  in	  iPS	  cells	  
are	  discussed	  here.	  	  
	  
5.1.1	  C2H2	  ZNF	  genes	  are	  highly	  conserved	  	  
	   C2H2	  ZNF	  genes	  are	  members	  of	  the	  ZNF	  gene	  superfamily	  that	  make	  up	  one	  of	  the	  largest	  
families	  in	  the	  mammalian	  genome,	  second	  only	  to	  olfactory	  receptor	  genes.	  	  There	  are	  approximately	  
~800	  ZNF	  genes	  organized	  in	  clusters	  across	  the	  human	  genome	  (Grimwood	  et	  al.,	  2004;	  Knight	  and	  
Shimeld,	  2001)	  and	  because	  of	  this,	  many	  studies	  have	  focused	  exclusively	  on	  their	  molecular	  evolution	  
(Emerson	  and	  Thomas,	  2009;	  Lorenz	  et	  al.,	  2010;	  Stubbs	  et	  al.,	  2011).	  	  Not	  much	  is	  known	  regarding	  the	  
mechanisms	  driving	  ZNF	  gene	  duplication	  but	  their	  coevolution	  with	  retroelements	  suggests	  that	  these	  
proteins	  may	  be	  involved	  in	  an	  “arms	  race”	  to	  prevent	  genome	  damage	  from	  retrotransposition	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(Thomas	  and	  Schneider,	  2011).	  	  Studies	  show	  that	  this	  family	  is	  still	  evolving	  and	  expanding	  in	  mammals	  
(Tadepally	  et	  al.,	  2008).	  	  	  
	   The	  ZNF	  family	  of	  genes	  is	  divided	  into	  subfamilies	  based	  on	  their	  type	  of	  zinc	  finger	  fold	  and	  
protein	  domains	  that	  enable	  ZNF	  proteins	  to	  interact	  with	  various	  molecules	  such	  as	  DNA,	  RNA,	  and	  
other	  proteins.	  	  There	  are	  six	  fold	  groups	  in	  the	  ZNF	  family	  specified	  by	  domains,	  namely	  C2H2	  (Miller	  et	  
al.,	  1985),	  TAZ	  (De	  Guzman	  et	  al.,	  2000),	  Zn2/Cys6	  (Carr	  et	  al.,	  1990),	  knuckle	  (Danielsen	  et	  al.,	  1989),	  
treble	  clef	  (Grishin,	  2001),	  and	  zinc	  ribbon	  (Qian	  et	  al.,	  1993).	  	  C2H2	  ZNF	  genes	  make	  up	  the	  majority	  of	  
the	  ZNF	  family	  and	  are	  the	  best	  characterized.	  	  	  	  
	   C2H2,	  or	  Krüppel-­‐like	  domains,	  are	  homologous	  to	  tandem	  repeat	  ZNF	  domains	  identified	  in	  the	  
Drosophila	  melanogaster	  transcription	  factor	  Krüppel	  (Schuh	  et	  al.,	  1986).	  	  These	  domains	  are	  
considered	  to	  be	  the	  “classical”	  zinc	  fingers	  where	  structural	  motifs	  of	  repeating	  pairs	  of	  cysteine	  and	  	  
histidine	  residues	  create	  folds	  stabilized	  by	  one	  or	  more	  zinc	  ions	  (Miller	  et	  al.,	  1985).	  	  C2H2	  domains	  
occur	  in	  two	  or	  more	  tandem	  repeats	  separated	  by	  a	  highly	  conserved	  linker	  region	  that	  is	  important	  for	  
DNA-­‐binding	  (Foster	  et	  al.,	  1997;	  Pabo	  et	  al.,	  2001)	  and	  mitotic	  regulation	  (Dovat	  et	  al.,	  2002;	  Rizkallah	  
et	  al.,	  2011;	  Figure	  5.1).	  	  In	  addition	  to	  providing	  binding	  strength,	  these	  zinc	  finger	  folds	  also	  confer	  
sequence	  specificity	  (Nardelli	  et	  al.,	  1991;	  Thukral	  et	  al.,	  1992).	  	  Although	  the	  C2H2	  domain	  has	  the	  
ability	  to	  also	  interact	  with	  RNA	  and	  proteins,	  its	  function	  in	  sequence-­‐specific	  DNA-­‐binding	  is	  the	  most	  
apparent;	  most	  characterized	  C2H2	  ZNF	  genes	  encode	  transcription	  factors,	  making	  up	  40%	  of	  all	  
transcription	  factor	  genes	  (Messina	  et	  al.,	  2004).	  	  Effector	  functions	  are	  carried	  out	  through	  additional	  
domains	  including	  KRAB	  (Krüppel-­‐Associated	  Box;	  Bellefroid	  et	  al.,	  1991),	  BTB/POZ	  (ZBTB;	  Zollman	  et	  al.,	  






5.1.2	  Many	  C2H2	  ZNF	  genes	  contain	  the	  transcription	  repressor	  KRAB	  domain	  
	   ZNF	  genes	  containing	  the	  KRAB	  domain	  make	  up	  the	  largest	  subfamily	  of	  C2H2	  ZNFs	  with	  423	  
genes	  encoding	  671	  distinct	  KRAB	  ZNF	  proteins	  in	  humans	  (Ding	  et	  al.,	  2009;	  Huntley	  et	  al.,	  2006)	  and	  
this	  subset	  of	  C2H2	  ZNF	  genes	  was	  strongly	  over-­‐represented	  in	  our	  set	  of	  mRNAs	  that	  were	  stabilized	  in	  
iPS	  cells	  (discussed	  in	  Chapter	  3).	  	  Figure	  5.1	  depicts	  a	  C2H2	  ZNF	  protein	  with	  a	  KRAB	  domain	  at	  its	  
typical	  location	  near	  the	  N-­‐terminus.	  	  This	  prevalent	  C2H2	  ZNF	  protein	  domain	  spanning	  75	  amino	  acids	  
is	  highly	  charged	  and	  divided	  into	  two	  regions,	  boxes	  A	  and	  B	  (Bellefroid	  et	  al.,	  1991).	  	  Upon	  binding	  of	  
the	  ZNF	  domain	  to	  DNA,	  the	  A	  box	  mediates	  transcriptional	  repression	  (Witzgall	  et	  al.,	  1994)	  through	  a	  
direct	  interaction	  with	  KAP1	  (KRAB-­‐Associated	  Protein	  1),	  also	  known	  as	  TRIM28	  or	  TIF1β	  (Friedman	  et	  
al.,	  1996).	  	  KAP1	  in	  turn	  recruits	  chromatin	  modifiers	  such	  as	  heterochromatin	  protein	  CBX5	  (Chromobox	  
Homolog	  5;	  Lechner	  et	  al.,	  2000)	  and	  histone	  methyltransferase	  SETDB1	  (SET	  Domain,	  Bifurcated	  1;	  
Schultz	  et	  al.,	  2002)	  to	  silence	  transcription	  promoter	  regions.	  	  KAP1	  and	  KRAB	  ZNFs	  have	  the	  ability	  to	  
mediate	  transcriptional	  repression	  in	  regions	  up	  to	  15	  kb	  away	  through	  heterochromatin	  spreading	  
characterized	  by	  loss	  of	  H3	  acetylation,	  increased	  H3	  methylation,	  and	  decreased	  RNA	  Pol	  II	  recruitment	  
(Groner	  et	  al.,	  2010).	  	  	  	  
	   Although	  the	  predominant	  function	  of	  the	  KRAB	  domain	  is	  transcriptional	  repression,	  ZNF	  
proteins	  bearing	  this	  region	  in	  addition	  to	  other	  domains	  are	  not	  limited	  to	  repressor	  activity.	  	  For	  
example,	  identification	  of	  targets	  regulated	  by	  ZNF263,	  which	  contains	  KRAB	  and	  SCAN	  domains,	  
revealed	  that	  this	  transcription	  factor	  has	  the	  ability	  to	  activate	  or	  repress	  transcription	  (Frietze	  et	  al.,	  
2010).	  	  Further,	  not	  all	  KRAB	  ZNF	  proteins	  interact	  with	  KAP1	  to	  elicit	  repression.	  	  Several	  SCAN-­‐KRAB	  
ZNF	  proteins	  exhibit	  KAP1-­‐independent	  repressor	  activity,	  alluding	  to	  an	  additional	  mechanism	  by	  which	  





5.1.3	  Expression	  of	  C2H2	  ZNF	  mRNAs	  is	  developmentally-­‐regulated	  
	   As	  noted	  above,	  in	  several	  species	  C2H2	  ZNF	  expression	  is	  widespread	  during	  early	  
embryogenesis	  but	  declines	  as	  development	  progresses	  (Adryan	  and	  Teichmann,	  2010;	  Schep	  and	  
Adryan,	  2013).	  	  This	  is	  consistent	  with	  the	  repressive	  role	  of	  C2H2	  ZNFs	  as	  pluripotent	  cell	  types	  are	  
characterized	  by	  a	  euchromatic	  genome	  structure	  requiring	  repression	  of	  lineage-­‐specific	  genes	  (Efroni	  
et	  al.,	  2008;	  Gaspar-­‐Maia	  et	  al.,	  2011).	  	  Co-­‐repressor	  KAP1	  is	  also	  required	  for	  silencing	  differentiation-­‐
specific	  genes	  and	  establishing	  DNA	  methylation	  patterns	  in	  stem	  cells	  (Hu	  et	  al.,	  2009;	  Quenneville	  et	  
al.,	  2012).	  	  Relatively	  few	  C2H2	  ZNF	  transcription	  factors	  have	  been	  individually	  characterized	  but	  
several	  have	  been	  identified	  with	  roles	  in	  embryogenesis	  such	  as	  ZFP281,	  a	  repressor	  for	  pluripotency	  
(Fidalgo	  et	  al.,	  2011)	  and	  ZFP57,	  a	  regulator	  of	  imprinted	  genes	  (Quenneville	  et	  al.,	  2011).	  	  Given	  the	  
importance	  of	  transcriptional	  silencing	  during	  pluripotency	  (Gaspar-­‐Maia	  et	  al.,	  2011),	  there	  are	  likely	  
several	  more	  C2H2	  ZNF	  genes	  required	  for	  an	  undifferentiated	  state	  that	  remain	  to	  be	  characterized.	  	  	  
	   Several	  mechanisms	  involved	  in	  coordinated	  regulation	  of	  C2H2	  ZNF	  genes	  during	  of	  embryonic	  
development	  have	  been	  uncovered.	  	  First,	  four	  miRNA	  families	  have	  been	  identified	  that	  target	  
sequences	  within	  the	  region	  encoding	  the	  repeating	  C2H2	  domains	  to	  initiate	  deadenylation	  and	  
translational	  repression	  of	  the	  mRNA	  (Huang	  et	  al.,	  2010;	  Schnall-­‐Levin	  et	  al.,	  2011).	  	  Although	  miRNAs	  
Figure	  5.1	  KRAB	  ZNF	  proteins	  have	  tandem	  C2H2	  DNA-­‐binding	  domains	  and	  an	  upstream	  transcription	  repressor	  
KRAB	  domain.	  	  Repeating	  C2H2	  domains	  are	  separated	  by	  linker	  domains	  that	  facilitate	  DNA-­‐binding.	  	  The	  KRAB	  











are	  known	  for	  binding	  sequences	  in	  the	  3’UTR	  of	  mRNAs,	  their	  interactions	  are	  not	  restricted	  to	  non-­‐
coding	  portions	  (Duursma	  et	  al.,	  2008;	  Forman	  et	  al.,	  2008).	  	  MicroRNA-­‐181a	  (miR-­‐181a)	  was	  the	  first	  
miRNA	  demonstrated	  to	  target	  the	  C2H2	  ZNF	  ORF	  region	  (Huang	  et	  al.,	  2010)	  but	  additional	  members	  of	  
the	  miR-­‐181	  family	  (miR-­‐181b-­‐d)	  and	  miRNA	  families	  miR-­‐23,	  miR-­‐188,	  and	  miR-­‐199	  have	  since	  been	  
shown	  to	  share	  this	  ability	  (Schnall-­‐Levin	  et	  al.,	  2011).	  	  These	  miRNAs	  bind	  target	  sequences	  within	  C2H2	  
and	  linker	  domains.	  	  As	  these	  domains	  are	  often	  present	  in	  tandem	  repeats,	  multiple	  binding	  sites	  
provide	  potential	  for	  increased	  miRNA	  activity.	  	  It	  is	  possible	  that	  this	  mechanism	  contributes	  to	  the	  
differential	  stability	  of	  C2H2	  ZNF	  mRNAs	  we	  observed	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  	  	  
	   Of	  the	  four	  miRNA	  families	  that	  target	  ZNF	  transcripts,	  several	  members	  have	  previously	  been	  
linked	  with	  various	  important	  development	  and	  differentiation	  processes.	  	  MicroRNA-­‐23	  has	  been	  
implicated	  in	  regulating	  neuronal	  differentiation	  of	  human	  teratocarcinoma	  cells	  (Kawasaki	  and	  Taira,	  
2003),	  neovascularization	  (Zhou	  et	  al.,	  2011),	  and	  neurogenesis	  of	  the	  embryonic	  spinal	  cord	  (Farrell	  et	  
al.,	  2011).	  	  Studies	  involving	  miR-­‐199	  show	  a	  role	  in	  organ	  development	  (Mungunsukh	  and	  Day,	  2013).	  	  
Members	  of	  the	  miR-­‐181	  family	  are	  important	  for	  myoblast	  differentiation	  (Naguibneva	  et	  al.,	  2006)	  and	  
in	  human	  leukemia	  cells,	  miR-­‐181	  disrupts	  the	  LIN28/let-­‐7	  feedback	  circuit	  to	  facilitate	  cell	  
differentiation	  (Li	  et	  al.,	  2012).	  	  As	  each	  of	  these	  miRNAs	  also	  targets	  other	  transcripts,	  it	  remains	  to	  be	  
seen	  whether	  any	  of	  these	  events	  occur	  through	  regulation	  of	  ZNFs.	  	  	  
	   The	  second	  interesting	  feature	  of	  C2H2	  ZNF	  genes	  that	  may	  allow	  for	  their	  coordinated	  
regulation	  is	  that	  the	  mRNAs	  they	  encode	  are	  bimorphic.	  	  Bimorphic	  transcripts	  are	  defined	  as	  those	  
having	  a	  significant	  population	  of	  unadenylated	  mRNAs	  in	  addition	  to	  the	  standard	  polyadenylated	  
population.	  	  ZNF	  transcripts	  were	  over-­‐represented	  among	  unadenylated	  mRNAs	  detected	  in	  both	  
embryonic	  stem	  cells	  and	  HeLa	  cells,	  although	  more	  so	  in	  the	  stem	  cells	  (Yang	  et	  al.,	  2011).	  	  Poly(A)	  tail	  
shortening	  could	  impact	  export	  from	  the	  nucleus	  or	  translation	  of	  these	  mRNAs	  as	  well	  as	  their	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turnover.	  	  While	  further	  investigation	  is	  needed,	  these	  data	  suggest	  that	  the	  poly(A)	  tail	  status	  of	  ZNF	  
mRNAs	  may	  be	  differentially	  regulated	  as	  a	  means	  of	  gene	  expression	  control.	  	  	  
	   	  As	  introduced	  in	  Chapter	  3,	  global	  analysis	  of	  mRNA	  decay	  rates	  in	  iPS	  cells	  revealed	  significant	  
stabilization	  of	  C2H2	  ZNF	  mRNAs	  compared	  to	  HFFs.	  	  Considering	  the	  role	  of	  C2H2	  ZNF	  genes	  as	  
transcription	  regulators	  and	  their	  importance	  for	  maintaining	  pluripotent	  gene	  expression	  profiles,	  we	  
sought	  to	  further	  investigate	  this	  class	  of	  transcripts	  to	  provide	  clues	  as	  to	  a	  mechanism	  of	  stabilization.	  	  
We	  hypothesized	  that	  this	  class	  of	  transcripts	  may	  be	  coordinately	  regulated	  by	  families	  of	  ZNF	  ORF-­‐
targeting	  miRNAs	  and	  that	  these	  miRNAs	  may	  be	  down-­‐regulated	  in	  iPS	  cells	  to	  allow	  for	  ZNF	  mRNA	  
stabilization.	  	  The	  results	  of	  this	  investigation	  are	  presented	  here4.	  	  	  
	  
5.2	  C2H2	  ZNF	  protein	  mRNAs	  are	  significantly	  stabilized	  in	  iPS	  cells	  
	   Analysis	  of	  functional	  domains	  enriched	  in	  the	  mRNAs	  stabilized	  in	  iPS	  cells	  compared	  to	  HFFs	  
found	  that	  KRAB	  (P-­‐value	  =	  1.2x10-­‐23)	  and	  C2H2	  (P-­‐value	  =	  7.4x10-­‐18)	  zinc	  finger	  domains	  were	  
significantly	  over-­‐represented	  (discussed	  in	  Chapter	  3).	  	  Within	  our	  dataset	  of	  significantly	  stabilized	  
mRNAs,	  C2H2	  ZNF	  mRNAs	  made	  up	  ~20%	  (118	  of	  548)	  of	  the	  transcripts.	  	  This	  was	  approximately	  twice	  
as	  many	  as	  would	  be	  predicted	  since	  532	  C2H2	  ZNF	  mRNAs	  were	  represented	  in	  the	  dataset	  of	  5,481	  
mRNAs	  (10%	  of	  the	  dataset).	  	  The	  stability	  of	  all	  C2H2	  ZNF	  mRNAs	  and	  all	  KRAB	  ZNF	  mRNAs	  were	  then	  
compared	  to	  half-­‐life	  changes	  for	  all	  ZNF	  mRNAs	  (including	  those	  containing	  ZBTB,	  SCAN,	  and	  other	  non-­‐
C2H2	  domains)	  and	  all	  5,481	  mRNAs	  in	  the	  dataset	  (Figure	  5.2).	  	  Overall,	  ZNF	  transcripts	  exhibited	  
stabilization	  (P-­‐value	  =	  4.2x10-­‐6)	  but	  not	  to	  the	  extent	  seen	  for	  ZNF	  family	  transcripts	  bearing	  the	  C2H2	  
(P-­‐value	  =	  5.5x10-­‐13)	  and	  especially	  KRAB	  (P-­‐value	  <2.2x10-­‐16)	  domains.	  	  Based	  on	  these	  results,	  we	  found	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4	  Many	  of	  the	  results	  presented	  in	  Chapter	  5	  appeared	  in:	  Neff	  et	  al.	  Global	  analysis	  reveals	  multiple	  
pathways	  for	  unique	  regulation	  of	  mRNA	  decay	  in	  induced	  pluripotent	  stem	  cells.	  Genome	  Research.	  




that	  there	  was	  significant	  stabilization	  of	  C2H2	  and	  KRAB	  ZNF	  mRNAs	  over	  and	  above	  the	  general	  trend	  
of	  all	  ZNF	  transcripts.	  	  	  
	  
Figure	  5.2	  C2H2	  ZNF	  and	  KRAB	  ZNF	  mRNAs	  are	  significantly	  stabilized	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  Fold	  
change	  in	  half-­‐life	  between	  HFF	  and	  iPS	  cells	  for	  different	  subsets	  of	  transcripts	  assessed	  from	  
microarray	  data.	  	  
	  
	  
	   We	  then	  went	  on	  to	  validate	  the	  stabilization	  of	  three	  C2H2	  ZNF	  mRNAs,	  ZNF43	  (19	  C2H2	  zinc	  
fingers	  plus	  KRAB	  domain),	  ZNF134	  (11	  C2H2	  zinc	  fingers),	  and	  ZNF627	  (10	  C2H2	  zinc	  fingers	  plus	  KRAB	  
domain)	  by	  qRT-­‐PCR	  where	  abundances	  at	  each	  time	  point	  were	  normalized	  to	  expression	  of	  GAPDH	  
mRNA	  (Figure	  5.3).	  	  To	  date,	  the	  function	  of	  ZNF134	  has	  not	  been	  characterized.	  	  Nucleotide	  
polymorphisms	  of	  ZNF627	  are	  associated	  with	  myocardial	  infarction	  (Horne	  et	  al.,	  2007;	  Koch	  et	  al.,	  
2011).	  	  Interestingly,	  ZNF43	  is	  a	  transcription	  repressor	  important	  for	  maintenance	  of	  an	  
undifferentiated	  state	  in	  Ewing	  sarcoma	  cells	  (González-­‐Lamuño	  et	  al.,	  2002)	  and	  may	  also	  function	  in	  
maintenance	  of	  pluripotency.	  	  Our	  microarray	  data	  indicated	  that	  HFF	  and	  iPS	  cells	  exhibit	  half-­‐lives	  of	  
344	  minutes	  and	  645	  minutes	  for	  ZNF43	  mRNA,	  185	  minutes	  and	  895	  minutes	  for	  ZNF134	  mRNA,	  and	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119	  minutes	  and	  391	  minutes	  for	  ZNF627	  mRNA.	  	  Although	  our	  qRT-­‐PCR	  measured	  half-­‐lives	  are	  shorter	  
than	  those	  determined	  by	  microarray,	  we	  found	  that	  all	  three	  mRNAs	  exhibit	  increased	  half-­‐lives	  in	  iPS	  
cells	  compared	  to	  HFFs	  as	  expected.	  	  Within	  this	  small	  subset	  there	  was	  no	  apparent	  correlation	  
between	  the	  number	  of	  C2H2	  or	  KRAB	  domains	  contained	  within	  the	  mRNA	  and	  the	  level	  of	  stabilization	  
seen	  in	  iPS	  cells.	  	  Specifically,	  ZNF134	  and	  ZNF627	  had	  very	  similar	  half-­‐lives	  in	  both	  cell	  lines	  despite	  the	  
presence	  of	  a	  KRAB	  domain	  in	  ZNF627,	  indicating	  that	  the	  KRAB	  domain	  was	  not	  required	  for	  
stabilization.	  	  Further,	  ZNF43	  mRNA	  exhibited	  stabilization	  to	  a	  lesser	  degree	  than	  ZNF134	  and	  ZNF627	  
mRNAs	  despite	  having	  a	  KRAB	  domain	  and	  more	  C2H2	  zinc	  finger	  domains	  than	  the	  other	  two	  
transcripts.	  	  Stabilization	  of	  ZNF43	  mRNA	  in	  iPS	  cells	  was	  also	  verified	  in	  an	  independent	  set	  of	  matched	  
cell	  lines	  (A.	  Jalkanen	  personal	  communication).	  	  Although	  it	  is	  not	  clear	  what	  mechanisms	  are	  
responsible	  for	  stabilization	  of	  these	  mRNAs	  in	  iPS	  cells,	  the	  half-­‐lives	  measured	  here	  suggest	  that	  





Figure	  5.3	  ZNF43,	  ZNF134,	  and	  ZNF627mRNAs	  are	  stabilized	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  Half-­‐lives	  
were	  assessed	  in	  HFF	  and	  iPS	  cells	  for	  each	  mRNA	  following	  actinomycin	  D	  treatment.	  Abundance	  levels	  
were	  measured	  for	  each	  indicated	  mRNA	  by	  qRT-­‐PCR	  at	  each	  time	  point	  and	  normalized	  to	  levels	  of	  
GAPDHmRNA.	  The	  standard	  deviations	  were	  derived	  from	  three	  independent	  replicates.	  	  Half-­‐lives	  for	  
each	  mRNA	  are	  denoted	  to	  the	  right	  of	  the	  cell-­‐line	  keys.	  
174	  +/-­‐ 15	  min
109	  +/-­‐ 5	  min
170	  +/-­‐ 9	  min
72	  +/-­‐ 3	  min
178	  +/-­‐ 20	  min
72	  +/-­‐ 5	  min
	  
	  
5.3	  ORF-­‐targeting	  miRNAs	  have	  decreased	  abundance	  in	  iPS	  cells	  	  
	   As	  discussed	  in	  Chapter	  3,	  hexamer	  analysis	  to	  identify	  putative	  cis-­‐acting	  elements	  revealed	  an	  
enrichment	  of	  sequences	  in	  the	  5’UTR,	  ORF,	  and	  3’UTR	  of	  stable	  and	  unstable	  mRNAs	  in	  iPS	  cells.	  	  Upon	  
further	  investigation	  we	  found	  that	  several	  hexamers	  identified	  as	  over-­‐represented	  in	  the	  ORF	  of	  stable	  
iPS	  cell	  mRNAs	  were	  complementary	  to	  seed	  sequences	  of	  miRNA	  families	  previously	  implicated	  in	  
C2H2-­‐domain	  targeting	  (Huang	  et	  al.,	  2010;	  Schnall-­‐Levin	  et	  al.,	  2011).	  	  Specifically,	  Figure	  5.4	  shows	  
these	  hexamer	  sequences	  and	  their	  heat	  map	  representation	  of	  significance	  score.	  	  The	  significance	  of	  a	  
hexamer	  was	  calculated	  by	  the	  Fisher’s	  exact	  test	  comparing	  its	  frequencies	  in	  the	  most	  stable	  and	  least	  
stable	  mRNA	  sets.	  	  A	  significance	  score	  was	  assigned	  to	  each	  hexamer	  equaling	  –log10(P-­‐value)*s,	  where	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s	  equals	  -­‐1	  if	  the	  hexamer	  was	  more	  common	  in	  the	  least	  stable	  transcripts,	  and	  s	  equals	  1	  if	  otherwise.	  	  
Six	  of	  these	  over-­‐represented	  ORF	  hexamers	  demonstrated	  sequence	  overlap	  with	  binding	  sites	  for	  
miRNA	  families	  miR-­‐23,	  miR-­‐181,	  and	  miR-­‐188.	  	  A	  putative	  binding	  site	  for	  miR-­‐199,	  another	  family	  that	  
targets	  C2H2	  ZNF	  mRNAs,	  was	  not	  identified	  among	  the	  top	  enriched	  hexamers.	  	  As	  we	  saw	  from	  the	  
heat	  map	  tiles	  correlating	  hexamer	  sequences	  with	  stability,	  these	  cis-­‐elements	  were	  strongly	  associated	  
with	  mRNA	  stabilization	  in	  iPS	  cells	  (yellow)	  and	  some	  sequences	  were	  also	  enriched	  in	  the	  least	  stable	  
HFF	  mRNAs	  (e.g.	  GAAUGU,	  UGUGGG,	  and	  AUGUGA;	  bright	  blue).	  	  	  
	  
Figure	  5.4	  Hexamer	  sequences	  similar	  to	  seed	  sequences	  of	  ZNF	  ORF-­‐targeting	  miRNAs	  are	  over-­‐
represented	  in	  stable	  iPS	  cell	  mRNAs	  compared	  to	  HFFs.	  	  Alignment	  of	  hexamer	  cis-­‐elements	  identified	  
in	  stabilized	  iPS	  cell	  mRNAs	  showing	  overlap	  with	  ZNF	  ORF-­‐targeting	  miRNA	  target	  sequences.	  	  
Hexamers	  over-­‐represented	  in	  stable	  mRNAs	  (SE)	  are	  depicted	  in	  yellow	  while	  hexamers	  over-­‐
represented	  in	  unstable	  mRNAs	  (DE)	  are	  in	  blue. Sequences	  of	  hexamers	  matching	  miRNA	  target	  
sequences	  are	  underlined	  in	  red	  and	  black.	  	  miRNA	  seed	  sequences	  are	  underlined	  in	  green.	  
	   	  
	  
	   For	  each	  of	  the	  three	  target	  sequences	  where	  overlap	  was	  detected,	  the	  corresponding	  hexamer	  
sequences	  were	  either	  a	  complete	  (red	  underscore)	  or	  incomplete	  (black	  underscore)	  match.	  	  Based	  on	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the	  heat	  map	  tiles	  in	  Figure	  5.4,	  hexamers	  with	  the	  best	  match	  to	  the	  target	  sequence	  were	  slightly	  
more	  likely	  to	  be	  found	  in	  mRNAs	  exhibiting	  a	  larger	  degree	  of	  differential	  stability	  than	  their	  
incomplete-­‐binding	  counterparts.	  	  However,	  perfect	  binding	  of	  the	  entire	  length	  of	  miRNAs	  to	  their	  
target	  transcripts	  leading	  to	  endonucleolytic	  cleavage	  and	  degradation	  is	  rarely	  used	  in	  humans	  (Bracken	  
et	  al.,	  2011;	  Karginov	  et	  al.,	  2010;	  Shin	  et	  al.,	  2010).	  	  Instead,	  imperfect	  binding	  of	  miRNAs	  to	  targets	  
leads	  to	  deadenylation	  and	  translational	  silencing	  (Pillai	  et	  al.,	  2005).	  	  It	  is	  also	  important	  to	  note	  that	  
more	  than	  one	  of	  these	  putative	  ORF	  miRNA	  binding	  sites	  is	  likely	  present	  within	  a	  single	  mRNA	  so	  a	  
true	  correlation	  between	  degree	  of	  stabilization	  and	  miRNA	  binding	  sites	  would	  require	  much	  more	  
detailed	  analysis	  to	  delineate	  contributions	  of	  each	  cis-­‐element.	  	  	  
	   To	  further	  investigate	  the	  association	  of	  miRNA	  target	  sequences	  with	  C2H2	  ZNF	  stabilization,	  
we	  looked	  at	  the	  representation	  of	  miRNA	  binding	  sites	  within	  stabilized	  C2H2	  ZNF	  mRNAs	  compared	  to	  
C2H2	  ZNF	  mRNAs	  that	  were	  not	  stabilized	  in	  iPS	  cells.	  	  By	  counting	  the	  number	  of	  target	  sequences	  for	  
each	  miRNA	  family,	  we	  identified	  the	  presence	  of	  miR-­‐23,	  miR-­‐181,	  miR-­‐188,	  and	  miR-­‐199	  binding	  sites	  
within	  all	  C2H2	  ZNF	  mRNAs	  that	  half-­‐lives	  were	  determined	  for	  in	  both	  cell	  lines.	  	  Bioinformatic	  analysis	  
highlighted	  the	  enrichment	  of	  these	  miRNA	  binding	  sites	  in	  the	  ORF	  and	  3’UTR	  and	  also	  showed	  that	  
stabilized	  C2H2	  ZNF	  mRNAs	  contain	  more	  miRNA	  binding	  sites	  than	  those	  not	  stabilized	  (Figure	  5.5).	  	  
This	  positively	  correlated	  miRNA	  binding	  sites	  for	  miR-­‐23,	  miR-­‐181,	  miR-­‐188,	  and	  miR-­‐199	  with	  
transcript	  stabilization	  in	  iPS	  cells.	  	  The	  trend	  of	  these	  data	  suggested	  that	  the	  presence	  of	  miRNA	  
binding	  sites	  in	  C2H2	  ZNF	  mRNAs	  may	  play	  a	  role	  in	  their	  stabilization	  in	  iPS	  cells	  although	  other	  factors	  




Figure	  5.5	  C2H2	  ZNF	  mRNAs	  containing	  target	  sites	  for	  ORF-­‐targeting	  miRNAs	  tend	  to	  be	  stabilized	  in	  iPS	  cells	  rather	  
than	  not	  stabilized	  compared	  to	  HFFs.	  The	  percentage	  of	  C2H2	  ZNF	  mRNAs	  that	  contained	  miRNA	  binding	  sites	  in	  
the	  5UTR,	  ORF,	  and	  3’UTR	  and	  were	  stabilized	  as	  compared	  to	  C2H2	  ZNF	  mRNAs	  that	  were	  not	  stabilized.	  	  
	  
	  
	   Given	  the	  enrichment	  of	  hexamers	  complementary	  to	  ORF-­‐targeting	  miRNA	  seed	  sequences	  in	  
the	  ORF	  of	  stabilized	  C2H2	  ZNF	  mRNAs,	  we	  hypothesized	  that	  lower	  abundance	  of	  these	  miRNA	  families	  
in	  iPS	  cells	  might	  contribute	  to	  their	  regulation.	  	  We	  therefore	  next	  sought	  to	  measure	  the	  abundance	  of	  
miRNAs	  miR-­‐23a,	  miR-­‐23b,	  miR-­‐181a,	  miR-­‐181b,	  miR-­‐181d,	  miR-­‐188-­‐3p,	  and	  miR-­‐199a	  relative	  to	  5S	  
rRNA	  by	  qRT-­‐PCR	  (Shi	  and	  Chiang,	  2005).	  	  Briefly,	  total	  RNA	  was	  collected	  from	  untreated	  cells	  and	  3’	  
elongated	  with	  >150	  adenosine	  nucleotides	  using	  Poly(A)	  Polymerase	  (PAP).	  	  An	  oligo(dT)	  adapter	  
containing	  a	  short	  stretch	  of	  12	  thymidine	  nucleotides	  and	  unique	  sequence	  was	  then	  annealed	  to	  all	  
transcripts	  to	  facilitate	  reverse	  transcription	  and	  cDNA	  synthesis.	  	  Samples	  were	  then	  amplified	  in	  
reactions	  containing	  a	  specific	  forward	  primer	  to	  detect	  individual	  miRNAs	  and	  a	  universal	  reverse	  
primer	  that	  bound	  the	  non-­‐oligo(dT)	  portion	  of	  the	  adapter.	  	  Oligos	  for	  miRNAs	  were	  selected	  based	  on	  
validated	  results	  from	  a	  previous	  study	  comparing	  various	  methods	  to	  measure	  miRNA	  abundance	  (Git	  
et	  al.,	  2010).	  	  A	  specific	  primer	  for	  miR-­‐181c	  was	  not	  listed	  within	  the	  validated	  primer	  sets	  of	  the	  Git	  et	  
al.	  study	  therefore	  this	  miRNA	  was	  not	  included	  in	  our	  qRT-­‐PCR	  analysis.	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   As	  shown	  in	  Figure	  5.6,	  each	  of	  the	  miRNAs	  measured	  were	  expressed	  at	  lower	  levels	  in	  iPS	  cells	  
compared	  to	  HFFs.	  	  The	  most	  dramatic	  differences	  were	  seen	  for	  miR-­‐23a/miR-­‐23b	  and	  miR-­‐199a	  whose	  
expression	  is	  ~17-­‐fold	  and	  ~50-­‐fold	  lower,	  respectively	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  These	  results	  are	  
not	  surprising	  as	  pluripotent	  cell	  types	  express	  only	  a	  subset	  of	  differentially	  regulated	  miRNAs	  and	  
lower	  levels	  overall	  compared	  to	  differentiated	  cells	  (Lakshmipathy	  et	  al.,	  2007).	  	  Nevertheless,	  the	  
reduced	  abundance	  of	  ORF-­‐targeting	  miRNAs	  in	  iPS	  cells	  correlated	  well	  with	  the	  increased	  mRNA	  
stability	  of	  C2H2	  ZNF	  transcripts.	  	  	  
	  
	  
	   	  
	   In	  order	  to	  determine	  which	  of	  the	  four	  miRNA	  families	  might	  make	  the	  largest	  overall	  
contribution	  to	  regulation	  of	  ZNF	  mRNA	  stability,	  we	  compared	  the	  abundances	  of	  these	  families	  to	  each	  
other.	  	  We	  found	  that	  of	  the	  C2H2	  ZNF	  ORF-­‐targeting	  miRNAs	  measured	  here,	  miR-­‐23a	  and	  miR-­‐23b	  
were	  the	  most	  abundant	  in	  both	  cell	  lines	  (Figure	  5.7).	  	  In	  HFFs,	  miR-­‐199a	  was	  expressed	  at	  ~10%	  the	  
level	  of	  miR-­‐23a	  while	  the	  remaining	  miRNAs	  were	  expressed	  at	  ~1%	  relatively	  (Figure	  5.7A).	  	  In	  iPS	  cells,	  
members	  of	  the	  miR-­‐181	  family	  were	  expressed	  at	  5-­‐10%	  the	  level	  of	  miR-­‐23a	  while	  miR-­‐199a	  and	  miR-­‐
Figure	  5.6	  C2H2	  ZNF	  ORF-­‐targeting	  miRNAs	  have	  decreased	  abundance	  in	  iPS	  cells	  relative	  to	  HFFs.	  	  Levels	  of	  ZNF-­‐
targeting	  miRNAs	  in	  iPS	  cells	  were	  measured	  by	  qRT-­‐PCR,	  normalized	  to	  the	  abundance	  of	  5s rRNA,	  and	  relative	  to	  
levels	  in	  HFFs.	  	  Standard	  deviations	  represent	  three	  replicates.	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188-­‐3p	  were	  expressed	  at	  a	  very	  low	  abundance	  measuring	  ~3%	  of	  miR-­‐23a	  levels	  (Figure	  5.7B).	  	  As	  
expression	  of	  individual	  miRNAs	  within	  tissues	  is	  known	  to	  vary	  (Liang	  et	  al.,	  2007),	  the	  differences	  in	  
abundance	  seen	  here	  within	  cell	  lines	  are	  not	  unexpected.	  	  Although	  we	  could	  not	  draw	  definitive	  
conclusions	  regarding	  the	  functional	  relevance	  of	  these	  differences	  in	  miRNA	  abundance,	  we	  noted	  that	  
miR-­‐23a	  is	  expressed	  at	  several-­‐fold	  higher	  levels	  when	  compared	  to	  expression	  of	  other	  C2H2	  ZNF	  ORF-­‐
targeting	  miRNAs	  in	  both	  cell	  lines	  and	  may	  therefore	  have	  a	  larger	  impact	  than	  the	  other	  miRNAs.	  	  	  
	  
	  	  
	   	  
	   Overall,	  our	  analyses	  have	  indicated	  that	  C2H2	  ZNF	  mRNAs,	  many	  of	  which	  include	  the	  KRAB	  
transcriptional	  repression	  domain,	  are	  significantly	  stabilized	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  Further,	  we	  
showed	  that	  hexamer	  sequences	  enriched	  in	  the	  coding	  region	  of	  stable	  iPS	  mRNAs	  potentially	  serve	  as	  
binding	  sites	  for	  miRNA	  families	  miR-­‐23,	  miR-­‐181,	  miR-­‐188,	  and	  miR-­‐199.	  	  Finally,	  we	  also	  demonstrated	  
that	  ORF-­‐targeting	  miRNAs	  are	  expressed	  at	  much	  lower	  levels	  in	  iPS	  cells,	  possibly	  contributing	  to	  the	  
marked	  stabilization	  of	  C2H2	  ZNF	  mRNAs.	  	  
	  
	  
Figure	  5.7	  ZNF	  ORF-­‐targeting	  miRNAs	  are	  differentially	  expressed	  within	  each	  cell	  line.	  	  Abundance	  of	  ZNF-­‐targeting	  
miRNAs	  in	  (A)	  HFF	  and	  (B)	  iPS	  cells	  as	  measured	  by	  qRT-­‐PCR,	  normalized	  to	  levels	  of	  5s rRNA,	  and	  relative	  to	  the	  
abundance	  of	  miR-­‐23a.	  	  Standard	  deviations	  represent	  three	  replicates.	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5.4	  Discussion	  	  
	   Given	  that	  C2H2	  ZNF	  transcription	  factors	  have	  elevated	  expression	  during	  early	  embryogenesis	  
but	  decreasing	  expression	  during	  development	  (Adryan	  and	  Teichmann,	  2010;	  Schep	  and	  Adryan,	  2013),	  
we	  were	  intrigued	  to	  find	  that	  C2H2	  ZNF	  mRNAs	  were	  more	  stable	  in	  iPS	  cells	  as	  compared	  to	  HFFs.	  	  This	  
family	  of	  transcripts	  typically	  encodes	  transcription	  repressors,	  factors	  important	  for	  suppressing	  	  
differentiation	  genes	  in	  pluripotent	  cell	  types	  (Efroni	  et	  al.,	  2008).	  	  The	  large	  size	  of	  the	  C2H2	  ZNF	  family	  
means	  that	  they	  potentially	  can	  have	  a	  significant	  impact	  on	  gene	  expression	  profiles	  either	  by	  acting	  
redundantly	  on	  a	  large	  scale	  to	  regulate	  a	  single	  pathway,	  or	  through	  multiple	  coordinated	  regulatory	  
events	  with	  each	  ZNF	  targeting	  a	  different	  set	  of	  genes.	  	  In	  addition,	  the	  sheer	  number	  of	  ZNF	  transcripts	  
within	  the	  cell	  means	  that	  they	  have	  the	  potential	  to	  “soak	  up”	  regulatory	  factors	  and	  indirectly	  effect	  
the	  expression	  of	  other	  genes.	  	  Examination	  of	  the	  literature	  uncovered	  two	  unusual	  features	  of	  ZNF	  
mRNAs	  which	  might	  contribute	  to	  this	  regulation	  leading	  to	  stabilization	  in	  iPS	  cells.	  	  	  
	   The	  open	  chromatin	  structure	  of	  stem	  cells	  supports	  the	  unique	  features	  characteristic	  of	  
pluripotent	  cell	  types	  (discussed	  in	  Chapter	  4).	  	  The	  loosely	  bound	  nature	  of	  the	  stem	  cell	  genome	  does	  
not	  provide	  physical	  repression	  gained	  through	  heterochromatin	  compaction,	  therefore	  transcriptional	  
repressors	  inhibit	  expression	  of	  lineage-­‐specific	  genes	  (Efroni	  et	  al.,	  2008;	  Gaspar-­‐Maia	  et	  al.,	  2011;	  
Lessard	  and	  Crabtree,	  2010).	  	  Although	  we	  cannot	  say	  at	  this	  time	  whether	  stabilization	  of	  ZNF	  mRNAs	  
results	  in	  increased	  production	  of	  ZNF	  proteins,	  it	  is	  likely	  that	  these	  differences	  in	  decay	  contribute	  to	  
the	  distinct	  expression	  pattern	  of	  C2H2	  ZNF	  transcription	  factors	  during	  embryogenesis.	  	  Additionally,	  a	  
global	  increase	  in	  the	  availability	  of	  these	  transcriptional	  repressors	  might	  be	  important	  for	  maintaining	  
genome	  integrity	  by	  preventing	  transcription	  and	  transposition	  of	  retroelements.	  	  The	  KAP1	  protein	  is	  
essential	  for	  controlling	  endogenous	  retroviruses	  in	  mouse	  ES	  cells	  (Rowe	  et	  al.,	  2010)	  and	  as	  KRAB-­‐ZNFs	  
are	  the	  major	  proteins	  that	  recruit	  KAP1,	  it	  is	  easy	  to	  imagine	  how	  elevated	  ZNF	  abundance	  might	  be	  
required	  for	  effective	  retrovirus	  repression.	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   Further	  investigation	  of	  C2H2	  ZNF	  mRNA	  stabilization	  was	  based	  on	  observations	  that	  ZNF	  
mRNAs	  can	  be	  targeted	  by	  miRNAs	  that	  recognize	  the	  tandem-­‐repeated	  C2H2	  zinc	  finger	  regions	  (Huang	  
et	  al.,	  2010;	  Schnall-­‐Levin	  et	  al.,	  2011)	  and	  that	  ZNF	  mRNAs	  often	  have	  short	  poly(A)	  tails	  (Yang	  et	  al.,	  
2011).	  	  This	  led	  us	  to	  the	  hypothesis	  that	  ZNF	  mRNAs	  may	  be	  targeted	  for	  deadenylation	  and	  decay	  by	  
miRNAs	  but	  to	  a	  lesser	  extent	  in	  iPS	  cells	  than	  in	  HFFs.	  	  In	  support,	  we	  found	  that	  all	  four	  miRNA	  families	  
that	  target	  ZNF	  mRNAs	  are	  less	  abundant	  in	  iPS	  cells	  which	  might	  explain	  the	  reduced	  decay	  of	  these	  
mRNAs	  in	  this	  cell	  type.	  	  Although	  we	  did	  not	  assess	  the	  poly(A)	  tail	  length	  of	  ZNF	  mRNAs	  in	  HFF	  and	  iPS	  
cells,	  we	  might	  expect	  the	  tails	  to	  be	  even	  shorter	  in	  HFFs	  than	  in	  iPS	  cells	  if	  the	  short	  poly(A)	  tail	  is	  
generated	  though	  miRNA-­‐induced	  deadenylation.	  	  While	  the	  Yang	  et	  al.,	  2011	  study	  found	  ZNF	  mRNAs	  
to	  have	  short	  poly(A)	  tails	  in	  ES	  cells	  compared	  to	  HeLa	  cells,	  genetically	  matched	  cell	  types	  were	  not	  
investigated.	  	  Therefore,	  determination	  of	  poly(A)	  tail	  lengths	  in	  both	  cell	  types	  would	  be	  necessary	  to	  
validate	  this	  possibility.	  	  Alternatively,	  it	  is	  possible	  that	  these	  are	  independent	  means	  of	  regulation	  and	  
ZNF	  transcripts	  have	  constitutively	  short	  poly(A)	  tails.	  	  In	  this	  case,	  the	  mechanism	  by	  which	  the	  miRNAs	  
target	  the	  ZNF	  transcripts	  for	  decay	  would	  be	  unclear	  as	  the	  canonical	  mechanism	  of	  action	  is	  for	  
miRNAs	  to	  induce	  deadenylation	  which	  in	  turn	  leads	  to	  decay.	  	  If	  ZNF	  transcripts	  are	  already	  
predominantly	  deadenylated,	  the	  miRNAs	  would	  have	  to	  recruit	  other	  components	  of	  the	  decay	  
machinery	  in	  order	  to	  induce	  decay.	  
	   	  Overall,	  the	  stabilization	  of	  C2H2	  ZNF	  mRNAs	  in	  iPS	  cells	  contributes	  to	  our	  understanding	  of	  
how	  these	  genes	  achieve	  elevated	  expression	  in	  early	  development.	  	  Although	  many	  follow	  up	  studies	  
remain,	  we	  have	  shown	  that	  miRNA	  families	  that	  target	  these	  transcripts	  have	  decreased	  expression	  in	  
iPS	  cells	  and	  may	  explain	  their	  increased	  stability.	  	  As	  many	  of	  these	  transcription	  factors	  bear	  a	  
repressor	  KRAB	  domain,	  it	  seems	  likely	  that	  stabilization	  of	  C2H2	  ZNF	  mRNAs	  supports	  the	  overall	  




Chapter	  6:	  mRNAs	  with	  C-­‐rich	  elements	  in	  their	  3’UTR	  are	  destabilized	  and	  




6.1	  Introduction	  	  
	   As	  stated	  in	  Chapter	  3,	  a	  third	  class	  of	  mRNAs	  identified	  as	  differentially	  regulated	  in	  iPS	  cells	  
compared	  to	  HFFs	  contained	  C-­‐rich	  elements	  in	  their	  3’UTRs	  and	  were	  less	  stable	  in	  iPS	  cells.	  	  C-­‐rich	  
sequence	  motifs	  are	  important	  determinants	  of	  mRNA	  stability	  (Kong	  et	  al.,	  2006;	  Lindquist	  et	  al.,	  2000;	  
Weiss	  and	  Liebhaber,	  1995)	  and	  also	  regulate	  alternative	  polyadenylation	  (Ji	  et	  al.,	  2013a),	  cytoplasmic	  
polyadenylation	  (Ji	  et	  al.,	  2013a;	  Paillard	  et	  al.,	  2000),	  and	  translational	  silencing	  (Ostareck-­‐Lederer	  and	  
Ostareck,	  2004;	  Reimann	  et	  al.,	  2002).	  	  The	  enrichment	  of	  C-­‐rich	  sequences	  in	  unstable	  iPS	  cell	  mRNAs	  
was	  striking	  for	  several	  reasons	  including	  (i)	  C-­‐rich	  elements	  were	  previously	  associated	  with	  very	  
abundant	  and	  stable	  transcripts	  such	  as	  those	  encoding	  α-­‐globin	  (Wang	  et	  al.,	  1995;	  Weiss	  and	  
Liebhaber,	  1995)	  and	  collagen	  I	  (Lindquist	  et	  al.,	  2000),	  (ii)	  C-­‐rich	  elements	  were	  not	  enriched	  in	  unstable	  
transcripts	  in	  any	  other	  global	  analyses	  to	  date	  (Dolken	  et	  al.,	  2008;	  Friedel	  et	  al.,	  2009;	  Lam	  et	  al.,	  2001;	  
Lee	  et	  al.,	  2010;	  Raghavan	  et	  al.,	  2002;	  Schwanhäusser	  et	  al.,	  2011,	  2013;	  Sharova	  et	  al.,	  2009;	  Thomsen	  
et	  al.,	  2010;	  Vlasova	  et	  al.,	  2008;	  Yang	  et	  al.,	  2003),	  suggesting	  that	  this	  regulation	  mechanism	  could	  be	  
specific	  to	  stem	  cells,	  and	  (iii)	  several	  proteins	  known	  to	  interact	  with	  C-­‐rich	  elements	  are	  also	  linked	  
with	  modulation	  of	  mRNA	  decay	  (Gherzi	  et	  al.,	  2004;	  Kiledjian	  et	  al.,	  1995;	  Kosinski	  et	  al.,	  2003;	  Makeyev	  
and	  Liebhaber,	  2000).	  	  
	   We	  hypothesized	  that	  RNA-­‐Binding	  Proteins	  (RBPs)	  that	  recognize	  C-­‐rich	  elements	  may	  be	  
differentially	  expressed	  in	  HFF	  and	  iPS	  cells	  and	  that	  such	  factors	  might	  contribute	  to	  coordinated	  
regulation	  of	  genes	  important	  for	  pluripotency.	  	  We	  therefore	  investigated	  the	  expression	  of	  four	  
Poly(C)-­‐Binding	  Proteins	  (PCBPs)	  in	  HFF	  and	  iPS	  cells	  with	  the	  goal	  of	  determining	  whether	  these	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proteins	  were	  involved	  in	  the	  destabilization	  of	  mRNAs	  with	  3’UTR	  C-­‐rich	  elements	  in	  iPS	  cells.	  	  As	  an	  
introduction	  to	  these	  studies,	  the	  role	  of	  C-­‐rich	  elements	  and	  the	  PCBP	  family	  are	  discussed	  below.	  	  
	  
6.1.1	  C-­‐rich	  cis-­‐elements	  are	  important	  for	  mRNA	  metabolism	  
	   C-­‐rich	  motifs	  are	  over-­‐represented	  in	  the	  3’UTRs	  of	  human	  mRNAs,	  often	  close	  to	  
polyadenylation	  sites	  (Louie	  et	  al.,	  2003).	  	  These	  are	  one	  of	  several	  identified	  motifs	  that	  influence	  
mRNA	  stability,	  but	  are	  among	  the	  least	  understood.	  	  Additional	  roles	  in	  regulating	  polyadenylation	  and	  
translation	  illustrate	  the	  importance	  of	  further	  characterizing	  these	  cis-­‐acting	  sequence	  elements.	  	  For	  
example,	  short	  stretches	  of	  C	  residues	  in	  the	  3’UTR	  are	  associated	  with	  stabilizing	  effects	  resulting	  in	  
longer	  transcript	  half-­‐lives,	  as	  demonstrated	  by	  the	  human	  α-­‐globin	  mRNA	  (Wang	  et	  al.,	  1995;	  Weiss	  
and	  Liebhaber,	  1995).	  	  RNA-­‐binding	  proteins	  interact	  with	  this	  motif	  to	  form	  a	  complex	  that	  protects	  the	  
poly(A)	  tail	  of	  the	  transcript	  from	  shortening	  (Kiledjian	  et	  al.,	  1995;	  Waggoner	  and	  Liebhaber,	  2003).	  	  C-­‐
rich	  motifs	  lying	  30	  -­‐	  40	  nucleotides	  upstream	  of	  poly(A)	  sites	  enhance	  cleavage	  and	  polyadenylation	  
reactions;	  important	  events	  in	  3’	  end	  processing	  (Hu	  et	  al.,	  2005;	  Louie	  et	  al.,	  2003).	  	  In	  another	  
mechanism,	  binding	  of	  trans-­‐acting	  factors	  to	  C-­‐rich	  Differentiation	  Control	  Elements	  (DICEs)	  in	  the	  
3’UTR	  blocks	  ribosome	  assembly	  on	  the	  initiation	  codon	  to	  impose	  translational	  silencing	  (Ostareck-­‐
Lederer	  and	  Ostareck,	  2004;	  Reimann	  et	  al.,	  2002).	  	  DICEs	  can	  also	  coordinately	  regulate	  transcription,	  
splicing,	  and	  translation	  (Meng	  et	  al.,	  2007),	  further	  highlighting	  the	  importance	  of	  C-­‐rich	  elements	  to	  
establishing	  expression	  profiles.	  	  	  	  	  	  
	   	  	  
6.1.2	  Poly(C)-­‐binding	  proteins	  are	  important	  trans-­‐acting	  factors	  
	   To	  date,	  the	  majority	  of	  trans-­‐acting	  factors	  that	  bind	  C-­‐rich	  elements	  are	  members	  of	  the	  
Heterogeneous	  Nuclear	  Ribonucleoprotein	  (hnRNP)	  K	  Homology	  (KH)	  domain	  superfamily,	  namely	  
HNRNP	  K	  (Siomi	  et	  al.,	  1993)	  and	  PCBP	  family	  members	  PCBP1-­‐4	  (HNRNP	  E1-­‐4;	  Kiledjian	  et	  al.,	  1995;	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Makeyev	  and	  Liebhaber,	  2000).	  	  Polypyrimidine	  Tract	  Binding	  Protein	  (PTBP1/HNRNP	  I;	  Kosinski	  et	  al.,	  
2003)	  also	  binds	  C-­‐rich	  elements	  to	  influence	  stability	  but	  its	  predominant	  function	  is	  as	  a	  splicing	  
regulator	  (Fred	  et	  al.,	  2006;	  Sawicka	  et	  al.,	  2008).	  	  NOVA1	  and	  NOVA2	  proteins	  also	  contain	  KH	  domains	  
and	  are	  important	  for	  mRNA	  metabolism	  although	  their	  expression	  is	  restricted	  to	  neurons	  (Buckanovich	  
and	  Darnell,	  1997;	  Yang	  et	  al.,	  1998).	  	  We	  focused	  on	  the	  PCBP	  family	  as	  candidates	  for	  regulating	  the	  
stability	  of	  C-­‐rich	  element-­‐containing	  mRNAs	  in	  HFF	  and	  iPS	  cells.	  	  	  
	   PCBP1-­‐4	  are	  encoded	  at	  separate	  loci	  but	  share	  a	  similar	  protein	  structure	  characterized	  by	  the	  
presence	  of	  two	  KH	  domains	  (KH1	  and	  KH2)	  in	  close	  proximity	  at	  the	  N-­‐terminus	  followed	  by	  a	  more	  
distant	  KH	  domain	  (KH3)	  at	  the	  C-­‐terminus	  (Makeyev	  and	  Liebhaber,	  2002).	  	  These	  conserved	  domains	  
serve	  as	  nucleic	  acid	  binding	  regions	  and	  are	  separated	  by	  less	  conserved	  hinge	  domains.	  	  In	  PCBP1	  and	  
PBCP2,	  a	  Nuclear	  Localization	  Signal	  (NLS	  I)	  is	  located	  in	  the	  hinge	  region	  between	  KH2	  and	  KH3.	  	  PCBP2	  
has	  a	  second	  signal,	  NLS	  II,	  embedded	  within	  KH3	  (Chkheidze	  and	  Liebhaber,	  2003).	  	  Although	  each	  
member	  is	  able	  to	  bind	  C-­‐rich	  sequences,	  the	  extent	  of	  their	  functional	  redundancy	  is	  not	  well	  
understood	  (Makeyev	  and	  Liebhaber,	  2002).	  	  These	  proteins	  are	  involved	  in	  an	  array	  of	  processes	  
including	  transcription,	  splicing,	  polyadenylation,	  translation,	  and	  mRNA	  decay.	  	  The	  expression	  of	  PCBPs	  
is	  regulated	  to	  alter	  these	  processes	  when	  changes	  in	  gene	  expression	  are	  necessary,	  such	  as	  during	  
development	  or	  differentiation	  (Paillard	  et	  al.,	  2000;	  Radford	  et	  al.,	  2008;	  Salomonis	  et	  al.,	  2009).	  	  The	  
ability	  of	  these	  proteins	  to	  function	  in	  a	  coordinated	  manner	  that	  influences	  multiple	  mRNA	  processes	  at	  
once	  (Meng	  et	  al.,	  2007)	  makes	  them	  intriguing	  candidates	  for	  modulating	  the	  stability	  of	  C-­‐rich	  3’UTR	  
mRNAs	  in	  iPS	  cells.	  	  	  
	  
6.1.2.1	  Expression	  of	  PCBPs	  is	  complex	  and	  differentially	  regulated	  	  
	   The	  PCBP	  family	  of	  four	  genes	  is	  estimated	  to	  encode	  at	  least	  eight	  distinct	  proteins	  (Figure	  6.1).	  	  
PCBP1	  is	  intronless	  and	  encodes	  a	  single	  protein.	  	  Interestingly,	  intronless	  genes	  are	  frequently	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important	  for	  proliferation	  and	  development	  in	  human	  cells	  (Grzybowska,	  2012).	  	  The	  remaining	  three	  
PCBP	  genes	  contain	  multiple	  introns	  and	  undergo	  alternative	  splicing.	  	  PCBP2	  mRNA	  produces	  an	  
alternative	  splice	  variant	  excluding	  exon	  8a	  corresponding	  to	  a	  31	  amino	  acid	  region	  between	  the	  KH2	  
and	  KH3	  domains	  (Funke	  et	  al.,	  1996).	  	  Two	  PCBP3	  mRNA	  isoforms	  result	  from	  alternative	  splicing	  of	  
exon	  8	  (RefSeq)	  and	  PCBP4	  mRNA	  is	  expressed	  in	  its	  full-­‐length	  form	  (PCBP4/MCG10)	  and	  as	  two	  splice	  
variants	  (PCBP4B/MCG10as	  and	  PCBP4C).	  	  PCBP4B	  mRNA	  excludes	  exon	  9	  within	  the	  KH2	  domain	  (Zhu	  
and	  Chen,	  2000)	  while	  PCBP4C	  excludes	  a	  portion	  of	  the	  last	  exon,	  exon	  15,	  encoding	  a	  region	  of	  KH3	  
(Makeyev	  and	  Liebhaber,	  2000).	  	  Although	  individual	  functions	  and	  relative	  contributions	  have	  not	  been	  
assigned	  to	  alternative	  splice	  variants,	  it	  seems	  likely	  that	  changes	  in	  KH	  RNA-­‐recognition	  domains	  
would	  affect	  their	  RNA-­‐binding	  capabilities.	  	  Distinct	  patterns	  of	  PCBP4	  alternative	  splicing	  are	  evident	  
during	  stem	  cell	  differentiation	  into	  cardiac	  precursor	  cells	  (Salomonis	  et	  al.,	  2009)	  and	  possibly	  indicate	  
that	  the	  roles	  of	  PCBP	  splicing	  isoforms	  are	  different	  from	  those	  of	  their	  full-­‐length	  counterparts.	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Figure	  6.1	  The	  PCBP	  family	  encodes	  eight	  proteins.	  	  Alternative	  splicing	  maps	  depict	  the	  ORFs	  of	  PCBP	  
mRNA	  isoforms	  that	  generate	  distinct	  protein	  variants.	  	  The	  numbers	  above	  the	  exons	  indicate	  nucleotides	  
while	  the	  numbers	  below	  indicate	  the	  exon	  number.	  	  The	  lighter	  shaded	  boxes	  indicate	  regions	  encoding	  
KH	  domains	  and	  the	  darker	  shaded	  boxes	  indicate	  portions	  of	  mRNA	  alternatively	  spliced.	  	  	  	  	  
	  
	   	  
	   Post-­‐translational	  events	  can	  alter	  the	  function	  or	  localization	  of	  PCBPs.	  	  Phosphorylation	  status	  
influences	  the	  ability	  of	  PCBPs	  to	  bind	  specific	  DNA	  and	  RNA	  sequences	  (Leffers	  et	  al.,	  1995),	  thereby	  
exchanging	  roles	  between	  transcription,	  splicing,	  and	  translation	  (Meng	  et	  al.,	  2007).	  	  Upon	  TGF-­‐β-­‐
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activation,	  PCBP1	  is	  phosphorylated	  and	  released	  from	  structural	  TGF-­‐β-­‐Activated	  Translation	  (BAT)	  
elements	  in	  the	  3’UTR	  of	  mRNAs	  important	  for	  cellular	  differentiation,	  permitting	  their	  translation	  
(Chaudhury	  et	  al.,	  2010).	  	  In	  another	  example,	  phosphorylation	  of	  PCBP1	  not	  only	  disrupts	  protein-­‐RNA	  
interactions	  but	  also	  alters	  protein	  localization,	  impacting	  endothelial	  Nitric	  Oxide	  Synthase	  (NOS3)	  
mRNA	  stability	  under	  hypoxic	  conditions	  (Ho	  et	  al.,	  2013).	  	  	  	  	  
	   Shuttling	  of	  PCBPs	  allows	  them	  to	  influence	  both	  nuclear	  and	  cytoplasmic	  events	  (Chkheidze	  and	  
Liebhaber,	  2003;	  Makeyev	  and	  Liebhaber,	  2002).	  	  PCBP1	  is	  predominantly	  nuclear,	  moving	  in	  and	  out	  of	  
nuclear	  speckles	  where	  splicing	  processes	  occur	  (Berry	  et	  al.,	  2006;	  Chkheidze	  and	  Liebhaber,	  2003).	  	  
PCBP2	  is	  also	  nuclear	  in	  localization	  although	  its	  truncated	  splice	  isoform	  localizes	  to	  both	  the	  nucleus	  
and	  cytoplasm	  (Chkheidze	  and	  Liebhaber,	  2003).	  	  In	  HeLa	  cells,	  PCBP3	  and	  PCBP4	  are	  restricted	  to	  the	  
cytoplasm	  (Chkheidze	  and	  Liebhaber,	  2003).	  	  Although	  PCBP3	  is	  not	  predicted	  to	  contain	  a	  NLS,	  the	  
protein	  can	  bind	  DNA	  at	  promoter	  regions	  (Choi	  et	  al.,	  2007),	  suggesting	  that	  it	  may	  enter	  the	  nucleus	  
under	  certain	  circumstances.	  	  It	  remains	  to	  be	  seen	  whether	  enrichment	  within	  defined	  cellular	  
locations	  are	  indicative	  of	  specialized	  functions	  performed	  by	  each	  PCBP.	  	  	  
	  
6.1.2.2	  PCBPs	  have	  diverse	  functions	  	  
	   PCBPs	  have	  been	  implicated	  in	  a	  number	  of	  mRNA	  processing	  events	  including	  transcription,	  
splicing,	  polyadenylation,	  translation,	  and	  mRNA	  stability.	  	  Although	  PCBP1	  and	  PCBP2	  are	  better	  
characterized	  than	  the	  more	  divergent	  PCBP3	  and	  PCBP4,	  all	  four	  proteins	  have	  demonstrated	  an	  
influence	  on	  mRNA	  metabolism	  through	  C-­‐rich	  cis-­‐acting	  elements,	  some	  of	  which	  are	  redundant.	  	  For	  
example,	  PCBPs	  can	  positively	  or	  negatively	  regulate	  transcription	  of	  the	  Mouse	  μ-­‐Opioid	  Receptor	  
(MOR)	  gene	  by	  binding	  a	  poly(C)	  element	  in	  the	  promoter	  region	  (Kim	  et	  al.,	  2005).	  	  PCBP1	  and	  PCBP2	  
activate	  transcription	  (Choi	  et	  al.,	  2008)	  while	  binding	  by	  PCBP3	  results	  in	  transcriptional	  repression	  
(Choi	  et	  al.,	  2007).	  	  However,	  transcriptional	  regulation	  by	  PCBPs	  has	  only	  been	  demonstrated	  for	  a	  few	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genes	  (Choi	  et	  al.,	  2009).	  	  Notably,	  PCBP1	  is	  required	  for	  maintaining	  a	  transcriptionally-­‐silent	  state	  in	  
mouse	  oocytes	  although	  the	  mechanism	  is	  unknown	  and	  could	  be	  direct	  through	  modulation	  of	  
transcription	  or	  indirect	  by	  affecting	  expression	  of	  other	  genes	  (Xia	  et	  al.,	  2012).	  	  As	  discussed	  in	  Chapter	  
5,	  differentiated	  cells	  are	  less	  transcriptionally	  active	  than	  pluripotent	  cells	  and	  PCBP1,	  or	  other	  PCBPs,	  
may	  function	  to	  maintain	  this	  status.	  	  	  	  
	   There	  is	  also	  evidence	  that	  PCBPs	  have	  a	  role	  in	  alternative	  splicing.	  	  PCBP3	  is	  an	  activator	  of	  tau	  
mRNA	  splicing	  in	  association	  with	  early-­‐onset	  dementia	  (Wang	  et	  al.,	  2010b)	  while	  PCBP1	  negatively	  
regulates	  alternative	  splicing	  of	  the	  CD44	  mRNA	  in	  HepG2	  cells	  (Zhang	  et	  al.,	  2010).	  	  Again,	  relatively	  few	  
mRNAs	  have	  been	  identified	  as	  targets	  of	  PCBP-­‐regulated	  alternative	  splicing.	  	  	  
	   An	  intriguing	  function	  of	  PCBP	  regulation	  is	  the	  ability	  to	  influence	  polyadenylation.	  	  Transcripts	  
are	  targeted	  to	  enhance	  3’	  end	  processing	  through	  an	  interaction	  between	  PCBPs	  and	  the	  3’	  processing	  
complex	  (Ji	  et	  al.,	  2011).	  	  Binding	  of	  PCBPs	  to	  mRNAs	  can	  also	  influence	  alternative	  poly(A)	  site	  usage	  (Ji	  
et	  al.,	  2013b).	  	  In	  Xenopus	  embryos,	  a	  poly(C)	  tract	  in	  the	  3’UTR	  of	  maternal	  mRNAs	  is	  bound	  by	  the	  
PCBP2	  homologue	  to	  mediate	  cytoplasmic	  polyadenylation	  during	  early	  development	  (Paillard	  et	  al.,	  
2000).	  	  Further,	  human	  α-­‐globin	  mRNA,	  which	  is	  stabilized	  by	  PCBPs	  in	  erythroid	  cells,	  undergoes	  
cytoplasmic	  polyadenylation	  in	  Xenopus	  embryos	  but	  not	  in	  a	  mature	  cell	  environment	  (Vishnu	  et	  al.,	  
2011),	  indicating	  that	  this	  function	  of	  PCBPs	  may	  be	  developmentally	  regulated.	  	  	  
	   PCBPs	  also	  have	  a	  role	  in	  translational	  regulation.	  	  In	  vivo	  experiments	  show	  that	  PCBPs	  stay	  
bound	  to	  α-­‐globin	  mRNAs	  during	  active	  translation	  (Ji	  et	  al.,	  2003).	  	  PCBP1	  binds	  a	  triple	  GCCCAG	  motif	  
in	  the	  5’UTR	  of	  PRL-­‐3	  mRNA	  encoding	  a	  gene	  associated	  with	  metastasis	  and	  represses	  translation	  
(Cloke	  et	  al.,	  2010)	  by	  physically	  inhibiting	  ribosome	  assembly	  (Wang	  et	  al.,	  2010a).	  	  PCBP1	  and	  PCBP2	  
also	  bind	  the	  Internal	  Ribosome	  Entry	  Site	  (IRES)	  in	  the	  5’UTR	  of	  transcripts	  made	  by	  several	  viruses	  to	  
influence	  replication	  and	  translation	  including	  poliovirus	  (Gamarnik	  and	  Andino,	  2000),	  coxsackievirus	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(Zell	  et	  al.,	  2008),	  human	  papilloma	  virus	  (Collier	  et	  al.,	  1998),	  and	  hepatitis	  C	  virus	  (Spångberg	  and	  
Schwartz,	  1999).	  	  	  
	   The	  most	  studied	  role	  of	  PCBPs	  is	  their	  regulation	  of	  mRNA	  stability.	  	  Binding	  to	  3’UTR	  C-­‐rich	  
elements	  allows	  PCBPs	  to	  increase	  mRNA	  half-­‐life	  by	  competing	  with	  destabilizing	  factors	  such	  as	  
miRNAs	  (Ho	  et	  al.,	  2013)	  and	  through	  a	  direct	  interaction	  with	  PABP	  to	  prevent	  deadenylation	  (Wang	  et	  
al.,	  1999)	  and	  endonucleolytic	  cleavage	  (Wang	  and	  Kiledjian,	  2000).	  	  As	  mentioned	  previously	  in	  Section	  
6.1.1,	  the	  stabilizing	  effects	  of	  C-­‐rich	  elements	  in	  the	  3’UTR	  of	  human	  α-­‐globin	  mRNAs	  has	  been	  
extensively	  studied	  and	  revealed	  that	  PCBPs	  are	  essential	  in	  this	  regulation.	  	  Additional	  support	  is	  found	  
wherein	  PCBP1	  binds	  the	  3’UTR	  of	  androgen	  receptor	  mRNA	  in	  human	  endometrial	  stromal	  cells	  to	  
regulate	  expression	  (Cloke	  et	  al.,	  2010)	  and	  NOS3	  mRNA	  to	  confer	  stabilization	  (Ho	  et	  al.,	  2013).	  	  Also	  
noteworthy	  is	  the	  role	  of	  PCBP1	  in	  stabilization	  of	  folate	  receptor	  (FR-­‐α)	  mRNAs	  in	  response	  to	  folate	  
deficiency	  (Tang	  et	  al.,	  2011).	  	  Folate	  is	  essential	  for	  proliferation	  of	  neural	  stem	  cells	  (Sato	  et	  al.,	  2006)	  
and	  levels	  must	  be	  maintained	  to	  ensure	  proper	  neural	  tube	  formation	  (Chen	  et	  al.,	  2012).	  	  In	  another	  
example,	  PCBP2	  binds	  and	  stabilizes	  collagen	  I	  (COL1A1)	  mRNA	  during	  hepatic	  cell	  activation	  (Lindquist	  
et	  al.,	  2000).	  	  There	  is	  also	  evidence	  that	  PCBPs	  destabilize	  mRNAs	  wherein	  PCBP4	  binds	  the	  3’UTR	  of	  
cyclin-­‐dependent	  kinase	  inhibitor	  p21	  mRNA	  (also	  known	  as	  CDKN1A)	  to	  modulate	  steady-­‐state	  and	  
induced	  levels	  by	  negatively	  regulating	  transcript	  stability	  (Scoumanne	  et	  al.,	  2011).	  	  p21	  is	  a	  regulator	  of	  
cell	  cycle	  progression	  (Czerniak	  et	  al.,	  1987;	  Jung	  et	  al.,	  2010)	  and	  also	  regulates	  expression	  of	  
pluripotency	  factor	  SOX2	  (Marqués-­‐Torrejón	  et	  al.,	  2013)	  to	  suppress	  pluripotency	  (Hong	  et	  al.,	  2009).	  	  	  
	   Although	  much	  remains	  to	  be	  learned	  regarding	  the	  involvement	  of	  PCBPs	  in	  pluripotency,	  the	  
ability	  of	  these	  proteins	  to	  regulate	  mRNA	  stability	  through	  3’UTR	  cis-­‐acting	  elements	  and	  the	  anti-­‐
proliferative	  role	  of	  PCBP4	  as	  a	  tumor	  suppressor	  (Zhu	  and	  Chen,	  2000)	  led	  us	  to	  hypothesize	  that	  this	  
family	  is	  involved	  in	  the	  regulation	  of	  mRNAs	  containing	  3’UTR	  C-­‐rich	  elements	  that	  are	  destabilized	  in	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iPS	  cells	  compared	  to	  HFFs.	  	  The	  results	  of	  experiments	  to	  elucidate	  the	  expression	  patterns	  of	  these	  
proteins	  in	  differentiated	  and	  pluripotent	  cells	  are	  presented	  below5.	  	  
	  
6.2	  C-­‐rich	  hexamers	  are	  over-­‐represented	  in	  3’UTRs	  of	  destabilized	  mRNAs	  in	  iPS	  cells	  
	   The	  analysis	  presented	  in	  Chapter	  3	  revealed	  that	  C-­‐rich	  hexamers	  were	  over-­‐represented	  in	  the	  
3’UTRs	  of	  151	  transcripts	  out	  of	  548	  destabilized	  iPS	  cell	  mRNAs	  (Appendix	  A4).	  	  The	  top	  20	  hexamer	  
sequences	  showed	  significant	  enrichment	  (up	  to	  P-­‐value	  =	  8.49x10-­‐14)	  in	  destabilized	  iPS	  mRNAs	  and	  are	  
summarized	  in	  Table	  6.1.	  	  We	  saw	  that	  the	  vast	  majority	  of	  these	  putative	  cis-­‐elements	  were	  rich	  in	  
cytosine	  residues	  while	  adenines	  and	  guanines	  were	  noticeably	  sparse.	  	  C-­‐rich	  3’UTR	  elements	  are	  
frequently	  linked	  with	  transcript	  stabilization	  (Scoumanne	  et	  al.,	  2011;	  Waggoner	  and	  Liebhaber,	  2003)	  
and	  their	  overwhelming	  representation	  seen	  here	  warranted	  further	  investigation	  of	  this	  class	  of	  
mRNAs.	  	  	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5	  Some	  of	  the	  results	  presented	  in	  Chapter	  6	  appeared	  in:	  Neff	  et	  al.	  Global	  analysis	  reveals	  multiple	  
pathways	  for	  unique	  regulation	  of	  mRNA	  decay	  in	  induced	  pluripotent	  stem	  cells.	  	  Genome	  Research.	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  6.1	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6.3	  Destabilized	  mRNAs	  encode	  factors	  associated	  with	  transcription,	  chromatin,	  and	  development	  
	   To	  determine	  whether	  the	  mRNAs	  bearing	  C-­‐rich	  3’UTR	  elements	  had	  any	  functional	  similarities,	  
the	  annotation	  program	  DAVID	  (Huang	  et	  al.,	  2009)	  was	  used	  to	  identify	  Gene	  Ontology	  (GO)	  terms	  
associated	  with	  this	  mRNA	  set.	  	  As	  shown	  in	  Table	  6.2,	  GO	  terms	  with	  the	  greatest	  enrichment	  described	  
functions	  of	  transcription	  regulators,	  chromatin	  modifiers,	  and	  factors	  important	  for	  embryonic	  
development.	  	  As	  discussed	  in	  Chapters	  4	  and	  5,	  stem	  cell	  gene	  expression	  requires	  unique	  regulation	  of	  
chromatin	  structure	  and	  controlled	  transcription	  of	  pluripotent-­‐	  and	  lineage-­‐specific	  genes.	  	  Therefore,	  
it	  was	  exciting	  to	  find	  that	  this	  class	  of	  differentially	  regulated	  mRNAs	  also	  encodes	  factors	  with	  roles	  in	  
these	  functions.	  	  Interestingly,	  we	  also	  saw	  enrichment	  of	  GO	  terms	  associated	  with	  neural	  tube	  
development	  and	  tube	  closure.	  	  This	  over-­‐representation	  is	  consistent	  with	  the	  hypothesis	  that	  PCBPs	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may	  be	  involved	  in	  modulating	  stability	  of	  these	  transcripts	  as	  PCBP1	  regulates	  the	  stability	  of	  folate	  
receptor	  mRNAs	  in	  neural	  stem	  cells	  to	  prevent	  neural	  tube	  defects	  (Chen	  et	  al.,	  2012;	  Sato	  et	  al.,	  2006).	  	  	  
	  
Table	  6.2	  List	  of	  Gene	  Ontology	  terms	  associated	  with	  mRNAs	  destabilized	  in	  iPS	  cells	  that	  
bear	  3’UTR	  C-­‐rich	  elements.	  	  The	  p-­‐value	  represents	  the	  level	  of	  significance	  of	  each	  term.	  	  	  
	  
	  
	   We	  then	  went	  on	  to	  validate	  the	  destabilization	  of	  three	  mRNAs	  with	  C-­‐rich	  elements	  in	  their	  
3’UTR.	  	  Although	  the	  stability	  of	  DGCR8,	  DUSP7,	  and	  TOB2	  mRNAs	  has	  not	  previously	  been	  studied,	  
microarray	  data	  indicated	  that	  these	  transcript	  were	  destabilized	  in	  iPS	  cells	  and	  hexamer	  analysis	  
identified	  the	  presence	  of	  3’UTR	  C-­‐rich	  elements.	  	  DGCR8	  mRNA	  encodes	  a	  component	  of	  the	  
Microprocessor	  that	  is	  important	  for	  miRNA	  biogenesis	  (Gregory	  et	  al.,	  2004)	  and	  silencing	  self-­‐renewal	  
in	  stem	  cells	  (Wang	  et	  al.,	  2007).	  	  DUSP7	  mRNA	  encodes	  a	  phosphatase	  important	  for	  pluripotent	  
regulation	  (Chappell	  et	  al.,	  2013)	  and	  TOB2	  mRNA	  encodes	  an	  anti-­‐proliferative	  factor	  that	  inhibits	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progression	  into	  S	  phase	  (Ikematsu	  et	  al.,	  1999).	  	  Destabilization	  of	  DUSP7	  mRNA	  in	  iPS	  cells	  was	  also	  
verified	  in	  an	  independent	  set	  of	  matched	  cell	  lines	  (A.	  Jalkanen	  personal	  communication).	  	  Figure	  6.2	  
below	  shows	  the	  3’UTR	  sequence	  of	  each	  mRNA	  where	  C-­‐rich	  hexamers	  containing	  five	  or	  six	  cytosine	  
residues	  are	  highlighted	  in	  yellow.	  	  However,	  we	  also	  noted	  that	  several	  U-­‐rich	  elements	  were	  present	  
and	  may	  have	  contributed	  to	  the	  differential	  regulation	  of	  stability	  of	  these	  transcripts.	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Figure	  6.2	  The	  3’UTR	  of	  DGCR8,	  DUSP7,	  and	  TOB2mRNAs	  contain	  several	  C-­‐rich	  hexamer	  sequences.	  	  3’UTR	  sequences	  
were	  retrieved	  from	  GenBank and	  analyzed	  for	  stretches	  of	  five	  or	  six	  C	  residues	  allowing	  one	  mismatch	  (highlighted	  in	  
yellow).	  	  Each	  row	  contains	  115	  nucleotides.	  	  	  






























































	   	  
129	  
	  
	   When	  measured	  by	  qRT-­‐PCR,	  we	  found	  that	  all	  three	  of	  these	  mRNAs	  have	  shorter	  half-­‐lives	  in	  
iPS	  cells	  compared	  to	  HFFs,	  as	  predicted	  by	  microarray	  (Figure	  6.3).	  	  DGCR8	  and	  DUSP7	  mRNAs	  exhibited	  
a	  ~3-­‐fold	  decrease	  of	  half-­‐life	  in	  iPS	  cells	  while	  TOB2	  mRNA	  was	  destabilized	  ~2-­‐fold.	  	  Our	  microarray	  
data	  indicated	  that	  HFF	  and	  iPS	  cells	  exhibited	  half-­‐lives	  of	  410	  minutes	  and	  231	  minutes	  for	  DGCR8	  
mRNA,	  371	  minutes	  and	  96	  minutes	  for	  DUSP7	  mRNA,	  and	  233	  minutes	  and	  113	  minutes	  for	  TOB2	  
mRNA,	  respectively.	  	  As	  these	  mRNAs	  are	  relatively	  stable	  in	  HFFs,	  especially	  DGCR8	  mRNA,	  half-­‐life	  
calculations	  relied	  on	  extrapolation	  and	  longer	  half-­‐lives	  may	  not	  be	  as	  accurate	  as	  those	  within	  the	  4	  
hour	  range	  of	  the	  experiment.	  	  Therefore,	  we	  were	  not	  able	  to	  reliably	  determine	  whether	  there	  was	  a	  
correlation	  between	  the	  number	  of	  C-­‐rich	  elements	  in	  each	  mRNA	  and	  the	  degree	  of	  stabilization.	  	  
Regardless,	  we	  were	  able	  to	  confirm	  that	  mRNAs	  bearing	  C-­‐rich	  3’UTR	  hexamer	  sequences	  have	  shorter	  




Figure	  6.3	  DGCR8,	  DUSP7,	  and	  TOB2mRNAs	  are	  destabilized	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  Half-­‐lives	  were	  assessed	  in	  
HFF	  and	  iPS	  cells	  for	  each	  mRNA	  following	  actinomycin	  D	  treatment.	  	  mRNA	  levels	  were	  measured	  by	  qRT-­‐PCR	  at	  each	  
time	  point	  and	  normalized	  to	  levels	  of	  GAPDHmRNA.	  	  The	  standard	  deviations	  represent	  three	  replicates.	  	  Half-­‐lives	  
for	  each	  mRNA	  are	  denoted	  to	  the	  right	  of	  the	  cell-­‐line	  keys.	  	  
169	  +/-­‐ 12	  min
508	  +/-­‐ 22	  min
92	  +/-­‐ 9 min
195	  +/-­‐ 31	  min
89	  +/-­‐ 11	  min
246	  +/-­‐ 45	  min
	  
	   	  
	   Since	  poly(C)-­‐binding	  proteins	  are	  known	  trans-­‐acting	  factors	  that	  associate	  with	  C-­‐rich	  
elements	  to	  influence	  mRNA	  stability	  (Cloke	  et	  al.,	  2010;	  Kiledjian	  et	  al.,	  1995;	  Lindquist	  et	  al.,	  2000;	  
Weiss	  and	  Liebhaber,	  1995),	  we	  investigated	  their	  expression	  in	  HFF	  and	  iPS	  cells	  in	  hopes	  of	  
determining	  whether	  they	  are	  differentially	  regulated	  in	  these	  two	  cell	  lines,	  possibly	  contributing	  to	  
destabilization	  of	  mRNAs	  with	  3’UTR	  C-­‐rich	  elements	  in	  iPS	  cells.	  	  
	  
6.4	  Expression	  of	  poly(C)-­‐binding	  proteins	  is	  differentially	  regulated	  in	  iPS	  cells	  
6.4.1	  Poly(C)-­‐binding	  proteins	  are	  differentially	  expressed	  	   	  
	   We	  first	  investigated	  the	  protein	  abundances	  of	  each	  PCBP	  by	  western	  blot	  analysis	  using	  whole	  
cell	  lysates	  prepared	  from	  approximately	  equal	  numbers	  of	  HFF	  and	  iPS	  cells	  with	  antibodies	  specific	  for	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PCBP1,	  PCBP2,	  PCBP3,	  and	  PCBP4C.	  	  Figure	  6.4	  shows	  a	  summary	  of	  these	  data	  where	  standard	  
deviations	  were	  derived	  from	  quantification	  of	  three	  independent	  western	  blot	  experiments.	  	  We	  found	  
that	  abundances	  of	  PCBP1	  and	  PCBP2	  were	  fairly	  similar	  between	  the	  cell	  lines	  while	  PCBP3	  and	  PCBP4C	  
are	  differentially	  expressed.	  	  Specifically,	  PCBP3	  was	  expressed	  ~5-­‐fold	  higher	  in	  iPS	  cells	  while	  
expression	  of	  PCBP4C	  was	  increased	  ~26-­‐fold	  in	  HFFs.	  	  This	  inverse	  regulation	  of	  PCBP	  protein	  













Figure	  6.4	  PCBPs	  are	  differentially	  expressed	  in	  HFF	  and	  iPS	  cells.	  	  Western	  blot	  analysis	  showing	  PCBP	  protein	  
abundances	  in	  HFF	  and	  iPS	  cells.	  	  Equal	  numbers	  of	  cells	  and	  amounts	  of	  whole	  cell	  lysate	  were	  resolved	  on	  a	  
10%	  SDS-­‐PAGE	  gel	  and	  transferred	  to	  polyvinylidene difluoride (PVDF)	  membranes.	  	  Quantification	  of	  iPS	  PCBP	  
abundances	  was	  normalized	  to	  levels	  of	  either	  α-­‐TUBULIN	  or	  GAPDH	  and	  relative	  to	  HFF.	  	  The	  standard	  
deviations	  represent	  three	  independent	  replicates.	  	  	  
	  
	  
6.4.2	  PCBP	  mRNA	  expression	  shows	  differential	  regulation	  
	   We	  wondered	  whether	  the	  different	  abundance	  of	  PCBP3	  and	  PCBP4C	  was	  caused	  by	  changes	  in	  
mRNA	  abundance	  or	  perhaps	  by	  post-­‐translational	  events.	  	  The	  levels	  of	  PCBP	  mRNAs	  were	  measured	  in	  
untreated	  HFF	  and	  iPS	  cells	  by	  qRT-­‐PCR	  to	  help	  define	  relative	  PCBP	  mRNA	  expression.	  	  The	  primers	  
were	  designed	  to	  constitutive	  exons	  and	  therefore	  detect	  all	  splice	  variants.	  	  As	  shown	  in	  Figure	  6.5,	  
PCBP1	  and	  PCBP2	  mRNA	  levels	  were	  not	  dramatically	  different	  in	  HFFs	  relative	  to	  expression	  in	  iPS	  cells,	  
exhibiting	  ~2-­‐fold	  increase,	  whereas	  PCBP3	  and	  PCBP4	  mRNAs	  appeared	  to	  have	  significantly	  different	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expression	  levels	  mirroring	  the	  changes	  in	  proteins	  levels.	  	  There	  was	  a	  ~6-­‐fold	  reduction	  in	  PCBP3	  
mRNA	  abundance	  in	  HFFs	  while	  PCBP4	  mRNA	  expression	  was	  increased	  almost	  ~14-­‐fold	  relative	  to	  iPS	  
cells,	  suggesting	  that	  PCBP3	  and	  PCBP4	  mRNA	  expression	  may	  somehow	  be	  altered	  in	  pluripotency	  
compared	  to	  the	  differentiated	  state.	  	  These	  results	  suggest	  that	  the	  changes	  in	  protein	  abundance	  are	  
primarily	  due	  to	  altered	  mRNA	  levels	  (Figure	  6.4).	  	  	  
	   	  	  	  	  
	  
Figure	  6.5	  PCBP1-­‐4mRNA	  abundances	  are	  differentially	  regulated	  in	  HFF	  and	  iPS	  cells.	  	  HFF	  and	  iPS	  cells	  were	  
assessed	  for	  mRNA	  abundance	  of	  each	  PCBP.	  	  mRNA	  levels	  were	  measured	  by	  qRT-­‐PCR,	  relative	  to	  the	  
abundance	  in	  iPS	  cells	  and	  normalized	  to	  GAPDHmRNA.	  	  The	  standard	  deviations	  represent	  pipetting	  error	  


























	   	  
	   We	  also	  considered	  the	  relative	  abundance	  of	  each	  PCBP	  mRNA	  within	  each	  cell	  line	  compared	  
to	  the	  level	  of	  PCBP1	  mRNA	  (Figure	  6.6).	  	  Here,	  abundance	  values	  (normalized	  to	  GAPDH	  mRNA)	  were	  
graphed	  relative	  to	  PCBP1	  mRNA	  abundance	  rather	  than	  relative	  to	  abundance	  levels	  in	  iPS	  cells	  (Figure	  
6.5).	  	  From	  Figure	  6.6,	  we	  saw	  that	  PCBP1	  and	  PCBP2	  mRNAs	  were	  expressed	  within	  a	  ~2-­‐fold	  range	  of	  
one	  another	  while	  PCBP3	  and	  PCBP4	  mRNAs	  were	  expressed	  at	  dramatically	  lower	  levels	  in	  both	  cell	  
lines.	  	  However,	  we	  cannot	  make	  assumptions	  about	  how	  these	  differences	  in	  relative	  PCBP	  mRNA	  
abundance	  influence	  protein	  abundance	  and	  function.	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Figure	  6.6	  Levels	  of	  PCBP1-­‐4mRNAs	  are	  differentially	  expressed	  in	  both	  HFF	  and	  iPS	  cells.	  	  mRNA	  abundance	  
data	  used	  to	  generate	  Figure	  6.5	  was	  analyzed	  to	  determine	  levels	  of	  each	  mRNA	  relative	  to	  levels	  of	  PCBP1














	  	  	  
	  	  	  
	  	  	  














6.4.3	  PCBP4	  mRNA	  is	  differentially	  spliced	  	  
	   As	  alternative	  splice	  isoforms	  of	  PCBP4	  are	  differentially	  expressed	  in	  embryonic	  stem	  cells	  
(Salomonis	  et	  al.,	  2009)	  and	  cancer	  cells	  (Pio	  et	  al.,	  2004,	  2010),	  which	  in	  many	  ways	  resemble	  stem	  cells	  
(Dreesen	  and	  Brivanlou,	  2007;	  O’Brien	  et	  al.,	  2010;	  Pardal	  et	  al.,	  2005;	  Reya	  et	  al.,	  2001),	  we	  examined	  
the	  splicing	  of	  PCBP4	  mRNA	  more	  closely.	  	  Analysis	  of	  PCBP4	  isoform	  expression	  by	  RT-­‐PCR	  indicated	  
that	  this	  transcript	  undergoes	  alternative	  splicing	  in	  both	  cell	  lines.	  	  Using	  cDNA	  made	  with	  equal	  
amounts	  of	  RNA	  and	  PCR	  primers	  flanking	  the	  entire	  coding	  region	  of	  PCBP4	  mRNA	  (and	  both	  
alternatively	  spliced	  introns),	  splice	  variants	  containing	  three	  different	  open	  reading	  frames	  were	  
identified,	  all	  of	  which	  were	  more	  abundant	  in	  HFFs	  compared	  to	  iPS	  cells	  (Figure	  6.7).	  	  This	  is	  consistent	  
with	  qRT-­‐PCR	  data	  that	  indicated	  PCBP4	  mRNA	  levels	  are	  much	  higher	  in	  HFFs	  (Figure	  6.5).	  	  Sequence	  
analysis	  performed	  on	  the	  HFF	  PCR	  products	  revealed	  that	  these	  bands	  corresponded	  to	  the	  full-­‐length	  
PCBP4	  isoform	  (PCBP4),	  an	  intermediate	  isoform	  excluding	  exon	  9	  (PCBP4B),	  and	  a	  smaller	  isoform	  
excluding	  a	  large	  portion	  of	  exon	  15	  (PCBP4C).	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Figure	  6.7	  PCBP4mRNA	  is	  alternatively	  spliced	  to	  produce	  mRNAs	  with	  three	  different	  open	  reading	  frames.	  	  
RT-­‐PCR	  was	  performed	  using	  HFF	  and	  iPS	  cell	  cDNA	  and	  primers	  flanking	  the	  PCBP4mRNA	  coding	  region.	  	  










	   	  
	   To	  more	  carefully	  quantify	  splicing	  patterns	  for	  PCBP4	  mRNA	  in	  HFF	  and	  iPS	  cells,	  we	  used	  RT-­‐
PCR	  with	  primers	  designed	  to	  detect	  the	  inclusion	  of	  exons	  9	  or	  15.	  	  As	  PCBP4	  mRNA	  levels	  are	  relatively	  
low	  in	  iPS	  cells,	  more	  RNA	  was	  used	  in	  the	  iPS	  cell	  PCR	  reactions.	  	  Splicing	  patterns	  for	  both	  of	  these	  
exons	  were	  then	  compared	  between	  cell	  lines.	  	  From	  Figure	  6.8	  below,	  we	  saw	  that	  there	  was	  little	  
difference	  in	  the	  percentage	  of	  transcripts	  that	  excluded	  or	  included	  exon	  9	  which	  represents	  splicing	  to	  
produce	  PCBP4B	  mRNA.	  	  In	  the	  lower	  panel,	  however,	  it	  was	  clear	  that	  HFFs	  have	  a	  higher	  propensity	  to	  
exclude	  a	  portion	  of	  exon	  15,	  indicating	  more	  PCBP4C	  transcripts	  are	  produced	  in	  HFFs	  than	  iPS	  cells	  
relative	  to	  total	  amounts	  of	  PCBP4	  mRNA.	  	  This	  was	  consistent	  with	  findings	  that	  PCBP4	  alternative	  
splicing	  is	  altered	  during	  differentiation	  of	  stem	  cells	  into	  cardiac	  precursor	  cells	  where	  many	  proteins	  













96	  ± 3 90	  ± 7%	  included
59	  ± 3 82	  ± 4%	  included
Figure	  6.8	  PCBP4mRNA	  is	  alternatively	  spliced	  to	  produce	  PCBP4Cmore	  frequently	  in	  HFFs	  compared	  to	  iPS	  
cells.	  	  Semi-­‐quantitative	  PCR	  was	  performed	  to	  determine	  PCBP4mRNA	  alternative	  splicing	  of	  exons	  9	  and	  15	  
in	  HFF	  and	  iPS	  cells.	  	  Schematics	  to	  the	  right	  indicate	  location	  of	  forward	  and	  reverse	  primers	  used	  for	  PCR	  
amplification	  (black	  arrows).	  	  Quantification	  of	  percent	  included	  based	  on	  density	  of	  band	  including	  the	  exon	  
relative	  to	  the	  density	  of	  both	  bands	  combined.	  	  The	  standard	  deviation	  was	  derived	  from	  three	  independent	  




portion	  of	  exon	  15
	  
	  
6.4.4	  PCBP4	  may	  regulate	  splice	  site	  selection	  at	  exon	  15	  
	   Close	  examination	  of	  the	  mRNA	  sequence	  excluded	  from	  exon	  15	  to	  produce	  PCBP4C	  reveals	  
that	  this	  region	  is	  C-­‐rich	  (Table	  6.3).	  	  Compared	  to	  the	  nucleotide	  representation	  for	  the	  coding	  region	  of	  
PCBP4	  mRNA,	  the	  spliced	  portion	  showed	  over-­‐representation	  of	  C	  residues.	  	  Specifically,	  the	  entire	  
coding	  region	  of	  PCBP4	  mRNA	  was	  33.2%	  C	  residues	  while	  the	  197	  nucleotide	  region	  of	  exon	  15	  
excluded	  from	  PCBP4C	  mRNA	  was	  comprised	  of	  46.2%	  cytosine.	  	  This	  part	  of	  the	  transcript	  encodes	  a	  
proline-­‐rich	  region	  and	  nuclear	  import	  and	  export	  signals	  (Scoumanne	  et	  al.,	  2011)	  and	  exclusion	  likely	  




Table	  6.3	  The	  portion	  of	  exon	  15	  excluded	  from	  PCBP4CmRNA	  is	  C-­‐rich.	  	  Percent	  nucleotide	  
representation	  of	  the	  full-­‐length	  PCBP4mRNA	  isoform	  was	  compared	  to	  the	  percent	  nucleotide	  




Spliced exon	  9	  
(129	  bases)
Spliced exon	  15	  
(197	  bases)
A 19.7 17.1 13.7
U 19.2 22.5 19.8
C 33.2 28.7 46.2
G 27.9 31.8 20.3
	  
	   	  
	   	  The	  expression	  of	  PCBP2	  and	  PCBP3	  mRNA	  splice	  variants	  were	  not	  investigated	  in	  this	  study	  
but	  it	  is	  worth	  mentioning	  that	  these	  mRNAs	  could	  also	  experience	  differential	  splicing	  between	  HFF	  and	  
iPS	  cell	  lines	  (Figure	  6.1).	  	  However,	  differential	  splicing	  during	  development	  has	  only	  been	  observed	  for	  
PCBP4	  to	  date	  (Salomonis	  et	  al.,	  2009).	  	  	  
	  
6.4.5	  PCBP4	  protein	  isoform	  abundances	  support	  patterns	  of	  alternative	  splicing	  	  
	   Since	  our	  initial	  western	  blot	  analysis	  of	  PCBP4	  abundance	  in	  HFF	  and	  iPS	  cells	  detected	  only	  
isoform	  PCBP4C,	  we	  also	  investigated	  the	  abundance	  of	  the	  full-­‐length	  isoform	  using	  another	  antibody.	  	  
As	  shown	  in	  Figure	  6.9	  below,	  protein	  abundance	  of	  PCBP4	  is	  similar	  between	  the	  two	  cell	  lines,	  despite	  
reduced	  mRNA	  expression	  in	  iPS	  cells	  (Figures	  6.5	  and	  6.7).	  	  Analysis	  of	  PCBP4	  and	  PCBP4C	  isoforms	  by	  
western	  blot	  did	  not	  allow	  comparison	  of	  relative	  abundances	  within	  a	  cell	  line	  due	  to	  variations	  in	  
antibodies	  and	  detection	  efficiencies.	  	  Therefore,	  we	  were	  not	  able	  to	  estimate	  which	  PCBP4	  protein	  
isoform	  was	  more	  abundant	  in	  each	  cell	  line	  but	  it	  would	  be	  possible	  to	  do	  this	  in	  the	  future	  using	  







Figure	  6.9	  PCBP4	  protein	  abundance	  is	  similar	  in	  both	  cell	  lines.	  	  Western	  blot	  analysis	  showing	  PCBP4	  
abundance	  in	  HFF	  and	  iPS	  cells.	  	  Equal	  numbers	  of	  cells	  and	  amounts	  of	  whole	  cell	  lysate	  were	  resolved	  on	  a	  
10%	  SDS-­‐PAGE	  gel	  and	  transferred	  to	  PVDF	  membranes.	  	  Quantification	  of	  iPS	  PCBP4	  abundance	  was	  
normalized	  to	  levels	  of	  GAPDH	  and	  relative	  to	  HFF.	  	  The	  standard	  deviation	  was	  derived	  from	  three	  
independent	  replicates.	  	  	  	  
	  
	   	  	  
	   Overall,	  we	  found	  that	  differential	  regulation	  of	  PCBP	  expression	  is	  evident	  through	  increased	  
abundance	  of	  PCBP3	  and	  decreased	  abundance	  of	  PCBP4C	  in	  iPS	  cells	  at	  the	  protein	  level.	  	  Further,	  
PCBP4C	  mRNA	  is	  more	  abundant	  in	  HFFs	  than	  iPS	  cells.	  	  	  
	  
6.4.6	  Poly(C)-­‐binding	  proteins	  may	  exhibit	  differential	  post-­‐translational	  modifications	  	  
	   Phosphorylation	  of	  PCBP1	  and	  PCBP2	  greatly	  reduces	  the	  ability	  of	  these	  proteins	  to	  bind	  C-­‐rich	  
sequences	  (Leffers	  et	  al.,	  1995).	  	  For	  instance,	  PCBP1	  bound	  to	  BAT	  elements	  in	  the	  3’UTR	  of	  TGF-­‐β-­‐
induced	  mRNAs	  is	  phosphorylated	  at	  serine	  43	  during	  Epithelial-­‐Mesenchymal	  Transdifferentiation	  
(EMT)	  causing	  the	  protein	  to	  release	  transcripts	  and	  allow	  translation	  (Chaudhury	  et	  al.,	  2010).	  	  It	  is	  
possible	  that	  the	  post-­‐translational	  status	  of	  PCBPs	  differs	  between	  HFF	  and	  iPS	  cells	  leading	  to	  
differential	  regulation	  of	  target	  mRNAs.	  	  By	  first	  separating	  proteins	  according	  to	  pH	  and	  then	  resolving	  
by	  molecular	  weight,	  western	  blot	  analysis	  was	  used	  to	  approximate	  the	  Isoelectric	  Point	  (pI)	  of	  each	  

























Figure	  6.10	  PCBPs	  demonstrate	  differences	  in	  pI	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  2D	  gel	  electrophoresis	  was	  
performed	  using	  equal	  numbers	  of	  cells	  and	  amount	  of	  whole	  cell	  lysate.	  	  The	  first	  dimension	  was	  run	  on	  pH	  
1-­‐10	  gradient	  strips	  and	  the	  second	  dimension	  was	  run	  on	  Mini-­‐Protean	  TGX	  gels.	  	  Proteins	  were	  transferred	  




	   Comparing	  the	  profile	  of	  spots,	  or	  foci,	  in	  each	  cell	  line,	  we	  noted	  several	  differences	  between	  
HFF	  and	  iPS	  cells.	  	  First,	  PCBP1	  immigrates	  predominantly	  in	  a	  single	  spot	  in	  HFFs	  but	  has	  both	  more	  
basic	  and	  more	  acidic	  isoforms	  in	  iPS	  cells.	  	  The	  predicted	  unmodified	  or	  basal	  isoelectric	  point	  of	  PCBP1	  
is	  pI	  =	  6.66	  (PhosphoSitePlus;	  www.phosphosite.org)	  but	  without	  further	  analysis	  it	  is	  difficult	  to	  
ascertain	  which	  spot	  corresponds	  to	  the	  unmodified	  protein.	  	  There	  was	  also	  a	  distinct	  species	  at	  the	  
acidic	  pole	  in	  HFFs	  that	  is	  not	  present	  in	  iPS	  cells.	  	  However,	  this	  species	  is	  outside	  of	  the	  range	  predicted	  
for	  PCBP1	  proteins	  and	  may	  be	  non-­‐specific.	  	  	  
	   The	  predicted	  pI	  of	  PCBP2	  is	  pI	  =	  6.33	  (PhosphoSitePlus)	  and	  PCBP2	  proteins	  in	  HFFs	  also	  
appeared	  to	  be	  more	  basic	  in	  contrast	  to	  iPS	  cells	  where	  more	  intense	  species	  are	  enriched	  at	  the	  pI	  3	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end	  of	  the	  profile.	  	  This	  could	  indicate	  that	  the	  protein	  is	  more	  phosphorylated	  or	  otherwise	  modified	  in	  
iPS	  cells.	  	  	  
	   When	  analyzing	  PCBP3,	  which	  has	  a	  predicted	  isoelectric	  point	  of	  pI	  =	  8.22	  (PhospoSitePlus),	  we	  
found	  that	  these	  proteins	  in	  HFF	  and	  iPS	  cells	  are	  considerably	  more	  acidic	  than	  expected.	  	  However,	  
few	  differences	  were	  noted	  when	  comparing	  spot	  profiles	  between	  cell	  lines.	  	  	  
	   PCBP4	  has	  a	  predicted	  pI	  =	  8.42	  while	  that	  predicted	  for	  PCBP4C	  is	  pI	  =	  6.55	  (ExPASy;	  
http://web.expasy.org/compute_pi).	  	  When	  both	  PCBP4	  protein	  isoforms	  were	  analyzed,	  we	  found	  
obvious	  differences	  in	  foci	  patterns.	  	  For	  PCBP4,	  a	  major	  species	  was	  evident	  near	  pI	  =	  10.	  	  Additionally,	  
comparing	  the	  fainter	  spots	  near	  the	  middle	  of	  the	  gradient,	  we	  saw	  that	  this	  protein	  is	  slightly	  more	  
acidic	  in	  HFFs.	  	  The	  profiles	  of	  PCBP4C	  proteins	  also	  showed	  slight	  variability.	  	  Here,	  two	  spots	  indicated	  
two	  predominant	  protein	  statuses	  with	  more	  PCBP4C	  proteins	  enriched	  at	  the	  more	  acidic	  focus.	  	  In	  iPS	  
cells,	  the	  more	  basic	  focus	  was	  slightly	  more	  pronounced.	  	  Slight	  dissimilarities	  in	  GAPDH	  profiles	  were	  
seen	  throughout	  2D	  analysis	  of	  PCBP	  proteins	  which	  may	  be	  explained	  by	  sample	  and	  experiment	  
variability	  (Appendix	  A4).	  	  	  	  	  	  	  	  
	   Although	  these	  analyses	  were	  not	  performed	  in	  triplicate,	  the	  slight	  differences	  in	  pI	  
demonstrated	  by	  PCBPs	  may	  be	  a	  result	  of	  differences	  in	  post-­‐translational	  modifications	  that	  occur	  in	  
HFF	  and	  iPS	  cells	  to	  modulate	  the	  specific	  function	  of	  these	  proteins.	  	  Further	  analysis	  using	  a	  narrower	  
pH	  gradient	  and	  treatment	  with	  phosphatases	  would	  be	  necessary	  to	  better	  characterize	  these	  pI	  
changes.	  	  Although	  the	  analysis	  presented	  here	  does	  not	  provide	  an	  in-­‐depth	  characterization	  of	  PCBP	  
regulation	  in	  differentiated	  and	  pluripotent	  stem	  cells,	  it	  does	  support	  the	  possibility	  that	  differences	  in	  
mRNA	  stability	  of	  transcripts	  with	  3’UTR	  C-­‐rich	  elements	  may	  be	  modulated	  through	  differential	  
regulation	  of	  the	  PCBP	  family.	  	  However,	  a	  direct	  interaction	  of	  these	  proteins	  with	  the	  destabilized	  C-­‐
rich	  mRNAs	  must	  be	  established	  to	  confirm	  their	  involvement.	  	  Unfortunately,	  multiple	  attempts	  to	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investigate	  RNA-­‐binding	  of	  PCBPs	  in	  HFF	  and	  iPS	  cells	  were	  unsuccessful	  and	  could	  not	  be	  included	  in	  
this	  study.	  	  	  
	  
6.5	  Discussion	  	  
	   Our	  global	  analysis	  of	  mRNA	  decay	  rates	  revealed	  that	  C-­‐rich	  hexamer	  sequences	  were	  over-­‐
represented	  in	  the	  3’UTR	  of	  mRNAs	  destabilized	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  This	  was	  intriguing	  as	  
global	  analyses	  have	  not	  previously	  implicated	  C-­‐rich	  cis-­‐acting	  elements	  in	  destabilization	  (Dolken	  et	  al.,	  
2008;	  Friedel	  et	  al.,	  2009;	  Lam	  et	  al.,	  2001;	  Lee	  et	  al.,	  2010;	  Raghavan	  et	  al.,	  2002;	  Schwanhäusser	  et	  al.,	  
2011,	  2013;	  Sharova	  et	  al.,	  2009;	  Thomsen	  et	  al.,	  2010;	  Vlasova	  et	  al.,	  2008;	  Yang	  et	  al.,	  2003),	  although	  
their	  involvement	  in	  mRNA	  stabilization	  is	  well-­‐documented	  (Lindquist	  et	  al.,	  2000;	  Wang	  et	  al.,	  1995;	  
Weiss	  and	  Liebhaber,	  1995)	  and	  suggests	  that	  this	  phenomenon	  is	  stem	  cell-­‐specific.	  	  In	  support,	  GO	  
analysis	  of	  these	  destabilized	  mRNAs	  determined	  that	  they	  encode	  proteins	  with	  functions	  in	  
transcription	  and	  chromatin	  remodeling	  (Table	  6.2),	  both	  of	  which	  are	  differentially	  regulated	  during	  
pluripotency	  (Efroni	  et	  al.,	  2008;	  Gaspar-­‐Maia	  et	  al.,	  2011;	  Lessard	  and	  Crabtree,	  2010).	  	  A	  common	  cis-­‐
acting	  element	  within	  functionally	  related	  mRNAs	  could	  allow	  coordinated	  regulation	  of	  stability	  
through	  one	  or	  few	  trans-­‐acting	  factors.	  	  We	  surmised	  that	  these	  transcripts	  are	  regulated	  through	  
Poly(C)-­‐Binding	  Proteins	  and	  that	  these	  PCBPs	  are	  differentially	  expressed	  in	  iPS	  cells	  compared	  to	  HFFs	  
to	  modulate	  cell-­‐specific	  functions.	  	  	  
	   Of	  the	  four	  PCBP	  members,	  PCBP4,	  an	  anti-­‐proliferative	  factor	  (Zhu	  and	  Chen,	  2000),	  
demonstrated	  the	  most	  dramatic	  differential	  expression	  in	  iPS	  cells	  relative	  to	  HFFs.	  	  We	  found	  that	  
PCBP4C	  mRNAs	  are	  generated	  by	  alternative	  splicing	  more	  frequently	  in	  HFFs	  (Figure	  6.8)	  which	  also	  
leads	  to	  increased	  abundance	  of	  this	  protein	  isoform	  compared	  to	  iPS	  cells	  (Figure	  6.4).	  	  These	  data	  are	  
consistent	  with	  previous	  reports	  that	  PCBP4	  mRNA	  exhibits	  stem-­‐cell	  specific	  splicing	  patterns	  
(Salomonis	  et	  al.,	  2009)	  and	  suggest	  that	  PCBP4C	  has	  functions	  separate	  from	  those	  of	  the	  full-­‐length	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isoform.	  	  It	  is	  of	  note	  that	  the	  spliced	  region	  of	  PCBP4C	  mRNA	  is	  C-­‐rich,	  possibly	  indicating	  a	  mechanism	  
for	  auto-­‐regulation.	  	  Although	  we	  did	  not	  determine	  which	  PCBP4	  isoform	  is	  more	  abundant	  in	  each	  cell	  
line,	  the	  overall	  up-­‐regulation	  of	  PCBP4	  mRNA	  and	  protein	  levels	  in	  HFFs	  was	  intriguing.	  	  Regardless	  of	  
whether	  PCBP4	  regulates	  the	  mRNAs	  identified	  in	  our	  dataset	  of	  destabilized	  transcripts,	  down-­‐
regulation	  of	  this	  tumor	  suppressor	  could	  be	  important	  for	  establishing	  or	  maintaining	  pluripotency.	  	  	  	  
	   PCBP3	  also	  demonstrated	  differential	  expression	  with	  increased	  protein	  and	  mRNA	  abundances	  
in	  iPS	  cells	  compared	  to	  HFFs	  (Figures	  6.4	  and	  6.5).	  	  As	  PCBP1	  and	  PCBP2	  levels	  were	  similar	  between	  the	  
cell	  lines,	  the	  inversely	  regulated	  expression	  of	  PCBP3	  and	  PCBP4	  hints	  at	  a	  mechanism	  by	  which	  C-­‐rich	  
mRNAs	  are	  differentially	  stabilized.	  	  It	  is	  possible	  that	  these	  proteins	  target	  the	  same	  mRNAs	  with	  PCBP3	  
conferring	  mRNA	  destabilization	  and	  PCBP4	  conferring	  stabilization.	  	  Alternatively,	  both	  proteins	  may	  
act	  to	  stabilize	  transcripts	  wherein	  PCBP4	  has	  greater	  stabilizing	  effects.	  	  Further	  experiments	  are	  
necessary	  to	  determine	  whether	  the	  mRNAs	  bearing	  3’UTR	  C-­‐rich	  elements	  destabilized	  in	  iPS	  cells	  are	  
directly	  associated	  with	  these	  proteins.	  	  	  
	   Post-­‐translational	  modification	  of	  PCBPs	  also	  modulates	  their	  RNA-­‐binding	  capabilities,	  as	  
demonstrated	  by	  PCBP1	  under	  hypoxic	  conditions	  (Ho	  et	  al.,	  2013).	  	  Here,	  phosphorylation	  of	  PCBP1	  
causes	  the	  RBP	  to	  release	  its	  bound	  mRNA,	  thereby	  exposing	  the	  transcript	  to	  miRNAs	  or	  other	  decay	  
factors	  leading	  to	  degradation.	  	  Our	  2D	  gel	  electrophoresis	  analysis	  indicated	  that	  PCBP1	  has	  a	  
decreased	  pI	  in	  iPS	  cells	  compared	  to	  HFFs	  (Figure	  6.10),	  consistent	  with	  increased	  phosphorylation.	  	  
This	  correlated	  well	  with	  our	  data	  in	  that	  phosphorylation	  of	  PCBP1	  in	  iPS	  cells	  would	  prevent	  the	  
protein	  from	  binding	  and	  stabilizing	  C-­‐rich	  targets,	  resulting	  in	  destabilization	  relative	  to	  HFFs.	  	  Thus,	  
although	  PCBP1	  abundance	  is	  similar	  in	  both	  cell	  types,	  it	  may	  have	  altered	  function	  that	  contributes	  to	  
differential	  regulation	  of	  mRNA	  stability.	  	  	  
	   Overall,	  we	  have	  shown	  that	  C-­‐rich	  hexamer	  elements	  are	  over-­‐represented	  in	  the	  3’UTR	  of	  
mRNAs	  destabilized	  in	  iPS	  cells	  and	  these	  transcripts	  encode	  proteins	  important	  for	  developmental	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regulation	  of	  gene	  expression.	  	  Although	  additional	  investigation	  is	  required	  to	  elucidate	  the	  role	  of	  
PCBPs	  in	  pluripotency,	  we	  have	  shown	  conclusively	  that	  these	  proteins	  are	  differentially	  expressed	  in	  
HFF	  and	  iPS	  cells.	  	  As	  PCBP3	  and	  PCBP4	  are	  not	  well	  characterized,	  this	  study	  has	  provided	  additional	  
insight	  to	  their	  expression	  and	  warrants	  more	  detailed	  follow-­‐up	  analyses.	  	  	  


























	   The	  goal	  of	  this	  project	  was	  to	  further	  our	  limited	  understanding	  of	  mRNA	  decay	  mechanisms	  
that	  are	  essential	  for	  pluripotency.	  	  Although	  it	  was	  clear	  that	  post-­‐transcriptional	  regulation	  would	  have	  
an	  influence	  on	  stem	  cell	  gene	  expression,	  since	  it	  is	  a	  determinant	  of	  mRNA	  levels	  in	  all	  cell	  types,	  the	  
nature	  of	  these	  influences	  are	  largely	  uncharacterized.	  	  Here,	  we	  showed	  that	  mRNA	  stability	  is	  
differentially	  regulated	  for	  three	  important	  classes	  of	  mRNAs	  in	  iPS	  cells	  to	  support	  defining	  
characteristics	  of	  pluripotent	  gene	  expression.	  	  	  
	   Marked	  stabilization	  of	  replication-­‐dependent	  histone	  mRNAs	  was	  demonstrated	  for	  nearly	  all	  
of	  the	  histone	  transcripts	  that	  half-­‐lives	  were	  determined	  for	  in	  both	  HFF	  and	  iPS	  cells,	  and	  this	  resulted	  
in	  increased	  levels	  of	  histone	  proteins.	  	  Genome	  hyperdynamics	  are	  required	  for	  stem	  cells	  to	  retain	  the	  
self-­‐renewal	  capability	  and	  histones	  play	  a	  fundamental	  role	  in	  establishing	  chromatin	  structure.	  	  We	  
found	  that	  differential	  mRNA	  stability	  is	  a	  mechanism	  used	  in	  iPS	  cells,	  likely	  to	  support	  the	  histone	  
demands	  of	  chromatin	  plasticity	  and	  this	  highlights	  the	  significance	  of	  regulated	  mRNA	  decay	  in	  
establishing	  cell-­‐specific	  expression	  patterns.	  	  To	  further	  elucidate	  differences	  in	  histone	  expression,	  
future	  experiments	  should	  include	  determining	  where	  excess	  histone	  mRNAs	  and	  proteins	  are	  stored	  in	  
iPS	  cells,	  since	  there	  must	  be	  mechanisms	  of	  bulk	  histone	  storage	  in	  place.	  	  It	  will	  also	  be	  important	  to	  
perform	  a	  more	  detailed	  analysis	  of	  possible	  cis-­‐elements	  within	  histone	  mRNAs	  in	  addition	  to	  their	  3’	  
stem	  loop	  that	  facilitate	  their	  differential	  regulation.	  	  This	  could	  also	  allow	  for	  the	  identification	  of	  other	  
important	  factors	  involved	  in	  histone	  mRNA	  and	  protein	  metabolism.	  	  	  
	   We	  also	  found	  evidence	  for	  the	  contribution	  of	  mRNA	  decay	  to	  pluripotency	  in	  the	  pronounced	  
stabilization	  of	  mRNAs	  encoding	  C2H2	  ZNF	  transcription	  factors,	  many	  of	  which	  included	  the	  repressor	  
KRAB	  domain.	  	  The	  expression	  of	  these	  transcription	  factors	  is	  developmentally	  regulated	  where	  
abundances	  are	  increased	  during	  early	  embryogenesis.	  	  Our	  analysis	  demonstrated	  that	  this	  class	  of	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mRNAs	  is	  coordinately	  regulated	  at	  the	  post-­‐transcriptional	  level	  and	  it	  is	  possible	  that	  the	  longer	  C2H2	  
ZNF	  mRNA	  half-­‐lives	  in	  iPS	  cells	  is	  needed	  for	  their	  increased	  protein	  abundances	  characteristic	  of	  early	  
embryogenesis.	  	  Future	  efforts	  to	  better	  understand	  C2H2	  ZNF	  expression	  in	  HFF	  and	  iPS	  cells	  should	  
likely	  include	  determination	  of	  the	  length	  of	  poly(A)	  tails	  of	  these	  mRNAs,	  as	  our	  model	  merely	  suggests	  
that	  the	  poly(A)	  tails	  would	  be	  shorter	  in	  HFFs.	  	  It	  will	  also	  be	  important	  to	  determine	  whether	  or	  not	  the	  
stabilized	  C2H2	  ZNF	  mRNAs	  are	  directly	  targeted	  by	  ORF-­‐targeting	  miRNAs	  and	  whether	  stabilization	  of	  
C2H2	  ZNF	  mRNAs	  also	  leads	  to	  increased	  protein	  abundance.	  	  	  	  	  
	   As	  we	  hoped	  to	  identify	  novel	  regulatory	  mechanisms	  specific	  to	  pluripotency,	  we	  were	  
intrigued	  to	  find	  C-­‐rich	  elements	  over-­‐represented	  in	  the	  3’UTR	  of	  mRNAs	  destabilized	  in	  iPS	  cells.	  	  
Although	  we	  were	  not	  able	  to	  directly	  demonstrate	  the	  functional	  importance	  of	  these	  sequence	  
elements,	  we	  explored	  the	  PCBP	  family	  of	  proteins	  as	  possible	  stability	  factors	  that	  regulate	  their	  
differential	  decay	  in	  iPS	  cells	  compared	  to	  HFFs.	  	  Further	  characterization	  of	  PCBPs	  in	  HFF	  and	  iPS	  cells	  
should	  include	  determination	  of	  the	  mRNAs	  that	  are	  targeted	  by	  each	  and	  also	  determining	  whether	  
PCBPs	  interact	  with	  other	  effector	  proteins	  to	  carry	  out	  additional	  roles	  important	  for	  gene	  expression.	  	  	  	  
Future	  analyses	  remain	  to	  determine	  their	  exact	  roles	  in	  stem	  cell	  gene	  expression	  but	  our	  results	  
revealed	  that	  PCBPs	  are	  differentially	  expressed	  in	  the	  two	  cell	  types,	  possibly	  contributing	  to	  
destabilization	  of	  iPS	  cell	  mRNAs	  with	  C-­‐rich	  3’UTRs.	  	  	  
	   The	  data	  presented	  in	  this	  dissertation	  emphasize	  the	  importance	  of	  post-­‐transcriptional	  control	  
in	  pluripotency	  and	  provide	  a	  foundation	  for	  further	  characterization	  of	  the	  mechanisms	  involved.	  	  
Although	  largely	  overlooked,	  regulated	  mRNA	  decay	  is	  clearly	  utilized	  during	  pluripotency	  to	  help	  
maintain	  stem	  cell-­‐specific	  gene	  expression	  patterns	  and	  identification	  of	  the	  factors	  involved	  could	  
indicate	  targets	  for	  increasing	  reprogramming	  efficiency.	  	  Overall,	  our	  dataset	  and	  the	  subsequent	  
analyses	  described	  here	  strengthen	  our	  understanding	  of	  pluripotent	  gene	  expression	  and	  the	  role	  of	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Appendix	  A1.	  Selection	  of	  HFF	  and	  iPS	  cell	  sample	  replicates	  for	  microarray	  hybridization.	  	  FOS	  and	  
TUT1	  mRNAs	  were	  used	  as	  short-­‐	  and	  longer-­‐lived	  test	  transcripts	  to	  determine	  half-­‐life	  correlation	  
between	  four	  HFF	  and	  iPS	  cell	  replicates	  (A,	  B,	  C,	  and	  D)	  where	  cells	  were	  treated	  with	  actinomycin	  d	  
and	  collected	  at	  time	  points	  0,	  15,	  30,	  60,	  120,	  and	  240	  minutes	  following	  treatment.	  	  The	  three	  
replicates	  with	  the	  lowest	  standard	  deviation	  between	  mRNA	  abundances	  at	  each	  time	  point	  were	  
selected	  for	  microarray	  hybridization.	  	  	  
	   	  
Comparative	  analysis	  of	  test	  mRNA	  abundance	  in	  HFFs	  for	  selection	  of	  sample	  replicates.
FOS
Time	   Expression Std	  Dev Expression Std	  Dev Expression Std	  Dev Expression Std	  Dev
0 1 0 1 0 1 0 1 0
15 0.8234 0.1498 0.7952 0.1399 0.7796 0.1180 0.8728 0.0665
30 0.5461 0.0423 0.5056 0.0877 0.5154 0.0899 0.4876 0.0634
60 0.2833 0.0046 0.3258 0.0698 0.3228 0.0724 0.3244 0.0712
TUT1
Time	   Expression Std	  Dev Expression Std	  Dev Expression Std	  Dev Expression Std	  Dev
0 1 0 1 0 1 0 1 0
60 0.6700 0.0225 0.8896 0.3629 0.8747 0.3756 0.8841 0.3681
120 0.5490 0.0263 0.5452 0.0328 0.5304 0.0307 0.5297 0.0294
240 0.2287 0.0367 0.2514 0.0701 0.2574 0.0694 0.2749 0.0455
Comparative	  analysis	  of	  test	  mRNA	  abundance	  in	  iPS	  cells	  for	  selection	  of	  sample	  replicates.
FOS
Time	   Expression Std	  Dev Expression Std	  Dev Expression Std	  Dev Expression Std	  Dev
0 1 0 1 0 1 0 1 0
15 0.6928 0.0982 0.6952 0.0990 0.7378 0.0358 0.6735 0.0759
30 0.4833 0.0845 0.4124 0.0550 0.4682 0.1064 0.4468 0.1121
60 0.3994 0.0938 0.3663 0.0390 0.4254 0.0730 0.4138 0.0888
TUT1
Time	   Expression Std	  Dev Expression Std	  Dev Expression Std	  Dev Expression Std	  Dev
0 1 0 1 0 1 0 1 0
60 0.9439 0.0934 0.8960 0.0942 0.8914 0.0862 0.9474 0.0873
120 0.8176 0.1824 0.7609 0.2381 0.6642 0.0879 0.7765 0.2326
240 0.4489 0.1999 0.4498 0.1990 0.3269 0.0281 0.4331 0.2120
ABC ABD ACD BCD
ABC ABD ACD BCD
ABC ABD ACD BCD






Appendix	  A2.	  	  Culture	  of	  HFF	  cells	  on	  Matrigel	  has	  no	  effect	  on	  mRNA	  abundance.	  	  HFFs	  were	  cultured	  
on	  0.3	  mg/ml	  Matrigel	  and	  mRNA	  levels	  were	  measured	  by	  qRT-­‐PCR	  to	  determine	  that	  expression	  of	  































Appendix	  A3.	  Abundances	  of	  core	  histone	  proteins	  were	  verified	  in	  an	  independent	  set	  of	  matched	  HFF	  
and	  iPS	  cells.	  	  Coomassie	  staining	  was	  used	  to	  verify	  increased	  abundance	  of	  core	  histone	  proteins	  in	  iPS	  
cells	  compared	  to	  HFFs.	  	  These	  results	  are	  consistent	  with	  the	  matched	  cell	  line	  used	  for	  experiments	  






































Appendix	  A4.	  151	  mRNAs	  destabilized	  in	  iPS	  cells	  compared	  to	  HFFs	  that	  bear	  C-­‐rich	  3’UTR	  elements.	  
The	  P-­‐value	  for	  each	  cell	  line	  indicates	  how	  well	  the	  time	  point	  abundance	  data	  fit	  to	  the	  exponential	  
decay	  curve	  used	  to	  generate	  each	  half-­‐life.	  	  





7933204 11067 C10orf10 64 5.71E-­‐05 517 3.64E-­‐04
7998898 9074 CLDN6 194 6.84E-­‐03 1455 3.40E-­‐02
8133326 9883 POM121 53 6.93E-­‐03 394 1.31E-­‐02
8131996 9586 CREB5 253 2.56E-­‐03 1733 1.87E-­‐02
7955589 3164 NR4A1 189 4.46E-­‐04 945 8.67E-­‐03
8066266 9935 MAFB 299 2.36E-­‐03 1395 4.36E-­‐02
8058498 7855 FZD5 391 1.12E-­‐03 1760 2.18E-­‐02
8138842 10392 NOD1 462 1.06E-­‐04 2119 1.30E-­‐02
7913644 1870 E2F2 431 2.49E-­‐03 1863 4.17E-­‐02
7897469 199953 TMEM201 339 9.46E-­‐03 1382 4.47E-­‐02
7948211 6749 SSRP1 363 4.98E-­‐06 1456 1.25E-­‐02
8087833 1849 DUSP7 96 8.32E-­‐04 371 2.41E-­‐02
8037079 478 ATP1A3 189 2.08E-­‐03 726 5.61E-­‐03
8072229 4744 NEFH 270 3.85E-­‐03 1048 1.60E-­‐02
7903980 128346 C1orf162 401 6.55E-­‐04 1514 4.52E-­‐03
8026155 112939 NACC1 194 4.66E-­‐03 721 4.44E-­‐02
7906128 9673 SLC25A44 177 5.68E-­‐04 644 1.23E-­‐02
8046524 3239 HOXD13 172 1.29E-­‐03 614 2.77E-­‐02
7989657 53944 CSNK1G1 259 7.77E-­‐05 902 9.47E-­‐03
8068361 6526 SLC5A3 215 3.01E-­‐04 719 4.34E-­‐02
8069880 7074 TIAM1 438 3.94E-­‐03 1449 1.79E-­‐02
8173506 54821 ERCC6L 329 3.22E-­‐03 1108 9.44E-­‐05
8166447 139411 PTCHD1 529 2.26E-­‐04 1691 2.85E-­‐02
7945944 391 RHOG 135 1.67E-­‐04 427 4.34E-­‐02
7941565 64837 KLC2 216 7.05E-­‐03 650 4.11E-­‐02
8109179 133522 PPARGC1B 457 4.16E-­‐03 1395 4.88E-­‐02
8040725 56896 DPYSL5 605 3.11E-­‐02 1838 2.17E-­‐02
7972259 1638 DCT 690 3.10E-­‐03 2031 1.48E-­‐02
8119444 116113 FOXP4 263 1.44E-­‐02 772 2.85E-­‐02
8123658 63027 SLC22A23 427 2.50E-­‐03 1210 2.78E-­‐02
7930264 9148 NEURL 377 2.22E-­‐02 1047 2.70E-­‐02
7989073 283659 PRTG 308 1.13E-­‐02 848 2.11E-­‐03
8160459 1993 ELAVL2 680 8.14E-­‐04 1913 4.21E-­‐03
8158839 84726 BAT2L1 192 1.74E-­‐03 535 1.14E-­‐02
8087685 11070 TMEM115 168 5.25E-­‐04 451 8.17E-­‐03
7920852 22889 KIAA0907 300 6.37E-­‐05 809 3.46E-­‐02
8128620 57673 BEND3 318 9.99E-­‐04 867 3.48E-­‐03
8034263 1995 ELAVL3 582 4.54E-­‐03 1515 1.64E-­‐02 	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7901788 4774 NFIA 364 9.00E-­‐04 962 1.86E-­‐02
7994889 10847 SRCAP 122 1.97E-­‐03 319 6.84E-­‐04
8031441 84446 BRSK1 397 1.82E-­‐03 1025 3.05E-­‐02
7992789 51330 TNFRSF12A 201 1.03E-­‐03 511 2.84E-­‐02
8175947 3054 HCFC1 197 1.86E-­‐02 501 1.90E-­‐02
8058627 2066 ERBB4 706 1.36E-­‐03 1812 1.19E-­‐02
8063437 128553 TSHZ2 657 4.07E-­‐03 1703 9.53E-­‐03
8047565 150864 FAM117B 356 2.89E-­‐03 925 1.21E-­‐02
7984952 56905 C15orf39 110 4.08E-­‐04 280 2.31E-­‐04
8000167 23049 SMG1 212 7.28E-­‐05 531 8.15E-­‐03
8130408 26034 IPCEF1 844 3.80E-­‐03 2095 2.74E-­‐02
8125731 9278 ZBTB22 317 1.15E-­‐03 775 4.66E-­‐02
8118509 9374 PPT2 353 1.25E-­‐04 863 4.44E-­‐02
8055952 4929 NR4A2 327 1.17E-­‐04 803 2.08E-­‐03
7996185 4324 MMP15 405 5.65E-­‐03 977 4.15E-­‐02
8054281 164832 LONRF2 624 4.81E-­‐02 1504 1.69E-­‐02
8022420 162655 ZNF519 531 9.24E-­‐03 1263 3.61E-­‐03
8025828 3949 LDLR 121 1.15E-­‐05 290 3.18E-­‐04
8104035 8470 SORBS2 760 1.15E-­‐02 1799 1.75E-­‐02
8097857 84057 MND1 489 3.65E-­‐02 1162 3.46E-­‐02
7955873 3223 HOXC6 318 2.30E-­‐03 755 2.15E-­‐03
8166230 55787 TXLNG 307 5.43E-­‐03 717 1.73E-­‐02
8052689 200734 SPRED2 146 1.32E-­‐04 341 9.85E-­‐05
7962951 8085 MLL2 216 3.34E-­‐03 497 1.14E-­‐02
7980233 5228 PGF 313 2.05E-­‐03 721 3.71E-­‐03
8002692 463 ZFHX3 312 1.90E-­‐03 723 1.72E-­‐02
8137953 84629 TNRC18 313 5.03E-­‐03 718 4.43E-­‐02
8170921 55558 PLXNA3 292 1.00E-­‐02 664 4.46E-­‐02
8072796 164656 TMPRSS6 638 5.97E-­‐03 1465 4.25E-­‐02
7975626 91748 C14orf43 470 8.20E-­‐03 1060 4.39E-­‐02
8071044 100132288 LOC100132288 231 3.39E-­‐04 509 1.15E-­‐03
7986359 3480 IGF1R 276 1.13E-­‐03 603 2.32E-­‐02
8008139 65264 UBE2Z 290 5.51E-­‐03 628 4.00E-­‐02
7977761 6297 SALL2 357 1.80E-­‐03 783 1.50E-­‐03
8075126 4330 MN1 500 4.64E-­‐03 1099 4.36E-­‐02
8013776 55731 C17orf63 154 1.78E-­‐03 333 1.31E-­‐03
8016628 84687 PPP1R9B 305 3.24E-­‐03 650 1.92E-­‐02
8014794 782 CACNB1 341 1.72E-­‐03 718 3.96E-­‐02 	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7940051 25921 ZDHHC5 308 3.59E-­‐04 652 3.42E-­‐02
8000638 23049 SMG1 306 2.59E-­‐03 644 1.50E-­‐02
7920000 23126 POGZ 157 1.84E-­‐03 335 3.76E-­‐03
7972713 1948 EFNB2 241 4.31E-­‐05 513 2.32E-­‐03
7949277 23130 ATG2A 294 7.84E-­‐03 632 6.95E-­‐03
8024391 84444 DOT1L 363 1.14E-­‐02 749 1.98E-­‐03
7918936 79679 VTCN1 1098 2.36E-­‐02 2276 4.54E-­‐02
7992347 23162 MAPK8IP3 323 4.88E-­‐03 666 2.29E-­‐02
8004671 23135 KDM6B 358 3.76E-­‐03 746 7.66E-­‐03
7999173 124402 FAM100A 193 7.58E-­‐03 400 8.13E-­‐03
7963698 11016 ATF7 383 1.56E-­‐02 801 4.73E-­‐02
8150036 23303 KIF13B 645 6.01E-­‐04 1309 2.65E-­‐02
7995739 2775 GNAO1 710 3.04E-­‐02 1455 2.74E-­‐02
7998211 8312 AXIN1 300 4.23E-­‐04 611 1.73E-­‐03
7972902 113622 ADPRHL1 532 9.09E-­‐03 1076 6.72E-­‐03
8169882 63035 BCORL1 216 1.30E-­‐03 444 1.96E-­‐03
8027956 9757 MLL4 275 2.04E-­‐03 568 4.82E-­‐03
8124726 7726 TRIM26 289 5.53E-­‐04 592 1.24E-­‐02
8053901 55654 TMEM127 268 2.94E-­‐03 543 2.49E-­‐02
8004404 284114 TMEM102 319 7.49E-­‐04 648 1.85E-­‐03
8108822 285613 RELL2 476 2.42E-­‐02 979 4.72E-­‐02
8025659 84971 ATG4D 300 3.32E-­‐03 612 3.67E-­‐03
8110430 23138 N4BP3 486 5.40E-­‐03 981 3.96E-­‐02
8162533 5727 PTCH1 253 2.37E-­‐03 505 3.12E-­‐03
8021047 26040 SETBP1 357 3.97E-­‐04 714 5.15E-­‐03
8001387 6299 SALL1 121 5.98E-­‐04 243 1.06E-­‐03
8112592 2297 FOXD1 158 2.96E-­‐03 317 6.14E-­‐03
8010188 57690 TNRC6C 258 1.17E-­‐03 502 1.04E-­‐02
8002969 4094 MAF 650 1.26E-­‐02 1269 3.17E-­‐02
7994655 79447 C16orf53 234 1.01E-­‐03 459 1.40E-­‐02
7949383 84447 SYVN1 227 2.85E-­‐03 445 2.05E-­‐02
8008566 252983 STXBP4 446 4.87E-­‐03 880 4.96E-­‐02
8171297 4281 MID1 440 1.40E-­‐03 856 2.95E-­‐02
7943282 55693 KDM4D 369 7.63E-­‐05 719 1.15E-­‐03
7904907 607 BCL9 332 3.47E-­‐03 646 2.64E-­‐02
8032518 148252 DIRAS1 428 2.04E-­‐03 823 2.76E-­‐02
7967331 79720 VPS37B 159 5.40E-­‐04 303 4.80E-­‐03
8178988 9278 ZBTB22 262 2.99E-­‐04 505 1.47E-­‐04 	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8063097 63935 PCIF1 427 1.60E-­‐02 817 2.29E-­‐02
8009995 85451 UNK 188 5.82E-­‐04 359 3.94E-­‐04
8032347 57455 REXO1 282 8.33E-­‐03 539 7.29E-­‐03
7931469 170394 PWWP2B 490 3.56E-­‐04 950 1.59E-­‐02
8133331 9883 POM121 149 6.03E-­‐03 285 1.25E-­‐02
8019308 4097 MAFG 304 3.08E-­‐04 578 4.35E-­‐03
7946180 10612 TRIM3 510 1.06E-­‐03 964 2.53E-­‐02
8040927 29959 NRBP1 281 4.05E-­‐04 525 2.38E-­‐02
8040552 8648 NCOA1 382 3.07E-­‐03 722 4.31E-­‐02
8103745 9464 HAND2 501 8.30E-­‐04 936 1.57E-­‐02
7907370 26052 DNM3 877 1.31E-­‐03 1665 2.17E-­‐03
8019463 1453 CSNK1D 292 1.23E-­‐03 547 2.33E-­‐02
8023646 596 BCL2 681 1.16E-­‐02 1284 4.41E-­‐02
8141595 64599 GIGYF1 399 5.53E-­‐03 735 1.11E-­‐02
8108579 55374 TMCO6 475 3.41E-­‐03 874 6.51E-­‐03
7906728 84134 TOMM40L 485 7.00E-­‐03 907 2.24E-­‐02
8002333 23049 SMG1 330 1.97E-­‐03 613 9.42E-­‐03
8000217 23049 SMG1 346 7.21E-­‐03 641 3.12E-­‐02
8003249 79791 FBXO31 401 1.43E-­‐04 749 2.19E-­‐02
7947462 25841 ABTB2 258 6.82E-­‐05 465 7.53E-­‐05
8029856 2909 GRLF1 205 5.98E-­‐05 369 9.97E-­‐04
7980998 55727 BTBD7 292 3.90E-­‐05 527 1.21E-­‐02
7930537 6934 TCF7L2 241 1.13E-­‐03 438 1.31E-­‐02
7994985 9739 SETD1A 194 1.47E-­‐03 350 9.45E-­‐04
7985605 9640 ZNF592 159 1.18E-­‐03 290 2.06E-­‐04
8002370 6483 ST3GAL2 341 3.62E-­‐03 617 3.96E-­‐02
7961798 6660 SOX5 659 9.44E-­‐04 1206 2.78E-­‐02
8034722 5989 RFX1 284 8.06E-­‐05 522 1.96E-­‐03
8075468 50487 PLA2G3 634 1.85E-­‐03 1160 3.45E-­‐02
7959361 22877 MLXIP 178 1.01E-­‐02 323 7.66E-­‐03
8023377 51320 MEX3C 293 3.43E-­‐03 535 3.82E-­‐02
7939676 9776 KIAA0652 366 8.90E-­‐03 668 3.97E-­‐02
8013071 201163 FLCN 317 3.44E-­‐04 578 7.73E-­‐03
8018379 57513 CASKIN2 283 1.93E-­‐03 511 7.50E-­‐03
8153876 80728 ARHGAP39 390 3.72E-­‐03 712 9.01E-­‐03
8071314 54487 DGCR8 231 2.68E-­‐05 410 1.53E-­‐03




Appendix	  A5.	  2D	  gel	  electrophoresis	  analysis	  of	  PCBPs	  and	  GAPDH	  or	  α-­‐TUBULIN	  in	  HFF	  and	  iPS	  cells.	  
Analysis	  was	  performed	  using	  equal	  numbers	  of	  cells	  and	  amount	  of	  whole	  cell	  lysate.	  	  The	  first	  
dimension	  was	  run	  on	  pH	  1-­‐10	  gradient	  strips	  and	  the	  second	  dimension	  was	  run	  on	  Mini-­‐Protean	  TGX	  
gels	  and	  transferred	  to	  PVDF	  membranes.	  	  Antibody	  detection	  was	  performed	  using	  the	  ChemiDoc	  XRS+	  
System	  and	  ImageLab3.0	  software.	  	  	  	  	  	  
	  
	  
